ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2019 American Transplant Congress » 2019 ATC Sessions

Date & Time:
None. Available on demand

Location: None listed

Session Type:

Meeting: 2019 American Transplant Congress

  • 5,000 Living Donor Liver Transplantations

    G. Song, S. Lee, S. Hwang, K. Kim, C. Ahn, D. Moon, T. Ha, D. Jung, G. Park, Y. Yoon, J. Kwon, H. Cho, Y. Jung, S. Kang, I. Jeong, J. Choi

  • A Comprehensive and Updated Analysis of Combined Heart-Kidney Transplants Utilizing the United Network for Organ Sharing Database

    V. M. Lim1, N. Khurmi1, W. R. Hewitt, Jr.2, A. K. Mathur2, O. E. Pajaro3, D. E. Jaroszewski3, B. D. Gaitan1

  • A Safe Anti-A2 Titer for a Succesful A2 Incompatible Kidney Transplantation

    G. Nair, M. Ajaimy, J. Graham, L. Liriano-Ward, A. Campbell, C. Pynadath, Y. Azzi, O. Andacoglu, S. Greenstein, M. Kinkhabwala, J. Rocca, E. Akalin

  • An 8-Gene Expression Assay in Peripheral Blood for Diagnosis of Antibody-Mediated Rejection after Kidney Transplantation

    E. Van Loon1, S. Gazut2, S. Yazdani1, E. Lerut1, H. de Loor1, M. Coemans1, L. Noël3, L. Thorrez1, L. Van Lommel1, F. Schuit1, D. Lambrechts1, T. Van Brussel1, B. Sprangers1, D. Kuypers1, M. Essig4, W. Gwinner5, D. Anglicheau6, P. Marquet7, M. Naesens1

  • Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Solid Organ Transplant Recipients at an Academic Medical Center

    J. S. Kerr, N. Law, S. Aslam

  • CD46 Transgene Modification and Thrombosis in Neonatal Porcine Islet Xenotransplantation

    M. Song, K. Samy, Q. Gao, R. P. Davis, F. Leopard, Z. Fitch, C. Bennett, G. R. Devi, B. H. Collins, A. D. Kirk

  • CEACAM1 – p38 Signaling Axis Alleviates Peri-Transplant Liver Injury: From Mouse-to-Human

    H. Hirao1, K. Nakamura1, S. Kageyama1, T. Ito1, K. Kadono1, M. Kujawski2, K. J. Dery1, R. A. Sosa1, E. F. Reed1, F. M. Kaldas1, R. W. Busuttil1, J. W. Kupiec‐Weglinski1

  • Costimulation Blockade Modulates Humoral Responses in Highly Sensitized Transplant Recipients

    J. Kwun, B. Ezekian, P. Schroder, M. Manook, J. Yoon, M. Mulvihill, K. Freischlag, J. Yi, S. Knechtle

  • Early Use of Everolimus Plus Reduced Tacrolimus vs Standard Tacrolimus in De Novo Livertransplant Recipients: 12 Months Efficacy and Safety Data from HEPHAISTOS Study

    B. Nashan1, P. Schemmer1, H. Schlitt1, A. Pascher1, C. Klein1, U. Neumann1, I. Kroeger2, P. Wimmer2, F. Braun1

  • Economic Impact of Donor Hepatitis C Kidney Transplantation: A Medicare Cost Analysis

    K. Lentine1, M. Schnitzler2, T. Alhamad3, H. Xiao2, H. Randall2, J. Wellen2, B. Kasiske4, G. Hess5, D. Axelrod6

  • Endothelial Cell Replacement – A Closer Step to Personalized, Tissue-Engineered Transplants

    S. Cohen, S. Partouche, M. Gurevich, V. Mezhybovsky, V. Tennak, S. Eisner, E. Nesher, E. Mor

  • Epitop Matching Predicts Immunization in Kidney Transplant Recipients with Allograft Failure Leading to Worse Outcomes

    F. Halleck1, M. Merkel1, P. Bach2, D. Schmidt1, M. Niemann3, N. Lachmann4, K. Budde1

  • External Validation of the DCD-N Score and a Linear Prediction Model to Identify Potential Candidates for Donation after Circulatory Death: A Nation-Wide Cohort Study

    M. F. Nijhoff1, R. A. Pol1, M. Volbeda1, A. M. Kotsopoulos2, J. P. Sonneveld3, J. van Dongen4, W. F. Abdo5, V. Silderhuis6, C. Moers1

  • Facial Composite Tissue Allotransplantation: First Canadian Experience

    S. Collette1, A. Govshievich2, S. F. Dufresne1, D. Désy1, H. St-Jacques1, D. Borsuk1

  • Factors Associated with Cardiovascular Subclinical Target Organ Damage in Liver Transplant Recipients

    C. Kuepper1, N. Memaran1, B. Borchert1, A. von Wick1, E. Bauer1, E. Jäckel2, S. Ziegert2, B. M. Schmidt3, A. Melk1

  • Galectin-3 and Long-Term Graft Failure in Renal Transplant Recipients: A Prospective Cohort Study

    C. G. Sotomayor1, C. A. Keyzer1, J. L. Anderson1, R. O. Gans2, I. M. Nolte3, M. H. de Borst1, S. P. Berger1, G. J. Navis1, R. A. de Boer4, S. J. Bakker1

  • Granulocyte – Colony Stimulating Factor (G-CSF) and Granulocyte – Macrophage Colony Stimulating Factor (GM-CSF) Administration Augments the Incidence of Peripheral Blood Suppressive Regulatory T Cells in Nonhuman Primates

    K. Sasaki, Y. Wang, L. Lu, J. Hughs, A. W. Thomson, M. B. Ezzelarab

  • Impact of Glomerulitis at 4-Month Biopsy on Long Term Kidney Allograft Outcomes

    M. Whigham, G. Mour, M. Buras, S. Sukumaran Nair, A. Jaramillo, D. Ramon, R. Heilman

  • Impact of Immunosuppressive Drug Withdrawal on Persistent Mixed Chimerism in Recipients of HLA Haplo-Identical Kidney and Hematopoietic Cell Transplants

    S. Busque, J. Scandling, R. Lowsky, J. Shizuru, E. Meyer, K. Jensen, A. Shori, R. Hoppe, E. Engleman, S. Strober

  • Impact of Race and Substance Use on Listing Decisions for Kidney Transplant

    R. N. DeBlasio1, L. Myaskovsky2, K. Kendall1, A. DiMartini1, G. Switzer1, D. M. Posluszny1, C. Puttarajappa1, A. D. Tevar1, S. Hariharan1, R. Shapiro3, M. A. Dew1

  • Incidence and Risk of Allograft Rejection after Cardiac Transplantation in Left Ventricular Assist Device Patients

    R. C. Patel1, L. B. Cooper2, S. D. Barnett2, R. T. Cole2, M. A. Psotka2, A. Cochrane2, S. Sinha2, L. J. Bogar2, S. S. Desai2, P. Shah2

  • Is Kidney Transplantation Actually a Cost-Effective Alternative Also for Older Patients?

    K. Heldal1, K. Lønning2, V. Tsarpali1, K. Midtvedt2

  • Laminin α5 Deficiency in Lymph Node Stromal Cells Promotes Treg Migration and Allograft Survival

    L. Li, M. Shirkey, W. Piao, Y. Xiong, V. Saxena, T. Zhang, T. Simon, N. Toney, C. Paluskievicz, J. S. Bromberg

  • Maternal and Pregnancy Outcomes after Living Donor Nephrectomy in a Multistate Cohort

    G. S. Lee1, R. X. Wang2, D. O. Walls3, P. P. Reese4, D. S. Goldberg4, P. L. Abt1

  • Microscopic Hepatic Steatosis Prior to Liver Transplantation Influences Clinical Outcomes

    K. Nakamura, H. Hirao, T. Ito, S. Kageyama, K. Kadono, K. J. Dery, J. Aziz, B. Ke, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski

  • Multi-Omics Approach to Accurately Assess Early Graft Injury in Liver Transplantation

    D. Maluf1, V. Sai Bontha1, A. Bajwa1, R. Helmick1, P. J. Horton1, C. Eymard1, J. Eason2, V. Mas3

  • National Landscape of Hope Act Transplant Candidates and Recipients in the United States

    A. R. Wilk1, R. Hunter2, M. A. McBride2, D. K. Klassen2

  • Patient-Reported Outcomes in a Prospective Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression Regimens in Kidney Transplantation

    J. M. Rohan1, J. P. Leone2, E. S. Woodle3, D. Kaufman4, A. R. Shields3, A. Wiseman5, A. J. Matas6, P. West-Thielke7, E. King3, R. R. Alloway3

  • Predicting Transplant Rejection by a Composite Urinary Injury Score

    J. Y. Yang, R. Sarwal, T. K. Sigdel, M. M. Sarwal

  • Predictors and Outcomes of Acute Graft-versus-Host Disease after Liver Transplant

    A. Caines1, S. Nagai2, R. Salgia1

  • Prevention of Graft Ischemia-Reperfusion Injury in Ischemia-Free Liver Transplantation

    Z. Guo, X. He, Q. Zhao, S. Huang, Z. Zhang, L. Wang, W. Ju, G. Chen

  • Quantifying Differential Infection Risks in HLA- and/or ABO- Incompatible Kidney Transplant Recipients

    R. Avery1, R. Montgomery2, J. Motter1, A. Massie1, E. Kraus1, K. Marr1, B. Lonze2, N. Alachkar1, K. Jackson1, M. Holechek1, D. Ostrander1, N. Desai1, M. Waldram1, S. Shoham1, S. Mehta1, J. Hiller1, J. Langlee1, S. Young1, D. Segev1, J. Garonzik Wang1

  • Regional Differences in Transplantation for Expected Post-Transplant Survival Top 20% Candidates

    S. Husain, K. King, D. Tsapepas, G. Dube, D. Cohen, L. E. Ratner, S. Mohan

  • Risk Factors for 1-5 Year De Novo Cancers after Kidney Transplant (KTx) with First-Year Immunosuppression (IS) Data: An Analysis of the Choosing Immune Suppression by Efficacy and Morbidity (CISTEM) Study

    V. Dharnidharka1, D. Axelrod2, Z. Zhang3, M. Schnitzler3, K. Lentine3, B. Kasiske4

  • Robotic-Assisted versus Open Techniques for Living Donor Kidney Transplant Recipients: A Comparison Using Propensity Score Analysis

    F. Tinney, J. Stracke, S. Nagai, L. Malinzak, T. McEvoy, S. Mohamed Ilias, A. Yoshida

  • Shroom3 Regulates Glomerular Hypertrophy after Uninephrectomy via mTOR

    K. Banu, F. Garzon, C. Wei, Z. Yi, W. Zhang, C. He, B. Murphy, M. C. Menon

  • Successful Weaning Of Parenteral Nutrition After Serial Transverse Enteroplasty: The Largest Series Of Adult Short Gut Syndrome Patients

    M. Fujiki, S. Armanyous, K. Abu-Elmagd

  • The Changing Face of T Cell-Mediated Rejection

    A. Perkowska-Ptasinska and INTERCOMEX investigators1, P. F. Halloran2

  • The Degree of Glomerulosclerosis in Procurement Renal Biopsy and its Implications in Predicting Graft Outcomes in Marginal Donor Kidneys

    W. Cheungpasitporn1, W. Chon2, E. Island2, L. Cummings2, J. Forster2, N. Leeaphorn2

  • The End of Non-Directed Living Kidney Donation: The National Kidney Registry’s Family Voucher Program

    M. Cooper1, D. Leeser2, S. Flechner3, J. Verbesey1, M. Ronin4, G. Hil4, A. Waterman5, J. Veale5

  • Tolerogenic Nanoparticles Targeting the Aryl Hydrocarbon Receptor

    K. Janek1, J. Fechner1, S. Gong2, Y. Wang2, J. Mezrich1

  • Transplantation of Kidneys from Hepatitis C Infected Donors to Hepatitis C Negative Recipients

    M. Z. Molnar, O. Cseprekal, M. Yazawa, M. Talwar, V. Balaraman, V. Mas, D. Maluf, R. Helmick, L. Campos, N. Nezakatgoo, C. Eymard, P. Horton, R. Verma, A. Jenkins, C. R. Handley, H. Snyder, C. Cummings, U. A. Agbim, B. Maliakkal, S. K. Satapathy, S. P. Nair, J. D. Eason

  • Urinary Cell mRNA Sequencing Profiles of Kidney Allograft Recipients Mirror Intragraft Events and Demonstrate Enrichment for Immune Cells

    M. Lubetzky1, A. Verma2, H. Yang1, T. Muthukumar1, S. Salvatore1, J. Lee1, D. Dadhania1, S. Seshan1, F. Mueller1, O. Elemento2, M. Suthanthiran1

  • Use of Marginal Liver Donors in Pediatric Transplantation: Diverse Profiles of Use in Major Transplant Centers

    C. S. Hwang1, A. Aqul2, A. Mufti3, S. Hanish1, D. Desai1, P. Vagefi1, M. MacConmara1

  • Using Transplant Referral Regions to Measure Access to Kidney Transplant

    K. Ross1, D. Axelrod2, R. Patzer1

  • Measuring and Monitoring Disparities in Access to Kidney Transplantation Associated with Being Listed for a Multi-Organ Transplant (MOT)

    D. E. Stewart, C. A. Custer, A. M. Robinson, A. R. Wilk

  • A Novel Genomic Approach for Acute Rejection across All Age Groups in Kidney Transplantation

    B. I. Shaw, D. K. Cheng, Q. Cheng, C. R. Acharya, A. D. Kirk, E. T. Chambers

  • Adipose Stem Cells Promote Composite Tissue Engraftment

    N. Shockcor1, B. Buckingham1, W. Hassanein1, D. Parsell1, U. Dhru1, B. Akinsiku2, E. Elster2, T. Davis2, J. Gimble3, A. Nam1, S. Bartlett1, R. Barth1

  • C4d Positivity in Renal Biopsies Following A2 to B Kidney Transplantation: Not All A B O Incompatibilities Are Equal

    S. Radomski1, G. Vranic2, B. Thomas2, P. Abrams2, M. Cooper2, A. Gilbert2

  • CD4 T Cell-Derived NGAL Mediates Experimental Acute Kidney Injury

    S. Lee, S. Noel, J. Kurzhagen, M. Sadasivam, A. Hamad, H. Rabb

  • Center-Level Probability of Kidney Transplant Varies Considerably for Waitlisted Patients

    K. L. King1, S. A. Husain1, P. Reese2, J. Schold3, S. Pastan4, S. Mohan1

  • Center-Level Variation in HLA-Incompatible Living Donor Kidney Transplantation Outcomes

    K. Jackson1, J. Long1, K. Covarrubias1, J. Motter1, M. Bowring1, J. Chen1, M. Waldram1, B. Orandi2, N. Desai1, A. Massie1, D. Segev1, J. Garonzik-Wang1

  • Cognitive Function & Risk Of Adverse Outcomes In Kidney Transplant Candidates

    N. Chu1, Z. Shi1, H. Ying1, C. Haugen1, S. Norman2, D. Segev1, M. McAdams-DeMarco1

  • Comparison of Minimal Incision Kidney Transplantation with Conventional Incision Kidney Transplantation: Interim Report of a Randomized Controlled Trial

    T. Lin, T. Song, Y. Jiang, Y. Fan, X. Wang, Z. Huang, J. Liu, Z. Wang

  • Diminishing Scientific Registry of Transplant Recipients Risk-Adjusted Mortality: Reaction to Flagging, Artifact of Modeling, or Both?

    J. A. Gregg1, K. L. Womer1, A. Santos1, S. J. Moore2, K. A. Andreoni3

  • Disparities in Pediatric Liver Transplant Waitlist Access

    S. C. Kim1, K. Ross1, E. Hsu2, R. Patzer1, R. J. Lynch1

  • Evaluation of the Safety and Tolerability of Clazakizumab® (Anti-IL-6 Monoclonal) as a Desensitization Agent in Highly-HLA Sensitized ESRD Patients (nct03380962)

    A. A. Vo, N. Ammerman, E. Huang, A. Peng, R. Najjar, S. Sethi, S. Williamsons, C. Myers, K. Lim, J. Choi, S. C. Jordan

  • Evolution of HHV6- and CMV-Specific T Cell Functional Responses and Immune Cell Populations after Kidney Transplant

    A. Gil1, M. Co2, M. Calvo-Calle1, J. Cruz1, L. Stern1, L. Gibson2

  • Extracellular Vesicles (EV) Mediate Antibody-Independent Tubular Senescence via Cyclin-Dependent Kinase Inhibitors p21/p16 in Antibody-Mediated Rejection (AMR)

    C. Divella1, A. Stasi1, R. Franzin1, F. Sallustio2, C. Curci1, G. Merlotti3, M. Quaglia3, L. Gesualdo1, V. Cantaluppi1, G. Castellano1

  • Global Kidney Exchange

    D. N. Bozek1, O. Ekwenna1, S. Paloyo2, T. Dunn3, K. Krawiec4, S. Rees5, A. Roth6, M. Zimmerman7, J. Punch8, R. Forbes9, C. Marsh10, C. Kuhr11, J. Rogers12, M. Tan13, L. Basagoitia14, R. Correa-Rotter15, J. Ortiz1, P. Sindhwani1, M. A. Rees1

  • Global and Domain Specific Cognition in Liver Transplant Recipients

    D. Ko1, L. Bratzke2

  • Histone Deacetylase-2 Knockout in Renal Tubular Cells is Protective in Renal Ischemia-Reperfusion Injury

    P. T. Hernandez1, S. J. Concors1, L. Krumeich1, D. D. Aufhauser1, Z. Wang1, D. D. Murken1, G. Ge1, W. Hancock2, M. Levine3

  • Hope in Action: A Multicenter Prospective Study of HIV to HIV Kidney Transplantation

    C. Durand1, S. Huprikar2, M. Bowring3, D. Brown1, B. Haydel4, N. Desai3, F. Naqvi1, R. Friedman-Moraco5, N. Turgeon6, V. Stosor7, J. Charette7, S. Mehta8, J. Husson9, A. Gilbert10, M. Cooper11, C. Butkus-Small12, G. Gupta13, S. Mehta14, O. Adebiyi15, P. Chin-Hong16, P. Stock17, A. Massie3, S. Florman4, D. Segev3

  • IgG4 Subclass Class 2 Donor Specific Antibody (DSA) is Associated with Subclinical Rejection in Stable Pediatric Liver Transplant (LT) Recipients with Normal Liver Tests

    A. Jackson1, S. Kanaparthi2, B. Burrell3, D. Lucas4, R. Vega4, A. J. Demetris5, S. Feng6

  • Impact of Functional Delayed Graft Function in the Modern Era of Kidney Transplantation

    D. Cucchiari, A. Molina-Andujar, E. Montagud-Marrahi, J. Rovira, F. Diekmann

  • Improved Transplant Outcomes in Ischemia-Free Liver Transplantation: A Report of the First 30 Cases

    X. He, Z. Guo, W. Ju, Q. Zhao, S. Huang, J. Yang, L. Wang, Y. Tang, Z. Zhang, Z. Zhu, L. Yang, Y. Zhu, F. Gong, C. Cai, W. Huang, G. Chen, M. Chen, F. Ji, M. Han, A. Hu, L. Wu, Y. Ma, D. Wang, J. Huang, X. Li

  • Improving Access to Lung Transplant through Donor Strategy: A Decision Analysis

    W. Tsuang, B. Udeh

  • Kidney Transplant Outcomes and Organ Acceptance Practice Patterns: Nationwide Analyses of the US and France

    O. Aubert1, P. P. Reese2, Y. Bouatou1, M. Raynaud1, C. Legendre1, D. Glotz1, C. Lefaucheur1, C. Jacquelinet3, A. Loupy1

  • Kidney Transplants Outcomes from Deceased Donors with Acute Kidney Injury

    C. Jung1, P. Sood2, R. Mehta2, D. Jorgensen2, M. Molinari2, S. Hariharan2, A. Ganoza2, D. Van Der Windt2, M. Wijkstrom2, C. Puttarajappa2, A. Tevar3

  • Low Frequency Of Canonical Human Leukocyte Antigen Alloimmunization In Heart Transplantation Candidates With Ventricular Assist Devices

    G. K. Mahowald1, S. L. Saidman1, G. Lewis2, V. Pattanayak1

  • Lower Incidence of Posttransplant Malignancies under Vitamin D (Calcidiol) Treatment in Kidney Transplantation

    I. Revuelta1, V. Tubita2, J. Ugalde1, D. Cucchiari1, F. Oppenheimer1, F. Diekmann1, J. Campistol1, J. Torregrosa1

  • MHC Molecule-Ablated Human Endothelial Cells Form Alloimmune-Evasive Microvessels

    J. Merola1, M. Reschke2, L. Qin1, S. Spindler1, R. W. Pierce3, T. D. Manes4, G. Li1, L. Bracaglia2, N. Kirkiles-Smith4, T. Baltazar4, W. Saltzman2, G. T. Tietjen1, G. Tellides1, J. S. Pober4

  • Mitochondrial Dysfunction and Metabolic Reprogramming: Critical Features of Cyclosporine A Nephrotoxicity

    A. A. Zmijewska, G. Benavides, V. Darley-Usmar, J. W. Zmijewski, R. B. Mannon

  • NK Cells Are Associated with Alloimmune Failure in Transplanted Children

    E. T. Chambers1, O. Martinez2, M. Robien3, C. Chan1, R. Ettenger4, P. Grimm5, H. Lee1, E. Reed4, L. Stempora6, M. Sarwal7, B. Warshaw8, C. Zhao1, A. D. Kirk6

  • Persistent Mixed Chimerism, Immune Reconstitution, and Tolerance in Recipients of HLA Matched Kidney and Hematopoietic Cell Transplants

    S. Busque, J. Scandling, R. Lowsky, J. Shizuru, E. Meyer, K. Jensen, A. Shori, R. Hoppe, E. Engleman, T. Pham, S. Strober

  • Population-Based Modeling of Prototypes and Determinants of Allograft Function Trajectories after Kidney Transplantation: Impact for Patient Monitoring and Risk Stratification

    M. Raynaud1, O. Aubert1, M. Naesens2, I. Juric3, N. Basic3, N. Kamar4, E. Huang5, S. Jordan5, B. Orandi6, D. Segev6, M. Stegall7, E. Morelon8, M. Giral9, E. Bailly10, E. Akalin11, G. Gupta12, M. Ladrière13, M. Buchler10, P. Reese14, C. Lefaucheur1, A. Loupy1

  • Progress Using Genetically Engineered Pigs for Lung Xenotransplantation

    L. Burdorf1, C. Laird2, S. Sendil2, T. Zhang2, D. Parsell2, I. Tatarov2, B. Cerel1, Z. Abady1, S. Pratts1, C. J. Phelps3, D. L. Ayares3, A. M. Azimzadeh1, R. N. Pierson III1

  • Pure Laparoscopic Donor Hepatectomy Based On Korean Multicenter Experience

    K. Suh1, S. Hong1, G. Choi2, K. Lee1, C. D. Kwon2, K. Kim3, S. Lee4, Y. Han5, J. Cho6, H. Han7

  • Regional Disparities In The Transplant Rates Across Unos Regions Pre- And Post-kidney Allocation System Policy Implementation

    A. C. Perez-Ortiz, E. Heher, N. Elias

  • Regulating T Cell Responses by Forced Transgenic Expression of Decay-Accelerating Factor

    D. Heja1, Z. He1, S. A. Lira1, F. Lin2, D. Homann1, P. S. Heeger1

  • Renoportal Anastomosis in Liver Transplantation: Results from a Propensity Score-Based Outcome Analysis

    G. D'Amico, S. Armanyous, L. Lomaglio, T. Diago Uso, K. Hashimoto, B. Eghtesad, M. Fujiki, F. Aucejo, K. Sasaki, H. Matsushima, C. Lindenmeyer, C. Miller, C. Quintini

  • Response to Treatment in Kidney Recipients with Acute T Cell-Mediated Rejection: Major Impact of Inflammation in Sclerotic Cortical Parenchyma (i-IF/TA) and Donor-Specific Antibodies

    Y. Bouatou, D. Viglietti, D. Pievani, J. Duong Van Huyen, O. Aubert, D. Glotz, C. Legendre, A. Loupy, C. Lefaucheur

  • Routine Molecular Clostridioides difficile Screening and Overtreatment in Solid Organ Transplant Recipients

    M. E. Newman1, C. Oehler1, M. Enriquez1, E. Landon1, C. T. Nguyen2, N. N. Pettit2, J. P. Ridgway1, J. Pisano1

  • Single Cell Sequencing of Human Kidney Allograft

    H. Yang1, H. Suryawanshi2, M. Lagman1, M. Lubetzky1, A. Alonso1, S. Seshan1, T. Tuschl2, M. Suthanthiran1, T. Muthukumar1

  • Super-resolution Evaluation Of The Glomerular Basement Membrane Changes In The Course Of Transplant Glomerulopathy

    D. Hammad, J. H. Miner, T. Alhamad, H. Suleiman

  • The Implementation and Impact of an Opioid Minimization Protocol in an Urban Renal Transplant Population

    A. Lichvar, M. Campara, E. Benedetti, J. Benken

  • The Role of the T Regulatory Cell Compartment in Intestinal Transplant Patients: Helpful or Unhinged?

    L. Belyayev1, M. Sadat2, K. Loh3, S. Moturi2, K. Khan2, J. Hawksworth2, C. Matsumoto2, T. M. Fishbein2, A. Kroemer2

  • What Are You Smoking? The Impact of Donor Drug Use on Long Term Survival Post-Transplant

    D. A. Baran1, A. Long1, J. T. Lansinger2, H. Copeland3, J. M. Herre1, W. Old1, G. Zeevi1, C. Barreiro1, C. Kemp1, B. H. Smith1, K. Stelling1, A. Ingemi1, P. Bourassa1, J. Philpott1

  • ZFYVE21 is a Novel Complement-Induced Rab5 Effector Protein Mediating Cardiac Allograft Vasculopathy

    D. Jane-wit1, C. Fang1, L. Liu1, L. Qin1, G. Guangxin Li1, P. Nigrovic2, G. Tellides3, J. Pober4

  • mTORC2 Restricts mTORC1 Metabolic Function in Dendritic Cells to Limit Their Allostimulatory Activity

    H. Dai1, A. Watson1, A. Menk2, D. Stolz3, G. Delgoffe2, A. Thomson1

  • A Randomized, Controlled, Trial of Interventions to Promote Walking after Abdominal Organ Transplantation: The LIFT Study

    M. Serper1, I. Barankay2, S. Chadha1, J. Shults3, P. Reese1

  • Absence of Protective Innate Lymphoid Cell Type 3 (ILC3) and Persistence of Proinflammatory Innate Lymphoid Cell Subsets Immediately Post-Transplant Plays a Appreciable Role in Early Intestinal Barrier Dysfunction

    J. Kang, L. Belyayev, K. Loh, P. Cha, S. Moturi, K. Khan, J. Hawksworth, C. Matsumoto, M. Zasloff, T. Fishbein, A. Kroemer

  • An International Multicentre Validation Study of the Toronto Listing Criteria for Pediatric Intestinal Transplant

    A. J. Roberts1, P. W. Wales2, S. V. Beath3, H. M. Evans1, J. Hind4, T. Wong5, D. Mercer6, J. Yap7, C. Belza8, D. Grant9, Y. Avitzur10

  • Anti- CD154 / CD40 Costimulation Blockade is Superior to Tacrolimus in Prolonging Survival in Pig-to-Nonhuman Primate Renal Xenotransplantation

    B. P. Lovasik1, A. J. Matar1, C. Breeden1, J. Jenkins2, J. Tector3, S. C. Kim1, A. B. Adams1

  • Changes in Kidney Offer Acceptance for Pediatric Candidates Post-KAS

    M. Bowring, K. Jackson, J. Garonzik-Wang, D. Segev, A. Massie

  • Circulating T Follicular Helper Proliferation And Memory B Cell Activation Correlate With Donor Specific Allo-antibody Occurrence And Antibody-mediated Rejection After Kidney Transplantation

    K. Louis1, C. Macedo1, M. Marrari1, B. Ramaswami1, M. Lucas1, B. Elinoff1, M. Yamada1, X. Gu1, G. Chalasani1, A. Zeevi1, P. Randhawa1, C. Lefaucheur2, D. Metes1

  • Compatible Pairs in Paired Kidney Exchange – Are There Winners and Loosers?

    V. Chipman1, B. Lee1, M. Cooper2, M. C. Cuffy3, M. Ronin4, G. Hil4, S. Flechner5, A. Thomas6, D. A. Mandelbrot7, A. D. Waterman8, C. E. Freise1, G. R. Roll1

  • Contemporary US Prevalence and Outcomes of Pneumocystis jirovecii Pneumonia and Toxoplasmosis in Pediatric Solid Organ and Hematopoietic Cell Transplantation Recipients

    M. I. Ardura1, J. Stanek2, B. Hanisch3, B. Hanisch4, K. Sprott5, H. Rangarajan6

  • Differences in CMV-Specific CD4 T Cell Population in De Novo Kidney Transplant Recipients Treated with Everolimus-Based Regimen Compared to a Standard Tacrolimus-MPA Regimen: Results from ATHENA

    I. A. Hauser1, S. Marx1, C. Sommerer1, B. Suwelack1, D. Dragun1, O. Witzke1, F. Lehner1, I. Kroeger2, M. Junge2, F. Thaiss1, B. Nashan1, M. Sester1

  • Difficult Outflow Reconstruction Using Eptfe Vascular Grafts In Ldlt: Technical Innovations And Outcomes.

    A. Thorat1, L. Jeng2, P. Li2, S. Hsu2, H. Yang2, C. Yeh2, T. Chen2, K. Poon2

  • Does the Type of Pre-Heart Transplant Desensitization Therapy Affect 5-Year Post-Transplant Outcomes?

    J. Patel, E. Kransdorf, R. Levine, S. Dimbil, L. Czer, J. A. Kobashigawa

  • Donor Derived Cell Free DNA Initiates De-Novo Donor Specific Antibody (DSA) Responses

    S. Jordan1, D. Sawinski2, S. Dholakia3

  • Donors and Drugs: How Often Do They Mix? Utilization of Donors Based on Toxicology Findings

    J. T. Lansinger1, A. Long1, C. Barreiro2, J. M. Herre2, H. Copeland3, W. Old2, G. Zeevi2, C. D. Kemp2, J. M. Philpott2, K. Stelling2, A. Ingemi2, B. H. Smith2, P. Bourassa2, D. A. Baran2

  • Enhanced Recovery after Surgery Protocols in Kidney Transplantation: Time to Change Practice?

    A. M. Elsabbagh, I. Ghoneim, A. Moiz, D. Mckenney, M. A. Zawaideh

  • Evaluation of Medication Burden in Kidney Transplant Recipients at Time of Index Hospitalization

    J. Hardcopf1, H. Meadows1, T. Harrison1, H. Corbo1, B. O'brien1, J. N. Fleming1, C. Perez1, N. Patel1, N. Pilch1, P. K. Baliga2, D. DuBay2, D. Taber1

  • Frailty Associated with Increased Rates of Acute Cellular Rejection within 3 Months after Liver Transplantation

    L. Fozouni, A. Lebsack, Y. Mohamad, C. Freise, P. Stock, J. Lai

  • Glycogen Synthase Kinase 3alpha Serine 21 Phosphorylation Inhibits Hepatocyte Autophagy to Facilitate Liver Ischemia Reperfusion Injury

    M. Ni1, H. Zhou2, R. Busuttil1, J. Kupiec-Weglinski1, X. Wang2, Y. Zhai1

  • Histologic Ischemia Reperfusion Injury in Liver Transplantation: A Large Single Center Experience

    F. M. Kaldas, T. Ito, S. Younan, J. Aziz, M. Lu, V. G. Agopian, J. DiNorcia III, H. Yersiz, D. G. Farmer, R. W. Busuttil

  • Hope Act Donors With Organs Recovered For Transplant: The First Two Years

    W. A. Werbel, O. Kusemiju, B. Barnaba, M. Bowring, B. Doby, C. Kirby, R. Fernandez, Y. Eby, J. Miller, D. Brown, S. Seaman, D. Ostrander, A. Tobian, D. Segev, C. M. Durand

  • IL-6R Blockade with Tocilizumab Increases Tregs and Decreases Early Graft Inflammation in Kidney Transplant Recipients: Results of a Randomized Controlled Trial

    S. Chandran, J. Leung, Z. Laszik, Q. Tang, C. Hu, M. Joanes, F. Vincenti

  • Impact Of Cold And Warm Ischemia Time On Outcomes For Kidneys Donated After Cardiac Death

    C. Brennan1, P. R. Sandoval2, S. A. Husain2, D. Tsapepas1, S. Mohan2, L. E. Ratner2

  • Impact Of Selective Cd28 Blockade On Protective Immunity To A Murine Epstein-Barr Virus Homolog

    R. L. Crepeau, J. A. Elengickal, M. L. Ford

  • Incorporating Tangible Benefits into the Risk-Benefit Analysis of Living Organ Donation Decisions

    M. Robin1, S. Rasmussen2, A. Saha2, A. Eno2, M. Waldram2, D. Segev2, M. Henderson2

  • Kidney Transplantation in the Lower-Income Bracket of South Korea; Widening Gap in Accessibility and Inferior Graft Outcome

    G. Park1, S. Park1, J. Kim1, M. Yu1, Y. Kim1, K. Kim1, M. Park2, Y. Kim1, H. Lee1

  • Living Kidney Donors Who Lose Weight in Order to Be Able to Donate, Gain More Weight after Donation

    S. R. Punjala, L. Silas, R. Gokmen, N. Karydis

  • Long-Term Outcomes of Eculizumab-Treated Positive Crossmatch Recipients: Allograft Survival, Histologic Findings, and Natural History of the Donor-Specific Antibodies

    C. Schinstock, A. Bentall, S. Byron, L. Cornell, M. Everly, M. Gandhi, M. Stegall

  • Lower Rates of Epstein-Barr Virus Viremia and Post-Transplant Lymphoproliferative Disease in Pediatric Solid Organ Transplant Recipients Who Received Valganciclovir Prophylaxis

    E. A. Moulton1, M. Karandikar2, S. Bond3, S. Burchett2, T. Sharma2, F. M. Marty3

  • Management of Anastomotic Biliary Strictures after Liver Transplant: Role of Covered Metal Stents

    A. Watson1, K. Haq1, K. Khorfan2, S. Singla1, A. Yoshida3, D. Moonka1

  • Microparticle Delivery to Lymph Nodes Induces Specific Suppression to Prolong Islet Survival

    Y. Xiong1, L. Tostanoski2, C. Jewell3, J. Bromberg1

  • Mortality and Morbidity in Kidney Transplant Recipients with a Failing Graft

    N. N. Lam1, D. J. Boyne2, R. R. Quinn2, P. C. Austin3, B. R. Hemmelgarn2, P. Campbell1, G. A. Knoll4, L. Tibbles2, S. Yilmaz2, H. Quan2, P. Ravani2

  • Myeloid AXL Promotes Cardiac Allograft Vasculopathy

    K. E. Glinton1, X. Yeap1, Z. J. Zhang2, X. Luo3, E. B. Thorp1

  • Nationwide Survey of Human T Cell Leukemia Virus Type 1-Infected Kidney Transplant Recipients in Japan

    J. Yamauchi1, Y. Yamano1, M. Matsuoka2, N. Ichimaru3, M. Nishikido4, Y. Shibagaki5, A. Sugitani6, N. Nakamura7, M. Mieno8, K. Yuzawa9

  • No Gains In Long-term Survival Of Pediatric Patients After Liver Transplantation – A Three Decade Analysis

    S. Bakhtiyar, A. Rana, S. Ahmed, H. Naseem, M. Kueht, N. T. Galvan, R. T. Cotton, C. A. O'Mahony, J. A. Goss

  • Novel Activation Responses by Endothelial Cells within the Pro-Tolerogenic Intragraft Microenvironment

    J. Wedel1, K. Liu1, P. T. Sage2, C. V. Carman3, P. Bobrowicz4, S. Kong5, B. McLaughlin4, D. M. Briscoe1

  • Plasmacytoid Dendritic Cell-Mediated Graft Prolongation Requires microRNA-181 and Semaphorin 4a

    J. Harden, X. Qi, A. Lau, S. Krams

  • Renal Failure as a Complication of Vascularized Composite Allotransplantation

    R. N. Barth1, J. T. Shores2, G. Brandacher2, M. H. Levine3, A. Weissenbacher4, A. J. Nam1, N. Shockcor1, E. D. Rodriguez5, S. Schneeberger4, W. Lee2, S. T. Bartlett1, L. Levin3

  • Sirna Uptake During Ex Vivo Hypothermic And Normothermic Liver Machine Perfusion: Beginning Of A New Era Of Organ Preservation

    A. Gillooly1, C. Moore1, J. Perry1, I. Bruggenwirth2, M. Thijssen2, X. Wang1, X. E1, P. Mandrekar1, T. Kowalik1, R. Porte2, H. Leuvenink2, R. Abdi3, A. Bozorgzadeh1, P. N. Martins1

  • Surgeon Readiness For Entry Into Practice: A Survey Of Abdominal Transplant Surgeons In The United States

    M. Abouljoud1, R. Hirose2, S. Nagai1, C. Gordon3, D. Farmer4

  • The Collaborative Improvement and Innovation Network (COIIN): Impact on Deceased Donor Transplant Rates and Offer Acceptance Practices

    A. Wey1, S. Gustafson1, B. Carrico2, J. Foutz2, K. Sisaithong3, M. McBride2, D. Klassen2, D. Klassen2, N. Salkowski1, B. Kasiske1, A. Israni1, J. Snyder1

  • The Economic Burden of Graft Failure in the United States

    J. A. Sussell1, A. R. Silverstein1, P. Goutam1, D. Incerti1, R. Kee1, D. S. Batty, Jr.2, C. X. Chen2, J. Jansen1, B. L. Kasiske3

  • The Effect Of Exclusive Virtual Crossmatch To Allocate Deceased Donor Kidney Transplant On Cold Ischemia Time And Acute Rejection

    E. Abuhelaiqa1, M. Alkadi1, S. Thappy1, S. Saleh2, J. Mahmoud3, M. Jarman3, O. Fituri1, M. Elkhalifa4, J. Wadström3, H. Al-Malki1

  • The Frequency of Tissue-Resident Donor T and NK Cells in Peripheral Blood after Lung Transplantation is Modulated by Normothermic Ex Vivo Lung Perfusion

    C. S. Falk1, B. Wiegmann2, A. Hitz1, R. Bellmas-Sanz1, K. Bläsing1, F. Ius2, C. Kühn2, M. Avsar2, I. Tudorache2, J. Kühne1, F. Wandrer1, A. Haverich2, G. Warnecke2

  • The Immigrant Bonus: Non US Deceased Donor Kidney Transplant Recipients Have Superior Outcomes versus US Citizen Recipients. A Retrospective Study of 30,092 Subjects Using the Organ Procurement and Transplant Network (OPTN) from 1992-2015

    T. Butler1, A. Rana2, S. Fink1

  • The Impact of Portal Flow after Reperfusion on Graft Outcomes after Deceased Donor Liver Transplantation

    H. Matsushima, K. Sasaki, M. Fujiki, T. Diago Uso, B. Eghtesad, F. Aucejo, C. Kwon, C. Miller, C. Quintini, K. Hashimoto

  • Use of Low Dose Interleukin-2 to Expand Regulatory T-cells and Facilitate the Complete Discontinuation of Immunosuppression in Human Liver Transplantation

    T. Lim1, P. Ruiz2, A. Kurt2, E. Kodela2, M. Martinez-Llordella2, T. Tree3, A. Sanchez-Fueyo1

  • An Immediate and Persistent Post-Reperfusion Metabolic Collapse Precedes Delayed Graft Function (DGF)

    J. Lindeman

  • Apoptotic Exosome-Like Vesicles Induce Endothelial Cell Plasticity and Accelerate Allograft Vascular Remodeling

    F. Migneault1, M. Dieudé1, J. Turgeon1, A. Karakeussian Rimbaud1, D. Beillevaire1, M. Hardy2, A. Brodeur1, N. Thibodeau1, C. Perreault2, M. Hébert1

  • Are We Underestimating The Number Of Paired Kidney Exchange Transplants In The United States? Relationship Insights From The National Kidney Registry

    A. Thomas1, A. Shaffer2, D. Segev2

  • Assessment of Serum Tim3 and Gal9 Levels in Predicting the Risk of Infection after Kidney Transplantation

    Y. Shi1, y. li2, Y. Li2, L. Yan2, J. Tang2, X. Wu2, Y. Bai2, Y. An2, B. Dai2, C. Yang2, L. Wang2

  • Association Of Kdpi And Dgf With Dcd Kidney Transplants Outcomes

    M. Sampaio, B. Abdalla, S. Bunnapradist

  • Dialysis Facility Profit Status and Referral for Kidney Transplantation

    E. R. Walker1, L. J. McPherson1, J. C. Gander2, S. Pastan1, R. E. Patzer1

  • Donor Safety for Minimal Invasive Hepatectoy in Liver Transplantation: The Korean Organ Transplantation Registry

    H. Yu, J. Yang, S. Ahn

  • Expansion of Regulatory T and B Cells in Swine Rendered Tolerant of Allogeneic Vascularized Composite Allografts via Mixed Chimerism

    G. Saviane1, A. Lellouch1, A. Andrews1, L. Lantieri2, M. Randolph1, G. Benichou1, C. Cetrulo Jr1

  • FTY720 Regulates Mitochondria Biogenesis in Dendritic Cells to Prevent Kidney Ischemic Reperfusion Injury

    A. Bajwa1, V. Bontha1, C. Kuscu1, L. Gallon2, C. Kuscu1, J. Eason3, D. Maluf1, V. Mas4

  • Factors Associated with Subclinical Cardiovascular Damage after Pediatric Liver Transplantation: A Longitudinal Observational Study

    N. Memaran1, I. Goldschmidt1, B. Borchert1, R. I. Sugianto1, H. Wilke1, R. Blöte1, U. Baumann1, E. Bauer1, A. von Wick1, N. Junge1, C. Leiskau1, E. D. Pfister1, N. Richter2, B. M. Schmidt3, A. Melk1

  • Hepatic Stellate Cells and Liver Derived Endothelial Cells Improve Scaffold-Free 3D-Bioprintied Liver Model

    A. M. Chen1, W. Zhang1, C. J. Koehler1, K. Saglam1, A. Isidan1, J. R. Walsh1, R. A. Naqvi1, E. Gramelspacher1, L. J. Smith2, P. Li1, B. Ekser1

  • Higher Level of Social Support is Associated with Higher Likelihood of Pursuit of Living Donor Kidney Transplant (LDKT)

    T. Ahmed1, S. Dano1, Z. Zhou1, I. Unarain1, M. Saqib1, V. Li1, Y. Khoo1, M. Novak2, I. Mucsi1

  • Humoral Immune Responses to Kidney Associated Non-HLA Antigens is Not Associated with Progression to Chronic Immune Injury in Kidney Transplant Recipients

    S. Sukumaran Nair1, R. Ravichandran2, R. Heilman1, A. Jaramillo1, D. Ramon1, M. Buras1, B. Kaplan1, T. Mohanakumar2

  • Identification Of Pre-transplant Biomarkers Of Recipient Immune Dysfunction That Predict Recipient Risk Of Death Following Liver Transplant: The Immune Frailty Index

    K. E. Lunsford1, N. Aware1, K. Cleveland1, C. J. Manner1, D. T. Nguyen2, E. A. Graviss2, J. V. Thomas1, H. Vyas1, L. W. Moore1, S. A. Dorman1, A. Saharia1, C. M. Mobley1, M. J. Hobeika1, X. C. Li1, R. M. Ghobrial1

  • Impact of Cytomegalovirus on the Immune System of Healthy Humans

    W. Zhang, J. Robertson, G. Karadkhele, B. Johnson, C. Larsen

  • Impact of Donor Hepatitis C Virus Infection on Kidney Transplant Outcomes in the Direct Acting Antiretroviral Era: Time to Revise the KDPI?

    R. M. Cannon, E. G. Davis, L. Mackelaite, H. Dave, M. Eng, C. M. Jones

  • Increase in Deceased Donor Acceptance Rate After Implementing Uniform Acceptance Criteria

    C. Klein, T. Ommert, J. Hundley, J. Lizcano, A. Ray, R. Cross, K. Payne

  • Infectious Complications of Eculizumab Use in Abdominal Organ Transplant Recipients

    A. M. Nolan1, E. J. Fraser2, H. K. Grewal3, J. G. Timpone3

  • Interruption of Notch Signaling via Blockade of Delta-Like Ligands 1 and 4 Prevents Co-Stimulation Blockade Resistant Allograft Rejection

    A. Matar, Y. Dong, B. Lovasik, D. Mathews, A. Ghosh, C. Breeden, A. Stephenson, W. Kitchens, A. Adams

  • Late Acute Rejection Increases Risk Of Graft Failure In Ldlt Recipients: Data From The A2all Cohort

    H. J. Braun, J. L. Dodge, J. D. Grab, S. M. Syed, G. R. Roll, C. E. Freise, J. P. Roberts, N. L. Ascher

  • Local IL-33 Regulates Heart Transplant Infiltrating Myeloid Cells Metabolism and Differentiation to Protect against Chronic Rejection

    Z. Zhang1, Q. Liu1, T. Li1, G. S. Hussey2, M. Velayutham1, J. L. Dziki2, L. R. Mathews1, Y. C. Lee2, G. K. Dwyer1, H. Dai1, A. S. Roessing1, S. Shiva3, M. H. Oberbarnscheidt1, S. F. Badylak2, H. R. Turnquist1

  • National Trends in Bariatric Surgical Practice for Patients with End-Stage Renal Disease

    K. H. Sheetz1, K. J. Woodside1, V. B. Shahinian2, J. B. Dimick1, S. A. Waits1

  • Non-Immunologic Donor-Recipient Pairing, HLA Matching, and Graft Loss in Deceased Donor Kidney Transplantation

    A. Vinson1, B. Kiberd1, R. Davis2, K. Tennankore1

  • Normothermic Regional Perfusion of Kidneys: A Single Non-Retrieval Centre Experience

    R. Pearson, C. Geddes, M. Clancy, J. Asher

  • OPO Aggressiveness Index: A Novel OPO Performance Metric That Incentivizes Pursuit of Marginal Deceased Donor Candidates

    L. Liyanage, Y. Yu, K. Jackson, J. Garonzik-Wang, D. Segev, A. Massie

  • Outcomes in Non-A1 and Non A1 B to B Deceased Donor Renal Transplantation Are Comparable to B Donor Renal Transplants

    A. Brar, L. Kwon, A. Gruessner, F. Tedla, R. Gruessner, N. Sumrani, D. John, J. Renz, M. O. Salifu

  • Platelets Augment Granzyme K Production By Macrophages In Antibody-mediated Rejection

    J. Dhar, K. Keslar, R. Fan, N. Dvorina, W. Baldwin

  • Post-Liver Transplant Atrial Fibrillation is Associated with Markedly Reduced Short- and Long-Term Patient Survival

    R. Rachwan1, I. Kutkut1, T. J. Hathaway2, L. R. Timsina2, M. S. Ghabril3, M. A. Lacerda3, C. A. Kubal2, P. D. Bourdillon4, R. S. Mangus2

  • Predicted Indirectly Recognizable H L A Epitopes Are Associated with T-cell Mediated Rejection among Kidney Transplant Recipients with Preformed and De Novo Donor-Reactive T-cells

    T. Schachtner1, M. Stein2, N. M. Otto3, P. M. Reinke2

  • Preliminary Results from a Multicenter National Trial of Antiviral-Facilitated Transplantation of Hepatitis C Hearts to Expand the Donor Pool

    K. Martits-Chalangari, A. K. Doss, M. Clark, J. Felius, S. A. Hall, R. L. Gottlieb

  • Racial Variation in ESRD Diagnosis Patterns among Prior Living Kidney Donors on the OPTN Kidney Waiting List

    J. Wainright1, A. Robinson1, A. Wilk1, D. Klassen2, W. Cherikh1, C. Custer1, R. Brown3, D. Stewart1

  • Regulation of Host microRNA Expression by Natural Variants of Epstein Barr Virus (EBV) Latent Membrane Protein 1 (LMP1)

    O. Hatton1, A. Harris-Arnold2, A. Hui2, E. Maloney2, S. M. Krams2, O. M. Martinez2

  • Robotic Assisted Kidney Transplant Outcomes in Obese Candidates

    I. G. Tzvetanov, K. A. Tulla, O. T. Okoye, C. Di Bella, P. Di Cocco, J. A. Almario Alvarez, M. Spaggiari, E. Benedetti

  • Room for Optimism; Improvement in Long-Term Patient and Graft Survival of Kidney Transplants in the United States over the past Three Decades

    C. Wu, A. Rana, N. Galvan, C. O'Mahony, J. Goss, B. Murthy

  • Safety and Efficacy of Imlifidase in Highly-Sensitized Kidney Transplant Patients: Results from a Phase 2 Study

    S. C. Jordan1, C. Legendre2, N. Desai3, T. Lorant4, M. Bengtsson4, L. Laxmyr5, B. Lonze6, A. Vo1, K. J. Wood7, C. Kjellman5, R. A. Montgomery6

  • Senescent Cell Clearance with Senolytic Drugs Improves Cardiac Allograft Survival by Targeting mt-DNA Mediated Immune Responses

    J. Iske1, M. Koichiro1, M. Seyda1, T. Heinbokel1, Y. Nian1, R. Maenosono1, H. Azuma1, C. Falk2, T. Tchokonia3, J. Kirkland3, A. Elkhal1, S. Tullius1

  • Surgical Management Of Five Hundred Patients With Chronic Gut Failure At A Single Center: Autologous Reconstruction Versus Transplantation

    S. Armanyous, Y. Fouda, M. Fujiki, N. Parekh, M. Osman, R. Girlanda, K. Hashimoto, G. Costa, K. Abu-Elmagd

  • The Impact of Sleeve Gastrectomy Following Liver Transplant in Patients with Non-Alcoholic Steatosis: A Five-Year Experience

    M. C. Morris1, A. D. Jung1, Y. Kim1, V. K. Dhar1, S. Shah1, D. Schauer2, E. Smith2, T. Diwan1

  • The Increasing Financial Challenge of Liver Transplantation

    D. Axelrod1, S. Hohmann2, K. Lentine3, H. Xiao3, B. Kasiske4, J. Snyder4, M. Ostrander5, M. Schnitzler3

  • The Role of CD47/SIRPα and CD47/TSP-1 Pathways in Pig-to-Baboon Kidney Transplantation Using hCD47 Transgenic Kidneys

    K. Takeuchi1, Y. Ariyoshi1, T. Pomposelli1, L. Boyd1, D. Ekanayake-Alper1, S. Arn1, R. Hawley1, D. Ayares2, M. Lorber3, M. Sykes1, D. Sachs1, R. Johnson4, K. Yamada1

  • Tolerance Induction with Hematopoietic Stem Cells in Kidney Transplantations

    K. Lee, J. Park, Y. Chung, S. Kim

  • Trends and Geographic Variation in the Recovery of Organs from Drug-Overdose Deaths with Donor Potential

    V. Garcia, D. Stewart, J. Rosendale

  • Upregulation of Endothelial HLA Class II as a Marker of Antibody Mediated Rejection in Heart Allograft Biopsies

    Q. Cai, Y. Butt, A. Hendricks, J. Torrealba

  • Vaccine Response as a Predictor of Kidney Transplant Rejection and Serious Infection

    A. Ta'eed, K. R. Polkinghorne, W. R. Mulley

  • Your Path to Transplant Education Increases Patients’ Transplant Knowledge, Attitudes, Informed Decision-Making, and Pursuit: An Randomized Controlled Trial

    A. D. Waterman1, Y. Cui2, J. D. Peipert3, J. L. Beaumont2, C. S. Anderson1, A. L. Paiva4, M. L. Robbins4

  • A Novel Program of Directed Domino and Split Liver Donations Increases Liver Transplants

    T. Fishbein, C. Matsumoto, N. Yazigi, R. Satoskar, S. Kaufman, K. Khan, K. Alexander, J. Hawksworth, M. Summer

  • A Molecular Analysis of Graft Survival in the INTERHEART Study

    P. Halloran1, J. Reeve and the INTERHEART investigators2

  • A National Survey of Immunosuppression Strategies in Intestinal Transplantation

    M. Segovia1, T. Beduschi2, J. Boike3, D. Farmer4, S. Horslen5, K. Iyer6, S. Jafri7, A. Langnas8, C. Matsumoto9, A. Mavis1, G. Mazariegos10, S. Nagai7, J. O'Leary11, Y. Patel1, D. Sudan1, N. Sulejmani7, B. Summers7, T. Schiano6

  • Angiotensin II Type 1 Receptor Antibodies Improve Risk Stratification for Kidney Allograft Outcomes at the Time of Transplantation

    C. Lefaucheur1, D. Viglietti1, Y. Bouatou1, A. Philippe2, D. Pievani1, O. Aubert1, D. Glotz1, C. Legendre1, A. Loupy1, D. Dragun2

  • Anti-HLA IgM Antibodies Are Reduced in Highly-HLA Sensitized Patients Transplanted after Imlifidase (IdeS) Treatment

    X. Zhang1, S. Jordan2

  • Assessment of the Global Practice of Pediatric Living Donor Liver Transplantation: Comparison of U.S. and International Programs

    J. Emamaullee1, M. Kim1, C. Conrad1, C. Lane1, P. Singh1, C. Niemann2, L. Sher1, Y. Genyk1

  • Association of Pretransplant and Posttransplant 5-Tier Ratings with Candidate Mortality after Listing

    A. Wey, S. Gustafson, N. Salkowski, B. Kasiske, M. Skeans, C. Schaffhausen, A. Israni, J. Snyder

  • Complement Blockade in Kidney Recipients Prevents Delayed Graft Function and Antibody-Mediated Rejection in Non-Human Primates

    M. Eerhart1, J. Reyes1, C. Blanton1, J. Danobeitia1, P. Chlebeck1, L. Zitur1, J. Coonen1, S. Capuano1, A. D’Alessandro1, J. Torrealba2, W. Zhong1, Y. Yankol1, L. Fernandez1

  • Correlation of Donor-Derived Cell-Free DNA with Histology and Molecular Diagnoses of Kidney Transplant Biopsies

    I. Moinuddin1, D. Kumar1, P. Halloran2, L. Kamal1, A. King1, P. Kimball1, M. Levy1, C. Bhati1, D. Massey1, G. Gupta1

  • Cytomegalovirus (CMV) Infection Induces an Angiogenic Response through Hepatic Stellate Cells (HSCs) and Leads to Early Post-Transplant Liver Fibrosis (LF) and Poor Graft Survival

    B. H. Ozdemir1, G. Ozgun1, E. H. Ayvazoglu Soy2, N. Haberal1, G. Moray2, M. Haberal2

  • Defatting Steatotic Rat Livers during Ex Situ Normothermic Perfusion Improves Lactate Clearance and Bile Quality

    S. Raigani1, C. Carroll2, S. Cronin2, C. Pendexter2, I. Rosales3, M. Yarmush1, K. Uygun1, H. Yeh1

  • Dendritic Cells Transduced with Autoimmune Regulator Exhibit Immature Properties and Prolong Heart Allograft Survival

    Y. Zhang, Z. Zhu, M. Chen, S. Huang, C. Sun, W. Ju, Z. Guo, X. He

  • Did COIIN Cohort A Maintain Graft Survival Performance While Increasing Moderate to High KDPI Transplants?

    J. Foutz, R. J. Carrico, K. Sisaithong, H. Tosoc-Haskell, D. Klassen

  • Dual Targeting Desensitization with Carfilzomib Plus Lulizumab Significantly Prolongs Kidney Transplant Survival in Allosensitized Nonhuman Primates

    P. M. Schroder, R. Schmitz, Z. Fitch, B. Ezekian, J. Yoon, A. Choi, A. Barbas, F. Leopardi, B. Collins, J. Kwun, S. J. Knechtle

  • Evaluating Liver Regeneration during Normothermic Machine Perfusion in Hepatectomized Rat Liver Model

    M. Aburawi1, S. Mert1, E. Hafiz2, P. Mahboub1, H. Yeh1, K. Uygun1, J. Markmann1

  • Exploring the Drivers of the Early Decline in One-Year Patient Survival after KAS

    K. Lindblad, A. Wilk, D. Stewart

  • Factors Related to International Travel for Transplantation among US-Listed Kidney Transplant Candidates

    B. Koons1, M. L. Henderson2, A. G. Thomas3, T. Kear4, H. Moriarty4

  • Hepatocyte SIRT1 Modulates ATF4/CHOP and Mitigates Liver Transplant Ischemia-Reperfusion Injury: From Bench-to-Bedside

    H. Hirao1, S. Kageyama1, K. Kadono1, K. Nakamura1, T. Ito1, K. J. Dery1, D. Oncel1, X. Li2, B. Ke1, F. M. Kaldas1, R. W. Busuttil1, J. W. Kupiec‐Weglinski1

  • How Do We Choose? Predicting Utilization Of Cardiac Donors And The Effect Of Era

    D. A. Baran1, J. T. Lansinger2, A. Long2, J. Philpott3, H. Copeland4, W. Old3, G. Zeevi3, C. Barreiro3, C. Kemp3, B. H. Smith3, K. Stelling3, A. Ingemi3, P. Bourassa3, J. M. Herre3

  • Identification and Determinants of Cardiac Allograft Vasculopathy Trajectories after Heart Transplantation

    G. Bonnet1, G. Coutance1, M. Racape1, M. Raynaud1, J. Van keer2, M. Bories1, S. Varnous3, P. Rouvier3, R. Guillemain4, L. Lecuyer4, P. Bruneval4, J. Duong-Van-Huyen1, J. Taupin5, M. Naesens2, C. Lefaucheur1, X. Jouven1, A. Loupy1

  • Impact Of Delayed Kidney Transplantation On Positive Crossmatch Liver Kidney Transplantation

    Z. Rokop, C. Kubal, B. Ekser, R. Mangus, J. Fridell, P. Mihaylov, W. Goggins

  • Machine Perfusion Allows Use of High KDPI and Prolonged Cold Ischemia Time in Deceased Donors: A Single Center Effort to Decrease Discard Rates

    M. Ortigosa-Goggins, J. Gaynor, A. Mattiazzi, J. Figueiro, G. Burke, G. Ciancio, G. Guerra

  • Mass Cytometry-Based Characterization of Adaptive Immunity in Transplant Recipients with Self-Limiting or Chronic EBV Viremia

    V. H. Ferreira1, C. J. Guidos2, A. Humar1, D. Kumar1

  • Minimizing Kidney Ischemia Reperfusion Injury by Transferring Exogenous Mitochondria

    A. Bajwa1, V. Bontha1, J. Eason2, D. Maluf3, V. Mas4

  • Multi-Organ Transplant Results in Lower Patient and Graft Survival Than Kidney Alone Transplant

    C. A. Custer1, J. Entwistle2, K. Ladin3, L. Cartwright1, E. J. Gordon4

  • Newly-Revealed Antibody Targets Lead to the Early Loss of Triple Knockout Pig Kidneys in a Pig to Baboon Model

    Y. Ariyoshi1, K. Takeuchi1, T. Pomposelli1, D. K. Ekanayake-Alper1, C. Schuetz1, H. Sahara1, L. Boyd1, E. Estime1, S. Arn1, D. Ayares2, M. Lorber3, M. Sykes1, D. Sachs1, K. Yamada1

  • Presence of DSA Class 2 is Associated with Fibrosis Progression after OLT

    M. Sterneck1, B. Sultani2, M. Rodriguez Lago3, E. Grabhorn4, A. Briem-Richter4, U. Herden5, L. Fischer5

  • Prophylactic Use of Eculizumab in Patients at High Risk of Post-Transplant aHUS Recurrence Improves Graft Outcomes

    J. Zuber, S. Caillard, M. Frimat, N. Kamar, P. Gatault, F. Petitprez, M. Louis, V. Chatelet, A. Thierry, D. Bertrand, R. Gaisne, L. Couzi, L. Albano, N. Jourde-Chiche, M. Matignon, J. Bamoulid, C. Pouteil-Noble, M. Peraldi, C. Legendre, E. Rondeau, M. Le Quintrec, V. Frémeaux-Bacchi

  • Proximal Splenic Artery Embolization For Refractory Ascites And Hydrothorax After Liver Transplant: A Single Center Analysis Of Factors Associated With Success

    L. Lomaglio, G. D'Amico, S. Armanyous, T. Diago Uso, K. Hashimoto, B. Eghtesad, M. Fujiki, F. Aucejo, K. Sasaki, C. Kwon, C. Coppa, M. Bayona Molano, C. Lindenmeyer, C. Miller, C. Quintini

  • Reduction In Early Readmission In Kidney Recipients – Outcomes At One Year With Standardized Intensive Follow Up

    A. Crane, M. Eltemamy, R. Fatica, E. Poggio, C. Modlin, A. Wee, V. Krishnamurthi

  • Results of Litmus (nct 02541916): The Liver Immune Tolerance Bio Marker Utilization Study

    A. Chruscinski1, V. Rojas-Luengas1, S. Moshkelgosha1, J. Luo2, H. Yowanto2, Z. Galvin1, L. Lilly1, R. Smith1, E. Renner1, J. Zhang1, D. Grant1, O. Adeyi1, H. Atkins3, P. Juni4, N. Selzner1, S. Juvet1, G. Levy1

  • Risk Factors for 1-5 Year Major Infection Events (MIE) after Kidney Transplant (KTx) Including First-Year Immunosuppression (IS) Data: An Analysis of the Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity (CISTEM) Study

    V. Dharnidharka1, D. Axelrod2, Z. Zhang3, M. Schnitzler3, K. Lentine3, B. Kasiske4

  • Simultaneous Robotic Kidney Transplantation and Bariatric Surgery for Morbidly Obese Patients with End-Stage Renal Failure

    P. West-Thielke, K. A. Tulla, O. T. Okoye, J. A. Almario Alvarez, M. Spaggiari, I. G. Tzvetanov, E. Benedetti

  • Spontaneous Bacterial Peritonitis Prophylaxis Increases the Risk of Multi-Drug Resistant Cultures and Infections in Liver Transplant Patients

    R. Rosenblatt, A. Schluger, M. Pereira, E. Verna

  • Sub-Optimal Renal Recovery and Progressive Chronic Kidney Disease after Living Kidney Donation

    Y. Kim1, C. Jeong2, H. Kim2, J. Ha3, C. Ahn1, Y. Kim1, H. Lee1

  • TDCA/Valine Reverse Obesity and Ameliorate Alloimmune Responses through a Decreased Hypothalamic Expression of MCH

    A. ElKhal1, M. Markus Quante1, T. Heinbokel1, Y. Nian1, K. Minami1, R. Maenosono1, J. Iske1, B. Desai2, A. Banks2, E. Maratos-Flier2, A. Elkhal1, S. G. Tullius1

  • Targeted Proteomic Analysis Detects Acute T Cell-Mediated Kidney Allograft Rejection in Belatacept-Treated Patients

    M. van der Zwan, D. A. Hesselink, M. C. Clahsen-van Groningen, C. C. Baan

  • The Clinical & Economic Impact Of Allosensitization In Liver Alone And Simultaneous Liver Kidney Transplantation

    M. Askar1, G. Saracino1, A. Elsabbagh2, J. Fung3, T. Srinivas4, S. Flechner5, J. Trotter1, G. Testa1, B. Kaplan6, G. Klintmalm1, J. Schold5, S. Asrani1

  • The Graft and Patient Survival of Kidney Transplantation According to Ethnicity in US Kidney Transplant Recipients

    H. Shin1, Y. Kim1, Y. Jung1, H. Rim1, A. Chandraker2

  • The Risk of Systematic Error in Kidney Transplant Opioid Research

    J. N. Fleming, N. A. Pilch, S. Ball, P. K. Baliga, V. Rohan, D. J. Taber

  • Tissue Resident Memory T Cells in Murine Renal Transplantation

    K. Abou-Daya, D. Zhao, R. Tieu, A. Williams, M. Oberbarnscheidt, F. Lakkis

  • Transplant Nephrologist

    K. A. AlMeshari1, D. Broering2, I. Alahmadi3, S. Raza3, T. Ali3, F. Alzayer4, A. Algharabli4

  • Urinary Injury Biomarkers in Deceased Donors and Acute Rejection Post Kidney Transplant

    P. Reese1, I. Hall2, S. Mohan3, H. Theissen-Philbrook4, Y. Jia4, M. Doshi5, J. Bromberg6, S. Mansour7, M. Harhay8, F. Weng9, E. Akalin10, C. Parikh4

  • Uterus Transplantation: A Single Center’s Experience of Peri and Postoperative Complications

    L. Johannesson, G. Testa

  • “Getting Life Back” – Kidney Transplantation in the Elderly Patient

    V. Tsarpali1, K. Lønning2, K. Midtvedt2, T. Bernklev3, N. von der Lippe4, M. H. Andersen2, K. Heldal1

  • A Potential Role for IgE-Mediated Immune Response in the Pathogenesis of Chronic Antibody-Mediated Rejection

    F. Rascio1, P. Pontrelli2, G. S. Netti3, E. Manno1, B. Infante1, S. Simone2, G. Castellano2, M. Seveso4, E. Cozzi4, L. Gesualdo2, G. Stallone1, G. Grandaliano1

  • Access To The Kidney Transplant Waitlist For Patients With Hiv And End-stage Renal Disease

    A. A. Shaffer1, H. Ying2, N. Chu1, A. G. Thomas3, C. Haugen2, S. Norman4, D. L. Segev1, M. A. McAdams-DeMarco1

  • Anti CD45RB Antibody Therapy Attenuates Renal Ischemia Reperfusion Injury by Inducing Regulatory B Cells

    S. Lee1, S. Park1, J. Hwang1, J. Ryu2, T. Koo2, C. Ahn2, J. Yang3

  • Apoptosis during Cold Ischemia and Rewarming Involves a Caspase Independent Pathway

    S. Jain1, R. Plenter2, T. Nydam2, A. Jani1

  • Brief Normothermic Machine Perfusion is Superior to Cold Storage Alone – A Paired Discarded Human Kidney Analysis

    A. Hameed1, E. Patrick2, D. B. Lu1, C. P'ng1, M. Hu2, Y. Chew2, R. De Roo1, L. Yuen1, W. Hawthorne1, N. Rogers1, H. Pleass1

  • CMV Risk Status Remains a Relevant Risk Factor for Long-Term Outcomes

    G. Karadkhele, W. Zhang, C. P. Larsen

  • Changes in Kidney Function Following Live Donor Nephrectomy

    N. N. Lam1, A. Lloyd1, K. L. Lentine2, R. R. Quinn3, B. R. Hemmelgarn3, S. Klarenbach1, A. X. Garg4

  • Circulating Mirnas Regulate Gene Expression In Kidney Tissue During Transplant Glomerulopathy

    C. Kuscu1, V. Sai Bontha1, C. Kuscu1, D. Maluf1, A. Bajwa1, J. Eason1, V. Mas1, E. Akalin2

  • Development and Characterization of Human-Derived Xenograft Model for Hepatocellular Carcinoma

    M. Nazzal1, R. Steele2, R. Ray3, N. Phillips2, J. Long4, R. Ray2

  • Early Tacrolimus Trough Concentration Variability Could Predict Rejection in Pediatric Liver Transplantation: A Single-Center and Retrospective Research

    G. Gu, Q. Xia

  • Eight-Year Outcomes Following ABO-Incompatible Kidney Transplantation Performed after Desensitization by Antigen-Unspecific Immunoadsorption Devices

    C. Speer1, F. Kälble1, L. Pego da Silva1, C. Nusshag1, M. Schaier1, C. Süsal2, C. Sommerer1, M. Zeier1, C. Morath1

  • Elevated Podocyte-specific Urinary Extracellular Vesicles In Patients With Fsgs Recurrence After Kidney Transplantation

    H. Lau, A. Shimomura, E. Tantisattamo, U. G. Reddy, D. Dafoe, H. Ichii

  • First Report and Mechanistic Analysis of Operational Tolerance after Intestinal Transplant

    J. Weiner1, S. Moturi1, C. Ashokkumar2, K. Khan1, S. Kaufman1, R. Sindhi2, C. Matsumoto1, T. Fishbein1, A. Kroemer1

  • Geographic Disparities in Heart Transplant Rates

    M. Kosztowski, S. Yu, A. Kilic, A. Massie, S. Zhou, D. Segev, S. Gentry

  • Graft Perfusion with Alvespimycin, an HSP90 Inhibitor, Suppresses IL-2 and IL-12p40 Production in Graft-Infiltrating Cells, Leading to Prolongation of Graft Survival in Murine Heart Transplantation

    T. Tanaka, T. Maehana, N. Masumori

  • Immune Cell Types and Host Gene Signatures Associated with Epstein-Barr Virus (EBV) Post-Transplant Lymphoproliferative Disorder (PTLD)

    J. Toh1, F. Vallania1, W. A. Haynes1, G. Bhagat2, F. E. Craig3, S. H. Swerdlow4, T. Tousseyn5, S. M. Krams1, P. Khatri1, O. M. Martinez1

  • Increased Access to Transplantation for Medicaid Patients Following Medicaid Expansion

    A. Massie, M. Henderson, T. Hwee, D. Segev

  • Integrated Analysis of Messenger RNA and Micro RNA Profiles in Fatty Liver Donors: Molecular Networks during Ischemia Reperfusion Injury

    D. Maluf1, A. Bajwa1, S. K. Satapathy2, V. Sai Bontha1, A. Kadimella1, J. Eason3, V. Mas4

  • Keeping Patients Lifetime Perspective in Focus: Modest Rates and Wide Variation in Preemptive Re-Listing for Kidney Transplantation in the US

    J. Schold, J. Augustine, A. Huml, J. O'Toole, J. Sedor, E. Poggio

  • Kidney Donor Outcomes ≥ 50 Years Post Donation

    D. Keys, S. Jackson, A. Matas

  • Kidney Paired Donation Transplant Outcomes: Experiences from the First Ten Years of the National Kidney Registry

    D. B. Leeser1, A. G. Thomas2, A. A. Shaffer2, J. Veale3, A. B. Massie2, M. Cooper4, S. Kapur5, S. Kapur5, S. Kapur5, N. Turgeon6, D. Segev2, A. Waterman3, S. Flechner7

  • Kidney Xenotransplantation from Genetically Engineered Pigs to Baboons with FDA-Approved Immunosuppressive Therapy

    T. Yamamoto1, H. Hara1, J. Foote1, E. C. Klein2, H. J. Schuurman3, L. Wang1, Q. Li1, H. Zhou1, J. Li1, J. A. Tector1, Z. Zhang2, M. Ezzelarab2, R. Lovingood1, D. Ayares4, D. E. Eckhoff1, D. K. Cooper1, H. Iwase1

  • Ligation Of Hla Class Il Molecules Disrupts Endothelial Barrier Through Src-dependent Ve-cadherin Destabilization

    F. Li1, R. A. Sosa1, N. M. Valenzuela1, E. Rozengurt2, E. F. Reed1

  • Longer-Term Outcomes for Hepatitis C Virus Negative Recipients of Kidneys from Hepatitis C Virus Nucleic Acid Test Positive Donors: The THINKER Trial

    P. Reese1, P. Abt1, E. Blumberg1, R. Bloom1, D. Sawinski1, P. Porrett1, A. Woodards1, K. Reddy1, V. van Deerlin1, R. Hasz2, M. Levine1, R. McLean1, A. Sicilia1, D. Goldberg1

  • MELD Score and Anti-Angiotensin Receptor Antibody Predict Long-Term Survival of Liver Re-Transplant

    Q. Xu1, A. Skaro2, V. C. McAlister2

  • More Than Meets the Eye: The Use of Serial Intravascular Ultrasound for Assessment of Cardiac Allograft Vasculopathy after Heart Transplantation

    Y. Moayedi1, C. Fan2, M. Tremblay-Gravel1, R. J. Miller1, M. Kawana1, J. Parizo1, G. Oro1, R. Wainwright1, H. I. Luikart1, N. D'Emilio1, J. Gordon1, R. Kameda1, M. Ikutomi1, C. Manlhiot1, W. F. Fearon1, H. J. Ross1, K. K. Khush1, J. J. Teuteberg1

  • One Study: A Consortium Model of Clinical Trials Optimized for Comparing New Immune Therapies via Centralized Immune Monitoring

    B. Sawitzki1, S. Schlickeiser1, M. Streitz1, K. Jürchott1, J. Hutchinson2, E. Geissler2, P. Investigators3

  • Patterns of Rejection in Murine, Porcine, and Human Vascularized Composite Allografts Based on Clinical, Histologic, and Immunohistochemical Analysis

    M. J. Grzelak, J. W. Etra, F. A. Chang, G. J. Furtmüller, A. R. Ahmadi, F. Nägele, Y. Guo, K. Kambarashvili, A. Jain, S. A. Beck, C. F. Brayton, I. B. Sander, W. A. Lee, G. Brandacher

  • Post-operative Opioid Requirements In Living Kidney And Liver Donors

    H. J. Braun, D. Adelmann, T. Grace, M. E. Pulcrano, C. U. Niemann, N. L. Ascher

  • Predictors of Multidrug-Resistant Organisms among Solid Organ Transplant Donors

    J. A. Anesi1, E. A. Blumberg1, J. H. Han1, D. H. Lee2, H. Clauss3, A. Climaco4, R. Hasz5, E. Molnar3, D. Alimenti1, S. West5, W. Bilker1, P. Tolomeo1, E. Lautenbach1

  • Preliminary Mechanistic Studies of Regulatory Dendritic Cell (DCreg) Cell Infusion in Living Donor Liver Transplant Recipients

    A. Thomson, C. Macedo, A. Zahorchak, H. Dai, A. Humar, F. G. Lakkis, M. Styn, D. Metes

  • Primary Indications and Waitlist Status for Pediatric Living Donor Liver Transplants

    K. Goli1, K. Hosek2, A. Rana3, J. Goss3, T. Miloh3

  • Quantifying Donor Effects on Transplant Outcomes Using Kidney Pairs from Deceased Donors

    K. F. Kerr1, E. R. Morenz1, H. Thiessen Philbrook2, S. G. Coca3, F. P. Wilson4, P. P. Reese5, C. R. Parikh2

  • Racial/Ethnic and Socio-Economic Disparities: Single versus Multi-Organ Transplant Recipients

    C. A. Custer1, K. Ladin2, J. Entwistle3, E. J. Gordon4

  • Renal Recovery and Prognostic Factors in Children Following Liver Transplantation

    R. Büscher, N. Gantenberg, A. Büscher, E. Lainka, P. Hoyer

  • Robotic-Assisted versus Open- Kidney Transplantation in Non-Obese Recipients

    P. R. Modi, B. Pal, S. Singla, R. Chauhan, V. Kothari, A. Mishra, M. Modi, B. Butala, V. Kute, H. Patel, V. Trivedi

  • Significant Increase in Moderate to High KDPI Kidney Transplants Using a Multi-Operational Approach: Results from the COIIN (Collaborative Innovation and Improvement Network) Initiative

    T. Pesavento1, J. Foutz2, K. Sisaithong2, D. Klassen2, L. Stillion1, A. Rajab1, R. Pelletier3, K. Washburn1, H. Tosoc-Haskell2

  • Tertiary Lymphoid Organs in Renal Chronic Allograft Rejection

    K. Abou-Daya, D. Zhao, A. Williams, M. Oberbarnscheidt

  • The Effect of Kidney Transplantation on Neurocognitive Function: A Prospective Study

    B. P. Concepcion, J. C. Jackson, A. Kiehl, R. Adu-Boahene, E. Collar, M. Reed, M. Sika, J. Van, R. C. Forbes

  • The Impact of Antibiotic Therapy on Clinical Outcomes in Kidney Transplant Recipients with Asymptomatic Bacteriuria

    J. Gabriel1, S. Shaikh2, J. Park1, S. Tischer1, D. Kaul1, T. Patel1

  • The Impact of Extra-Anatomical Hepatic Artery Reconstruction during Living Donor Transplantation on Biliary Complications and Graft and Patient Survival

    Y. Chung, J. Kim, S. Kim, J. Rhu, S. Lee, K. Lee, S. Lee, G. Choi, J. Park, S. Kim, J. Joh, S. Lee

  • The Impact of Transplant Hospital Organ Procurement on Medicare Cost Report Reimbursement

    E. Y. Zavala1, J. Rogers2

  • Unique Gene Expression Signatures in Urine Distinguish T Cell Mediated Acute Rejection from BK Virus Nephropathy in Kidney Transplant Patients

    K. S. Keslar1, W. Xu2, A. A. Zmijewska3, K. A. Newell4, J. J. Friedewald5, M. I. Abecassis5, P. S. Heeger6, J. S. Bromberg7, R. B. Mannon3, R. L. Fairchild1

  • Variation in Racial Disparities in Liver Transplant Outcomes by Hospital Quality

    K. Ross, R. Patzer, R. Lynch

  • p40 Homodimer Indirectly Induce Proliferation of Endogenous Donor-Reactive Memory CD8 T Cells within High-Risk Allografts via IL-15 Signaling

    H. Tsuda, A. Valujskikh, R. Fairchild

  • An International Comparison of Kidney Utilization in the United States and United Kingdom: What Can Be Learned?

    D. Stewart1, G. Vece1, M. Ibrahim2, C. Callaghan2

  • Accelerating Kidney Allocation: Simultaneously Expiring Offers

    M. Kosztowski1, M. Mankowski2, S. Raghavan3, J. Garonzik-Wang1, D. Axelrod4, D. L. Segev1, S. E. Gentry1

  • Adult Living Donor vs. Deceased Donor Liver Transplant (LDLT vs. DDLT) at a Single US Center- Time to Change Our Paradigm for Liver Transplant

    A. Humar, D. Jorgensen, S. Ganesh, A. Tevar, M. Molinari, C. Hughes

  • An Open-Label Proof-of-Principle Phase 2A Study to Evaluate Autologous Hematopoietic Stem Cell Transplantation for Allogeneic Organ Transplant Tolerance (ASCOTT)

    A. Chruscinski1, H. Atkins2, A. Clement2, D. Grant1, C. Bredsen2, E. Renner1, J. Zhang1, M. Epstein1, L. Lilly1, N. Selzner1, O. Adeyi1, R. Smith1, S. Moshkelgosha1, A. Humar1, S. Juvet1, G. Levy1

  • Bisphosphonates Effectively Improve the Long Term Renal Transplant Outcomes; A Single Center Retrospective Study

    S. Song1, K. Huh2, H. Choi3, J. Lee2, D. Kim2, Y. Kim2, M. Kim2, S. Kim2, D. Joo2, B. Kim3

  • Bortezomib Based Induction Therapy Decreases Delayed Graft Function in High Risk Kidney Transplantation

    K. Mahendran1, N. Koizumi2, J. K. Melancon1

  • Chronic Changes on Time Zero Living Donor Allograft Biopsy Do Not Portend Future Kidney Function

    A. Agarwal1, A. Sites2, K. L. Brayman1, A. Doyle3, J. Oberholzer1, A. Nishio-Lucar3

  • Clinical Implications of Serum Mac-2 Binding Protein in Regular Follow Up after Pediatric Living Donor Liver Transplantation

    T. Ueno1, T. Kodama1, Y. Noguchi1, M. Nomura1, R. Saka1, Y. Takama1, Y. Tazuke1, K. Bessho2, H. Okuyama1

  • CyTOF and RNAseq Analyses Unravel Early Phenotypic and Transcriptional Changes in Antibody-Secreting and Memory B Cells >1 Year Prior to Antibody-Mediated Rejection

    C. Fischman1, M. Fribourg1, J. Ansari2, L. Gallon2, F. Ginevri3, P. Comoli4, M. Cioni3, A. Nocera3, M. Bruschi3, C. Cantarelli1, L. Perin5, P. Cravedi1

  • Earlier Transplant Education as CKD Progresses? CKD 3-5 Patients and Providers Weigh In

    A. D. Waterman1, O. N. Ranasinghe1, A. F. Lipsey2, C. S. Anderson1, A. Alem3, C. Bozzolo4, B. Dub3, S. L. Henry3, B. Mittman3

  • Effectiveness Of Percutaneous Embolization As Treatment Compared To Nephrectomy For Renal Graft Intolerance Syndrome In Late Graft Failure Patients

    S. Kwon, J. Go, S. Park, S. Yoon, J. Kim, I. Moon

  • Ex-Vivo Perfusion Mediated Delivery of Rituximab to Clear Latent Epstein-Barr Virus

    T. Ku, M. Cypel, R. V. Ribeiro, V. H. Ferreira, D. Kumar, A. Humar

  • Hard-to-Place Kidney Offers: Through the Lens of the United Network for Organ Sharing Organ Center

    S. M. Noreen, R. S. Brown, M. Lane, B. Wolford, C. A. Humphries

  • Impact of Coronary Artery Disease on Long-Term Mortality after Liver Transplantation

    S. S. Patel1, V. A. Rodriguez2, M. B. Siddiqui1, J. Laurenzano3, F. Lin3, J. Clinton3, M. Faridnia4, A. Chandrakumaran4, T. Reichman5, C. Bhati5, M. S. Siddiqui1

  • Impact of Early Borderline Histological Changes on Subsequent Events in Renal Transplant Recipients

    R. Mehta, S. Tandukar, D. Jorgensen, I. Owoyemi, N. Shah, C. Puttarajappa, C. Wu, S. Hariharan

  • Impact of Preoperative Rifaximin Use on Reducing Graft Injury in Liver Transplantation: A Propensity Matched Analysis

    T. Ito, K. Nakamura, S. Kageyama, H. Hirao, K. Kadono, J. Aziz, J. DiNorcia, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, J. Kupiec-Weglinski, F. M. Kaldas

  • Infectious Complications in Tocilizumab-Treated Kidney Transplant Recipients

    S. Sethi, A. Peng, R. Najjar, A. Vo, S. Jordan, E. Huang

  • Kidney Regeneration with Biomimetic Vascular Scaffolds Based on Vascular Corrosion Casts

    S. Min1, H. Mo1, A. Han1, J. Ha1, J. Yoo2

  • Long-Term Outcomes Following Uncontrolled Donation after Cardiac Death Kidney Transplantation: Opportunity for Increasing Donor Pool?

    R. A. Choudhury, K. Prins, D. Yoeli, H. B. Moore, T. L. Nydam

  • Molecular Analysis of Rejection and Injury in Human Liver Transplant Biopsies: First Results of the INTERLIVER Study

    P. F. Halloran and The INTERLIVER Study Group

  • Multicenter Cohort Study of Frailty and Access to Kidney Transplantation

    C. Haugen1, N. Chu1, H. Ying1, N. Desai1, S. Norman2, J. Garonzik-Wang1, A. Bingaman3, D. Segev1, M. McAdams-DeMarco1

  • Non-adherence With Diet And Dialysis Prescription: Predictors Of Non-adherence Post-transplant?

    A. Padiyar1, A. Agrawal1, D. Hricik1, P. Bate2, J. Rockwell2, A. Eliason2, N. Sarabu1, A. Jittirat1, K. Yadav2, E. Sanchez2, M. Debroy2, V. Humphreville2, J. Rabets2, A. Palanisamy2, K. Chavin2

  • Outcomes Of Single And En-bloc Pediatric Kidneys According To Kdpi

    M. Sampaio, E. Lum, A. Gritsch, S. Bunnapradist

  • PD-1+CD3+CD4-CD8- (Double Negative T-cells) Are Early Responders during Kidney Ischemia Reperfusion Injury and Regulated by Non-Classical MHC Molecules

    M. Sadasivam, S. Noel, S. Lee, J. Gong, A. Hamad, H. Rabb

  • Patient Perspectives of Informed Consent for Deceased Donor Organ Intervention Research

    E. Gordon1, B. Knopf1, A. Mussell2, C. Phillips2, R. Veatch3, P. Abt2, P. Reese2

  • Prolongation of Allograft Survival via Donor MHC Chimerism Induced by Exosomes

    B. Gonzalez Nolasco1, M. Wang1, W. Orent1, A. Prunevieille1, J. O1, K. Ahrens1, J. C. Madsen2, G. Benichou1

  • Proteomics Reveals Compartment-Specific Alterations in the Extracellular Matrix of Kidney Allografts with Antibody-Mediated Rejection

    S. Clotet Freixas1, C. McEvoy1, I. Batruch2, M. Kotlyar3, C. Pastrello3, J. Van1, A. Bozovic1, V. Kulasingam1, P. Chen4, I. Jurisica3, A. Chruscinski1, R. John1, A. Konvalinka1

  • Recipient Antibiotics Pretreatment Protects Liver Transplants from Ischemia-Reperfusion Injury via Prostaglandin E2: From Bench-to Bedside

    K. Nakamura, S. Kageyama, T. Ito, H. Hirao, K. Kadono, K. J. Dery, J. Aziz, B. Ke, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski

  • Rejection Of Optic And Sciatic Transplants

    M. Yonar1, M. Uehara1, V. Kasinath1, F. Bei2, R. Abdi1

  • SIRPα Typing as a Potential Tool for Risk Stratification in Kidney Transplantation

    A. Casillas-Abundis, A. Tambur, D. F. Pinelli, R. Hod-Dvorai, C. Garcia-Sanchez

  • Simulated Tier Variability

    N. Salkowski, A. Wey, J. Snyder

  • Social Loafing: Distribution of Kidneys with Multiple Renal Arteries in a National Paired Kidney Exchange Program

    G. R. Roll1, W. Irish2, M. Cooper3, M. Ronin4, G. Hil4, A. D. Waterman5, D. B. Leeser2

  • Sphingosine 1-Phosphate Receptor 2 Regulates Migration through Endothelial Cell VCAM and Adherens Junctions

    Y. Xiong1, W. Piao1, C. Brinkman1, L. Li1, J. Kulinski2, A. Olivera2, A. Cartier3, T. Hla3, K. Hippen4, B. Blazar4, S. Schwab5

  • The Comparative Safety and Efficacy of Direct Acting Oral Anticoagulants Relative to Warfarin Following Liver Transplantation

    A. Santeusanio, A. Weinberg, T. Schiano

  • The Evolving Clinical Presentation of Acute Rejection in Face Transplantation

    V. Haug, B. Kollar, D. Obed, H. Kiwanuka, M. Turk, L. Wo, S. Tasigiorgos, M. Kueckelhaus, L. Riella, B. Pomahac

  • The National Landscape of Heart Transplant Candidates with HIV

    A. A. Shaffer1, A. G. Thomas2, D. L. Segev1

  • The Outcomes after an Infection in Older Liver Transplant Recipients is Comparable to Younger Adults

    J. Garcia-Diaz1, M. Kerkelis2, T. Shah3, M. Tucker4, M. Gastanaduy5, J. Woo1, M. Ponder1, M. Malinis6, M. Malinis6

  • The Safety of Surveillance and Indication Biopsies in Kidney Transplantation: A Series of 2000 Biopsies

    A. S. Naik1, Y. Huang2, D. M. Cibrik3, E. Shaban1, M. McGuire1, C. Boyer1, S. P. Norman1

  • The Use of dd-cfDNA as a Predictive Tool for Outcome Decreased Kidney Function

    T. Alhamad1, E. Poggio2, D. Hiller3, S. Dholakia3, P. Sood4

  • Unos Analysis Of Deceased Donor Renal Transplant (ddrtx) Outcomes In Sensitized Patients After Implementation Of The Kidney Allocation System (kas)

    R. J. Crew, K. L. King, M. Fajardo, J. Hedvat, N. Lange, S. Husain, S. Mohan, L. E. Ratner, S. S. Patel

  • Utilizing Changing Patterns of T-cell Metabolism in Aging for Effective Immunosuppression

    Y. Nian, T. Heinbokel, K. Minami, R. Maenosono, J. Iske, A. El Khal, S. G. Tullius

  • Utilizing Ides To Eliminate Residual Antibodies Targeting Xenografts

    C. Rickert, K. Lee, N. Tanimine, J. Lei, A. Cuenca, N. Feeney, K. Deng, H. Yeh, J. F. Markmann

  • Viability Testing and Transplantation of Marginal Donor Livers (VITTAL) Trial: Metabolomics of Ex Vivo Normothermically Machine Perfused Livers Discloses Molecular Signatures Predictive of Graft Viability and Post Transplant Outcomes

    J. Attard1, W. Dunn2, L. Wallace1, R. Laing1, Y. Boteon1, H. Mergental3, D. Mirza3, T. Perera3, S. Afford1

  • Visceral Arterial Embolization – An Important Tool For Managing Blood Loss In Multivisceral Transplant Candidates With Portomesenteric Thrombosis

    D. P. Borle, J. A. Shah, R. Kadiyala Venkata, D. Vikraman, B. Collins, S. Knechtle, A. Rege, A. Barbas, C. Kim, T. Smith, P. Sohocki, D. L. Sudan

  • Validation Of The Optimized Prediction Of Mortality (Opom) Machine Learning Model For Non-hepatocellular Carcinoma Candidates Awaiting Liver Transplant

    L. Lau1, X. Xie2, F. Jia2, P. D. Greig1, T. C. Chan2

  • 6-Minute Walk Testing in Patients on the Kidney Transplant Waitlist

    X. S. Cheng1, J. Lee2, K. V. Discipulo1, J. Myers3, J. C. Tan1

  • The Effects of Anti-BAFF Monoclonal Antibody in the HLA-A2 Sensitized Mouse Model

    J. Min1, H. Lee2, B. Kim3, K. Park4, K. Doh3, T. Kim5, H. Yoon6, C. Yang7, E. Oh2, B. Chung7

  • A CMV Vaccine Based on Non-Replicating Lymphocytic Choriomeningitis Virus Vectors Expressing gB and pp65 is Safe and Immunogenic in Healthy Volunteers and Entering a Phase 2 Trial in Kidney Transplant Recipients

    C. N. Kotton1, M. Schwendinger2, G. Thiry3, B. De Vos4, F. De Boever5, G. Leroux-Roels6, A. Lilja7

  • A Prospective Randomized Multicenter Trial (B E S T Trial) of Belatacept-Based C N I- and Corticosteroid-Free Immunosuppression: Final Two Year Results

    D. B. Kaufman1, A. R. Shields2, J. P. Leone3, A. Wiseman4, A. J. Matas5, P. West-Thielke6, J. Lipscomb2, E. King2, R. R. Alloway7, E. S. Woodle for the BEST Study Group2

  • A Randomized Controlled Clinical Trial of Thymoglobulin® and Extended Delay of Calcineurin Inhibitor Therapy for Renal Protection after Liver Transplantation: A Multicenter Study

    L. Coromina1, S. Shah2, B. Xervos3, M. Zimmerman4, K. Sasaki1, T. Diago1, K. Hashimoto1, F. Aucejo1, m. Fujiki1, H. Block-Beach1, A. Patterson2, C. Miller1, C. Quintini1, B. Eghtesad1

  • Adjuvant Immunotherapeutic Approach For Liver Transplant Recipients With Hepatocellular Carcinoma Using Donor Liver Derived Natural Killer Cells

    M. Ohira1, R. Hotta1, Y. Imaoka1, K. Sato1, Y. Tanaka1, A. G. Tzakis2, S. Nishida3, H. Ohdan1

  • Antirejection Efficacy in De Novo Renal Transplant Recipients Receiving Everolimus with a Reduced-Exposure Calcineurin Inhibitor-Based Regimen: 24-Month Results from the TRANSFORM Study

    H. Tedesco Silva1, F. Citterio1, M. Henry1, T. R. Srinivas1, Y. Watarai1, S. Steinberg1, N. Basic-Jukic1, V. D. Garcia1, E. Mor1, V. R. Peddi1, P. Narvekar2, M. P. Hernandez Gutierrez2, P. Bernhardt2, J. Pascual1

  • B Cell IL-4 Signaling Induces the IL-10 Secreting TIM-1+ Bregs and Suppresses T Cell Inflammatory Cytokines

    Z. Song, K. Mohib, D. M. Rothstein

  • Capitalizing On Donor Density To Increase Organ Pool – An Analysis Of Urban And Rural Organ Donors

    S. Bakhtiyar, S. Ahmed, J. A. Goss, A. Rana

  • Clazakizumab as an Agent to Reduce Donor Specific HLA Antibodies and Improve Outcomes in Patients with Chronic & Active Antibody-Mediated Rejection Post-Kidney Transplantation

    S. C. Jordan1, N. Ammerman1, M. Toyoda2, E. Huang1, C. C. Nast3, A. Peng1, S. Sethi1, R. Najjar1, I. Kim1, K. Lim1, J. Choi1, A. Vo1

  • Concentric Circles, One Year in: Concentrated Organ Discard and Waitlist Deaths in High Traffic Areas

    R. J. Lynch1, S. Karp2, W. Chapman3

  • Consideration for Offering Hepatitis C Antibody Positive Donor Grafts to All Patients Listed for Transplant

    L. Smith

  • Dialysis Facility Provider Transplant Knowledge after a Randomized Multilevel Intervention to Increase Kidney Transplant Referral and Evaluation in the Southeast

    K. Maroney1, R. Hamoda1, L. McPherson1, A. Cruz2, S. Pastan1, L. Plantinga1, S. Paul1, M. Ellis3, D. DuBay4, A. Reeves-Daniel5, R. Detwiler6, E. Hartmann7, H. Jones8, B. Thrasher9, C. Zayas10, L. Mulloy10, S. Wright11, R. Patzer1

  • Eculizumab Deposition in Renal Transplants

    D. WANG1, S. H. Nasr1, A. B. Farris2, C. A. Schinstock3, M. P. Alexander1, L. D. Cornell1

  • Effect of Induction Therapy on Outcomes of De Novo Renal Transplant Recipients Receiving Everolimus with Reduced-Dose Calcineurin Inhibitor: 24-Month Results from the TRANSFORM Study

    R. Oberbauer1, F. Vincenti1, O. Viklicky1, U. Huynh-Do1, D. Kim1, J. M. Cruzado1, Y. Qazi1, M. S. Kim1, P. Narvekar2, M. P. Hernandez Gutierrez2, P. Bernhardt2, D. Kuypers1

  • Efficacy and Safety with Empagliflozin in Renal Transplant Recipients with Post-Transplant Diabetes Mellitus

    K. E. Kvitne1, T. S. Halden2, A. Åsberg2, K. Midtvedt2, A. Hartmann2, T. Jenssen2

  • Epidemiology and Outcomes of BKV Nephropathy Management by Screening Policy in a Real-Life Setting

    V. D. GARCIA1, F. V. Raupp1, G. MEINERZ1, K. Piegas2, E. KEITEL1

  • Evaluation of Influenza Virus Antibody Response in Naturally Infected and Vaccinated Transplant Recipients by Protein Microarray

    C. Hirzel, A. Chruscinski, V. H. Ferreira, A. G. L'Huillier, A. Humar, D. Kumar

  • High Numbers of Differentiated CD8+CD28– T Cells Are Associated with a Substantially Lowered Risk for Late Rejection and Graft Loss after Kidney Transplantation

    M. G. Betjes, A. Langerak, M. Klepper, N. Litjens

  • Human Urine-Derived Stem Cells Protect against Renal Ischemia Reperfusion Injury via Releasing Exosomal miR-146a-5p Which Targets IRAK1 in a Rat Model

    X. Li, Z. Bi, Q. Su, H. Huang, L. Liu, C. Wang

  • Incidence of Autoresuscitation in Donation after Cardiac Death Donors

    C. W. Koo1, R. A. Helmick1, K. Van Frank2, K. Gilley2, J. D. Eason1

  • Increase in 48 Month Cumulative Acute Rejection Rates in the Most Recent Cohort: The 2018 Transplant Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)

    V. Dharnidharka1, C. Cramer2, A. Chua3, A. Moudgil4, K. Martz5, T. Blydt-Hansen6, J. Smith7, A. Neu, on Behalf of The NAPRTCS Investigators8

  • Increasing Time-in-Therapeutic Range of Tacrolimus is Associated with Superior Outcomes in Living Kidney Transplants

    T. Lin, T. Song, S. Yin, Y. Jiang, Z. Huang, X. Wang, J. Liu, Z. Wang

  • Mismatched Epitope and De Novo DSA Development: An Analysis of the Benefit and Benefit-EXT Renal Transplant Cohorts

    V. Jucaud1, V. Burnett1, H. Gebel2, R. Bray2, M. Polinsky3, M. Everly1

  • Not All Poor Metabolizers Are Clinically Equal: Evaluating Weight-Based Tacrolimus Outcomes in CYP3A Loss of Function Variants

    A. Q. Maldonado, W. Irish, T. E. Asempa, J. Gooden, M. L. Davis, C. Haisch, H. Jones, D. Leeser, L. Rebellato

  • Not for the Faint of Heart: The Impact of Post-Reperfusion Syndrome during Liver Transplantation Using Livers with Significant Macrosteatosis

    K. P. Croome, D. Lee, S. Croome, R. Chadha, D. Livingston, P. Abader, A. P. Keaveny, C. Taner

  • Opening the Doors of Hope: HIV-Positive Living Kidney Donation

    S. Rusch, L. Fieldman, M. Hemmersbach-Miller, C. R. Wolfe

  • Opioid Minimization in Kidney Transplant: Achievable Quicker Than You Think

    J. N. Fleming, N. Patel, H. Gonzales, N. A. Pilch, S. Parks, C. Perez, P. K. Baliga, S. N. Nadig, D. J. Taber, V. Rohan

  • Opioid and Benzodiazepine Use in Lung Transplant Candidates: A National Survey of Policies and Practices

    H. Bruschwein1, V. Andersen1, H. Patel2, J. Fleming3, A. Shahane1, M. Weder1

  • Outcomes for Robotic Pancreas Transplants in Obese Candidates

    M. Spaggiari, K. A. Tulla, O. T. Okoye, C. Di Bella, P. Di Cocco, J. A. Almario Alvarez, I. G. Tzvetanov, E. Benedetti

  • Patterns and Predictors of Alcohol Use after Early Liver Transplant for Alcoholic Hepatitis

    B. P. Lee1, M. Rinella2, G. Im3, J. Rice4, O. Fix5, G. Therapondos6, H. Han7, D. Victor8, E. Weinberg9, C. Hsu10, M. Voigt11, H. Maddur2, S. Eswaran12, D. Foley4, R. Ghobrial8, L. Dinges5, J. Dodge1, N. Mehta1, M. Lucey4, N. Terrault1

  • Pre-Transplant Transcriptomic Signature in Peripheral Blood Predicts Early Acute Rejection after Kidney Transplant

    W. Zhang1, Z. Yi1, C. Wei1, K. Keung2, Z. Sun1, C. Xi1, C. Woytovich1, S. Farouk1, L. Gallon3, M. Menon1, C. Magee4, N. Najafian4, M. Samaniego5, A. Djamali6, S. Alexander2, I. Rosales7, R. Smith7, P. O'Connell2, R. Colvin7, P. Cravedi1, B. Murphy1

  • Preemptive Kidney Transplantation: Is There a Role for ABO Incompatible Transplantation?

    M. N. Mustian1, B. A. Shelton1, P. A. MacLennan1, R. D. Reed1, G. McGwin1, B. J. Orandi1, D. Sawinski2, V. Kumar1, J. E. Locke1

  • Preserved Heart Rate Variability and Endothelial Function One Year after Pancreas Transplantation

    E. Nordheim, T. Halden, K. Birkeland, A. Åsberg, T. Jenssen

  • Single Nucleotide Polymorphisms in NFACT1 rs2290154 Associated with the Risk of T Cell-Mediated Rejection of Recipients Following Kidney Transplantation

    Z. Wang, S. Fei, H. Chen, L. Sun, Z. Han, J. Tao, X. Ju, R. Tan, M. Gu

  • Targeting Cell Metabolism for Efficient Large-Scale Expansion of Functional Regulatory T Cells

    R. Gedaly-Eidelman, F. Marti, L. Turcios, E. Chacon, D. Valvi

  • The Protective Effects of siRNA Conjugated Nanoparticles in Pancreatic Islet Cells after Transplant

    T. Pomposelli, P. Wang, Y. Ariyoshi, K. Takeuchi, C. Schuetz, A. Moore, K. Yamada

  • The Risk of Systematic Error in Liver Transplant Opioid Research

    J. N. Fleming, N. A. Pilch, S. Ball, P. K. Baliga, D. DuBay, D. J. Taber

  • Total Parenteral Nutrition in Ex Vivo Lung Perfusion: Addressing Metabolism Improves Both Inflammation and Overall Graft Performance

    M. T. Buchko, S. Hatami, C. J. Stewart, S. Himmat, D. H. Freed, J. Nagendran

  • Transplant Center Practices Are the Primary Drivers of United States Donation after Circulatory Death Liver Transplantation

    L. Beal1, D. T. Nguyen2, T. Menser3, S. Zajac1, E. A. Graviss2, M. J. Hobeika1

  • Transplanting Thoracic Organs From Hcv Donors To Uninfected Patients: Evaluation Of Lung Allografts

    Y. Lo1, R. F. Padera1, H. R. Mallidi2, H. J. Goldberg3, S. K. Singh2, A. Coppolino, III4, L. R. Baden5, A. E. Woolley5

  • Utilization of Donor Kidneys with Acute Kidney Injury in Pediatric Transplantation

    C. S. Hwang1, B. Tanriover2, S. Levea2, D. Desai1, V. Ariyamuthu2, P. Vagefi1, M. MacConmara1

  • Vo2peak Superior to Current Established Measure of Post Kidney Transplant Survival Score (EPTS Score)

    H. Chakkera1, R. Butterfield1, M. Buras1, B. Kaplan2

  • A Comparison of Cell-Mediated Immune Responses among Organ Transplant Recipients Receiving High-Dose vs Standard-Dose Influenza Vaccine

    A. G. L'Huillier, V. H. Ferreira, Y. Natori, T. Ku, C. Hirzel, M. Ierullo, A. Humar, D. Kumar

  • African American Living Kidney Donors’ Perceptions of APOL1 Genetic Testing and Its Impact on Ethnic Identity

    E. J. Gordon1, D. Amortegui1, C. Wicklund1, J. Friedewald1, R. Sharp2

  • Association between Medicaid Expansion under the Affordable Care Act and Preemptive Kidney Transplantation of Low-Income Medicaid Beneficiaries

    M. N. Harhay1, R. McKenna2

  • Belatacept Based Simultaneous Calcineurin Inhibitor Avoidance/Early Corticosteroid Withdrawal is Associated with Low New Onset Diabetes Risk

    A. R. Shields1, P. West-Thielke2, E. S. Woodle1, D. B. Kaufman3, J. Lipscomb4, J. P. Leone5, A. Wiseman6, E. King4, A. J. Matas7, R. R. Alloway for the BEST Study Group4

  • Biomarker Candidate Discovery for Kidney Allograft Monitoring via Urinary Exosome Proteome Analysis

    J. Kim1, Y. Wee1, M. Choi1, H. Jung1, J. Choi1, H. Kwon1, J. Jung1, Y. Ko1, D. Kim1, K. Kim2, Y. Cho3, H. Go3, Y. Kim1, D. Han1, S. Shin1

  • Can Cardiac Risk Predictor Models Be Trusted in Kidney Transplant Recipients?

    K. L. Hoffman1, R. R. Alloway1, A. Shields2, E. Woodle2, A. Govil1

  • Care of International Living Kidney Donor Candidates in the U.S.: A Survey of Contemporary Experience, Practice & Challenges

    K. Lentine1, M. Henderson2, S. Rasmussen2, E. Shukhman3, J. Hunt4, F. Al Ammary2, V. Kumar5, D. Lapointe-Rudow4, H. Schaefer6, M. Cooper7, R. Hays8, M. Dunbar-Forrest9, A. Nishio-Lucar10, D. Mandelbrot8

  • Clazakizumab (CLZ, Anti-IL-6 Antibody) and Tocilizumab (TCZ, Anti-IL-6 Receptor [r] Antibody) Treatments Differentially Affect IL-6/IL-6R Signaling by Modulating Soluble IL-6R (sIL-6R) and gp130 (sgp130) in Kidney Transplant Patients (KTx Pts) Treated for Chronic Antibody-Mediated Rejection (cABMR)

    B. Shin, S. Ge, A. Petrosyan, N. F. Ammerman, A. A. Vo, S. C. Jordan, M. Toyoda

  • Conversion from Calcineurin Inhibitors to Belatacept in Kidney Recipients with Donor-Specific Anti-HLA Antibodies and Calcineurin Inhibitor Nephrotoxicity Decreases the Pathogenicity of Donor-Specific Anti-HLA Antibodies

    K. Louis1, D. Viglietti1, D. Pievani1, O. Aubert1, D. Glotz1, C. Legendre1, A. Zeevi2, A. Loupy1, C. Lefaucheur1

  • Donor Graft CMV Serostatus Influences the Development of Arterial and Venous Vascular Events in Seronegative Recipients after Organ Transplantation

    S. Belga, C. MacDonald, D. Chiang, D. Kabbani, S. Shojai, J. G. Abraldes, C. Cervera

  • Effect of ATG on Monocytic Myeloid-Derived Suppressor Cells and Its Associated Mechanisms in Kidney Transplantation Recipients

    Y. Jiang, X. Zhang

  • Efficacy and Safety Outcomes with De Novo Use of Everolimus-Based Regimen in Renal Transplant Recipients with Delayed Graft Function from the TRANSFORM Study

    S. Chadban1, F. Oppenheimer1, F. Citterio1, O. Witzke1, V. D. Garcia1, A. Gutierrez-Dalmau1, P. Narvekar2, M. P. Hernandez Gutierrez2, P. Bernhardt2, A. Wiseman1

  • Epstein Barr Virus (EBV)-Specific T Cells as a Diagnostic Marker for the Individual EBV-Specific Immune Response after Pediatric Kidney Transplantation

    T. Ahlenstiel-Grunow, L. Pape

  • Frailty and BMI in Liver Transplant Candidates: 9-Center Functional Assessment in Liver Transplantation Study

    C. Haugen1, M. McAdams-DeMarco1, D. Segev1, E. Verna2, R. Rahimi3, M. Kappus4, M. Volk5, M. Dunn6, A. Duarte Rojo6, D. Granger7, J. O'Leary8, D. Ladner7, J. Lai9

  • Have Graft Outcomes Improved for Pediatric Transplant Recipients Since the Implementation the Kidney Allocation System

    C. S. Bell1, S. Hebert2, A. De Golovine3, R. Swinford1

  • High Fibre Diet Prevents Transplant-Associated Dysbiosis and Prevents Kidney Allograft Rejection

    J. J. Singer1, H. Wu1, T. Kwan1, Y. Loh1, C. Wang1, J. Tan2, L. Macia2, S. Alexander3, S. Chadban1

  • How and Why Dyrk1a is Required for Optimal Foxp3+ Treg Functions

    W. W. Hancock, N. Zhou, R. Han, L. Wang

  • Iguratimod Inhibits the Donor Specific Antibodies Production and Attenuates the Antibody Mediated Rejection in Rat Kidney Transplantation

    Z. Wang, M. Zheng, H. Chen, S. Li, Z. Han, J. Tao, X. Ju, R. Tan, M. Gu

  • Impact Of Subclinical Bk Virus-associated Nephropathy In High-risk Recipients

    M. E. Seifert, E. P. Kasik, M. Bernard, G. Agarwal, H. Fatima, R. Gaston, B. Julian, C. Kew, V. Kumar, S. Mehta, S. Ong, F. Rosenblum, G. Towns, R. B. Mannon

  • Impact of Liver Recipient Genotype on Tacrolimus

    S. Tremblay1, T. Fukuda2, T. Mizuno2, A. A. Vinks2, E. Woodle1, J. Klawitter3, J. Klawitter3, U. Christians3, R. R. Alloway1

  • Islet Xenotransplantation: A Quest for Clinically Available Immunosuppression Regimens

    Z. W. Fitch1, Q. Gao1, R. P. Davis1, M. S. Mulvihill1, M. Song1, F. Leopardi1, M. Ribeiro1, T. How1, K. Reimann2, G. R. Devi1, B. H. Collins1, A. D. Kirk1

  • Lineage Tracing Identifies C-­Kit Cells as a Population of Kidney-Specific Stem Cells during Development and in Acute and Chronic Kidney Diseases

    E. B. Rangel1, E. Higuti-Sousa1, G. Goss2, B. Goldstein2, B. Seidler3, D. Saur3, S. A Gomes4, J. M. Hare2

  • Long-Term Survival after Kidney-Pancreas Transplantation: Lessons from World Largest Series of Long-Term Survivors

    S. Parajuli, F. Aziz, N. Garg, B. Muth, A. Djamali, R. Redfield, D. Kaufman, J. Odorico, D. Mandelbrot, H. Sollinger

  • Normothermic Ex-Vivo Kidney Perfusion Preservation Consistently Improves Extreme Marginal Graft Function Compared to Hypothermic Machine Perfusion

    P. Urbanellis1, M. Hamar1, I. Linares1, D. Kollmann1, S. Ganesh1, F. Oquendo1, M. Sharma1, R. John1, A. Ghanekar1, I. Mucsi1, D. Bagli2, A. Konvalinka1, L. Robinson3, M. Selzner1

  • Occult Liver Graft Fibrosis Prior to Transplantation Influences Clinical Outcomes

    H. Hirao, T. Ito, K. Kadono, S. Kageyama, K. Nakamura, K. J. Dery, B. Ke, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski

  • Optimal Timing of Hepatitis C Treatment among HIV/HCV Co-Infected End-Stage Renal Disease Patients: Pre vs. Post-Transplant

    B. Shelton1, G. Berdahl1, D. Sawinski2, B. Linas3, P. Reese2, M. Mustian1, R. Reed1, P. MacLennan1, J. Locke1

  • Policy Changes in Facilitated Pancreas Allocation Support Pancreas Utilization

    R. Urban1, J. S. Odorico2, S. V. Niederhaus3, R. Carrico1, A. Fox1

  • Prevention of Ischemia Reperfusion Injury (IRI) & ABMR in HLA Sensitized Patients Treated with C1 Esterase Inhibitor (C1INH): Long-Term Follow Up

    A. A. Vo, E. Huang, N. Ammerman, J. Choi, I. Kim, A. Peng, R. Najjar, S. Sethi, K. Lim, S. C. Jordan

  • Promotion of Chimerism by Lymphohematopoietic Graft-versus-Host Responses in Patients Receiving Intestinal Transplantation

    J. Fu1, J. Zuber1, B. Shonts1, A. Obradovic1, K. Frangaj1, E. E. Waffarn1, S. Lau1, T. M. Savage1, S. Yang1, K. Rogers1, P. Satwani2, S. Ho1, Y. Shen3, A. Griesemer4, M. Martinez2, T. Kato4, M. Sykes1

  • Prospective Multi-Regional Study of Down-Staging of Hepatocellular Carcinoma to within Milan Criteria before Liver Transplantation

    N. Mehta1, J. Guy2, C. Frenette3, P. Tabrizian4, M. Hoteit5, R. Dhanasekaran6, J. Dodge1, M. L. Holzner4, L. Frankul3, S. Florman4, N. Parikh7, F. Yao1

  • Racial and Ethnic Disparities in Access to Living Donor Kidney Transplantation in the US: Have We Made Any Progress among Pediatric Candidates over the Last Twenty Years?

    T. Purnell1, S. Bae1, X. Luo1, A. Chen1, D. Crews1, L. Cooper1, O. N. Bignall II2, K. Covarrubias1, D. Segev1

  • Recipient Outcomes Following Transplantation Of Allografts From Older Live Kidney Donors With Hypertension

    F. Al Ammary1, S. Yu2, A. D. Muzaale3, D. C. Brennan4, A. C. Wiseman5, D. L. Segev3, A. B. Massie3

  • Recipients with Model for End-Stage Liver Disease Sodium Score Driven by Renal Dysfunction Have Increased Post-Transplant Mortality

    T. Bittermann, D. Goldberg

  • Reduction in Waitlist Time Using HCV Positive Liver Grafts in HCV Negative Recipients

    E. M. Bugeaud, N. Bzowej, J. Hand, J. Scheuermann, H. Bohorquez, C. Brown, D. Bruce, I. Carmody, A. Cohen, S. Joshi, N. Latt, J. Seal, D. Sonnier, G. Therapondos, G. Tyson, N. Girgrah, G. Loss

  • Role of Procurement and Reperfusion Biopsy in Kidney Transplant in Evaluating and Predicting Outcomes of Deceased Donor Kidneys

    S. Faiz, A. Pai, A. De Golovine, A. Edwards, W. Glass, A. Tchakarov

  • Selective CD28 Blockade-Mediated Inhibition of T Follicular Helper Cell and DSA Responses is CTLA-4 Dependent

    G. M. La Muraglia II, M. L. Ford, I. R. Badell

  • Success in Lung Transplantation Outcomes after Receiving a Standardized Desensitization Therapy

    S. Ganesh1, C. L. Prohaska2, C. Mares2, M. J. Everly3

  • Successful Kidney Transplantation of Highly Sensitized Candidates across Positive Cross Match and Strong Donor-Specific HLA-DP Antibodies without Desensitization

    R. Rajalingam1, D. D. Gae2, Z. G. Laszik3, M. M. Tavakol4, A. B. Webber5, K. Cunniffe2, G. da Gente2, R. Hirose4, G. Roll4, C. E. Freise4, J. P. Roberts4

  • Ten Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Living Donor Renal Transplant Recipients

    J. Leventhal1, J. Galvin1, L. Gallon1, D. Stare1, K. Ravindra2, M. Horwitz2, M. Abecassis1, S. Ildstad3

  • The Burden of Recipient Driving Distance and Post Lung Transplant Outcomes: A National Cohort Study

    W. Tsuang, S. Arrigain, R. Lopez, M. Snair, K. McCurry, M. Budev, J. Schold

  • The More You Wait, the More You Lose: Prostatectomy and Kidney Transplant Waiting Time in End Stage Renal Disease

    N. Sarabu1, N. Schiltz2, K. D. Chavin1, D. E. Hricik1

  • Ultra-Short Duration Direct Acting Anti-Viral Prophylaxis to Prevent Virus Transmission from Hepatitis C Viremic Donors to Hepatitis C Negative Kidney Transplant Recipients

    G. Gupta, I. Yakubu, C. Bhati, A. Ferreira-Gonzalez, D. Kumar, I. Moinuddin, L. Kamal, A. King, M. Levy, A. Sharma, A. Coterell, T. Reichman, A. Khan, P. Kimball, R. Stiltner, M. Baldecchi, N. Brigle, T. Gehr, R. Sterling

  • Variations in DCD Procurement Procedures across Opos and Their Effects on Liver Transplant Outcomes

    A. P. Choubey1, G. Mitro1, E. J. Siskind2, A. C. Ortiz3, M. Nayebpour4, N. Koizumi4, P. Wiederhold5, J. Ortiz1

  • Recipient Myeloid Notch1 Disruption Shifts Neutrophil towards Anti-Inflammatory Phenotype and Protects Liver Grafts from Ischemia-Reperfusion Injury

    S. Kageyama1, H. Hirao1, K. Kadono1, K. Nakamura1, K. J. Dery1, T. Ito2, D. Oncel1, J. Aziz1, B. Ke1, F. M. Kaldas2, R. W. Busuttil2, J. W. Kupiec‐Weglinski1

  • Lifestyle Intervention in Renal Transplant Recipients: A Multicenter, Randomized Clinical Trial

    E. Corpeleijn1, G. Klaassen2, D. M. Zelle2, D. Dijkema3, I. van Vliet2, F. J. Bemelman4, G. J. Navis2, S. J. Bakker2

  • Assessing Pressure to Donate among Potential Living Kidney Donors

    D. R. Helfer1, J. Stanton2, E. A. King1, A. K. Eno1, J. M. Ruck1, A. A. Shaffer1, A. G. Thomas1, M. M. Waldram1, A. M. Cameron1, J. Kahn1, L. Erby1, M. L. Henderson1, D. L. Segev1, J. M. Garonzik Wang1

  • Belatacept Monotherapy in Kidney Transplant Recipients with Failed Allografts Reduces Humoral Sensitization in a Single Center Randomized Controlled Trial

    I. R. Badell, R. Elbein, R. A. Bray, H. M. Gebel, A. B. Adams, C. P. Larsen

  • Circulating Donor Specific Antibody and Biopsy C4d Positivity in Pancreas Rejection Increase the Probability of Earlier Return to Insulin after Rejection

    S. M. Riad1, S. Jackson2, E. B. Finger3, R. Kandaswamy3

  • Circulating Exosomes Isolated from Human Lung Transplant Recipients with Respiratory Viral Infections Contain Nucleic Acids Specific to Virus and Can Lead to Activation of Stress Proteins

    S. Bansal, R. Bremner, M. Smith, T. Mohanakumar

  • Comparison of Pregnancy Outcomes by Conception Age in Female Kidney Transplant Recipients

    S. Rao1, L. A. Coscia2, D. Kliniewski2, S. Constantinescu3, M. J. Moritz4

  • Creating Geographic Catchment Areas for Solid Organ Transplant Centers

    K. Ross1, R. Patzer2, D. Axelrod3

  • Decay Accelerating Factor (DAF) Regulates Germinal Center B-cell and Alloantibody Formation

    A. Cumpelik1, G. Varano2, D. Heja1, D. Homann3, S. Lira4, D. Dominguez-Sola2, P. S. Heeger1

  • Deceased-Donor Acute Kidney Injury Associates with Less BK Viremia in Kidney Transplant Recipients

    I. E. Hall, P. P. Reese, S. G. Mansour, S. Mohan, M. D. Doshi, Y. Jia, H. R. Thiessen-Philbrook, E. Akalin, M. N. Harhay, T. Muthukumar, B. Schröppel, P. Singh, F. L. Weng, J. S. Bromberg, C. R. Parikh

  • Differences of Gut Microbiota Composition between Donor and Recipient May Predict 1-Year Graft Function

    J. Kim1, H. Cho2, J. Park3, J. Jeong1, M. Kwak4, B. Kim4, D. Kim1, J. Lee5, B. Kim6, Y. Kim1, H. Lee1

  • Digital Imaging Software vs. the “Eyeball” Method in Quantifying Steatosis in a Liver Biopsy

    J. Long1, J. Motter1, S. Besharati1, S. Jerman2, R. Anders1, A. Ortiz2, D. Bowman2, T. Dunn3, D. Lee4, A. Massie1, R. Barth5, B. Philosophe1

  • Donation After Circulatory Death Kidneys With Prolonged Delayed Graft Function Present Widespread Metabolic And Translational Deficiencies At Time Of Retrieval

    M. L. Lo Faro1, K. Rozenberg1, H. Huang1, S. Maslau1, H. Leuvenink2, E. Sharples3, R. Ploeg1

  • Early Impact of the New United Network for Organ Sharing Simultaneous Liver-Kidney Transplantation Allocation Policy: Improved Standardization but Similar Utilization

    G. Cullaro1, E. C. Verna2, J. C. Lai1

  • External Validation of the Living Kidney Donor Profile Index (LKDPI) in the Canadian Kidney Transplant Recipient Population

    M. Shantier1, Y. Li1, M. Ashwin1, O. Famure1, S. K. Singh2

  • Gender Disparity In Access To Liver Transplant Larger In White Than Black Patients

    K. Guo, J. Peipert, M. Abecassis, L. Zhao, D. Ladner

  • Hepatitis C Treatment and Transplant Outcomes in Liver Transplant Recipients with Hepatitis C Positive Donors

    I. Booth, J. Clark, J. C. LaMattina, A. Haririan, R. N. Barth, B. Ravichandran

  • Impact of Recipient Age in Combined Liver-Kidney Transplantation (CLKT): Caution is Needed for Elderly Patients≥70 Years

    B. Ekser1, W. C. Goggins1, R. S. Mangus1, P. Mihaylov1, J. A. Fridell1, M. A. Lacerda2, M. S. Ghabril2, J. A. Powelson1, C. A. Kubal1

  • Improving Living Donor Follow Up

    L. Aronoff, V. Nair, C. Flores, M. Bhaskaran, E. Molmenti, A. Fahmy, M. Zhou, E. Grodstein, D. Campbell, C. Literello, L. Teperman

  • Improving Medication Adherence and Outcomes in Adult Kidney Transplant Patients Using SystemCHANGETM: Results of the Medication Adherence Given Individual Change (MAGIC) Randomized Clinical Trial

    M. R. Wakefield1, C. M. Ashbaugh2, L. Remy3, D. Aholt3, C. Miller3, S. Ye3, D. K. Hathaway4, D. Clark4, V. S. Staggs5, K. Goggin6, R. J. Ellis7, C. L. Russell3

  • Lung Transplant Outcomes after CABG

    S. Huddleston1, R. Aggarwal1, S. Jackson2, N. Lemke1

  • Monitoring Circulating T Follicular Helper Cells Polarization, Activation and Function Distinguishes Asymptomatic Donor-Specific Anti-HLA Antibody Positive Kidney Transplant Recipients from Those Undergoing Antibody-Mediated Rejection

    C. Macedo1, K. Louis1, P. Fadakar2, M. Yamada2, B. Elinoff1, K. Hadi1, P. Randhawa1, D. Metes1

  • More Advanced Heart Failure Prior To Transplant May Influence The Cytomegalovirus Specific T Cell Response In Cytomegalovirus Positive Recipients.

    U. López Cardoza, E. García, C. Díez, J. Roca, N. Sabé, N. Manito, I. Tatjer, A. Cequier, O. Bestard, J. González

  • Pancreas Transplant Alone Using Donation After Cardiac Death Donors Has Similar Outcomes As Donation After Brain Death Donors

    K. Espinoza1, D. Wall1, K. L. Lentine2, J. R. Wellen1, D. Hammad1, D. C. Brennan3, T. Alhamad1

  • Positron Emission Tomography (PET-CT) Global Coronary Flow Reserve (CFR) Stratifies Cardiovascular Risk among Renal Transplant (RTx) Candidates

    M. Minder, S. Mason, J. Ethington, R. McCubrey, D. Min, N. Sekaran, J. Orford, D. Morris, S. Anand, T. Srinivas

  • Preservation of Pancreatic Islets with Stem Cell Derived CD34+ Vascular Endothelial Progenitor Cells

    C. Ward1, L. Vo2, E. De Klerk2, G. Faleo2, Y. Kelly1, J. Bluestone2, M. Hebrok2, P. Stock1, Q. Tang1

  • Risk Factors to Define an Extended Criteria Donor Heart Do Not Appear to Have Cumulative Adverse Effects after Heart Transplantation

    M. Olymbios, S. Dimbil, R. J. Levine, F. Esmailian, J. Patel, J. A. Kobashigawa

  • Role of MHC Class II in B Cell and Regulatory T Cell Development

    S. K. Germana, Z. Wang, C. A. Huang, L. Kojima, C. G. Rickert, J. F. Markmann, C. LeGuern

  • Solving Target Recognition and Activation Mediated by Non-HLA Agonistic Antibodies Targeting ETAR

    A. Philippe1, R. Catar1, P. Scheerer2, M. Szczepek2, D. Dragun1

  • Standardizing Blood Pressure Measurement across 17 Pediatric Transplant Centers: The Improving Renal Outcomes Collaborative

    M. E. Seifert1, R. Garro2, R. P. George2, G. Barletta3, C. W. Belsha4, A. Chaudhuri5, J. W. Goebel6, L. Wickman7, D. Matossian8, J. Misurac9, C. Nailescu10, C. R. Nguyen11, M. Pearl12, A. Pollack13, C. S. Pruette14, P. Singer15, P. S. Verghese16, B. A. Warady17, D. S. Dahale18, D. K. Hooper18

  • Sustained Biologic Response To Neoadjuvant Therapy Predicts Excellent Liver Transplant Outcomes For Locally Advanced Intrahepatic Cholangiocarcinoma

    K. E. Lunsford1, M. Javle2, K. Heyne3, R. A. Ali2, C. M. Mobley1, A. Saharia1, D. W. Victor1, M. J. Hobeika1, A. Kasab2, R. S. McFadden1, T. A. Aloia2, X. C. Li1, H. P. Monsour1, A. O. Gaber1, A. O. Gaber1, J. Vauthey2, R. M. Ghobrial1

  • Tacrolimus Pharmacokinetics in Young, Middle Age and Older Renal Transplant Recipients- Impact of CYP3A5*3*6*7 Metabolic Composite

    K. Tornatore1, K. Attwood2, D. Brazeau3, R. Venuto4

  • The Role of Neutrophil Extracellular Traps in Kidney Acute Antibody-Mediated Rejection

    R. Villca-Gonzales1, J. Torres-Ruiz2, D. Gomez-Martin2, L. Morales-Buenrostro1, J. Alberu3

  • The Use of mTOR Inhibitors Prevents Acute Cellular Rejection in Kidney Transplantation on Belatacept Therapy

    J. Shoji, J. C. Leung, Q. Tang, J. P. Roberts, F. Vincenti

  • To Each Their Own: Center-Level Variation in Tailoring Induction Immunosuppression to Kidney Transplant Recipients

    S. Bae, A. Massie, J. Garonzik Wang, M. McAdams DeMarco, J. Coresh, D. Segev

  • Treg And Bone Marrow Infusion Promotes Survival Of Donor Kidney Grafted Months After Disappearance Of Mixed Chimerism

    K. Bruestle, P. Alonso-Guallart, E. Lopes, G. Pierre, N. Llore, H. Sakai, S. Kofman, D. Ekanayake-Alper, M. Sykes, A. Griesemer

  • Treg Suppressor Function within Allografts is Required for Tolerance

    J. Ossart, A. Pena, H. Dai, L. Bauer, A. Williams, G. Camirand

  • Type-1 Interferons Impair the Key Immunoregulatory Activity of IL-10 in the Promotion of Transplant Tolerance

    M. Iglesias Lozano, M. Chicco, D. Bibicheff, G. Brandacher, G. Raimondi

  • Undernutrition is Associated with Impaired T Cell Protective Immunity in Pediatric Kidney Transplantation

    E. T. Chambers1, C. Chan1, R. Ettenger2, P. Grimm3, E. Reed2, M. Sarwal4, L. Stempora5, B. Warshaw6, C. Zhao1, O. Martinez7, A. Kirk5

  • Use of Latent Class Analysis to Identify Patient Symptom Burden Subgroups after Living Donor Kidney Transplant

    J. Peipert, J. Caicedo-Ramirez, K. Ensor, J. Friedewald, M. Abecassis, D. Cella, D. Ladner, Z. Butt

  • Using Ensembles of Machine Learning Classifiers to Maximize the Accuracy and Stability of Molecular Biopsy Interpretation

    J. Reeve1, K. S. Madill-Thomsen2, P. F. Halloran and the INTERCOMEX Study Group3

  • Utilization of DCD Donors >50 Years Old for Liver Transplantation

    T. Chaly, K. Hoidal, C. Cashman, J. Brink, A. Mehrotra, W. Van der Werf

  • Vaccination Rates and Relation to Health Beliefs in Inner-City Kidney Transplant Recipients (KTRs)

    Y. Akivis, J. Leong, I. Rosenstein, A. Myrie, M. Moy, M. Markell

  • microRNA-375 Provides an Objective Measure of Pancreas Quality in Organ Donors

    I. Shapey1, A. Summers1, J. O'Sullivan1, P. Yiannoullou1, J. Casey2, S. Forbes2, M. Rosenthal3, P. Johnson4, P. Choudhary1, J. Bushnell5, J. Shaw6, N. Hanley1, T. Augustine1, M. Rutter1, D. van Dellen1

  • Blockade of C3aR1 Signaling Suppresses Alloreactive CD8+ T Cell Immunity and Prolongs Murine Cardiac Allograft Survival

    J. Horwitz, D. Mathern, P. Heeger

  • A Clinical Pharmacogenetic Model to Predict the Efficacy of Sirolimus during the Early Administration in Renal Transplant Recipients

    Z. Wang, S. Fei, Z. Han, J. Tao, R. Tan, M. Gu

  • A Comparison of the BAR, DRM, DRI, sRRI, ET-DRI, D-MELD and SOFT Score to Predict Outcome after Liver Transplantation in the SRTR Database

    J. D. de Boer1, H. Putter2, J. J. Blok1, I. P. Alwayn1, B. Van Hoek3, A. E. Braat1

  • A Metagene Signature of Lymphocytic Bronchitis Following Lung Transplantation

    J. R. Greenland1, P. Wang2, J. J. Brotman2, R. Ahuja1, T. A. Chong2, M. Kleinhenz2, L. E. Leard2, J. A. Golden2, S. R. Hays2, J. P. Singer2, J. Kukreja3, N. Y. Greenland4, Z. Lasik4, P. Blanc1

  • Aorto-Iliac Calcification is a Risk Factor for Inferior Patient and Graft Survival in Kidney Transplant Recipients; A Systematic Review and Meta-Analysis

    A. A. Rijkse, J. L. van Dam, H. J. Kimenai, J. N. IJzermans, R. C. Minnee

  • Association Of Lymphocyte-depleting Antibody And Steroids Induction With The Risk And Outcomes Of Post-transplant Diabetes: Analysis Of Deceased-donor Kidney Transplants

    A. Santos1, J. Gregg2, U. L. Akanit3, K. Alquadan1, H. Bejjanki1, K. L. Womer1

  • Autoantibody Production Significantly Decreased with APRIL/BLyS Blockade in Murine Chronic Rejection Kidney Transplant Model

    N. Bath, X. Ding, B. Verhoven, S. Reese, N. Wilson, A. Sukhwal, R. Redfield III

  • Bronchoalveolar Lavage Biomarkers Predict Lung Transplant Survival

    A. Zarinsefat1, J. Y. Yang2, R. Sarwal1, J. Liberto1, D. Watson3, S. Verleden4, M. Sarwal1

  • Burden of Respiratory Syncytial Disease among Hospitalized Immunocompromised Adults

    H. Nam, M. Ison

  • Cardiovascular Mortality in Transplant Patients; A Population-Based Cohort Study 1988-2013 in Australia and New Zealand

    M. Wyld1, N. De La Mata2, P. Masson3, E. O'Lone2, A. Webster2

  • Changes in the Fate of KDPI < 35% Kidneys before and after Implementation of the New Kidney Allocation System

    K. Eng, E. Grodstein, L. Castellanos Reyes, L. Teperman, C. Sethna, P. Singer

  • De Novo Donor Specific Antibody and Panel Reactivity Antibody Are Critical Risk Factors for Antibody Mediated Rejection of Kidney Allograft after Simultaneous Liver-Kidney Transplantation (a Single Center Study Using Surveillance Renal Biopsies)

    Y. Sun1, A. Zhang2, Z. Zaky2

  • Differences in Wait Time, Graft Quality and Outcome for Pediatric Kidney Recipients in the Post-Kidney Allocation System Era

    P. Singer, K. Eng, L. Castellanos Reyes, C. Sethna, L. Teperman, E. Grodstein

  • Discard Patterns in Donors with Non Alcoholic Fatty Liver Disease

    M. MacConmara1, A. Mufti2, S. Hanish1, P. Vagefi1, S. Tujius2, C. Hwang1

  • Donor Insulin Therapy Predicts Better Graft Survival in Pancreas Transplantation

    I. Shapey, A. Summers, H. Khambalia, C. Fullwood, N. Hanley, T. Augustine, M. Rutter, D. van Dellen

  • Donor-Derived Cell-Free DNA in Urine Identifies BKVN with Graft Injury in BK Viruria Kidney Transplant Recipients

    G. Huang1, X. Chen1, S. Yang2, W. Chen2, P. Chen3, X. Hou4, T. Jiang5, H. Liu5, X. Li5, C. Wang1

  • Early Steroid Withdrawal in African American Deceased Donor Renal Transplant Recipients with Alemtuzumab Induction: Is Graft Loss on the Horizon?

    R. Lynn, B. Ravichandran, T. Sparkes, A. Haririan, J. Bromberg, J. Casale

  • Elevated Donor Derived Cell Free DNA (dd-cfDNA) Levels in the Presence of Donor Specific Antibodies (DSA) Are a Strong Predictor of Antibody Mediated Rejection (ABMR) in Pediatric Renal Transplant Recipients

    D. Puliyanda1, R. D. Swinford2, H. Pizzo1, J. Garrison1, I. Kim1, A. M. De Golovine2, S. Jordan1

  • Elevated Visceral Adiposity is Associated with Post-Liver Transplant Mortality and Poorly Correlates with BMI in a Prospective Cohort Study

    R. Sharma, R. Rosenblatt, R. Knotts, J. Pisa, E. Verna

  • Engineering Regulatory T Cells With TCR-Signaling-Responsive Interleukin 2 Nanoparticles Provides In Situ Suppression Of Alloimmunity

    S. K. Eskandari1, M. B. Melo2, I. Sulkaj1, N. Li2, S. Cai1, H. Allos1, J. Y. Choi1, D. J. Irvine2, J. R. Azzi1

  • Ex Vivo Normothermic Perfusion Of Discarded Human Kidneys Reveals Cold-storage-induced Renal Fibrinogen And Provides A Platform For Therapeutic Repair

    J. DiRito1, S. A. Hosgood2, M. Reschke3, M. L. Nicholson2, G. T. Tietjen4

  • FcγRIIB is a Novel CD8+ Effector T Cell Intrinsic Regulatory Pathway That Correlates with Freedom from Rejection in Renal Transplant Patients

    A. B. Morris1, D. F. Pinelli1, D. Liu1, J. M. Boss2, C. D. Scharer2, M. Fribourg3, P. Cravedi3, P. S. Heeger3, M. L. Ford1

  • Four-Year Follow Up of Kidney Transplantation Using Alemtuzumab Induction and Belatacept/Sirolimus Maintenance Therapy

    A. Kirk1, H. Xu1, A. Ghali2, A. Mehta2, A. Guasch2

  • Hepatitis C Positive Donor to Negative Recipient Kidney Transplantation: A Single Center Real World Experience

    N. Jandovitz, V. Nair, E. Grodstein, E. Molmenti, A. Fahmy, M. Bhaskaran, L. Teperman

  • Hephaistos Study Outcome on Renal Function after 12 Month Everolimus Plus Reduced Tacrolimus in De Novo Liver Transplant Recipients versus Standard Tacrolimus

    F. Braun1, P. Schemmer1, H. Schlitt1, A. Pascher1, C. Klein1, U. Neumann1, I. Kroeger2, P. Wimmer2, B. Nashan1

  • Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection

    D. Kumar1, M. Raynaud2, P. Halloran3, A. Loupy2, J. Chang3, J. Reeve3, I. Yakubu1, S. Bobba1, L. Kamal1, M. Levy1, C. Bhati1, P. Kimball1, A. King1, G. Gupta1

  • Inhibition of mTORC2 Causes Hyper Phosphorylation of ERK Induced by Co-Ligation of HLA-I and II Antibody

    Y. Jin1, J. Sinnet-Smith2, E. Rozengurt2, E. F. Reed1

  • Kidney Evaluation in Living Kidney Donors: Survey of US Transplant Centers 2018

    N. Garg1, K. L. Lentine2, L. Inker3, A. X. Garg4, J. Rodrigue5, D. Segev6, D. A. Mandelbrot1

  • Letermovir For The Treatment And Secondary Prophylaxis Of Drug Resistant CMV In Solid Organ Transplant Recipients

    M. R. Pereira1, J. G. Aaron1, C. J. Kubin2

  • Long-Term Outcomes in Patients with Obesity and Renal Disease after Sleeve Gastrectomy

    A. Kassam, A. Mirza, Y. Kim, E. S. Woodle, S. A. Shah, M. C. Cuffy, R. C. Quillin III, L. Sage Silski, A. Govil, M. Cardi, T. S. Diwan

  • Murine Cmv Infection Impairs Transplantation Tolerance: A Critical Role Of Intragraft Anergic Cd4 T Cells

    A. Dangi1, E. B. Thorp2, X. Luo1

  • Outcomes of Adult Lung Transplant Recipients of Donation after Circulatory Death Allografts in the US

    W. S. Cherikh1, J. Stehlik2, A. Sadavarte1, D. Van Raemdonck3

  • Outcomes of Liver Transplantation for Mixed Hepatocellular-Cholangiocarcioma

    M. Najjar1, K. Bruestle1, P. Jiang1, S. Robbins-Juarez1, R. Hwang1, A. Mathur1, E. C. Verna1, A. Griesemer1, B. Samstein1, T. Kato1, Y. M. Saenger1, K. J. Halazun2, J. C. Emond1

  • Pancreata From Donors With Renal Insufficiency: Viable For Transplant?

    X. Luo1, J. Garonzik Wang2, M. B. Doyle1, A. Khan1, T. Alhamad3, W. C. Chapman1, A. Massie2, D. Segev2, J. R. Wellen1

  • Patient-Reported Transplant-Related Symptoms in Kidney Transplant Recipients

    J. L. Beaumont1, I. Purnajo1, M. Polinsky2, E. Alemao2, M. J. Everly1

  • Ready for Prime Time: Intentional Allocation of Hepatitis C Positive Livers into Hepatitis C Negative Recipients

    P. N. Martins1, B. Movahedi1, D. Devuni2, P. Mahboub1, A. Bozorgzadeh1

  • Resolution of Hyperglycemia Following Islet Allograft Transplantation in Non-Immunosuppressed Mice

    J. Ge1, K. Lee1, C. Yang1, R. White2, I. Rosales2, P. Russell1, C. Rickert1, J. Markmann1, J. Madsen1, R. Colvin2, A. Alessandrini1

  • Risk Factors for Recurrence and Predictors of Response in Kidney Transplant Recipients with Primary FSGS

    A. Uffing1, T. TANGO-consortium2, P. Cravedi3, L. V. Riella1

  • Significantly High FOXP3 mRNA in the Renal Allograft as a Mechanism of Tolerance Induced by Transient Mixed Chimerism in Non-Human Primates

    M. Matsunami1, I. Rosales1, T. Oura1, B. Adam2, M. Mengel2, R. Smith1, A. Cosimi1, R. Colvin1, T. Kawai1

  • TORC1 Inhibition In Vitro and in a Humanized Mouse Model Protects Activated Human Regulatory T Cells from Self-Inflicted Damage via Granzyme B

    B. S. Al Dulaijan, S. K. Eskandari, S. Cai, J. Y. Choi, H. Allos, I. Sulkaj, A. Bano, E. Al-Hussein, J. Azzi

  • Tacrolimus Concentrations Can Be Reliably Measured in Capillary Microsamples

    M. T. Gustavsen, N. Vethe, M. Lauritsen, A. Andersen, A. Åsberg, S. Bergan, K. Midtvedt

  • Treatment Modality Affects Outcomes of Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A US Multicenter Analysis of 2786 Patients

    P. Tabrizian1, K. J. Halazun2, M. L. Holzner1, N. Mehta3, F. Y. Yao3, J. Roberts3, J. C. Emond4, B. Samstein2, R. S. Brown4, S. Florman1, M. E. Schwartz1, M. M. Doyle5, W. C. Chapman5, M. Najjar4, R. W. Busuttil6, V. G. Agopian6

  • Using Liver Transplant (LT) Data And Analytics to Improve Program Clinical and Financial Performance

    A. Bonham1, Z. Tulu2, W. Concepcion1, A. Gallo1, M. Melcher1, P. Kwo1, A. Ahmed1, C. Esquivel1

  • Women Who Undergo Liver Transplant Have Increased Health Care Utilization in the Peri-Transplant Period Compared with Men

    J. B. Rubin, G. Cullaro, J. Ge, J. C. Lai

  • De Novo Complement-Activating Donor Specific Antibodies in Pediatric Renal Transplant Recipients Are Highly Responsive to Therapy

    V. Sigurjonsdottir, A. Chaudhuri, P. Grimm

  • A Priori Identification of Hard-to-Place Livers

    A. Wey1, N. Hadley1, J. Rosendale2, R. Hunter2, J. Prinz2, K. Audette1, N. Salkowski1, D. Zaun1, J. Snyder3

  • A Single Measurement of Torque Teno Virus Helps to Predict Mortality in Renal Transplant Patients

    E. Gore1, C. van Leer1, A. de Joode2, I. Nolte3, J. Westra4, A. Gomes Neto2, H. G. Niesters1, S. J. Bakker2

  • A Single-Center Experience with a 6-Month Regimen of Pneumocystis jiroveci Pneumonia Prophylaxis in HIV-Positive Kidney Transplant Recipients

    C. Mejia1, G. Malat2, D. H. Lee3, S. Epstein1, M. Harhay3, L. Levin Mizrahi3, K. Ranganna3

  • Advanced Immunological T-cell Ageing Defined by a Very Low Thymic Function Identifies Patients with a Substantial Increased Risk for Long-Term Mortality after Kidney Transplantation

    M. G. Betjes, A. Langerak, M. Klepper, N. Litjens

  • After 10 Years: The Results of HLA Mismatched Combined Kidney and Bone Marrow Transplantation for Renal Allograft Tolerance

    T. Kawai1, D. H. Sachs1, T. Spitzer1, N. Tolkoff-Rubin1, R. B. Colvin1, N. Elias1, M. Sykes2, A. Cosimi1

  • Association between a Chronic Kidney Disease Treatment Education Class and Receipt of a Kidney Transplantation in the Southeastern U.S. Population

    J. C. Gander1, L. Cromwell1, A. S. Wilk2, R. E. Patzer2, M. Sesay1, D. Walker-Williams1, T. Davis1, J. P. Austin1, N. Mukerji1

  • B Cell-Specific IRE1a Deficiency Protects Renal Allografts from Rejection via Inhibition of Donor-Specific Antibodies and Induction of B Regulatory Cells

    L. Qiu1, J. Wang1, X. Yeap1, D. Fang2, Z. J. Zhang1

  • Basiliximab versus T-cell Depleting Induction Therapy in Elderly Kidney Transplant Recipients

    G. Vranic, H. Shah, B. Thomas, B. Javaid, J. Moore, M. Cooper, A. Gilbert

  • Belatacept Treated Patients Experience Improved Health-Related Quality of Life and Lower Symptom Distress Compared to Cyclosporine Treated Patients: An Analysis of the Benefit and Benefit-EXT Cohorts

    M. J. Everly1, I. Purnajo1, J. L. Beaumont1, M. Polinsky2, E. Alemao2

  • Center Variability in Organ Offer Acceptance and Waitlist Mortality in Lung Transplantation

    A. Y. Choi1, M. S. Mulvihill2, J. Weber3, H. Lee3, M. Cox2, B. Yerokun2, M. Kuchibhatla3, J. A. Klapper2, M. G. Hartwig2

  • Chronic Kidney Disease among Liver Transplant Candidates: A Rising Burden and Its Impact on Post-Liver Transplant Outcomes

    G. Cullaro1, E. C. Verna2, B. P. Lee1, J. C. Lai1

  • Comparative Analysis of Belatacept and Mycophenolate Monotherapy-Based Regimens for HLA Identical Living Donor Kidney Transplantation

    M. Yamada, K. Meganathan, A. Shields, P. Brailey, S. Tremblay, A. Govil, R. R. Alloway, S. Shah, E. S. Woodle, B. G. Abu Jawdeh

  • Comparing Antibody-Mediated Rejection with or without Detectable DSA: Similar Pathology and Similar Poor Prognosis

    G. Einecke1, J. Reeve2, P. F. Halloran3

  • Computational Assessment of T-cell and B-cell Allorecognition to Predict Donor HLA Immunogenicity

    H. C. Copley1, M. Elango1, V. Kosmoliaptsis2

  • Differentiation and Characterization of Human Endodermal Precursors for Liver Cell Therapies­

    W. S. Fagg1, N. Liu1, M. Shoja1, I. Patrikeev2, M. Motamedi2, J. Fair1

  • Early Outcomes Comparing Two Steroid-Avoidance Protocols in Pediatric Renal Transplantation

    D. Puliyanda1, H. Pizzo1, N. Rodig2, M. Somers2

  • Estimated Glomerular Filtration Rate at Donor Screening to Predict Measured Glomerular Filtration Rate after Living Kidney Donation

    J. van der Weijden, M. van Londen, M. Y. Said, S. J. Bakker, S. P. Berger, G. Navis, M. H. de Borst

  • Extremes of Body Mass Index is Associated with Inferior Renal Allograft Outcomes in Type 2 Diabetic Deceased Donor Renal Transplant Recipients

    A. Brar, A. Gruessner, F. Tedla, R. Gruessner, J. Renz, N. Sumrani, D. John, M. O. Salifu

  • Halt-hcc At The Time Of Listing Is Superior To Other Allocation Metrics At Predicting Waitlist Dropout; An Srtr Analysis

    J. C. McVey1, K. Sasaki1, D. J. Firl2, C. M. Miller1, K. Hashimoto1, C. Quintini1, F. N. Aucejo1

  • Impact of Simultaneous Pancreas-Kidney Transplantation on Cardiovascular Risk in Type 1 Diabetic Patients

    E. Montagud-Marrahi

  • Intra-abdominal Hypertension And Abdominal Compartment Syndrome: An Organ Procurement Organization’S Experience

    J. Stefek1, L. E. Markham1, M. Ott1, S. S. Johnson2, J. C. Olson3, H. Sangha4, D. G. Vasquez5, S. P. Whitt6, H. E. Wilkins1, P. A. Webster1, M. Iliakova7, M. Moncure7

  • Lymphotoxin Signaling Regulates T Cell Lymphatic Trafficking

    W. Piao1, L. Li2, V. Saxena2, Y. Xiong2, M. WillsonShirkey2, C. Paluskievicz2, J. Bromberg3

  • Not All Donor-Specific Antibodies Are Equal: Predictors of Risk of Chronic Lung Allograft Dysfunction

    C. J. Iasella1, C. R. Ensor2, M. Marrari3, M. Mangiola3, C. A. Moore1, M. R. Morrell4, J. Pilewski4, J. F. McDyer4, A. Zeevi3

  • Nothing Lasts Forever, So Of The Donor Risk Index For Liver Transplant

    K. Okubo, K. Sasaki, A. Moro, J. McBey, M. Fujiki, T. Diago Uso, B. Eghtesad, D. Kwon, C. Miller, C. Quintini, K. Hashimoto, F. Aucejo

  • Organ Resilience Contributes to Different Impact of Delayed Graft Function (DGF) on Graft Survival in Kidneys Donated by Brain Death (DBD) and Circulatory Death Donors (DCD)

    M. J. de Kok, A. F. Schaapherder, L. G. Wijermars, D. K. de Vries, J. L. Lindeman

  • Outcomes after Simultaneous Kidney Pancreas versus Pancreas after Kidney Transplantation

    S. Parajuli, A. Arunachalam, K. Swanson, F. Aziz, N. Garg, R. Redfield, D. Kaufman, A. Djamali, J. Odorico, D. Mandelbrot

  • Patient Centered AUC-Monitoring of Tacrolimus Using Capillary Microsampling

    M. T. Gustavsen, K. Midtvedt, N. Vethe, S. Bergan, A. Åsberg

  • Polymorphisms in Mycophenolate Mofetil Glucuronidation Gene Are Associated with Leukopenia and Decreased CLAD-Free Survival

    A. Barnes, D. R. Calabrese, E. Henricksen, R. Florez, K. Dewey, P. Wang, J. Teraoka, K. Lien, S. Hays, J. P. Singer, J. Golden, J. Kukreja, J. R. Greenland

  • Potential Living Kidney Donors’ Interest in Kidney Paired and Non-Directed Donation

    D. R. Helfer1, A. D. Love1, J. M. Konel1, J. Stanton2, M. G. Bowring1, K. Kumar1, S. R. Weeks1, M. L. Henderson1, D. L. Segev1, A. M. Cameron1, J. M. Garonzik Wang1

  • Predicting HCC Recurrence Following Liver Transplant – A Machine Learning Approach

    L. F. Lau1, W. Nelson2, A. Gorgen1, L. Erdman2, P. Abreu1, A. Goldenberg2, G. Sapisochin1

  • Prognostic Value of C3d Fixing Preformed Donor-Specific Antibody in Crossmatch-Positive Living Kidney Transplantation

    K. Miyake1, M. Okumi1, Y. Kakuta1, K. Unagami2, M. Furusawa1, H. Ishida2, K. Tanabe1

  • Rapid Growth of HCV-Infected Donors for HCV-Uninfected Kidney and Liver Transplant Recipients in the United States

    M. Bowring, A. Shaffer, A. Massie, N. Desai, M. Sulkowski, A. Cameron, J. Garonzik-Wang, D. Segev

  • Recurrent Diabetic Nephropathy Despite Intensive Glycemic Control: An Observational Cohort Study

    M. Coemans, E. Van Loon, E. Lerut, D. Kuypers, B. Sprangers, P. Gillard, C. Mathieu, G. Verbeke, M. Naesens

  • Risk Stratification of Cytomegalovirus Seropositive Kidney Transplant Recipients for CMV Infection

    M. M. Azar1, A. Baghban1, K. Belfield1, R. Assi2, M. Malinis1

  • The Benefit of Kidney Transplantation over the Waitlist Depends on the Patient’s Comorbidities

    A. Andrade Izquierdo1, J. V. Reusing Jr1, V. Onusic1, F. Agena1, F. C. Lemos1, F. de Paula1, F. Gerab2, E. David-Neto1

  • The Complexity of T Cell-Mediated Rejection Scenarios: Identifying BK in Biopsies with TCMR

    P. F. Halloran and The INTERCOMEX Investigators1, G. Gupta2, J. Reeve3

  • Tocilizumab for Refractory Antibody-Mediated Rejection in Pediatric Kidney Transplantation

    A. Dokras, C. Butler, Q. Zhang, E. Reed, R. Ettenger, P. Weng, M. Pearl

  • Tolerance Induction by Myeloid Progenitor Cells Modulates T and B Cell Responses

    J. Domen, Y. Li

  • Toll Like Receptor 2 Mobilizes Regulatory T Cell Lymphatic Migration by Stimulating Lymphotoxin Expression

    W. Piao1, Y. Xiong2, L. Li3, V. Saxena3, C. Paluskievicz3, J. Bromberg4

  • Undernutrition and Leptin Deficiency Modulates T Cell Immunity in Transplantation

    E. David1, M. Zhu2, B. Bennett2, D. Cheng1, A. Nichols1, W. Parker2, P. Schroder2, N. McIver1, A. Kirk2, E. Chambers1

  • United Kingdom National Outcomes of Transplants from Paediatric Donors: 10 Years Experience

    M. A. Khurram, N. Karydis, C. Callaghan, I. Loukopoulos, T. Kasimatis, P. Chandak, F. Calder, N. Mamode, N. Kessaris

  • Using an Electronic Medical Record Tool to Document Transplant Option Discussions among Patients with EGFR ≤ 20 mL/min/1.73m2

    A. Yishak1, R. R. Brentari2, R. M. Love La Londe3, E. Clark4, E. Clark4, J. Sun5, S. Vupputuri6

  • Wide Geographic Variability in the Proportion of Donors with Cardiac Death – Lost Opportunities for Organ Donation?

    E. M. Sonnenberg1, D. S. Goldberg2, J. Y. Hsu3, P. P. Reese2, P. L. Abt1

  • FK506 Influence Glucose Metabolism by Short Chain Fatty Acid

    W. Jiao1, Z. Zhang1, L. Liu2, X. Hu1

  • A 15-year Experience With Kidney Transplant In Undocumented Immigrants: Outcomes And An Argument For Transplantation

    M. G. Janeway1, A. Foster2, S. De Geus1, K. Curreri1, T. Dechert1, M. Nuhn1, M. Nuhn1

  • Age-Related Effects on Thymic Output and Homeostatic T Cell Expansion Following Depletional Induction

    H. Xu, H. Lee, A. Kirk

  • Allogenic Islets Cure Diabetes Following Transplantation in Omental Pouch in a Non-Human Primate Model

    J. Lei1, H. Deng1, K. Lee1, C. Peters1, G. Rickert1, R. Ivy1, M. Coronel2, E. Yolcu3, H. Shirwan4, A. García5, J. Markmann1

  • Antibody-Suppressor CD8+ T Cells Require CXCR5

    J. Zimmerer1, B. A. Ringwald1, C. L. Avila1, S. M. Elzein1, R. T. Warren1, M. Abdel-Rasoul2, G. L. Bumgardner1

  • Antithymocyte Globulin is Associated with Mature T Cell Phenotypes and Decreased Risk of Non-EBV Infections in Transplanted Children

    B. I. Shaw1, L. Stempora1, C. Chan1, R. B. Ettenger2, P. C. Grimm3, H. Lee1, E. F. Reed2, M. M. Sarwal4, B. L. Warshaw5, C. Zhao1, O. M. Martinez3, A. D. Kirk1, E. T. Chambers1

  • Apolipoprotein L1 Genotyping in Potential African American Living Kidney Donors

    P. Gudsoorkar, M. Anand, T. Kaur, S. Shah, S. Bumb, A. Govil, B. G. Abu Jawdeh

  • Assessment of Physical Frailty is Positively Correlated with LAS Score in Lung Transplant Candidates

    S. Jaladanki1, L. Shih1, O. Kwon2, N. Ventigan2, D. Nanayakkara2, S. Weigt3, J. Singer4, A. Ardehali1, R. Biniwale1, D. Goldwater5, J. Schaenman2

  • Association of Tacrolimus-Level Variance with De Novo DSA within the First 2 Years after Renal Transplantation

    M. J. Everly1, I. Purnajo1, K. P. Briley2, J. L. Beaumont1, P. Bolin2, S. A. Kendrick3, H. Jones3, K. McLawhorn3, A. Q. Maldonado4, D. Leeser2, C. E. Haisch2, L. M. Rebellato2

  • CD19+ Cell Behavior in the 12 Months Following a Single Dose of Rituximab in Patients with Humoral Rejection: Clinical and Histological Outcomes

    L. Marino, I. A. Martínez-Juárez, J. R. Marino-Sánchez, J. I. Santander-Velez, F. Zamora, H. Juarez, R. Vazquez, L. Llorente, G. Lima, A. Cohen-Bucay, L. E. Morales-Buenrostro

  • Characterizing the Dominant Phenotype in Kidney Transplant Biopsies: Improving the Prediction of Risk by a Global View of Rejection, Injury, and Atrophy-Fibrosis

    P. F. Halloran and The INTERCOMEX Investigators1, J. Reeve2

  • Continuous Distribution: LSAM Simulation Study

    T. Weaver1, N. Salkowski1, J. Snyder1, D. Schladt1, J. Pyke1, A. Herreid1, B. Thompson1, W. Kim2, J. Lake3, A. Israni1

  • Decline in Club Cell Secretory Protein Results in Immune Responses to Lung Self-Antigens (Kα1 Tubulin and Collagen V) and Development of Chronic Rejection Following Human Lung Transplantation

    Y. Itabashi1, R. Ravichandran1, M. Sharma1, R. Hachem2, R. Bremner1, M. Smith1, T. Mohanakumar1

  • Decreased Cancer Susceptibility in Tolerant Liver Transplant Recipients: Another Benefit of Tolerance?

    M. P. Bhat1, E. Pasini1, C. Baciu1, S. M. Kurian2, J. Levitsky3

  • Development of a Pharmacy Collaborative Practice Agreement to Improve Efficiency and Management of Prescribing in a Renal Transplant Clinic

    R. Chelewski1, K. Johnson1, A. Zuckerman2, J. DeClercq3, L. Choi3, M. Peter2, A. J. Langone4

  • Donate HCV Trial: Transplanting Thoracic Organs from Hepatitis C Donors to Uninfected Patients

    A. E. Woolley1, S. K. Singh2, H. J. Goldberg3, M. M. Givertz4, M. R. Mehra4, A. Coppolino, III5, V. Cheng1, J. Fanikos6, D. P. Harrington7, H. R. Mallidi2, L. R. Baden1

  • Early CXCR5+PD1+ICOS+ Circulating Follicular T Helpers Are Associated with De Novo Donor-Specific Anti-HLA Antibodies after Renal Transplantation

    R. Danger1, M. Chesneau1, F. Delbos2, S. Lebot1, C. Kerleau1, A. Chenouard1, A. Cesbron2, M. Giral3, S. Brouard3

  • Effect of Everolimus with Reduced-Exposure Tacrolimus and Early Steroid Elimination in Pediatric Kidney Transplant Recipients: 36-Month Outcomes from the CRADLE Study

    H. Tedesco Silva1, R. Ettenger1, A. Bjerre1, M. Christian1, L. Dello Strologo1, S. D. Marks1, L. Pape1, P. Lopez2, M. Cousin2, P. Pandey2, B. Rauer2, M. Meier2, B. Tönshoff1

  • Effects of Static Subnormothermic Preservation of Extended Warm Ischemic Porcine Kidneys Assessed by Ex-Vivo Machine Perfusion and Renal Transplant Model

    H. Sahara, Y. Ariyoshi, M. Sekijima, T. Iwanaga, A. Shimizu, K. Yamada

  • Erythropoietin Ameliorates Parent to F1 Murine Graft versus Host Disease by Inhibiting TFH

    A. Angeletti1, C. Donadei1, A. Cumpelik1, C. Cantarelli1, C. Guglielmo1, G. La Manna2, P. Heeger1, P. Cravedi1

  • Expanding the Donor Pool with Extended Criteria DCD Livers

    P. Mihaylov1, B. Ekser2, R. Mangus2, J. Fridell2, D. Soma2, C. Kubal2

  • Favorable Waitlist Outcomes in Patients with Alcoholic Liver Disease in the MELD-Na Era

    M. Safwan, K. Collins, D. Moonka, S. Jafri, M. Rizzari, A. Yoshida, M. Abouljoud, S. Nagai

  • Immunosuppression Increases Regenerative Potential of Adult Rat Cardiac Progenitor Cells in Allogeneic Rat Myocardial Infarction Model

    M. Gunasekaran, R. Mishra, S. Sharma, P. Saha, M. Y. Arfat, C. Ambastha, D. Morales, F. Xuebin, G. J. Bittle, D. Li, S. Kaushal

  • Impact of Belatacept Conversion on Renal Function, Histology and Gene Expression in Kidney Transplant Patients with Interstitial Fibrosis and Tubular Atrophy

    G. Gupta1, D. Kumar1, M. Raynaud2, A. Loupy2, J. Chang3, J. Reeve3, P. Sanghi1, I. Yakubu1, L. Kamal1, M. Levy1, C. Bhati1, P. Kimball1, A. King1, H. Massey1, P. Halloran3

  • Impact of Steroid-Free Protocol on Incidence of Posttransplantation Diabetes Mellitus: A Prospective, Randomized, Multicenter, Open-Label, Controlled Trial in Renal Transplant Recipients

    J. Ekberg1, S. Baid-Agrawal1, B. Jespersen2, R. Källén3, E. Rafael3, K. Skov2, P. Lindnér1

  • Implication of Melanocortin Receptors in Alloimmunity

    M. Uehara, B. S. Al Dulaijan, J. Azzi, R. Abdi

  • LCP-Tacrolimus (LCPT; Envarsus XR) Dosing Considerations in De Novo Kidney Transplant Recipients

    D. Cibrik1, P. West-Thielke2, S. J. Patel3, D. R. Stevens4, U. Meier-Kriesche4

  • Long Term Outcomes Using Tocilizumab For The Treatment Of Chronic Antibody Mediated Rejection

    J. Choi1, E. Huang1, O. Aubert2, A. Vo1, A. Peng1, R. Najjar1, S. Sethi1, N. Ammerman1, K. Lim1, D. Puliyanda1, A. Loupy2, S. Jordan1

  • Lower Extremity Impairment and Frailty among Adults with Diabetes Awaiting Kidney Transplantation

    E. Lorenz, A. Kukla, C. Kennedy, R. McCoy, L. Hickson

  • Memory T Follicular Helper Cell Alloresponse is Memory B Cell Independent and Inhibited by CD28 Costimulation Blockade

    S. Zeng, G. M. La Muraglia II, M. L. Ford, I. R. Badell

  • Organ Donation is an Indication for Renal Replacement Therapy (RRT)

    A. L. Friedman, E. Marquez, J. A. Lewis

  • Physiochemical Hla Properties Identify Low Immunogenic Donor/recipient Pairs Predicting Long-term Kidney Graft Survivals

    D. Bekbolsynov1, B. Mierzejewska2, C. Ho1, M. Rees2, S. Stepkowski2

  • Pre-Transplant Cardiac Work Up Does Not Predict Post-Transplant Cardiac Events at One Year among Kidney and Pancreas Transplant Recipients

    S. M. Riad1, S. Konety1, S. Jackson2, N. Raj1, V. Vakil1, D. Keys1, E. Finger3, R. Spong1

  • Predictors of Response to Intravenous Immunoglobulin for Treatment of Polyoma Nephropathy

    S. Sethi, A. Vo, A. Peng, R. Najjar, K. Lim, S. Jordan, E. Huang

  • Racial and Income-Based Disparities in Access to Kidney Transplantation in the Context of a Nationally-Financed Health System in Brazil

    A. Saha1, G. Ferreira2, Y. Yu1, M. Waldram1, V. Colares2, J. Bastos2, M. Henderson1, D. Segev1, A. Massie1

  • Renal Outcomes from Expander-1: Pilot Study of HCV+ Donor Kidneys for HCV- Kidney Recipients

    S. Thaduri1, C. Durand1, N. Desai2, D. Segev2, N. Bair1, D. Brown1, F. F. Naqvi1

  • Repeat-Pancreas Transplant after Pancreas Graft Failure in Simultaneous Pancreas and Kidney Transplants is Associated with Better Kidney Graft Survival

    S. Parajuli, A. Arunachalam, K. Swanson, F. Aziz, N. Garg, R. Redfield, D. Kaufman, A. Djamali, J. Odorico, D. Mandelbrot

  • Simultaneous Pancreas and Kidney Transplant Outcomes after Induction Therapy with Thymoglobulin Compared with Alemtuzumab

    B. Masters1, F. Bartlett2, C. Drachenberg3, S. Bartlett3, R. Barth3, J. Scalea3, A. Haririan3

  • Technology Triggered Adherence Intervention – Preliminary Findings

    T. E. Kaiser1, N. S. Ejaz1, S. Tremblay1, N. J. Parrish2, J. Benavides2, B. Rehe2, A. Govil1, E. S. Woodle1, R. R. Alloway1

  • The Evolution of Body Mass Index after Kidney Transplantation in Recipients with a Previous Laparoscopic Sleeve Gastrectomy

    G. Chan, F. Briere

  • The Model For Predicting eGFR At A Year After Donation In Living Related Kidney Transplant Donors

    K. Shinoda, K. Sakurabayashi, T. Mizutani, Y. Takahashi, Y. Hyodo, Y. Itabashi, M. Muramatsu, T. Kawamura, S. Shishido, K. Sakai

  • The Spread of HIV Donation throughout a DSA

    A. Friedman, E. Marquez, J. A. Lewis, K. Delli Carpini

  • The Use of Native Kidney Biopsy to Predict Renal Dysfunction Following Liver Transplantation

    D. O. Walls1, L. Muraveika1, M. B. Palmer2, D. L. Sawinski3, B. J. Keating1, P. L. Abt1

  • Using a Commercially Available Assay That Measures Cytomegalovirus-Specific CD4+ and CD8+ T-cell Immunity to Predict Clinically Significant Cytomegalovirus Events in Solid Organ Transplant Recipients

    R. Rogers1, K. Saharia2, A. Chandorkar2, Z. Weiss3, D. Farmakiotis1

  • CD19+Tim-1+ Regulatory B Cells Mediate the Balance of Th17 Treg to Decrease the Level of Donor-Specific Antibodies in Mice Secondary Skin Transplantation Model

    Z. Wang, S. Fei, H. Chen, L. Sun, Z. Han, J. Tao, X. Ju, R. Tan, M. Gu

  • A Naturalistic Study of De Novo Extended-Release Tacrolimus Tablets vs. Tacrolimus Immediate-Release Capsules in Kidney Transplant Recipients

    T. A. Horwedel1, C. E. Carthon1, S. E. January1, A. Gharabagi1, R. Delos Santos2, J. C. Hagopian1

  • A Novel Ex Vivo Normothermic Perfusion Model of Human Antibody Mediated Rejection

    P. Chandak1, B. L. Phillips1, R. Uwechue1, C. J. Callaghan1, O. Shaw2, T. Maggs3, L. Woodford3, D. Veniard3, R. Perera4, K. Parmar3, B. Hunt5, D. Bennett6, N. Kessaris1, A. Dorling7, N. Mamode1

  • A Novel Multi-Thermic, Antiseptic, and Anthropomorphic System for Ex-Vivo Face Perfusion

    J. W. Etra1, J. Brassil2, F. A. Chang1, S. A. Fidder1, D. S. Cooney1, G. Brandacher1

  • A Nurse-Driven Influenza Vaccine Ordering Protocol Improves Vaccination Rates in Abdominal Organ Transplant Recipients

    T. Ho1, C. D. Sifri2, J. D. Lewis3

  • A Prognostic Biomarker to Estimate the Likelihood of Developing De Novo Donor Specific Antibody in Kidney Transplant Recipients

    S. Kawakita1, L. M. Rebellato2, K. P. Briley2, A. Q. Maldonado3, C. E. Haisch2, P. Bolin2, S. A. Kendrick4, H. Jones4, K. McLawhorn4, D. Leeser2, V. Jucaud1, V. Burnett1, M. J. Everly1

  • A Prognostic Model to Identify Deceased Donor Kidney Transplant Recipients at High Risk for Delayed Graft Function

    S. Kawakita, J. L. Beaumont, M. J. Everly

  • A Randomized Pilot Trial of Home-Based Physical Activity Plus Dietary Intervention to Improve Physical Function in Patients with Advanced Liver Disease

    H. Chen1, A. A. Ferrando2, M. G. White2, M. Pauly2, T. Bartter2, M. A. Dunn1, W. R. Kim3, A. Duarte-Rojo1

  • A Retrospective Observational Analysis of Tacrolimus Metabolism Rate: No Evidence for Impact on Renal Function

    A. J. Hughes, J. E. Kimpton, I. MacPhee

  • A2 To B Kidney Transplants Under Kidney Allocation System: A Prospective Study Of Anti A Titers And Correlation With Outcomes

    H. Schaefer, I. Feurer, S. Rega, R. Forbes, D. Shaffer

  • AMD3100 (Plerixafor) as a Single-Dose Stem Cell Mobilizing Agent in Vascularized Composite Tissue Allograft (VCA) Transplantation in a Canine DLA-Mismatch Model

    B. Swearingen1, S. Graves2, R. Storb2, D. W. Mathes1

  • AMD3100 and Low-Dose FK506 Prevent De Novo Donor Specific Antibody Formation and Rejection in a Sensitized Kidney Transplantation Model

    A. R. Ahmadi, L. Qi, R. N. Wesson, A. M. Cameron, Z. Sun

  • APRIL-/-/BLyS-/- Deplete Antibody Secreting Cells and Alloantibody Production in Sensitized Antibody Mediated Rejection Model

    N. Bath, B. Verhoven, N. Wilson, R. Redfield III

  • Abatacept as Rescue Immunosuppression after Calcineurin Inhibitor Treatment Failure in Renal Transplantation

    I. R. Badell, P. Vasanth, A. B. Farris, J. M. Robertson, G. M. Karadkhele, C. P. Larsen

  • Absolute Quantification of Micro RNA and Messenger RNA Using a Customized Amplicon in Real Time Quantitative Polymerase Chain Reaction Assays

    C. Li, C. Snopkowski, M. Cassidy, B. Botticelli, S. Albakry, J. R. Lee, M. Lubetzky, D. Dadhania, H. Yang, R. Ding, T. Muthukumar, M. Suthanthiran

  • Achieving Robust Targeting of Antibody-Conjugated Nanoparticles Delivered during Ex Vivo Machine Perfusion of Human Kidneys

    J. R. DiRito1, S. Hosgood1, M. L. Nicholson1, G. Tietjen2

  • Adverse Effect Differences between Tacrolimus-IR and LCP-Tacrolimus

    J. Hagopian1, C. Carthon1, S. January1, A. Gharabagi2, R. Delos Santos3, T. Horwedel4

  • Alpha-1 Antitrypsin Reduces Liver Ischemia Reperfusion Injury during Ex-Vivo Normothermic Machine Perfusion

    D. Detelich1, R. de Vries1, C. Carroll1, M. Stein2, K. Uygun1, H. Yeh1, J. Markmann1

  • Analysis of Immune Cell Proportions in Kidney Transplant Biopsies of Acute Cellular Rejection and Antibody Mediated Rejection Compared with Non-Rejecters

    C. R. Dorr1, A. Muthusamy1, D. P. Schladt1, W. Guan2, B. Wu2, J. S. Maltzman3, W. S. Oetting2, P. A. Jacobson2, A. K. Israni1

  • Analysis of Islet Exosomal miRNAs Released Post-Transplant in Response to Inflammation

    P. Saravanan1, M. Kanak1, G. Yoshimatsu2, C. Darden2, M. Lawrence2, M. Levy1, B. Naziruddin3

  • Application of Small Molecule Fluorescent Probes in Early Activation Imaging of CD8+ T Lymphocytes

    P. Rong, X. Zhou

  • Aquaporins May Be Involved in Renal Ischemia-Reperfusion Injury by Affecting the Pyroptosis of Renal Tubular Epithelial Cells

    T. Lin, Y. Fan, Y. Jiang, J. Liu, Z. Wang, L. Li, T. Song, Z. Huang, X. Wang

  • Assessment of Culture/Preservation Conditions on Survival and Function of Islets

    Y. Shindo, M. F. Levy, M. A. Kanak

  • Assessment of Proteinuria Reported as Adverse Events in De Novo Renal Transplant Recipients Receiving an Everolimus-Based Regimen: 24-Month Results from TRANSFORM

    C. Legendre1, S. Berger1, F. Oppenheimer1, A. Wiseman1, S. Steinberg1, O. Viklicky1, G. Russ1, R. Danguilan1, N. Basic-Jukic1, E. Mor1, P. Narvekar2, M. P. Hernandez Gutierrez2, P. Bernhardt2, C. Sommerer1

  • Assessment of the Relationship between Inflammation and Glomerular Filtration Rate

    J. B. Ramirez-Gonzalez1, L. E. Morales-BuenRostro2, J. Furuzawa-Carballeda3, L. Garcia-Covarrubias4, R. L. Pacheco-Domínguez5, R. Durazo-Arvizu6, J. Alberu3, E. N. Cuevas-Medina7, M. López-Cervantes5, R. A. Osorio-Juárez5

  • Automated Histology Lesion Interpretation in Kidney Transplant Biopsies Shows That Pathologists Often Deviate from Banff Guidelines

    K. S. Madill-Thomsen1, J. Reeve2, G. Bohmig3, F. A. Eskandary4, A. Perkowska-Ptasinska5, M. Myslak6, P. F. Halloran and the INTERCOMEX Study Group1

  • B Cell Derived Exosomes Are Associated with Antibody Mediated Rejection in Kidney Transplant Recipients Desensitized for a Positive Cross-Match

    D. Cucchiari1, V. Tubita2, M. J. Ramirez-Bajo2, J. Rovira2, F. E. Borràs3, L. Carreras-Planella3, A. Hertig4, F. Oppenheimer1, F. Diekmann1, I. Revuelta1

  • B Cell Immunophenotypes in Transplantation

    M. Cascalho1, M. de Mattos-Barbosa2, E. A. Farkash3, J. L. Platt2

  • BCMA Expression by Alloreactive B Cells Increases during De Novo Alloantibody Responses

    N. Chai, G. Wu, I. Kim, A. Klein, S. Jordan

  • BTLA Suppressed Acute Rejection by Regulating T Cell Receptor Downstream Signal Pathways and Cytokine Production in Renal Transplant and Contributed to Prolongation of Allograft Survival

    J. Zhang, Z. Wang, S. Fei, H. Chen, L. Sun, Z. Han, J. Tao, X. Ju, R. Tan, M. Gu

  • Back Signaling of HLA Class I Molecules and NK Cell Receptor Ligands in Renal Epithelial Cells Contributes to the Rejection-Specific Microenvironment

    E. Chichelnitskiy1, J. Egelkamp1, K. Daemen1, J. Keil1, C. Neudörfl1, J. Bräsen2, J. Schmitz2, H. Haller3, C. Blume4, C. Falk5

  • Belatacept Conversion for Calcineurin Inhibitor-Associated Thrombotic Microangiopathy in Kidney Transplant Recipients

    S. A. Muhsin, K. Safa, H. M. Gilligan, E. C. Heher, W. W. Williams, D. M. Wojciechowski

  • Belatacept Use in High Kidney Donor Profile Index Kidney Transplant Recipients

    D. Britt1, A. Gharabagi1, K. Botkin1, T. Horwedel2, C. Carthon1, J. Hagopian1

  • Beta2-Adrenergic Receptor Activation Prolongs Survival of Vascularized Composite Tissue Allotransplants in a Murine Model

    M. Kim1, D. Fisher1, J. Loo1, P. Bogner2, U. Sharma3, J. Skitzki1, E. Repasky4

  • Breakthrough Invasive Fungal Infections in Solid Organ Transplant Patients Receiving Isavuconazole

    M. Fung, C. Devoe, B. S. Schwartz, S. B. Doernberg, J. Babik, P. V. Chin-Hong

  • Burden of Respiratory Virus Infections in Solid-Organ Transplant Recipients: A Nationwide Multi-Season Cohort Study

    M. Mombelli1, D. Neofytos2, J. Aubert1, C. Benden3, C. Berger3, K. Boggian4, A. Egli5, P. Gasche2, H. Hirsch5, C. Hirzel6, N. Mueller3, C. Van Delden2, O. Manuel1

  • CCR5-Mediated Recruitment of NK Cells to the Kidney is a Critical Step for Host Defense to Candida albicans Infection

    H. R. Cho1, V. G. Tran2, N. N. Nguyen3, S. Lee4, S. W. Kang4, J. Kim4, H. J. Kim4, S. J. Park1, J. S. Lee5, B. Kwon6

  • CD38 Inhibition: A Novel Target for Hepatic Ischemia Reperfusion Injury

    C. Akateh1, B. F. Reader1, Y. Lee1, J. Kim1, K. Maynard1, K. W. Washburn1, J. L. Zweier2, B. A. Whitson1, S. M. Black1

  • CD56+CD57+ Infiltrate is a Predominant Subset of Infiltrating Natural Killer Cell in Renal Transplant Biopsies with Antibody-Mediated Rejection

    H. Jung1, Y. Wee2, J. Kim2, M. Choi2, J. Choi2, H. Kwon2, J. Jung2, S. Kim3, Y. Cho4, Y. Park4, H. Go4, M. Han5, Y. Kim2, D. Han2, S. Shin2

  • CYP3A5 Genotype Had No Influence on Renal Function after Renal Transplantation

    J. E. Kimpton, A. J. Hughes, I. MacPhee

  • Calcineurin Inhibitor Holiday for Management of Post Transplant Acute Kidney Injury

    S. Sriperumbuduri, D. Lazarus, T. Fairhead, S. Hoar, J. Karpinski, G. Knoll

  • Candida auris after Liver Transplant

    N. M. Theodoropoulos, R. Ellison, J. S. Daly, A. Bozorgzadeh, D. A. Mack, L. Gibson, S. M. Levitz

  • Cell Coding Transcriptomic Analysis Of Serial Blood And Biopsy Samples In A Large Cohort Of Kidney Transplant Recipients

    W. Zhang1, Z. Yi1, Z. Sun1, K. Keung2, C. Wei1, C. Xi1, S. Farouk1, M. Menon1, P. Cravedi1, P. O'Connell2, B. Murphy1

  • Change in Estimated Glomerular Filtration Rate and Risk of Allograft Failure in Patients Diagnosed with Active Antibody-Mediated Rejection Following Kidney Transplantation

    W. Irish1, P. Nickerson2, B. Astor3, E. Chong4, C. Wiebe2, F. Moreso5, D. Seron5, M. Crespo5, L. Gache6, A. Djamali3

  • Characterization of HLA Antibodies by C3d Assay and IgG Subclasses in Sensitized Kidney Transplant Patients

    A. Casillas-Abundis, J. M. Arreola-Guerra, J. Alberu, M. I. Solis-G, L. Llorente, J. Granados, M. Vilatoba, R. Cruz-Martinez, L. Morales-Buenrostro, A. G. Contreras

  • Characterization of Innate Lymphoid Cells in Full Facial and Limb Transplant Recipients

    T. J. Borges1, J. T. O’Malley2, B. Kollar3, B. Pomahac3, S. G. Talbot3, L. V. Riella1

  • Characterization of Intra-Exosomal Cargoes of Circulating Donor Heart Specific Exosomes in Murine Heart Transplantation Model

    J. Harmon, V. Korutla, L. Korutla, R. Hu, S. Rostami, A. Habertheuer, P. Zielinski, A. Freas, C. Ram, A. Naji, M. Davis, P. Vallabhajosyula

  • Chloroquine’s Effect on T cell Proliferation

    R. Muschalek1, P. Jindra2, R. Kerman2, M. Kueht2, W. Etheridge2, M. Cusick2

  • Cholecystitis in High-Acuity Patients Undergoing Liver Transplantation: A Five-Year Analysis of Incidence, Causes and Impact

    D. S. Graham, T. Ito, M. M. Lu, J. DiNorcia, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas

  • Clazakizumab (CLZ, Anti-IL-6 Monoclonal Antibody) Treatment of Patients (Pts) with Chronic Antibody-Mediated Rejection (cABMR) Reduces Total Immunoglobulin (Ig) and Anti-HLA IgG Antibody Levels

    B. Shin, N. F. Ammerman, A. A. Vo, X. Zhang, S. C. Jordan, M. Toyoda

  • Clazakizumab Acts on Endothelial Cells to Limit Antibody Mediated Damage

    J. Lion1, K. Poussin1, E. Chong2, D. Glotz3, N. A. Mooney1

  • Clinical Impact of Race and Timing of Acute Rejection on Recipients of Kidney Transplant on Early Steroid Withdrawal Protocol

    O. Adebiyi, S. Yaqub, W. Goggins, D. Mishler, T. Taber, A. Sharfuddin

  • Clinical Implications of Belatacept Conversion in a High-Risk, Urban Renal Transplant Population

    B. Valdepenas, J. Benken, E. Benedetti, Z. Hajjiri, A. Lichvar

  • Clinical Response to Pathological Finding in Uterus Transplantation

    L. Johannesson, G. Testa

  • Clinical, Aging, Morphometric Measures & Adverse Outcomes in Kidney Transplant Recipients

    A. Muzaale1, N. Chu1, H. Ying1, B. Ross2, D. Segev1, M. McAdams-Demarco1

  • Clonal Composition And Single-cell Characterization Of T-cell Infiltrates In Cardiac Allograft Vasculopathy

    M. V. Habal1, A. Myung2, H. Yan2, S. Rao2, S. Lin2, S. See2, P. Roy2, R. Shihab2, C. Marboe3, S. Restaino1, A. Han2, M. Givertz4, J. C. Madsen5, L. Addonizio1, M. Farr1, E. Zorn2

  • Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in De Novo Kidney Transplant Recipients: ER-Tac vs LCPT

    G. Spagnoletti, M. P. Salerno, F. De Gennaro, J. Romagnoli, F. Citterio

  • Combined Liver and Delayed Kidney Transplantation (CLKT) Enables Similar Patient Survival as Liver Transplantation Alone (LTA): Propensity Score-Based Comparison

    B. Ekser1, C. A. Kubal1, R. S. Mangus1, P. Mihaylov1, J. A. Fridell1, L. R. Timsina1, M. Lacerda2, M. Ghabril2, J. A. Powelson1, W. C. Goggins1

  • Comparable Outcomes of Deceased Donor Liver Transplant Outcomes in Recipients with Previous Abdominal Surgery (PAS) after Pre Listing Surgical Categorization. A Propensity-Score Matched Pair Analysis

    H. Sharma, H. Bohorquez, D. Oganesyan, D. Bruce, E. Bugeaud, I. Carmody, A. Cohen, J. Seal, D. Sonnier, G. Loss

  • Comparison of Initial Sirolimus (SRL) and Everolimus (EVR) Exposure Patterns in Kidney Transplant Recipients

    C. Rosso Felipe, L. Viana, M. Pontello Cristelli, M. Nakamura, L. Ramagnoli, S. Braga, V. Lima, A. Carnevalle, D. Casarini, J. Medina Pestana, H. Tedesco Silva Junior

  • Comparison of Isolated Transplant Glomerulopathy with Chronic Antibody-Mediated Rejection in Regards to Endothelial-to-Mesenchymal Transition and Graft Survival

    B. H. Ozdemir1, F. N. Ozdemir2, G. Moray3, M. Haberal3

  • Comparison of Proton Pump Inhibitors versus Histamine-2-Receptor Antagonists on Clostridium difficile Rates in Liver Transplant Recipients

    S. Wiehe, K. Roach, A. Qamar

  • Comparison of Two Dosing Regimens of Valganciclovir for Cytomegalovirus Prophylaxis in High-Risk Liver Transplant Recipients

    A. L. Bixby, L. Fitzgerald, L. Cotiguala, J. M. Park, D. Kaul, C. Sonnenday, S. Tischer

  • Comparison with Solid Organ Transplants Reveals Distinct Face Transplant Rejection Gene Signature That Reflects the Unique Immunobiology of Skin

    T. Win, B. Dyring-Andersen, R. Lopdrup, J. Teague, N. Murakami, A. Chandraker, S. G. Tullius, B. Pomahac, L. V. Riella, R. A. Clark

  • Conceptual Extension of SNP Based Abundance Profiling to Infer Donor Derived Cell-Free DNA Fraction as an Indication of Organ Rejection

    R. Sinha, K. Mickey, J. Grantham, M. Wissel, M. Altrich, S. Kleiboeker

  • Conversion from Tacrolimus Immediate Release to Tacrolimus Extended Release (Envarsus XR®): A Real World Cohort Highlighting Dosing Variability among Patients

    K. D. Belfield1, D. Malhotra2, M. Waleed3, E. A. Cohen1

  • Conversion to Belatacept in Kidney Transplant Recipients with Systemic Lupus Erythematosus

    I. Carrión Barberà, M. C. Fajardo, D. Tsapepas, J. Gartshteyn, A. Askanase, H. E. Fernandez

  • Cryopreserved Human Iliac Arteries Allografts: Different Thawing Rates Affect on Their Structural Changes and Mechanical Properties

    R. Novotny1, J. Chlupac1, R. Matejka2, T. Marada1, P. Mericka3, L. Sterba3, L. Janousek1, J. Fronek1

  • DR53, You Can’t See Me: A Deceased Donor Tale of Ambiguous Typing

    S. Dionne1, S. Shetty1, L. Santiago1, K. Klama2

  • Daptomycin Perioperative Prophylaxis for Prevention of Vancomycin-Resistant Enterococcus Infection in VRE-Colonized Liver Transplant Recipients during the Early Post-Transplant Period

    S. Sarwar, S. Gleeson, M. Malinis, M. M. Azar

  • De Novo Belatacept to Delay Tacrolimus Initiation in Renal Transplants with Delayed Graft Function

    A. Dao, A. Reyad, L. Kautzman, M. Madhrira, I. Memon, O. Elmhishi, B. Sankarapandian, J. Johnson, S. Patel, S. Allam

  • De Novo Glomerulonephritis after Non Renal Abdominal Organ Transplantation

    C. Farkas1, R. B. Ettenger1, J. Zuckerman2, R. S. Venick3, P. Weng1

  • De-Novo Letermovir Resistant Mutations in Cytomegalovirus-Infected Tissues of Solid Organs Transplant Recipients

    S. HAN, H. Cho, S. Min, Y. Hong

  • Deceased Donor Vascularized Abdominal Wall Allograft Procurement – Lessons Learned from Early Experiences

    J. A. Shah, D. L. Sudan, D. Erdmann, K. V. Ravindra

  • Delayed Achievement of Therapeutic Tacrolimus Levels with De Novo Extended-Release Tacrolimus Tablets and the Incidence of Rejection in Kidney Transplant Patients

    C. E. Carthon1, J. C. Hagopian1, S. E. January1, A. Gharabagi1, R. Delos Santos2, T. A. Horwedel3

  • Depletional Induction Therapy in Non-Human Primates – Preclinical Modeling of Polyclonal Depletion with Rhesus-Specific ATG

    R. Schmitz1, M. S. Mulvihill1, P. M. Schroder1, Z. Fitch1, F. Leopardi1, D. Magnani2, J. Kwun1, S. J. Knechtle1, A. D. Kirk1

  • Desensitization Using Costimulatory Blockade and Bortezomib Does Not Prevent DSA Formation and Rejection in Reconstructive Transplantation

    F. Messner1, Y. Guo1, R. Chen2, Y. Kuo2, G. Brandacher1, B. Oh1

  • Determining the Molecular Nature and Role of Cytoglobin in Chronic Allograft Nephropathy

    D. Patel1, T. Divanyan1, E. Acosta1, K. Carnes2, D. Howard3, F. Jourd’heuil3, D. Jourd’heuil3, R. Lopez-Soler4

  • Development of Non-Human Leukocyte Antigen Antibodies in Cardiac Antibody-Mediated Rejection

    S. B. See1, B. S. Mantell2, K. J. Clerkin3, B. Ray4, E. R. Vasilescu5, C. Marboe5, Y. Naka6, S. Restaino1, P. C. Colombo3, L. J. Addonizio2, M. A. Farr3, E. Zorn1

  • Difference in DSA Formation between Tacrolimus-XR and Tacrolimus-IR

    J. Hagopian1, C. Carthon1, S. January1, A. Gharabagi2, R. Delos Santos3, T. Horwedel4

  • Differential Expression of B Cell Activating Factor in Experimental Models of Acute and Chronic Active Antibody-Mediated Rejection

    S. Reese, N. Wilson, L. Ptak, R. Redfield, A. Djamali, S. E. Panzer

  • Differential Impact of Donor and Recipient Age on Post-Lung Transplantation Outcomes

    K. Patel1, C. Li1, C. Wallace1, J. Kilkenny1, D. P. Allen1, S. Nadig1, M. Goddard2, C. Krieg1, C. Atkinson1

  • Differential Regulation of Phosphokinases by Anti-HLA Class I and 11 Antibodies

    A. Babu1, B. Tran2, M. Hamdorf2, V. Jucaud2, S. Daga3, D. Mitchell4, M. Everly2

  • Distinct Delayed Classical Complement Pathway Activation Highlights Transition of Ischemic Acute Kidney Injury to Chronic Kidney Disease with Interstitial Fibrosis/Tubular Atrophy

    S. Kumar, S. Jordan

  • Dobutamine Stress Echocardiography is a Poor Predictor of Clinically Significant Coronary Artery Disease in Patients Undergoing Liver Transplant Evaluation

    D. L. Hughes1, J. Rice1, J. R. Burton1, E. A. Pomfret2, J. J. Pomposelli2, A. V. Ambardekar3, S. M. Mandell4, M. S. Kriss1

  • Does Secondary Simultaneous Liver Kidney versus Liver Alone Make a Difference in Terms of Patient and Graft Survival

    C. Blanton, J. Reyes, M. Eerhart, P. Chlebeck, L. Fernandez

  • Donor And Recipient Age Matching Versus Mismatching In Expanded Criteria Donor Kidney Transplants: Does It Make A Difference?

    D. Harriman, V. Gurram, A. Farney, J. Rogers, G. Orlando, C. Jay, A. Reeves-Daniel, A. Mena-Gutierrez, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta

  • Donor Derived Cell Free DNA (dd-cfDNA) May Aid in the Diagnosis of BK Virus Nephropathy

    D. Brennan1, J. Bromberg2, J. Yee3, S. Dholakia3, M. Haas4

  • Donor Derived Strongyloidiasis, a Preventable Event

    R. M. La Hoz1, G. Vece2, L. Danziger-Isakov1, D. Florescu1, M. Malinis1, K. Lilly1, L. Strasfeld1, R. P. Wood1, S. Tlusty2, C. R. Wolfe1, M. G. Michaels1

  • Donor Derived Tuberculosis in Solid Organ Transplantation in the United States: 10 Years of UNOS Ad Hoc Disease Transmission Advisory Committee Experience

    M. F. Malinis1, R. LaHoz1, G. Vece2, S. Tlusty2, S. Aslam1, R. Bag1, J. Bucio1, L. Danziger-Isakov1, D. F. Florescu1, M. Rana1, C. Wolfe1, M. G. Michaels1

  • Donor Renal Macrophages in Post-Transplant Ischemia/Reperfusion Injury (IRI): Role of IL-1R8 in Modulating Fate, Phenotype and Function

    S. Aiello, P. Rodriguez, N. Azzollini, F. Casiraghi, M. Noris, G. Remuzzi, A. Benigni

  • Donor-Derived Cell-Free DNA is Associated Specifically with Antibody Mediated Injury in Patients with Renal Allograft Dysfunction

    B. Obrisca1, C. Blosser2, I. De Castro2, C. Johnson2, B. Sorohan1, L. Sibulesky2, R. Bakthavatsalam2, G. Ismail1, N. Leca2

  • Donor-Recipient Matching in Kidney Transplant: The Whole is Greater Than the Sum of the Parts

    A. Vinson, K. Tennankore, B. Kiberd

  • Donor-derived Cell-free Dna In Donor Specific Antibody Positive Kidney Transplant Recipients

    D. Cheng1, X. Li2, T. Jiang2, H. Liu2, Y. Zhou3, H. Shi3

  • Dosing Requirements Of Astagraf Xl In African American Kidney Transplant Recipients Converted From Twice-daily Tacrolimus (aaaktrs)

    J. N. Fleming, M. A. Posadas-Salas, D. J. Taber

  • Dosing and Exposure over 2 Years with LCP-Tacrolimus (LCPT) vs. Immediate-Release Tacrolimus (IR-Tac) in De Novo Kidney Transplantation

    K. Budde1, S. Bunnapradist2, S. Patel3, D. Stevens3, U. Meier-Kriesche3, B. Suwelack4

  • Dual Treatment of CD40 Silencing or Mesenchymal Stem Cells Infusion with Sub-Therapeutic Doses of Cyclosporine Effectively Prevents Acute Rejection in an Allogenic Model of Renal Transplantation

    J. Guiteras1, L. De Ramon1, N. Bolaños1, M. Franquesa2, M. Gomà3, J. Cruzado4, N. Lloberas1, J. Grinyó4, J. Torras4

  • Dynamic Characterization of Cells in the Perfusate from Cold Ischemic Liver Grafts

    R. J. de Vries, C. Pendexter, S. E. Cronin, B. Marques, J. F. Markmann, S. L. Stott, H. Yeh, M. Toner, K. Uygun, S. N. Tessier

  • Early Achievement of Sustained Virological Response in Liver Transplant Recipients with Hepatitis C Reduces Risks of End Stage Renal Disease

    M. Yoshikawa1, T. Fukumoto2

  • Early Conversion to Belatacept in High Risk Renal Transplant Recipients

    A. Santeusanio, A. Bhansali, R. Shapiro, V. Delaney, S. Florman, G. De Boccardo

  • Early Rejection Outcomes with IL-2 vs. ATG Induction among Kidney Transplant Recipients Induction Differences with Early Steroid Withdrawal

    C. Burelli, A. Szczepanik, K. Yadav, E. Sanchez, M. Debroy, V. Humphreville, J. Rabets, A. Padiyar, N. Sarabu, A. Jittirat, A. Palanisamy, K. Chavin

  • Early Renal Allograft Failure after Simultaneous Liver-Kidney Transplantation: Evidence for Utilization of the Safety Net

    G. Cullaro1, E. C. Verna2, B. J. Orandi3, J. C. Lai1

  • Early Tacrolimus Trough Attainment in De Novo Kidney Transplant Recipients Treated with LCP-Tacrolimus (LCPT) vs. Immediate-Release Tacrolimus (IR-Tac)

    K. Budde1, S. Bunnapradist2, S. J. Patel3, D. R. Stevens3, U. Meier-Kriesche3, B. Suwelack4

  • Eculizumab in Kidney Transplant Recipients with Atypical Hemolytic Uremic Syndrome – Single Center Experience

    A. Bhalla, S. Alasfar, N. Alachkar

  • Effect of Chronic Kidney Disease on Allo-Immune Response in Mice

    P. D. Winterberg1, H. Li1, M. E. Wagener2, M. L. Ford2

  • Effect of Everolimus on IgM and IgG Memory B Cell Growth and Survival In Vitro and Applications for Effective Administration in Clinical Practice

    Y. Matsuda

  • Effect of Human Leukocytic Antigen Matching on Clinical Outcomes after Deceased Donor Renal Allograft Transplant: A Single Centre Experience

    M. E. Gramlick1, M. K. Heer2, S. Yausis2, P. R. Trevillian2

  • Effectiveness Of The Vittal Viability Criteria During Ex Situ Normothermic Machine Perfusion To Discriminate Hepatobiliary Organ Injury And Investigation Of Biochemical Markers For Post-transplant Complications

    Y. L. Boteon, R. Laing, J. Attard, L. Wallace, A. Smith, M. Perera, D. Mirza, H. Mergental, S. Afford

  • Effects of Standard Drug Immunosuppression on Peripheral Transitional B Cells and Gene Expression in Non-Human Primates

    A. Bean1, J. Paster1, K. Pruner1, J. O1, W. Sommer2, K. Robinson3, I. Hanekamp1, G. Benichou1, J. Madsen1

  • Efficacy of Belatacept Conversion Protocols

    M. Yazdi, J. Kahwaji, S. Meguerditchian, R. Lee

  • Efficacy of Filgrastim in Solid Organ Transplant Recipients

    M. Spinner1, K. Gaffney1, S. Gundling2

  • Efficacy of Photobiomodulatory Therapy Combined with Short-Term Immunosuppressants Prolonged Allograft Survival in a Rodent Hind-Limb Model

    Y. KUO1, Y. Li1, C. Chen1, R. Chen11, G. Brandacher2

  • Elevated Urinary Injury Biomarkers in Deceased Donors Are Not Associated with Long-Term Kidney Transplant Outcomes

    N. Koyawala, I. E. Hall, Y. Jia, S. G. Mansour, P. P. Reese, H. R. Thiessen-Philbrook, E. Akalin, J. S. Bromberg, M. D. Doshi, M. N. Harhay, S. Mohan, T. Muthukumar, B. Schroppel, P. Singh, F. L. Weng, C. R. Parikh

  • Endothelial Cell Cytoskeleton Rearrangement (ECCSKR) and Endothelial to Mesenchymal Transition (EndoMT) in Liver Allografts Following Acute Rejection (AR): Its Significance on the Development of Liver Fibrosis (LF) and Graft Survival

    B. H. Ozdemir1, G. Ozgun1, E. H. Ayvazoglu Soy2, N. Haberal1, G. Moray2, M. Haberal2

  • Estimated Post Transplant Survival Allocation: Not Just Better Kidneys, but Faster Ones as Well

    L. Ormiston1, G. Vranic2, J. Moore2, B. Thomas2, M. Cooper2, A. Gilbert2

  • Estimated vs. Actual Graft Failure and Patient Survival after Kidney Transplantation

    J. Buggs1, T. Thigpen2, E. Rogers1, A. Kumar3, V. Bowers1

  • Evaluating Adherence to Immunosuppressive Drugs through Trackyourmed® an Innovative Qr Code-Scanner App in Renal Transplantation: Preliminary Results from i-COM Trial

    E. Melilli1, M. Meneghini1, N. Montero1, A. Coloma1, I. Revuelta2, F. Moreso3, V. Torregrosa2, J. Grinyo1, O. Bestard1

  • Evaluation of Delayed Renal Allograft Function after DCD with New Biomarkers in Donor Blood

    X. Zheng

  • Evaluation of Envarsus XR in African American Kidney Transplant Recipients

    L. R. Lineberger1, E. Hollinger2, N. Kenyon1, M. Brokohf1, N. Alvey1

  • Evaluation of Liver Transplantation among Advanced Age Recipients in a Large Multicenter U.S. Cohort

    A. Goel1, A. Kwong2, D. Devuni3, C. Wang2, J. Boike4, J. Jo4, L. VanWagner4, M. Serper5, L. Jones5, R. Sharma6, E. Verna6, J. Shor3, M. German7, A. Hristov7, A. Lee7, E. Spengler7, A. Koteish8, G. Sehmbey9, A. Seetharam9, N. John1, Y. Patel10, M. Kappus10, T. Couri11, R. Salgia12, Q. Nhu13, C. Frenette13, J. Lai2

  • Evaluation of New Baskent University Preservation Solution for Liver, Kidney and Intestine Graft during Cold Ischemia: Preliminary Experimental Animal Study

    M. Haberal1, M. Kirnap1, R. Erdem2, H. Ozdemir3, M. Lux2, D. Bacanli4

  • Evaluation of Pneumocystis jirovecii Pneumonia Prophylaxis among Kidney and Liver Transplant Recipients; Trimethoprim/Sulfamethoxazole vs Alternative Therapies

    E. Aldag, C. Pagels, R. Pedersen, I. Nadeem, V. Gunabushanam, A. Sahajpal, T. J. Dilworth

  • Evaluation of an Invasive Fungal Infection Prophylaxis Strategy after Liver Transplantation at a Large Academic Medical Center

    M. Jorgenson1, J. Descourouez1, D. Felix1, N. Marka2, G. Leverson2, J. Smith2, L. Fernandez2, D. Foley2

  • Everolimus/Low Tacrolimus Exposure versus Sodium Mycophenolate/Standard Tacrolimus for the Elderly Kidney Transplant Recipient. A 4-y Follow-Up of the nEverOld Trial

    E. David-Neto, F. Agena, F. J. Paula, N. Z. Galante, D. S. David, F. Ramos, A. K. Triboni, P. Romano, P. A. Ebner, V. Coelho, M. Altona, R. Falci, A. Piovesan, W. C. Nahas

  • Evidence to Support the Use of Kidney Allograft Function as a Clinical Trial Outcome Measure

    M. Kadatz, J. Gill, S. Clark, J. S. Gill

  • Exosomes Carry Stress and Damage Specific miRNAs during Peritransplant Period in TPIAT

    P. Saravanan1, M. Kanak1, S. Vasu2, M. Lawrence2, M. Levy1, B. Naziruddin3

  • Exosomes Isolated from Human Lung Transplant Recipients Diagnosed with Bronchiolitis obliterans Syndrome are Unique in Their Ability to Induce IL-6 via Rab27A Signaling Pathway

    M. Rahman, M. Sharma, S. Angara, M. Smith, R. Bremner, T. Mohanakumar

  • Experience With Letermovir Use For The Management Of Cytomegalovirus In Solid Organ Transplant Recipients

    J. L. Orejas1, F. M. Marty1, A. M. McDonnell2, M. P. Cheng1, E. Arbona-Haddad1, S. P. Hammond1, S. Koo1

  • Expression of Prostaglandin E2 Receptors Track with Rejection in Porcine Kidney Transplants

    A. Harner1, Y. Wang2, X. Fang2, R. Lassiter1, T. D. Merchen1, S. Ho3, S. Nahman Jr2

  • External Validation of Donor-Derived Cell-Free DNA to Detect Rejection in Kidney Transplant Recipients

    E. Huang, S. Sethi, A. Peng, R. Najjar, A. Vo, S. Jordan

  • Extreme Hyponatremia as a Risk Factor for Early Mortality after Liver Transplantation in the Model for End-Stage Liver Disease-Sodium Period

    H. Mouzaihem, M. Safwan, L. C. Chau, D. Moonka, M. Abouljoud, S. Nagai

  • Feasibility of a Rapid Magnetic Resonance Protocol to Assess Body Composition Profiles in Adult Liver Transplant Candidates

    S. Pine1, L. Adamski1, D. Gregory1, C. Padilla1, J. Gottstein2, A. Lemmer1, M. Forsgren3, M. Rinella1, L. B. VanWagner4

  • Flow Cytometric Analysis of Leukocyte Migration during Ex Vivo Lung Perfusion with CXCR4 Inhibition

    J. Yerxa1, Q. Gao1, R. P. Davis2, M. Zhang1, U. Scheuermann1, W. Parker1, M. G. Hartwig2, A. Barbas1

  • Functional Characterization of Orthotopic Hind-Limb Transplants in Rats

    F. Zheng, X. Zhang, L. Qiu, J. Wang, X. Yeap, K. M. Koss, J. Wertheim, Z. J. Zhang

  • Functional Measures of Frailty and Not Sarcopenia Predict Mortality in a Prospective Cohort of Liver Transplant Candidates

    R. Sharma, R. Rosenblatt, R. Knotts, J. Pisa, E. Verna

  • Galectin-3 Levels Are Associated with the Incidence and Severity of Chronic GVHD One Year after Allogeneic Hematopoietic Cell Transplantation

    N. Navarro-Alvarez1, A. R. Andrews1, Z. DeFilipp2, Y. A. Chen2, V. T. Ho3, J. Ritz3, T. R. Spitzer4, C. A. Huang5

  • Graft Survival of Fourth Time Renal Transplant Recipients Are Similar to Third Time Transplants: A SRTR Database Analysis

    B. Petrun, R. Nygaard, M. Hill, C. Richardson, A. Israni, P. Stahler

  • Graft TIM4 Deficiency Protects Liver from Ischemia Reperfusion Injury: From Mouse to Human

    S. Kageyama1, K. Kadono1, H. Hirao1, K. Nakamura1, T. Ito2, K. J. Dery1, D. Oncel1, B. Ke1, F. M. Kaldas2, R. W. Busuttil2, J. W. Kupiec-Weglinski1

  • Gut Microbiome And Acute Rejection After Kidney Transplantation

    H. Cho1, Y. Yang1, J. Kim2, J. Moon2, J. Jeong2, J. Park3, M. Kwak4, B. Kim4, D. Kim2, J. Lee5, B. Kim6, Y. Kim2, H. Lee2

  • HIV Resistance among HOPE Donor Referrals

    B. Barnaba1, W. Werbel1, O. Kusemiju1, C. Kirby1, Y. Eby1, R. Fernandez1, J. Miller1, A. Redd2, D. Segev1, A. Tobian1, C. Durand1

  • HTLV Screening among Solid Organ Transplant Candidates at a Large Transplant Center

    J. Simkins1, J. A. Morillas-Rodriguez1, M. I. Morris1, L. M. Abbo1, J. F. Camargo1, S. Anjan1, W. Kupin1, P. Ruiz2, C. Fernandez-Bango2, J. C. Ramos1

  • Heart-Associated Cytokine and Endothelial Patterns Dominate the Ischemia/Reperfusion Response in Recipients of Combined Heart/Lung Transplantation in Comparison to Lung Transplantation

    F. Wandrer1, B. Wiegmann2, N. Ledwoch1, R. Bellmas Sanz1, F. Ius2, W. Sommer2, S. Rojas2, C. Kühn2, I. Tudorache2, M. Avsar2, A. Haverich2, G. Warnecke2, C. S. Falk1

  • Hepatoblastoma Tumors Requiring Liver Transplantation Manifest Dysregulated Ciliary, Autophagy and Cell Cycling Pathways in Systems Biology Analysis

    T. Narayanan1, M. Ningappa2, B. W. Higgs2, S. Subramaniam3, R. Sindhi2

  • Heterozygous Gene Mutations In The Complement Factor I (cfi) Was Susceptibility Gene For The C3 Glomerulonephritis In Native Kidney And Renal Allograft

    J. Wen, H. Song, X. Ni, M. Zhang, F. Xu, X. Zhu

  • High Urinary Neutrophil Gelatinase Lipocalins (NGAL) Levels in Kidney Perfusates as Predictor of a Better Renal Function

    A. Angeletti, C. Donadei, V. De Pace, I. Capelli, V. Corradetti, C. Zannini, F. Alviano, L. Bonsi, G. Comai, M. Ravaioli, G. La Manna

  • Higher Population Donor Service Areas Are Associated With Lower Meld At Death On Wait List And Higher Meld At Removal For “Too Sick

    Y. Hung, Y. Bababekov, C. Rickert, Y. Hsu, D. Chang, H. Yeh

  • Human Leukocyte Antigen Class I (HLA-I) Antibodies in Patients Undergoing Liver Transplantation: Implications for Platelet Transfusion Support

    M. Wong1, R. Narra2, M. Selim1, M. A. Zimmerman1, A. Padmanabhan3, J. C. Hong1

  • Human Mesenchymal Stem Cells Inhibits Hypoxia-Induced Islets Apoptosis via Regulation of Autophagy

    R. Pengfei, X. Yuzhi

  • Hypothermic Protection Attenuates Kidney Injury in Renal Ischemia-Reperfusion Injury via Phosphorylation of ERK

    D. Choi1, J. Jeong2, K. Lee1, K. Na1, Y. Chang3, Y. Ham1, J. Jeon1, H. Kim1

  • IE-1 Specific T Cell Receptor Repertoire Diversity and Protection against CMV Reactivation

    M. Lucia Perez1, F. Rubelt1, S. Busque1, C. O. Esquivel1, S. M. Krams1, O. Bestard2, O. M. Martinez1

  • IL-1β and IL-6 Facilitate T Cell Reconstitution in Heart Allograft Recipients Treated with Anti-Thymocyte Globulin

    S. Hasgur, R. Fan, A. Valujskikh

  • Identification of Antibodies Reactive to Vimentin in a Rat Kidney Transplant Model of Chronic Antibody-Mediated Rejection

    S. Reese, N. Wilson, L. Ptak, J. Sullivan, W. Burlingham, A. Djamali, S. E. Panzer

  • IgG Glycosylation Causes Podocyte Injury in Transplant Glomerulopathy through Calcium Calmodulin Kinase IV

    R. Bhargava, K. Maeda, M. Pavlakis, G. Tsokos

  • Iguratimod Attenuates the Production of Donor Specific Antibody by Inducing CD19+Tim-1+ Regulatory B Cells and Imbalance of Th17 Treg

    Z. Wang, S. Fei, H. Chen, Z. Han, L. Sun, J. Tao, X. Ju, M. Zheng, R. Tan, M. Gu

  • Illustration of Renal Recovery in SLK with Utilization of Most Recent Allocation Criteria

    B. Patel, R. Prashar, A. Babu

  • Immunomics of Renal Allograft Acute T-Cell Mediated Rejection Biopsies of Tacrolimus- and Belatacept- Treated Patients

    M. van der Zwan1, C. C. Baan1, R. C. Colvin2, R. N. Smith2, R. A. White2, D. N. Ndishabandi2, A. L. Nigg1, T. P. van den Bosch1, G. N. de Graav1, M. C. Clahsen-van Groningen1, D. A. Hesselink1

  • Immunosuppression after Organ Transplantation Does Not Enhance Patency of Cold-Stored Vein Allografts for Critical Limb Ischemia -Single Centre Experience

    J. Chlupac, T. Marada, R. Novotny, K. Lipar, L. Janousek, J. Fronek

  • Impact Of The Provision Of Transplant Information On Access To First And Repeat Kidney Transplantation

    S. Clark, A. Abdalla, M. Kadatz, J. Gill, J. S. Gill

  • Impact of Extremely Prolonged Cold Ischemia Time in Combination with AKI on Kidney Transplantation Outcome – A Single Center Experience

    N. Sharma, Z. Haddad, Y. Qazi

  • Impact of HLA-DR Matching on HLA-DQ Matching Status and the Development of Anti-HLA-DQ De Novo DSA under Calcineurin Inhibitor or Belatacept Immunosuppression

    V. Jucaud1, H. Gebel2, R. Bray2, M. Polinsky3, M. Everly1

  • Impact of IgG Subclass and C1q Binding Donor-Specific HLA Antibodies on Antibody Mediated Rejection in Kidney Transplant Recipients

    H. Lee1, J. Ryu1, S. Yun1, T. Ban2, E. Ko2, C. Yang2, E. Oh1

  • Impact of Induction Choice and Early Steroid Withdrawal on Outcomes in HLA Zero Mismatched Kidney Transplant Recipients

    C. Votruba1, K. Holdener1, B. Astor2, F. Aziz2, D. Mandelbrot2

  • Impact of Multidrug-Resistant Microbes of Donor Lower Respiratory Tract on Early Posttransplant Pneumonia in Bilateral Lung Transplant Recipients without Pretransplant Infection

    S. HAN1, S. Kim2, M. Park3, J. Lee4, H. Paik4

  • Impact of Multidrug-Resistant Organisms among Donors on Organ Utilization

    J. A. Anesi1, E. Lautenbach1, J. H. Han1, D. H. Lee2, H. Clauss3, A. Climaco4, R. Hasz5, E. Molnar3, D. Alimenti1, S. West5, W. B. Bilker1, P. Tolomeo1, E. A. Blumberg1

  • Impact of Tacrolimus Formulation on Tacrolimus Level Coefficient of Variations

    S. January1, T. Horwedel2, J. Hagopian1, C. Carthon1, A. Gharabagi3, R. Delos Santos4

  • Impact of Time-of-Day of Declamping on Kidney Transplant Outcome

    D. Montaigne1, N. Al Hawajri2, M. Jacquelinet1, A. Coppin1, M. Frimat3, S. Bouyé3, G. Lebuffe3, F. Bayer2, M. Lassalle2, B. Staels1, M. Hazzan3, C. Jacquelinet4

  • Impact of Vancomycin-Resistant Enterococci Gut Colonization on Liver Transplant Outcomes

    D. Chiang, T. C. Dingle, S. Belga, D. Kabbani, J. Walter, J. G. Abraldes, C. Cervera

  • Impact of a Short Duration, Narrow Spectrum Perioperative Antibiotic Prophylaxis Regimen on Multi-Drug Resistant Surgical Site Infections in Adult Orthotopic Liver Transplantation

    M. John1, K. Maguigan1, D. Schain2, E. Thomas3, P. Efron4, J. Nelson5

  • Impacts of Mycophenolate Mofetile Addition to Very Low Exposure Everolimus and Calcineurine Inhibitor Based Immunosuppression in De Novo Kidney Transplantation 5 Years Results

    Y. Watarai1, S. Narumi1, T. Tomosugi1, M. Okada1, K. Futamura2, M. Tsujita2, T. Hiramitsu1, T. Kobayashi3, N. Goto2

  • Implementation of a De Novo Belatacept Protocol

    D. Wojciechowski1, M. Jacobs2, K. Safa1, H. Gilligan1, H. Eliot1, W. W. Williams, Jr1

  • Improvement of the Outcome of Clinical Islet Transplantation Depending on the Era in Japan

    Y. Akashi1, T. Kenmochi2, T. Ito3, K. Kurihara2, N. Aida2, A. Kawai2, M. Hayashi4, K. Kouketsu4

  • In Vitro Model for Detection of HLA Antibodies from Long Lived Plasma Cells

    M. Merzkani1, N. Moore1, X. Benavides1, B. Smith1, W. Park1, A. Bentall1, K. Medina2, M. Gandhi3, M. Stegall1

  • In Vitro Model to Study the Effect of Irradiation Preconditioning on Alloimmune Responses: Development of Potential Predictive Markers

    K. Shimozawa, K. Janec, L. Contreras-Ruiz, E. C. Guinan

  • Incidence and Predictors of Post-Kidney Biopsy (KBx) Bleeding in Liver Transplant (LT) Candidates with Renal Dysfunction

    H. M. Wadei1, P. Abader1, N. Aslam2, T. Jarmi1, A. P. Keaveny1, K. Croome1, D. D. Lee1, C. Taner1

  • Incidence of Cytomegalovirus in Moderate Risk Kidney Transplant Recipients Receiving Low Dose Valganciclovir

    T. Fallah1, A. Logan2, L. Beltran Garcia3, L. Bowman2

  • Increase in Proinflammatory CD14++CD16+ Monocytes in Samples from Aspiration Cytology Compared with Peripheral Blood in Kidney Transplant Patients with Borderline Rejection

    T. Vazquez-Sanchez1, A. Caballero-Gonzalez2, E. Sola1, P. Ruiz-Esteban1, E. Marques1, J. Alonso-Titos1, E. Palma1, C. Jironda1, M. Cabello1, V. Lopez1, P. Hidalgo1, M. Leon1, D. Hernandez1

  • Increased Number of Intragraft FoxP3+ T Cells is Strongly Correlated with Decreased Graft Survival in Chronic Active Antibody Mediated Rejection

    K. Sablik1, K. Jordanova2, M. Clahsen-van Groningen1, M. Betjes1

  • Increasing Expression of B-cell Maturation Antigen during the Development of Recall Antibody Responses: A Prospective Pharmaceutical Target for B-cell Suppression?

    G. Wu, I. Kim, N. Chai, A. Klein, S. Jordan

  • Indocyanine Green Fluorescence Imaging during Normothermic Ex Vivo Liver Perfusion for the Assessment of Hepatocyte, Biliary, and Vascular Function

    T. Goto, I. Linares, S. Ganesh, L. Mazilescu, P. Urbanellis, N. Selzner, M. Selzner

  • Infectious Complications in 71 Heart Transplant Recipients at King Chulalongkorn Memorial Hospital, Thailand

    N. Sangpornsuk1, J. Wanichwatphibun2, A. Ariyachaipanich3, P. Ongcharit4, K. Jutivorakool5, J. Vanichanan5

  • Infectious Complications in Kidney Transplant Recipients Age 65 and Older

    L. E. Liriano-Ward1, M. Barbachan e Silva2, Y. Azzi1, M. Ajaimy1, A. Cambell1, J. Graham1, J. Rocca1, C. Pynadath1, G. Nair1, O. Andacoglu1, S. Greenstein1, P. Ó Broin2, E. Akalin1

  • Infective Complications after Renal Transplantation – A Single Centre Experience Comparing Alemtuzumab to Basiliximab Induction

    R. Czajka, M. Welberry Smith, M. Gittus, E. Lindley, M. Vernon

  • Inhibition of Autophagy Prolongs Recipients Survival through Accelerating CD8+ T Cell Apoptosis in a Rat Liver Transplantation Model

    X. Chen1, Q. Yang1, X. Li2, Y. Deng1, G. Chen1, G. Wang1

  • Inhibition of Cyclin-Dependent Kinase 2 Signaling Prevents Liver Ischemia and Reperfusion Injury

    Z. Xue, J. Xu, C. Zhang, Y. Liu, R. Busuttil, J. Kupiec-Weglinski, H. Ji

  • Insulin Treatment in Pancreas Donors on the Intensive Care is a Marker of Beta Cell Death as Evidenced by microRNA Data

    I. Shapey, A. Summers, J. O'Sullivan, P. Yiannoullou, N. Hanley, T. Augustine, M. Rutter, D. van Dellen

  • Integrative Analysis of Immune Repertoire and Gene Expression from RNA-seq in Kidney Organ Transplants

    S. Pineda1, A. Ravoor2, O. Bestard3, M. Sarwal1, M. Sirota2

  • Interleukin-27 is Required for Donor Specific Antibody Production in Response to Heart Allograft Transplantation

    M. Nicosia, S. Miyairi, R. Fan, A. Beavers, V. Gorbacheva, A. Valujskikh

  • Intraoperative Portal Vein Flow Can Predict Early Acute Kidney Injury Following Allogeneic Liver Transplantation: A Retrospective Observational Study

    J. Zhang1, A. Jiao2, Q. Liu1, C. Zhang1, N. Sun1, X. Li1

  • Investigating Deceased Donor Kidney Discard Trend – An Opportunity To Expand The Donor Pool

    J. A. Shah1, D. P. Borle1, K. Koontz2, W. Irish1, K. V. Ravindra1

  • Involvement of Genetic Variation and Related Gene Expression Changes on Acute Rejection in Renal Transplant Recipients

    H. Hwang1, J. Seo1, J. Kim1, Y. Kim1, J. Moon1, K. Jeong1, C. Kim2, J. Park3, B. Chung4, Y. Kim5, S. Lee1

  • Is Bariatric Surgery Feasible in the Setting of Liver and Kidney Transplants?

    L. M. Potter, A. Saharia, C. Mobley, K. Lunsford, M. Hobeika, N. Tariq, H. Podder, A. O. Gaber, R. M. Ghobrial

  • Is Exposure to Wildfires Associated with Invasive Fungal Infections?

    J. S. Mulliken1, A. G. Rappold2, M. Fung1, J. M. Babik1, S. B. Doernberg1

  • Ischemic Preconditioning Attenuates Renal Ischemia-Reperfusion Injury through Activating the Nrf2/HO-1 Pathway Enhanced Autophagy

    H. Choi1, Y. Kim2, M. Kim2, K. Jun2, S. Kim2, S. Park3, J. Kim4, I. Moon5, J. Hwang6

  • Islet Stress Leads to Increased Release of Exosomes That Stimulate Immune Cell Response

    S. Vasu1, C. Darden2, K. Kumano1, B. Naziruddin3, M. Lawrence3

  • JAK Inhibitor as a Novel Conditioning Approach to Establish Mixed Chimerism and Prevent Type 1 Diabetes Nonmyeloablatively

    H. Xu1, A. Merchak1, J. Xu2, Y. Huang1, S. T. Ildstad1

  • Kidney Allograft Recipient Absence of Myeloperoxidase Decreases Donor-Specific Antibody Titers and Attenuates Antibody-Mediated Allograft Rejection

    S. Miyairi, N. Dvorina, A. Valujuskikh, W. M. Baldwin 3rd, R. L. Fairchild

  • Kidney Grafts From Donors After Circulatory Death Provide Comparable Outcome To Donors After Brain Death Without Intracorporeal In Situ Cooling

    H. Harada, M. Miura, A. Mitsuke, H. Higuchi, N. Fukuzawa, H. Tanaka, T. Hirano, T. Seki

  • Kidney-Intrinsic Innate Immunity and Endoplasmic Reticulum Stress Pathways are Key Determinants of Severity of Ischemia-Reperfusion Injury Following Transplantation

    L. Qiu1, J. Wang1, X. Yeap1, C. Lin1, Y. S. Kanwar2, D. Fang2, M. M. Abecassis1, Z. J. Zhang1

  • Kupffer Cells Are Critical for Inflammation Resolution in Liver Ischemia Reperfusion Injury via TIM-4 Mediated Efferocytosis

    M. Ni1, H. Wang1, D. Jin1, J. Zhang1, R. Busuttil1, J. Kupiec-Weglinski1, X. Wang2, Y. Zhai1

  • Lack of Response to Tocilizumab in Kidney Transplants with Chronic Antibody-Mediated Rejection

    D. Kumar1, F. Safavi1, R. Sandhu1, P. Halloran2, I. Yakubu1, M. Levy1, I. Moinuddin1, P. Kimball1, L. Kamal1, A. King1, H. Massey1, G. Gupta1

  • Letermovir for CMV Treatment in Solid Organ Transplant

    O. Witkowsky, M. Chunduru, A. Chung, A. Diez

  • Liquid Biopsy for Chronic Rejection after Kidney Transplantation. A Novel Non-Invasive Biomarker Involved in Inflammatory Amplifier

    Y. Takada1, D. Kamimura2, H. Higuchi1, D. Iwami1, K. Hotta1, N. Iwahara1, N. Shinohara1, M. Murakami2

  • Liver Transplant Centers Select Different Characteristics for Recipients and Deceased Donors: Implications for Patients When Choosing a Center

    C. R. Schaffhausen1, M. J. Bruin2, S. Chu2, D. Schladt1, S. Chinnakotla3, J. R. Lake4, W. Kim5, S. W. Biggins6, J. J. Snyder7, B. L. Kasiske7, A. K. Israni1

  • Liver Transplant Outcomes in Patients with Atrial Fibrillation

    D. Devuni1, P. Mahboub2, P. Martins2, C. Barry1, I. Zacharias1, B. Movahedi2, G. Barnard1, A. Bozorgzadeh2

  • Liver Transplantation for Acute Liver Failure: A 16 Year Experience with 214 Patients in the Post-MELD Era

    R. McMillan, T. Ito, A. Aziz, A. Amin, A. Murray, J. DiNorcia III, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas

  • Long Term Outcomes in Kidney Transplant Recipients Receiving Everolimus (EVR) or Mycophenolate (MPS) in Combination with Tacrolimus (TAC)

    K. Ficher, C. Rosso Felipe, Y. Cardoso Dreige, K. Linhares, A. Ferreira Brígido, S. Stopa, L. Viana, M. Cristelli, P. Gessolo Lins, W. Aguiar, H. Proença, R. Marco, M. Gerbase de Lima, H. Tedesco Silva Junior, J. Medina Pestana

  • Long-Term Efficacy and Safety of Everolimus Based Immunosuppression on De Novo Kidney Transplantation with 10 Years Follow-Up

    Y. Watarai1, S. Narumi1, T. Tomosugi1, K. Futamura2, M. Okada1, M. Tsujita2, T. Hiramitsu1, T. Kobayashi3, N. Goto2

  • Long-Term Kidney Graft Evolution in Simultaneous Liver-Kidney Transplants with Immunological Risk

    G. J. Piñeiro1, E. Montagud1, J. Ugalde1, R. Gelpi1, V. Torregrosa1, J. Rovira2, J. Colmenero3, F. Diekmann1, N. Esforzado1

  • Long-Term Outcomes after Face Transplantation

    B. Kollar, S. Tasigiorgos, M. Turk, E. Bueno, B. Perry, M. Alhefzi, H. Kiwanuka, M. Nizzi, N. Krezdorn, T. Win, M. I. Dorante, V. Haug, D. J. Annino, F. M. Marty, A. Chandraker, S. G. Tullius, L. V. Riella, B. Pomahac

  • Long-Term Outcomes of Early Conversion to Sirolimus-Based Immunosuppression in Children with Living Donor Kidney Transplants

    B. Stotter1, S. Lui1, E. Weller2, L. Ganapathi1, M. Ferguson1, A. Traum1, M. Somers1, N. Rodig1

  • Long-Term Survival Analysis of Kidney Transplant Recipients Receiving Mizoribine as a Maintenance Immunosuppressant

    J. Kim1, D. Lee1, J. Oh1, J. Lee1, H. Kim1, Y. Son2

  • Loss of FXR Exacerbates Liver Damage by Activating NLRP3 Inflammasome Induced Pyroptosis in Liver Ischemia Reperfusion Injury

    Z. Zhu, Y. Zhang, Y. Tang, S. Huang, Q. Zhao, W. Ju, Z. Guo, X. He

  • Management of Inactive Candidates on the Kidney Transplant Waitlist: Results from a National Survey

    J. Hiller, J. Chen, K. Covarrubias, K. Jackson, J. Long, S. DiBrito, D. Segev, J. Garonzik Wang

  • Matrix Metalloproteinase-9 and Neutrophil Extracellular Traps in Human and Mouse Liver Ischemia and Reperfusion Injury

    S. Duarte, A. Zarrinpar, R. W. Busuttil, A. J. Coito

  • Mechanical Irritation in Vascularized Tissue Allotransplantation Triggers Localized Skin Rejection

    F. Messner, A. Fischer, E. Runggaldier, S. Eiter, B. Zelger, B. Zelger, S. Sprung, D. Öfner, S. Schneeberger, T. Hautz

  • Microfluidic Study Analyzing the Effect of Immediate-Release and Extended-Release Tacrolimus on Islet Function

    P. West-Thielke1, J. Oberholzer2, Y. Wang3

  • Mitochondrial Permeability Regulates Heart Graft Ischemia – Reperfusion Injury and Rejection

    A. Qamar1, J. Jiang1, X. Huang2, P. McLeod2, A. M. Jevnikar2, Z. Zhang2

  • Molecular Microscope Proves i-IFTA Lack of Specificity

    A. Perkowska-Ptasinska1, M. Ciszek2, D. Deborska-Materkowska1, A. Debska-Slizien3, P. F. Halloran4, M. Myslak5

  • Molecular Phenotype of Proliferative Arteriopathy in Kidney Grafts

    A. Perkowska-Ptasinska1, M. Ciszek1, D. Deborska-Materkowska1, A. Debska-Slizien2, P. F. Halloran3, M. Myslak4

  • Monitoring And Management Of Proteinuria Is Often Ignored In Patients Receiving mTOR Therapy Following Orthotopic Liver Transplantation

    R. Kaur1, O. Sadiq2, M. Alimirah1, F. Kumssa1, A. Patel3, S. Jafri2

  • Monitoring Inflammatory Cytokine Levels in Kidney Transplant Patients (KTx Pts) with Chronic Antibody Mediated Rejection (cABMR) Treated with Clazakizumab (CLZ, Humanized Anti-IL-6 Monoclonal Antibody)

    S. Ge1, A. Petrosyan1, M. Chu1, N. Ammerman2, A. Vo2, S. C. Jordan2, X. Zhang3, M. Toyoda1

  • Multi-omic Analysis Of Hepatic Ischemia/reperfusion Injury Identifies Novel Targets To Mitigate Hepatocellular Damage

    S. Duarte1, V. Boominathan2, Z. Huo3, A. Kobayashi2, U. Kim2, Y. Lai2, A. Coito1, A. Zarrinpar2

  • Multiple Non-HLA Antibodies Are Significantly Increased in Chronic Active Antibody Mediated Rejection

    K. Sablik1, E. Kamburova2, D. Roelen3, H. Otten2, M. Betjes1

  • Multiplexed Droplet Single-Cell RNA-Sequencing for Cellular Profiling of Transplant Rejection

    A. Schroeder, T. Sigdel, I. Damm, S. Sur, G. Hartoularos, J. Ye, M. Sarwal

  • NK Cell Quantification by Paraffin Immunohistochemistry is Not Predictive of Graft Outcome in 1-Year Surveillance Biopsies

    J. Barnes1, F. Suliman2, A. Shammout1, E. A. Farkash1

  • NQO-1 Attenuates Renal Ischemia-Reperfusion Injury in Mice

    D. Choi1, J. Hwang2, J. Jeong3, K. Lee1, K. Na1, Y. Ham1, J. Jeon1, H. Kim1, Y. Chang1

  • Natural Anti-a Antibody Production In Mice Is Cd4 T Cell-independent

    I. Adam1, B. Motyka2, L. West3

  • Natural Antibodies and Left Ventricular Assist Device Complications

    S. B. See1, A. Pinsino2, R. Shihab1, N. Kunimune1, D. Onat2, E. Hittesdorf3, A. R. Garan2, V. K. Topkara2, Y. Naka4, H. Takayama4, K. Takeda4, P. Colombo2, M. Yuzefpolskaya2, G. Wagener3, E. Zorn1

  • Natural Killer Cells Express Significantly More CD16 during Chronic Active Antibody Mediated Rejection Which is Not Caused by a Single Nucleotide Polymorphism within the CD16 Gene

    K. Sablik, N. Litjens, A. Peeters, M. Clahsen-van Groningen, M. Klepper, M. Betjes

  • Need For Protocol Driven Mmr/vzv Serologic Screening

    A. Agarwal1, L. Brumble1, H. Wadei2, C. Libertin1

  • Next Gen ABO Antibody Assessment: Development of a Bead-Based ABO Antibody Detection Assay

    A. Halpin1, J. Pearcey2, B. Motyka2, S. Maier2, J. Zhou3, T. L. Lowary4, C. W. Cairo4, L. J. West1

  • Non-HLA Antibodies against Structural and Non-Structural Target in C4d Negative Antibody Mediated Rejections after Renal Transplantation

    S. Kanangat1, I. Kurbegovic-Skaljic2, D. Cimbaluk2, M. Oppermann2, S. Jensik3, E. Hollinger3, O. Olaitan4, R. DeCresce2

  • Non-Invasive Monitoring of the Kidney Allograft

    S. Bontha1, G. Darville1, C. Kuscu1, C. Kuscu2, A. Bajwa1, J. Eason3, D. Maluf4, V. Mas5

  • Normothermic Ex Situ Liver Perfusion with Different Clinical Perfusates and Their Effect on Pig Liver Transplant Outcomes in a Donation after Circulatory Death Model

    I. Linares-Cervantes, D. Kollmann, T. Goto, J. Echeverri, M. Kaths, M. Hamar, P. Urbanellis, L. Mazilescu, R. Rosales, C. Bruguera, F. Oquendo, S. Ganesh, O. Adeyi, P. Yip, N. Selzner, M. Selzner

  • Novel Flow-Based Assay to Identify Allo-Specific T Cell Exhaustion

    N. Tanimine1, C. Rickert1, K. Lee1, K. Deng1, N. Feeney1, C. Leguern1, B. Burrell2, J. Markmann1

  • Novel Molecular Mechanisms Associated with Normothermic Ex-Vivo Kidney Perfusion

    C. McEvoy1, T. Tokar2, S. Reid3, P. Urbanellis3, M. Hamar1, M. Kaths1, I. Jurisica2, L. Robinson4, M. Selzner1, A. Konvalinka1

  • Optimizing Opportunity and Benefits of Steroid Avoidance in the New KAS Era

    S. Sultan, M. Aull, R. Friedlander, V. K. Sharma, D. Serur, A. Watkins, S. Kapur, D. Dadhania

  • Optimizing a Protocol for Extended Ex-Vivo Extremity Perfusion

    C. J. Stewart1, M. T. Buchko2, X. Wang1, G. Brandacher3, A. Ladak4, D. H. Freed2, J. Nagendran2

  • Oral Preconditioning of Donors after Brain Death with Calcineurin Inhibitors vs. Inhibitors of Mammalian Target for Rapamycin in Pig Kidney Transplantation

    S. Abbasi Dezfouli1, M. Golriz1, O. Ghamarnejad1, E. Khajeh1, S. Mohammadi1, M. Nikdad1, A. Majlesara1, M. Sabagh1, P. Fathi1, S. Shafiei1, M. Kentar2, A. Younsi2, C. Eckert3, T. Poth3, A. Mehrabi1, A. Nickkholgh1

  • Orthotopic Liver Transplantation in MPV17 Deficiency: A Case Series

    E. A. Gerzina1, E. D. Witte1, M. L. Kueht2, R. W. Himes3

  • Outbreak of Pneumocystis Pneumonia in a Transplant Center Linked to a Single Genotype of Pneumocystis jirovecii: Effects of Cytomegalovirus Infection and Allograft Rejection

    S. Hosseini-Moghaddam1, S. Dufresne2, M. Shokoohi3, G. Singh1, E. HunterGutierrez1, P. Dufresne2, A. House1, P. Luke1, A. Nagpal1, P. Marotta1, A. Humar4, A. Jevnikar1, D. Kumar4

  • Outcomes for Liver Transplant Recipients on Renal Replacement Therapy: Who Cannot Wait for Safety Net

    A. Pita1, N. Kaur1, M. Lo2, A. F. Sabour1, V. Tristan1, Y. Genyk1, M. K. Nadim3, L. Sher1

  • Outcomes in Kidney Transplant Recipients after Conversion from Tacrolimus to Belatacept-Based Regimens

    H. Underwood, N. Lange, J. Hedvat, C. Brennan, D. Tsapepas, K. King, S. Husain, D. Salerno, S. Patel, S. Mohan, R. Crew

  • Outcomes of ABO Incompatible Transplant on Steroid Free Immunosuppression

    A. Wang, D. Mishler, T. Taber, M. Yaqub, A. Sharfuddin, W. Goggins, O. Adebiyi

  • Outcomes of En Bloc Simultaneous Liver-Kidney Transplantation Compared to the Traditional Technique

    A. R. Cortez, T. C. Lee, A. Kassam, M. C. Morris, L. K. Winer, L. Sage Silski, M. C. Cuffy, T. S. Diwan, R. C. Quillin, S. A. Shah

  • Outcomes of Inguinal and Incisional Hernias in Patients Undergoing Liver Transplant

    H. Aziz, V. Tristan, Y. Genyk, K. Etesami

  • Outcomes of Side-to-Side Cavocavostomy versus Traditional Piggyback Implantation in Liver Transplantation

    T. Lee, V. Dhar, M. Morris, L. Winer, A. Cortez, L. Sage Silski, M. Cuffy, T. Diwan, R. Quillin, III, S. Shah

  • Pancreatic Extracellular Matrix Improves Human Islet Culture and Function In Vitro

    Y. Shindo, R. Pouillot, B. M. Young, P. Link, R. L. Heise, M. F. Levy, M. A. Kanak

  • Parathyroid CD34+ Cells Induce Neovascularization of Donor and Recipient Leading to Chimeric Vessel Formation and Improved Engraftment of Co-Transplanted Pancreatic Islets

    Y. Kelly1, C. Ward1, Q. Duh1, W. Chang2, P. Stock1, Q. Tang1

  • Patterns Of Anti-retroviral Use Among U.s. Liver Transplant Candidates With Hiv

    A. A. Shaffer1, A. G. Thomas2, D. L. Segev3

  • Perceptions and Attitude of Transplant Clinicians towards Antimicrobial Resistance and Stewardship in Transplant Recipients: A Survey of the American Society of Transplantation

    M. So1, J. Hand2, M. Richmond1, A. Morris3, S. Husain1

  • Perfluorocarbon (PFC) Solutions for Organ Preservation

    N. Battula, T. Parsons, J. Zhu, C. Giordano, A. Esnakula, B. Spiess, M. Johnson, A. Zarrinpar, K. Andreoni

  • Pharmacological Mobilization of Host Stem Cells Prevents Delayed Graft Function Following Kidney Transplantation in Rats

    W. Wang, L. Qi, J. Huang, A. Ahmadi, A. Krishnan, R. Wesson, A. Cameron, Z. Sun

  • Phylogenetic Analysis of the Epstein Barr Virus Nuclear Antigen-1 and Associated Correlates among Canadian Transplant Patients

    M. Abdulnoor1, S. Isabel1, T. Paton1, N. Khodai-Booran1, T. Schechter1, P. Birk2, T. Blydt-Hansen3, B. Foster4, S. Mital1, V. Phan5, S. Urschel6, G. Casallo1, T. Papaz1, L. Hamiwka7, S. Min1, U. Allen1

  • Pneumocystis Prophylaxis in Solid Organ Transplant Recipients at Two Large Transplant Centers from 2015-2016: Why Not Trimethoprim-Sulfamethoxazole?

    J. M. Lum1, V. Athans2, I. Echenique3, C. E. Koval1

  • Poor Long-Term Outcome of Liver Transplant Recipients with Preexisting Renal Insufficiency

    M. Sterneck1, M. Touma1, T. Horvatits2, S. Pischke2, U. Herden3, A. Lohse2, L. Fischer3

  • Portal Vein Thrombosis Discovered at Liver Transplant: Barrier to Success

    J. Seltman1, M. Kazimi2, J. Duque3, R. Cross2, A. Ray2, T. Ommert2, R. A. Rubin2

  • Post-Reperfusion Hepatic Beta-Catenin Activation Regulates Graft Damage, Inflammatory Responses and Transplant Outcomes

    H. Hirao, K. Kadono, S. Kageyama, K. Nakamura, T. Ito, J. Aziz, K. J. Dery, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski

  • Pre-Liver Transplant Renal Dysfunction is an Independent Predictor of Post-Liver Transplant Return to the Operating Room

    H. M. Wadei, M. L. Mai, C. Taner, A. P. Keaveny, S. Mao, P. Abader, P. Kroner, K. Croome

  • Pre-Transplant Donor-Specific IFN-γ ELISPOT as a Predictor of Allograft Rejection: A Diagnostic Test Accuracy Meta-Analysis

    S. Farouk1, I. Gandolfini2, N. Montero3, E. Crespo4, M. Jarque4, M. Meneghini4, U. Maggiore2, O. Bestard3, P. Cravedi1

  • Predicting Allograft Outcomes of Renal Transplantation with Pretransplant Metrics

    J. Tchervenkov1, M. Nguyen2, S. Negi1, S. Paraskevas1

  • Predicting Kidney Discards with Donor Admission Text

    A. Placona, C. Martinez, B. Carrico

  • Predicting Post-Transplant Graft Function in Deceased Donor Kidney Transplant Recipients

    K. Archer1, Y. Zhang1, V. Bontha2, J. Eason3, L. Gallon4, E. Akalin5, D. Maluf2, V. Mas2

  • Predictors of Clostridium difficile Infection and Recurrence among 2,622 Solid Organ Transplant Recipients

    A. Schluger, R. Rosenblatt, R. Knotts, E. Verna, M. Pereira

  • Predominant Role of Microvascular over Tubular Injury as Driver of Progressive Renal Damage and Fibrosis Post Ischemia Reperfusion Injury

    S. Lan1, B. Yang1, M. Dieudé1, J. Sabo-Vatasescu2, A. Karakeussian-Rimbaud2, J. Turgeon2, S. Qi3, N. Patey4, M. Hébert1

  • Preoperative Risk Factor-based Cardiac Catheterization Is Associated With Low Cardiac Morbidity And Mortality In Liver Transplant Patients

    R. Rachwan1, I. Kutkut1, P. D. Bourdillon2, L. R. Timsina3, M. Ghabril4, C. A. Kubal5, M. A. Lacerda6, R. S. Mangus5

  • Preventing Donor Derived Cryptococcal Infections: Should We Screen Potential Organ Donors with a Serum Cryptococcal Antigen? A Cost Analysis

    C. Santos1, E. Ritz1, Y. Rhee1, I. George2, J. Pulvirenti3, N. Moore1, E. Hollinger1, L. Proia1

  • Profile of Invasive Fungal Disease after Kidney Transplantation in a Single Brazilian Center

    S. C. Miranda, G. M. Pereira Junior, C. A. Felipe, A. S. Alvarenga, P. A. Macedo Souza, C. Ribeiro, S. C. Cantini

  • Promoting Mitochondrial Fusion Alters the Interaction between Endothelial Cells and T Cells in Models of Transplantation

    D. T. Tran, C. Atkinson, S. N. Nadig

  • Protection of the Donor Kidney Vascular Endothelium by Ex-Vivo Perfusion with a Pan-Caspase Inhibitor

    R. Plenter1, S. Jain2, T. Nydam1, A. jani2

  • Proteomics Reveals Molecular Window and Metabolism of Normothermically Perfused Human Kidneys

    A. Weissenbacher1, H. Huang2, A. Thorne3, L. M. Lo Faro3, J. Hunter3, R. Ploeg3, C. C. Coussios4, P. J. Friend3, B. Kessler5

  • Psychosocial Factors and Medication Adherence among Recipients of Vascularized Composite Allografts

    S. Rasmussen1, M. Henderson1, C. Cooney1, J. Shores1, W. Lee1, E. Goldman2, C. Kaufman2, D. Segev1, G. Brandacher1

  • Quantitative Proteome Profiling in T Cell-Mediated Rejection

    L. Song1, G. Zeng2, P. Liu3, F. Fang4, H. Liu4, X. Xie1, P. Randhawa2, K. Xiao4

  • RNA Sequencing Guided Identification of Shared mRNAs in Human Kidney Allograft Recipients with Acute T Cell Mediated Rejection or Active Antibody Mediated Rejection

    B. Dooley1, A. Verma2, R. Ding1, C. Li1, C. Snopkowski1, H. Yang1, B. Botticelli1, S. Albakry1, E. Edusei1, T. Muthukumar1, M. Lubetzky1, D. Dadhania1, J. Lee1, O. Elemento2, M. Suthanthiran1

  • RNA Sequencing Identifies a Differential Role of Coding and Non-Coding Genes by Types of Rejection

    S. Pineda1, O. Bestard2, T. K. Sigdel1, M. Sirota3, M. Sarwal1

  • Race-Sex Effects on Immune Response Potential during Tacrolimus Minimization Therapy in Stable Renal Allograft Recipients

    K. Tornatore1, K. Attwood2, R. Venuto3, H. Minderman4

  • Randomized Controlled Trial Of Spironolactone Effect In Kidney Transplant Recipients Of Living Donors

    N. A. Bobadilla1, L. E. Morales-Buenrostro1, J. A. Ortega-Trejo1, R. Perez-Villalva1, L. Marino1, Y. González-Bobadilla1, H. Juarez1, F. Zamora-Mejía1, N. Gonzalez1, R. Espinoza2, J. Barrera-Chimal3

  • Rapid Detection of Kidney Transplant Injury by Quantifying Donor-Derived Cell-Free Deoxyribonucleic Acid via Massively Multiplex Polymerase Chain Reaction

    T. K. Sigdel1, F. Acosta2, S. Navarro2, B. Zimmermann2, Z. P. Demko2, S. Moshkevich2, P. R. Billings2, M. M. Sarwal1

  • Real-Life Food Safety Behavior and Incidence of Food-Borne Infections in Solid-Organ Transplant Recipients

    M. Lindup, D. Golshayan, M. Pascual, O. Manuel, M. Mombelli

  • Recipient Monocytes Activated by Endobronchial Toll-Like Receptor 2 Agonist Prevent Tolerance Induction after Lung Transplantation

    S. Tanaka1, J. M. Gauthier1, Y. Terada1, T. Takahashi1, W. Li1, R. Higashikubo1, A. Y. Tong1, V. Puri1, A. S. Krupnick2, A. E. Gelman1, D. Kreisel1

  • Recipient Sex Interacts with Primary Diagnosis to Affect Liver Transplant Graft Survival

    D. Yoeli1, R. Choudhury1, H. Moore1, M. Simpson2, A. Sauaia1, E. Pomfret1, T. Nydam1

  • Recombinant Apoptosis Inhibitor of Macrophage Protein Ameliorates Transplant Ischemia-Reperfusion Injury

    J. Y. Lee1, X. Zhang2, D. Lian3, A. R. Haig4, T. Miyazaki5, L. Gunaratnam6

  • Reevaluating Cut-Off Points for the Expansion of Deceased Donor Criteria for Kidney Transplantation in Japan

    Y. NAKAGAWA1, M. Masahiro2, M. Tasaki2, K. Saito3, K. Takahashi4

  • Regulatory T Cells Combined with Costimulation Blockade Prevent Rejection of Vascularized Composite Allografts

    B. Oh1, G. Furtmüller1, M. Grzelak1, L. Vuong2, M. Iglesias1, M. Fryer3, D. Cooney1, R. Chen4, Y. Guo5, W. Lee1, G. Raimondi1, G. Brandacher1

  • Relationship between Comorbilities and Infectious Disease in Kidney Transplant Recipients Receiving Rituximab

    A. Molina-Andújar1, E. Hermida1, J. Rovira2, F. Cofan1, P. Ventura-Aguiar1, N. Esforzado1, V. Torregrosa1, D. Cucchiari1, E. de Souza1, I. Revuelta1, F. Oppenheimer1, F. Diekmann1, G. Piñeiro1

  • Renal Failure after Liver Transplantation: Benefits from a Little Pinch of KALT

    R. Ruiz1, K. Holmes2, G. McKenna1, N. Onaca1, G. Testa1, H. Fernandez1, J. Bayer1, A. Wall1, E. Martinez1, E. Martinez1, A. Gupta1, R. Goldstein1, G. Klintmalm1

  • Renal Safety Of Entecavir And Tenofovir With Hepatitis B Immunoglobulin In Liver Transplant Patients

    D. Kim1, J. Lee1, E. Kim1, S. Kim1, K. Ihn1, D. Joo1, K. Huh1, B. Kim2, M. Kim1, S. Kim1, Y. Kim1, J. Lee1

  • Renal Transplantation in Patients Older Than 60 Years with High Comorbidity. Is There a Survival Benefit? A Multicenter Study in Argentina

    G. D. Fragale1, G. A. Laham2, L. Bisignano3, A. Antik3, P. M. Raffaele4, M. Fortunato4, H. Trimarchi5, V. Pomeranz5, R. Maldonado6, N. Matamala6, N. C. Imperiali7, M. C. Giordani7, M. F. Taylor8, J. M. Ciappa8, J. L. De La Fuente9, S. Naser10, G. Soler Pujol2

  • Replication of Diagnostic Biomarkers Using Orthogonal State-of-the-Art Technologies

    M. Cassidy, B. Dooley, A. Verma, H. Yang, T. Muthukumar, R. Ding, C. Li, C. Snopkowski, B. Botticelli, S. Albakry, E. Edusei, M. Lubetzky, D. Dadhania, J. Lee, O. Elemento, M. Suthanthiran

  • Respiratory Viral Infections and Patient Outcomes in Solid Organ Transplant Recipients

    M. Gonzalez1, A. Vostal1, N. Darling2, C. Papastamelos2, M. Natarajan3, P. Kumar3, J. Timpone3

  • Reverse Signaling through CD137 Ligand Promotes Tissue Repair after Ischemia-Reperfusion Kidney Injury

    H. R. Cho1, S. Lee2, J. S. Lee3, S. J. Park1, B. Kwon2

  • Risk Factors for Initial Sub- and Supra-Therapeutic Tacrolimus Trough Levels in Renal Transplant Recipients

    M. Kapugi, K. Cunningham, C. D'Agostino, C. Kane, A. Novak, J. Schulte

  • Risk Stratification of Patients Undergoing Simultaneous Liver Transplantation and Cardiac Surgery

    T. Diago Uso, G. D'Amico, S. Armanyous, L. Lomaglio, B. Eghtesad, M. Fujiki, F. Aucejo, K. Sasaki, N. K. Menon, M. Fares, M. Tong, K. Hashimoto, C. Miller, C. Quintini

  • Risk of Delayed Graft Function after Deceased Donor Kidney Transplantation in the Current Era

    I. Helanterä1, H. N. Ibrahim2, M. Lempinen1, P. Finne3

  • Sequential Liver Kidney Transplant Has Comparable Outcomes As Combined Liver Kidney Transplant Except For Ckd 5 In Patient With Cld With Ckd In Live Donor Program- Retrospective Analysis Of 2182 Cases

    S. Verma, S. Naganathan, S. Gupta

  • Should First and Second Transplant Candidates Be Treated Equally?

    S. Clark, M. Kadatz, J. Gill, J. S. Gill

  • Should Kidney Retransplants Be Performed From Either Extended Criteria Donor Or Donation After Cardio Circulatory Death Donors?

    D. Harriman, V. Gurram, A. Farney, J. Rogers, G. Orlando, C. Jay, A. Reeves-Daniel, A. Mena-Gutierrez, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta

  • Sigma-1 Receptor Agonists Are Renoprotective in a Rat Model of Kidney Transplantation

    A. Hosszu1, Z. Antal2, L. Illesy2, L. Lenart1, D. B. Balogh1, L. Wagner3, A. Vannay4, A. J. Szabo2, A. Fekete1

  • Significance of Histopathologic Features for Predicting Progression in Patients with Transplant Glomerulopathy

    X. Li, J. Chen, D. Cheng, R. Wang, W. Wang, M. Zhang, F. Xu, J. Wen, Z. Tang

  • Single Cell Analysis of Kidney Allograft Rejection

    C. M. Castro-Rojas1, K. M. Roskin2, C. G. Moore2, B. Abu Jawdeh3, N. Salomonis2, R. R. Alloway4, E. Woodle4, D. A. Hildeman1

  • Single Cell RNA-seq Analysis of Antibody-Mediated Rejection Reveals Endothelial – Pericyte NOTCH Signaling

    A. F. Malone, A. Chadha, H. Wu, S. Ramakrishnan, E. Donnelly, B. D. Humphreys

  • Single Center Deceased Donor Renal Transplant (DDRTx) Outcomes in Sensitized Patients after Implementation of the Kidney Allocation System (KAS)

    S. S. Patel, K. L. King, J. Kamal, E. Vasilescu, A. Husain, S. Mohan, L. E. Ratner, R. Crew

  • Sirolimus (SRL) versus Everolimus (EVR) versus Mycophenolate (MPA) in Kidney Transplant Recipients Receiving Anti-Thymocyte Globulin Induction (r-ATG), Tacrolimus (TAC), and Prednisone

    C. Rosso Felipe, L. Viana, M. Pontello Cristelli, J. Toniato, K. Ficher, S. Poletto, H. Proença, R. de Marco, M. Gerbase-Lima, A. Brigido, J. Medina Pestana, H. Tedesco-Silva

  • Soluble C Type Lectin Receptor Protein Inhibition of Natural Killer Cell Mediated Tubular Epithelial Cell Death

    S. Balaji1, B. Fuhrmann2, D. Lian3, H. Diao3, S. Ma3, Z. Zhang3, A. M. Jevnikar3

  • Staged Procedure In Simultaneous Liver And Kidney Transplant -the “Swedish” Experience

    A. Gravetz

  • Statin Underutilization in Patients Listed for Liver Transplant

    K. Mishra1, S. Naffouj1, S. Modi1, C. Dagher1, S. Gorgis1, D. Venkat2

  • Stem Cell and Granulocyte- Colony Stimulating Factor Therapies to Improve Functional Outcomes in Limb Transplantation

    J. Weiss1, C. Phillips1, E. Malin1, V. Gorantla2, S. K. Salgar3

  • Subclinical Rejection by Biopsy or Gene Expression Profile Predicts Long Term Kidney Function in Patients in the CTOT08 Trial

    R. Heilman1, D. Taber2, K. Guo3, S. Brietigam3, j. charette3, S. Kurian4, M. Abecassis3, J. Friedewald3

  • Subtyping Of Histologically Stable Kidney Transplants In Molecular Meta-analysis

    D. Rychkov1, T. Sigdel2, J. Liberto2, M. Sarwal2, M. Sirota3

  • Surveillance Biopsy Utilization Reported Higher In Transplant Centers Performing Over 100 Kidney Transplants Per Year.

    D. M. Lee1, R. First1, S. Rose1, M. Abecassis2

  • Symptom Burden after Living Donor Kidney Transplant Measured with the Functional Assessment of Cancer Therapy – Kidney Symptom Index is Associated with Worse Transplant Outcomes

    J. Peipert, J. Caicedo-Ramirez, K. Ensor, J. Friedewald, M. Abecassis, D. Cella, D. Ladner, Z. Butt

  • Syphilis Transmission in Solid Organ Transplantation

    M. Morrison, M. Hurtik, G. M. Lyon, S. Pouch

  • T Cell Repertoire of Tissue Infiltrating T-cells at Time of Rejection

    R. Reindl-Schwaighofer1, J. Vetter2, J. Weinberger3, S. Schaller2, A. Heinzel1, G. Gualdoni1, C. Aschauer1, K. Jelencsics1, K. Hu1, S. Winkler2, R. Oberbauer1

  • TACI Polymorphisms Associated with Increased Alloimmunity and Allograft Rejection

    M. Garcia de Mattos-Barbosa1, E. A. Farkash2, J. L. Platt1, M. Cascalho1

  • Tacrolimus Concentration/Dose Ratio is an Independent Predictor of Death-Censored Kidney Allograft Survival

    T. Jouve1, J. Noble1, X. Fonrose2, B. Janbon1, G. Fiard3, P. Malvezzi1, L. Rostaing1

  • Target Itraconazole Trough Concentration for Prophylaxis in Lung Transplant

    J. A. Morillas-Rodriguez1, H. Hassouna2, F. Marco-Canosa3, K. D. Brizendine1

  • Targeted Antifungal Prophylaxis in Liver Transplant Recipients: Two Year, Retrospective Cohort Analysis

    N. Persun1, J. Doyon2, E. Blumberg2, S. Prenner2, V. Khungar2, P. Abt3, C. Sammons1

  • Temporal Trends of First-Year Mortality on the Adult Kidney-Only Wait List in the United States

    F. Tedla, A. Gruessner, I. Puri, A. Brar, N. Sumrani, D. John, J. Renz, R. Gruessner, M. Salifu

  • The Combination of 3-Month Estimated Glomerular Filtration Rate and Proteinuria is a Valuable Tool for Evaluating Long-Term Kidney Graft Survival

    C. Mottola1, N. Girerd2, K. Duarte3, A. Aarnink4, M. Kessler5, L. Frimat6, S. Girerd6

  • The Economic Impact of Surgical Site Infections in Liver Transplantation

    Y. Natori1, D. Kumar2, A. Humar2, S. Husain2, C. Rotstein3

  • The Effect Of Tacrolimus Trough Variability On Kidney Transplant Outcomes

    S. Heeney1, K. R. Szempruch1, R. Lee1, A. Mintz2, P. Serrano1, R. Detwiler1, C. Doligalski1

  • The Effect of Lifestyle Intervention on Physical Functionality, Progress of Liver Disease and Mortality in Decompensated Cirrhosis Patients in a Community Model

    S. Habib, F. Alsafar

  • The Effect of a Novel Dosing Protocol for the De Novo Use of LCP Tacrolimus in Kidney Transplant Recipients Managed on a Steroid-Free Maintenance Immunosuppression Regimen

    R. Wolff1, A. Nasstrom1, C. Borscheid1, C. Martin1, A. Temelie1, R. Spong2, D. Keys2, T. B. Dunn3

  • The Efficacy of Spheroidal Hepatocytes for Hepatocyte Transplantation

    K. Shibuya, M. Watanabe, Y. Ganchiku, R. Kanazawa, Y. Koshizuka, M. Zaitsu, R. Goto, A. Taketomi

  • The Impact of Biological Behavior of Allograft Infiltrating Lymphocytes during Early Phase

    Y. Ganchiku, R. Goto, R. Igarashi, R. Kanazawa, K. Shibuya, Y. Fukasaku, N. Kawamura, M. Zaistu, M. Watanabe, M. Fukai, A. Taketomi

  • The Impact of Calcineurin Inhibitors on De Novo DSA in Primary Kidney Transplantation

    T. Hiramitsu, T. Tomosugi, K. Futamura, M. Okada, M. Tsujita, T. Ichimori, N. Goto, S. Narumi, Y. Watarai

  • The Impact of Eplet Mismatches on Kidney Transplant Outcome: A Single-Center Cohort Study

    A. Senev1, M. Coemans1, V. Van Sandt2, B. Sprangers3, D. Kuypers3, M. Emonds2, M. Naesens3

  • The Impact of KDPI on Post Transplant Kidney Function: Intercept versus Slope. A Single Center Study

    M. Molinari1, D. Jorgensen2, R. Mehta3, P. Sood3, A. Ganoza2, C. Puttarajappa3, R. Lopez2, M. Wijkstrom2, A. Tevar2, S. Hariharan3

  • The Impact of Pneumonia after Liver Transplant

    N. M. Theodoropoulos, P. Mahboub, A. Bozorgzadeh

  • The Innsbruck Handtransplant Program: Eighteen Years of Experience

    F. Messner, T. Hautz, A. Weissenbacher, S. Schneeberger

  • The Liver Frailty Index is Associated with Current and Subsequent Disability in Liver Transplant Candidates

    J. C. Lai, J. L. Dodge, C. E. McCulloch, K. E. Covinsky, J. P. Singer

  • The Polish Troubled Kidney Transplant Biopsy Study: External Validation of the Molecular Microscope System

    M. Myślak1, D. Deborska-Materkowska2, M. Ciszek2, J. Mazurkiewicz1, A. Debska-Slizien3, P. F. Halloran4, A. Perkowska-Ptasińska5

  • The Risks Are Not Always The Same; Peak Timing Of Risk In Liver Transplantation

    K. Sasaki, J. McVey, D. Firl, K. Okubo, M. Fujiki, T. Diago Uso, D. Kwon, B. Eghtesad, C. Quintini, C. Miller, F. Aucejo, K. Hasimoto

  • The Scope and Limitations of Current Public Education Materials on Vascular Composite Allotransplantation and Donation in the United States

    M. Henderson1, S. Rasmussen1, J. Uriarte2, N. Anderson2, B. Doby1, C. Cooney1, G. Brandacher1, D. Segev1, E. Gordon2

  • Time within Therapeutic Range: A Comparison of Three Tacrolimus Formulations within Ninety Days of Renal Transplant

    S. Patel, K. Khalil, A. Lichvar, E. Benedetti, P. West-Thielke

  • Timing and Donor-Specific Antibodies, but Not C4d Deposition, Determine Leukocyte Infiltration in Renal Allograft Biopsies with the Histological Picture of Antibody-Mediated Rejection

    J. Callemeyn1, A. Senev1, E. Lerut2, M. Coemans1, D. Kuypers1, W. Gwinner3, M. Essig4, D. Anglicheau5, P. Marquet6, M. Naesens1

  • Transcriptional Changes in PBMC Associated with Development of Infection and Rejection in Older and Younger Kidney Transplant Recipients

    J. Schaenman1, M. Rossetti2, E. Liang1, O. E. Beaird1, S. Bunnapradist3, E. F. Reed2, S. Cole4

  • Transcriptome Profiling Of Renal Transplant Biopsies With Acute Cellular Rejection From Patients On Calcineurin Inhibitor-based Or Cni-avoidance Immunosuppression

    D. Dobi1, F. Vincenti2, Z. G. Laszik1

  • Transmission of Infections from Organ Donor to Recipient – German Data

    K. Moench, A. Rahmel, A. P. Barreiros

  • Transplantation of the Highly Sensitized Renal Transplant Candidate in the Post-KAS Era: Who is Left Out?

    C. Schinstock, B. Smith, A. Bentall, M. Stegall

  • Treatment of Pseudomonas Infection with Beta-Lactams Including Ceftolozane-Tazobactam in Solid Organ Transplant Recipients

    M. Henry1, J. Puvvula2, J. John Schoen1, L. Puzniak3, J. Raddatz4, T. Van Schooneveld2, S. Bergman1

  • Treg Plasticity is Induced by ENV,HERV1_I and UPR Activation in De Novo Autoimmune Hepatitis

    J. Yao1, A. Ling1, A. Arterbery1, Y. Avitzur2, S. Lobritto3, M. Martinez3, U. Ekong1

  • Treg-Lymphatic Crosstalk: Lymphotoxin Signals as Modulators of Immunity and Suppression

    W. Piao1, L. Li2, V. Saxena2, Y. Xiong2, C. Paluskievicz2, J. Bromberg3

  • Trends in Vascularized Composite Allograft Transplantation in the United States

    J. Wainright1, C. Wholley2, W. Cherikh1, D. Klassen3

  • Trimming the Fat?: Optimizing Utilization of Liver Allografts with Macrosteatosis >30% in Recipients with MELD Scores <35

    J. A. Steggerda1, M. B. Bloom1, T. Todo2, T. V. Brennan2, N. N. Nissen2, A. S. Klein2, I. K. Kim2

  • Tubastatin-A, an HDAC6 Inhibitor, is Protective in Liver Ischemia Reperfusion Injury and Acetaminophen-Mediated Liver Injury

    S. Concors1, D. Murken1, P. Hernandez1, D. Aufhauser1, Z. Wang1, G. Ge1, L. Krumeich1, T. Bhatti2, A. Kozikowski3, W. Hancock2, M. H. Levine1

  • Unifying Interpretation of Molecular HLA Typing Data between the Solid Organ Allocation Match Run and Virtual Crossmatch

    N. Kaur1, E. Kransdorf2, M. Pando3, L. Gragert1

  • Urinary Biomarkers of Kidney Injury in Liver Transplant Recipients with Calcineurin Inhibitors Based Immunosuppression

    D. Maluf1, V. Bontha1, A. Bajwa2, A. Abdelaal1, C. Koo1, J. D. Eason2, V. Mas2

  • Urinary Biomarkers- CXCL9 and CXCL10 for Non-Invasive, Early Diagnosis of Rejection in Pediatric Renal Transplantation

    R. P. George1, B. Hanberry2, I. Dave2, B. Lee2, R. Garro1, C. McCracken2, B. Warshaw1

  • Urinary Exosomal microRNA as a Non-Invasive Biomarker for the Diagnosis of Acute Rejection in Kidney Transplant Recipients

    J. Seo1, Y. Lee1, S. Jung1, Y. Kim1, J. Moon1, K. Jeong1, C. Kim2, J. Park3, B. Chung4, Y. Kim5, S. Lee1

  • Urine Uromodulin Associates with Deceased Donor Acute Kidney Injury and Allograft Failure

    S. G. Mansour1, I. Hall2, P. Reese3, T. Ashkar4, Y. Jia4, H. Thiessen-Philbrook4, M. Doshi5, C. R. Parikh4

  • Use Of Perirenal Adipose Tissue As A Source Of Donor Cells Allowing Evaluation Of Endothelial Inflammation And Quality Of Expanded Criteria Kidneys

    R. Boissier1, L. Lyonnet2, P. Francois3, M. Meunier4, B. Gondran-Tellier5, T. Legris6, J. Magalon5, C. Picard7, F. Dignat George5, E. Lechevallier8, G. Karsenty8, F. Sabatier9, P. Paul1

  • Use of a CMV Specific T Cell Immunity Assay in Late-Onset CMV Infection

    O. Beaird1, M. Carlson1, P. Gaynor1, D. Nanayakkara1, B. Abdalla2, S. Bunnapradist2, J. Schaenman1

  • Use of mTOR Inhibitors in Hypersensitized Kidney Transplant Recipients: Breaking False Myths

    D. Cucchiari1, A. Molina-Andujar1, E. Montagud-Marrahi1, F. J. Centellas-Pérez2, I. Revuelta1, F. Oppenheimer1, F. Diekmann1

  • Using Multidimensional Quality of Life Measurement to Better Understand the Benefit of Living Donor Kidney Transplant

    J. Peipert, J. Caicedo-Ramirez, K. Ensor, J. Friedewald, M. Abecassis, D. Cella, Z. Butt, D. Ladner

  • Uterine Graft Procurement in a Living Donor

    L. Johannesson, A. Wall, J. Bayer, G. J. McKenna, G. Testa

  • Uterus Transplantation: Recipient Surgery

    L. Johannesson, A. Wall, J. Bayer, G. J. McKenna, G. Testa

  • Utility Of SIPAT Scoring System In Predicting Risk Of Recidivism In Patients With Alcoholic Liver Disease.

    A. Ur Rahman1, H. Singh1, M. Abusaif1, J. Shaw2, O. Knighton2, L. Clark2, T. Santos2, S. Ebaid2, D. Reino2, J. Vanatta2, A. Tzakis2, K. Alkhalloufi2, X. Zervos2

  • Utility of AlloSure Monitoring in Simultaneous Kidney and Pancreas Recipients

    J. A. Klein, A. Gupta, P. Budhiraja, D. Cibrik

  • Utilizing Imagestream Technology to Determine Hepatocellular CD38 Localization

    Y. Lee, J. Kim, B. F. Reader, C. Akateh, K. R. Maynard, K. W. Washburn, J. L. Zweier, B. A. Whitson, S. M. Black

  • VCA Deceased Donor Solid Organ Yield

    J. Wainright1, G. Vece1, C. Wholley2, J. Rosendale1, W. Cherikh1, C. Curran3, A. Robinson1, D. Di Battista4, D. Klassen5

  • Vaccination And Allosensitization In Solid Organ Transplant Candidates

    L. Lourenco1, K. B. Bain2, L. Bowman3, D. C. Brennan4, G. A. Ewald5, R. R. Hachem6

  • Validation of Gene Expression Signatures Associated with Antibody-Mediated Rejection (ABMR) in Renal Allograft Biopsies (Bx) of HLA-Sensitized Patients

    H. Zhang1, C. C. Nast2, N. Ammerman3, A. A. Vo3, S. C. Jordan3, M. Toyoda1

  • Whole-Exome Sequencing Identifies PMS1 and DYRK1A Genes Contributing to Occurrence of Liver Cancer

    Y. Zhao, B. Yang, D. Chen, L. Wei, Z. Chen

  • Withaferin A Shifts Circulating Lymphocytes toward Protective T Cell Subsets and Prolongs Islet Allograft Survival in a Mouse Transplant Model

    K. Kumano1, M. Kanak2, C. Darden3, S. Vasu1, Y. Liu4, M. C. Lawrence1, B. Naziruddin4

  • Withaferin A as a Possible Therapy for Chronic Allograft Nephropathy

    T. Divanyan1, D. Patel1, E. Acosta1, D. Howard2, F. Jourd'heuil2, D. Jourd'heuil2, R. Lopez-Soler3

  • ilearnKAS: An Animated Video to Educate African Americans about Key Concepts of Kidney Allocation

    J. Narvaez, B. Dolph, T. Feeley, L. Kayler

  • ‘Back-to-Base’ Normothermic Clinical Liver Perfusion – Cold before NMP Does Not Compromise Protective Benefit

    K. Dajani, M. Bral, D. leon Izquierdo, D. Bigam, N. Kneteman, J. Shapiro

  • Delayed Kidney Transplantation in Combined Liver Kidney Transplantation: A Validation Analysis by the UNOS Registry

    L. Chau, M. Safwan, M. Rizzari, K. Collins, A. Yoshida, M. Abouljoud, D. Moonka, S. Nagai

  • A Kidney Transplant Recipient with Severe Acute GvHD Promptly Rescued by Donor HLA-Targeted Serotherapy

    J. Zuber1, O. Boyer1, B. Neven1, R. Berthaud1, M. Ould Rabah1, I. Jollet2, V. Renac2, F. Pirenne2, S. Gross2, R. Djoudi2, P. Tiberghien2, J. Taupin3, S. Blanche1, R. Salomon1

  • AKI and Long-Term Risk for Cardiovascular Events in Patients after Kidney Transplantation

    R. Rahamimov1, M. Molcho2, I. Vahav2, E. Mor3, T. Y. van Dijk4, B. Rozen-Zvi1

  • Alcohol Recidivism In Liver Transplant Recipients With Alcoholic Liver Disease: Does Six-months Abstinence Rule Still Holds True?

    S. K. Satapathy1, C. Thornburgh1, J. Yu2, J. Eason1, S. Kedia2, D. Maluf1

  • Anti-Donor M H C Class I I Alloantibody Induce Glomerular Injury in Mouse Renal Allografts Subjected to Prolonged Cold Ischemia

    V. Gorbacheva, R. Fan, A. Beavers, R. Fairchild, W. Baldwin, A. Valujskikh

  • Association between Respiratory Virus Infections and the Development of De Novo HLA Donor-Specific Antibodies in Lung Transplant Recipients

    M. I. Ali, J. Hata, J. Mallea, M. Elrefaei

  • Belatacept Based CNI Free Immunosuppression in Pancreas Transplantation. Results at 4 Years

    J. Chen, J. Fridell, M. Yaqub, T. Taber, D. MIshler, O. Adebiyi, M. Mujtaba, A. Sharfuddin

  • CNI-Free Therapy with Iscalimab (anti-CD40 mAb) Preserves Allograft Histology Compared to Standard of Care after Kidney Transplantation

    E. Farkash1, A. Naik1, H. Tedesco-Silva2, B. Nashan3, O. Witzke4, M. van den Hoogen5, S. Berger6, D. M. Cibrik7, S. Mulgaonkar8, D. B. Leeser9, R. Alloway10, A. Patel11, J. Pratchke12, C. Sommerer13, A. Wiseman14, A. Van Zuilen15, U. Laessing16, J. Rush16, B. Haraldsson16

  • Can Imputation of HLA Allele Level Typing Be Used Clinically in a Multiethnic Population?

    R. M. Engen1, A. M. Jedraszko1, A. Tambur2

  • Circulating Donor T and NK Cells in Lung Transplantation Recipients Are Derived from the Donor Lung Parenchyma and Represent Tissue-Resident Memory Cells

    J. F. Kuehne1, R. Ballmàs Sanz1, A. Hitz1, B. Wiegmann2, K. A. Bläsing1, F. Ius2, A. Knoefel2, I. Tudorache2, M. Avsar2, D. Jonigk3, A. Haverich2, G. Warnecke2, C. Falk1

  • Comparison of Two Glucagon-Like-Peptide-1 Analogs (GLP -1) Dulaglutide vs Liraglutide for the Management of Diabetes in Solid Organ Transplant (SOT)

    P. Singh, M. Taufeeq, T. E. Pesavento, K. Washburn, D. Walsh, S. Meng

  • DOME: A New Strategy for Prioritizing Hepatocellular Carcinoma Patients on the Liver Transplant Waitlist

    C. Rickert1, M. Akan2, Z. Leung3, J. F. Markmann1, S. Tayur2, H. Zhao3, H. Yeh1

  • Donation after Cardiac Simultaneous Liver-Kidney: An Updated Perspective

    R. Nunez, P. Morgan, A. Mathur, K. S. Reddy, A. Moss, B. Aqel, C. Jadlowiec

  • Emergence of Anti-HLA Antibodies after Catch-Up Vaccinations in Pediatric Kidney Transplant Candidates

    H. Sweiss1, J. Lyons1, D. Ranch2, K. Hitchman2, E. Kincaide1, B. Crowther1

  • Geographic Trends in Drug Intoxicated Deceased Donor Recovery and Utilization

    R. Urban, D. Klassen, J. Rosendale

  • Gut Dysbiosis Predominates Post-Transplant Diarrhea in Kidney Transplant Recipients: A Validation Study

    L. Zhang, J. Lee, M. Magruder, E. Edusei, D. Dadhania, M. Lubetzky, S. Albakry, B. Botticelli, E. Pamer, M. Suthanthiran

  • HOPE in Action: A Multicenter Prospective Study of HIV to HIV Liver Transplantation

    C. Durand1, S. Florman2, M. Bowring3, D. Brown1, B. Haydel2, J. Hamilton1, P. Stock4, J. Price5, T. Pruett6, V. Kirchner7, D. Wojciechowksi8, N. Turgeon9, C. Wolfe10, V. Stosor11, J. Charette11, A. Cameron3, S. Ottmann3, S. Huprikar12, D. Segev3

  • Impact of Once-Daily Tacrolimus on Trough Concentration Variability in Stable Adolescent and Young Adult Renal Transplant Recipients

    M. Moss, J. Goebel, A. Lofton, E. Steinberg, M. Bock

  • Improving the Organ Donation Process: Updated

    J. Yeh, M. P. Jarrett, L. Teperman

  • Increasing Net Immunosuppression after BK Viremia

    L. Cotiguala, A. Masood, J. Park, A. Naik

  • Intravenous Immunoglobulin Significantly Reduces Bioavailability of Concomitantly Administered Anti-C5 Monoclonal Antibodies

    S. C. Jordan1, K. Kucher2, M. Bagger2, H. Hockey3, K. Wagner4, N. Ammerman1, J. Choi1, A. Vo1

  • Is Alemtuzumab Induction Safe In Septuagenarians Undergoing Deceased Donor Kidney Transplantation?

    D. Harriman, V. Gurram, C. Jay, J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, A. Mena-Gutierrez, R. Stratta

  • Kinetics of Pretransplant DSA, Post-Transplant Histology, and Graft Failure after Kidney Transplantation

    A. Senev1, E. Lerut2, V. Van Sandt3, J. Callemeyn1, M. Coemans1, B. Sprangers2, D. Kuypers2, M. Emonds1, M. Naesens2

  • Liver Transplant Candidate Attitudes towards Organs from Increased Risk Donors: A Single Center Survey

    S. S. Humar, J. Liu, N. Pinzon, D. Kumar, M. Bhat, L. Lilly, N. Selzner

  • Living Donor Conversion Rates as a Quality Measure for Kidney Program Efficiency for Both New Referrals and Existing Listed Candidates

    E. Woodle1, C. Siemers2, B. Woodle3, C. King2, R. Alloway1, S. Tremblay1

  • MDSCs Prolong Allogeneic Cardiac Graft Survival by Regulating Interferon Type 1 Signaling

    S. Cai1, P. T. Sage1, T. J. Borges1, T. Ichimura1, S. K. Eskandari1, J. Y. Choi1, I. Salkuj1, B. S. AI Dulaijan1, H. Allos1, J. Miao2, L. V. Riella1, A. K. Chandraker1, J. R. Azzi1

  • Metabolic and Cardiovascular Evaluation in Living Kidney Donors: Survey of US Transplant Centers 2018

    N. Garg1, K. L. Lentine2, L. Inker3, A. X. Garg4, J. Rodrigue5, D. Segeb6, D. A. Mandelbrot1

  • Organ Donation Survey among Health Care Professionals in Argentina

    V. R. Ruiz1, A. D. Midley1, P. E. Rodriguez2, S. Bauque2, V. Morozovsky1, A. G. Da lozzo3

  • Outcomes and Clinical Utility of the kSORT Assay in the Prism Prospective Clinical Trial of Highly Sensitized Kidney Transplant Recipients

    A. Schroeder, P. Towfighi, C. Hu, S. Hsieh, J. Liberto, I. Damm, T. Sigdel, P. Millar, M. Sarwal, F. Vincenti

  • Portal-endocrine And Gastric-exocrine Drainage Technique In Pancreatic Transplantation

    G. Zibari, B. Samant, R. McMillan, N. Singh, H. Shokouh-Amiri

  • Preemptive Therapy is Cost Effective When Compared to Prophylaxis in Cytomegalovirus Donor Positive – Recipient Negative Liver Transplant Recipients

    M. M. Wagener1, D. J. Winston2, R. R. Razonable3, G. M. Lyon III4, F. P. Silveira5, A. P. Limaye6, N. Singh1

  • Protocol Cardiac Cathaterization in Renal Transplant Candidates

    D. B. Leeser1, C. B. Stone2, A. Maldonado2, D. L. Morris3, K. L. McLawhorn2, H. B. Jones2

  • Racial Disparity in Pre-Kidney Transplant Work-Up

    J. Buggs1, H. Mohamed2, C. Myer3, S. Lloyd4, E. Rogers1, H. Pearson1, J. Clement1, D. Zunick1, A. Kumar2, V. Bowers1

  • Results from the LIVE-C Free Trial

    J. N. Fleming1, D. DuBay1, N. L. Jonassaint2, R. S. Satoskar3, K. D. Chavin4

  • Role of NF-kB in Release of Isletokines via Exosomes in Response to Islet Stress

    P. Saravanan1, M. Kanak1, J. Kalivarathan1, M. Lawrence2, M. Levy1, B. Naziruddin3

  • Spindle and Kinetochore Associated Complex Subunit 3 Promotes Tumor Growth by Regulating CDK2/p53 Phosphorylation in Hepatocellular Carcinoma

    Y. Hou1, Z. Wang2, L. Wu3

  • Successful Use of Hizentra to Address BK Viremia in Pediatric Transplant Population

    K. Gruenkemeyer, E. Wood, A. Beck, C. Belsha

  • TIPS Effectively Treats Refractory Hepatic Hydrothorax: A Multi-Center U.S. Retrospective Study of 1,260 Patients

    M. German1, A. Lee1, A. Hristov1, A. Said1, J. Boike2, J. Ge3, N. Jest4, G. Morelli4, K. Kolli3, J. Lai3, A. Desai5, S. Junna6, B. Pokhrel6, T. Couri7, S. Paul7, C. Frenette8, N. Christian-Miller8, E. Verna9, U. Rahim10, A. Goel10, A. Das2, S. Pine2, D. Gregory2, L. VanWagner2, E. Spengler1

  • The Impact of Removing DSA as a First Unit of Lung Allocation: Preliminary Results

    R. R. Lehman1, K. Uccellini2, M. Skeans3, M. Valapour3, E. D. Lease4, R. Daly5, K. M. Chan6

  • The mIR17-92 Cluster Promotes Costimulation Resistant Effector Memory T Cell-Mediated Alloresponses

    H. Xu1, Q. Guo1, M. Song1, A. Miler1, Q. Li2, A. Kirk1

  • What’s in a High Dose? An Analysis of Tacrolimus Pharmacokinetic Parameters in Rapid Metabolizers

    P. West-Thielke1, A. Maldonado2, S. J. Patel3, D. R. Stevens3, U. Meier-Kriesche3, D. Brennan4

  • miR-20a Inhibits Autophagy by Targeting AKT and BIM in Renal Reperfusion Injury

    T. Lin, T. Song, Y. Jiang, J. Liu, Z. Wang, L. Li, Z. Huang, Y. Fan, X. Wang

  • 3-year Outcome Of Heart Transplantation In Patients With Amyloidosis

    J. Patel, M. Kittleson, D. H. Chang, R. Levine, S. Dimbil, L. Czer, F. Esmailian, J. A. Kobashigawa

  • 5-Year Post-Transplant Outcomes with Bortezomib-Based Desensitization in Renal Transplant Recipients

    K. Zheng1, S. Tremblay1, A. R. Shields2, M. A. Cardi2, J. Kremer2, R. R. Alloway1, E. S. Woodle1

  • 500 Pediatric Liver Transplants At A Freestanding Pediatric Hospital – Where It Is Done Best

    A. Rana, M. Kueht, N. Galvan, R. Cotton, C. O'Mahony, J. Goss

  • Combined Thoracic-Liver Transplants Using Normothermic Machine Perfusion for Liver Preservation: A Case Series

    M. Rizzari, K. Crombez, S. Nagai, J. Stracke, A. Al-Kurd, K. Collins, A. Yoshida, M. Abouljoud

  • Effect of Donor-Recipient Serologic CMV Matching on 1-Year Post-Lung Transplant Outcomes

    H. Ehrenfeld, M. Manson, R. Yau

  • Evaluation of Rabbit Antithymocyte Globulin (rATG) Dosing and Incidence of Opportunistic Viral Infections in Kidney Transplant Recipients Using Tacrolimus (TAC), Mycophenolate (MPA) and Steroid Free Maintenance Immunosuppression

    L. Von Stein, A. Leino, R. Amer, T. Pesavento, H. Winters

  • A Clinical Analysis for Low-Dose Immunoglobulin United with Plasmapheresis in High Sensitization Renal Transplantation Recipients

    L. Xu1, J. Zhang2

  • A Cluster of Late Onset of Pneumocystis jirovecii Pneumonia (PJP) in Renal Transplant Patients: First Cluster Report from Saudi Arabia

    Y. Aljishi, M. AlBugumi, A. Abadi, A. AlJanobi, M. Al Lawiam, N. Alzawad, M. Al Sardi, Z. AlMaa, H. Al-Ramadan, J. Kabanja, N. Rayyan, k. Beleed-Akkari

  • A Collaborative AI Framework to Improve the MELD Exception Request Policy Process

    A. M. Placona, S. M. Noreen, R. Carrico

  • A Comparison of the Safety and Efficacy of Apixaban Use in Renal Transplant vs. Non-Renal Transplant Recipients

    T. Loosier, K. Gutierrez, A. James, A. Dodson

  • A Cost Saving Quality Improvement Project in Solid Organ Transplant Population Following Tacrolimus Switch from Prograf® to Adoport® Immunosuppression – A Single Centre Experience

    L. Mulreid, M. Vincent, L. Laycock, A. Summers, S. Bhutani

  • A Cytomegalovirus Antiviral Stewardship Program at a Large Transplant Center

    M. Jorgenson1, J. Descourouez1, D. Felix1, C. Saddler2, J. Smith2, D. Mandelbrot2

  • A Financial Analysis of Elderly Kidney Transplant Recipients

    A. Yaldo, I. Bajjoka, C. Crombez, M. Abouljoud

  • A Mouse Model of Vascularized Heterotopic Spleen Transplantation for Studying Lymphocyte Biology and Transplant Immunity

    L. Qiu1, J. Wang2, R. Fernandez3, X. Yeap1, S. Han1, F. Zheng1, C. Lin2, Z. J. Zhang1

  • A Multi National Study Ofkidney Transplantation In Inmates

    Y. Qazi, A. Mahajan, D. Bahl, F. Jan

  • A Multicenter Study Of mTOR Inhibitor Use In Intestine And Multivisceral Transplantation

    M. C. Segovia1, A. Mavis1, J. Boike2, Y. Patel1, T. Schiano3, S. Jafri4

  • A National Cohort Validation of Graft Outcomes of Elderly Kidney Transplant Recipients

    I. Bajjoka, A. Yaldo, C. Crombez, M. Abouljoud

  • A New Risk Stratification Scoring System for Deceased Donor Kidneys and Suitable Candidates for Marginal Kidneys in Korea

    T. Koo1, J. Ryu1, S. Park2, S. Lee2, J. Hwang2, C. Ahn3, J. Yang1

  • A Novel Apparatus Mimicking Hypertensive Kidney With Primary Cultured Human Kidney Cells Using Rotational Force: Application To In Vitro Drug Screening In Kidney Transplant Recipients

    Y. Kim1, S. Lee2, J. Moon1, J. Kim1, M. Yu3, C. Lee4, Y. Kim1, S. Yang5, J. Jeong1, J. Seon1

  • A Novel Method for Ex Vivo Treg Expansion via Human iNKT Cell Activation

    R. Ishii1, I. Masako1, H. Katsumata1, T. Kanzawa1, T. Yamakawa1, H. Ishigooka1, T. Hirai1, K. Saiga1, M. Okumi1, Y. Ishii2, K. Tanabe1

  • A Novel Protocol to Produce Massive Amounts of Autologous Thymus-Derived Treg Cells (ThyTreg) to Be Employed as Cellular Therapy in Heart Transplanted Children: A New Paradigm for the Prevention of Graft Rejection

    E. Bernaldo de Quirós1, R. López1, V. Pérez1, M. Clemente2, J. Gil-Jaurena3, M. Camino4, N. Gil4, E. Panadero4, C. Medrano4, M. Pion1, R. Correa-Rocha1

  • A Novel Trapezoidal Area Under Curve (AUC) Based Glomerular Filtration Rate (GFR) Measurement Using Non Radioactive Iohexol Plasma Clearance in Potential Kidney Donors

    V. Ariyamuthu1, L. Anderson2, N. AbdulRahim1, S. Levea3, M. MacConmara4, C. Hwang4, K. Fankhauser5, I. Hashim5, B. Tanriover1

  • A Pilot Study of Organ Donor Registration among Persons Living with HIV (PLWH)

    D. Bhamidipati1, P. Veldkamp2, L. Despines1, C. Sullivan3, S. Stuart3, D. McMahon2, G. Haidar2

  • A Pilot Study of the mDOT Platform for Immunosuppression Adherence in Adult Kidney Transplant Recipients

    J. Langlee, L. Lees, A. Saha, D. Helfer, M. Waldram, A. Love, F. Rivera, A. Massie, D. Segev, D. Brennan, M. Henderson

  • A Prognostic Drug Development Tool to Assess the Transplantability at the Time of Listing for Kidney Transplant Candidates

    S. Kawakita1, L. Hidalgo-Semlek2, J. L. Beaumont1, J. Lee2, M. J. Everly1

  • A Prospective, Randomized, Multicenter Trial of Bela-Based CNI Free and Steroid Withdrawal Immunosuppression: Best Trial Two Year Characterization of Rejection and Renal Function

    A. Wiseman1, A. R. Shields2, R. R. Alloway2, D. Kaufman3, J. P. Leone4, A. J. Matas5, P. West-Thielke6, J. Lipscomb2, E. King2, E. S. Woodle for the BEST Study Group2

  • A Regulatory T Cell-Intrinsic Role for Ikaros in Acquired Transplant Tolerance

    R. M. Thomas, L. Wang, W. W. Hancock, A. D. Wells

  • A Retrospective Analysis Evaluating Various Tissue Biopsy Scoring Systems in Predicting Recipient Outcomes Following Transplantation of Extended Criteria Donor Kidneys

    A. Hijazi1, D. Nap1, M. Gabril2, M. Moussa2, V. Ibrahim3, M. A. Levine4, M. Madruah4, P. Luke4, A. Sener4

  • A Retrospective Matched Case-Control Study of Medical and Psychiatric Outcomes in Kidney Transplant Recipients with Bipolar Disorder

    A. GOSWAMI BANERJEE1, S. Hamel2, R. Weinrieb1, S. Dave1, V. Johnson3, D. Sawinski4, J. Trofe-Clark3

  • A Robust and Portable Protocol for RNA Isolation from Urinary Cells for Noninvasive Monitoring of Kidney Allograft Recipients

    B. Botticelli, S. Albakry, E. Edusei, H. Yang, M. Cassidy, C. Li, C. Snopkowski, M. Lubetzky, J. Lee, D. Dadhania, T. Muthukumar, M. Suthanthiran

  • A Step-Wise Desensitization Using Rituximab&Bortezomib Combined with Antithymocyte Globulin for Highly Sensitized Kidney Transplant Candidates

    H. Ohdan, K. Ide, M. Ohira, H. Tahara, Y. Tanaka

  • A Video Intervention to Increase Organ Donor Registration (ODR) at the Department of Motorized Vehicles (DMV)

    D. A. DuBay1, T. Morinelli1, D. Redden2, N. Ivankova2, I. Herbey3, C. L. Holt4, L. Siminoff5, M. Fouad2, Z. Su6, M. Martin7

  • ABMR In Low-single Dose Thymoglobulin Induction Protocol In Renal Transplant Recepients From A Tertiary Care Centre In A Developing Country

    R. Parthasarathy1, M. Mohammed1, P. Koshy2, I. Pradeep2, M. Mathew1, G. Abraham1

  • ALcohol Relapse after Liver Transplantation

    B. Movahedi, p. Mahboub, P. Martings, A. Bozorgzadeh

  • Ablation of Interferon Regulatory Factor 4 in T Cells Induces “Memory” of Transplant Tolerance That is Irreversible by Immune Checkpoint Blockade

    H. Zhang1, J. Wu2, D. Zou3, W. Chen3

  • Aborted Live Donor Organ Recovery Procedures in the United States

    M. Henderson, M. Waldram, A. Thomas, N. Desai, S. Ottman, J. Garonzik Wang, A. Massie, D. Segev, J. Bannon, F. Al Ammary, D. Brennan

  • Absence of Antibodies in Human Neonates and Infants to Gtko/cmahko/β4galnt2ko (Triple Gene Knockout) Pig Cells: Relevance to Cardiac Xenotransplantation for Complex Congenital Heart Disease

    H. Hara1, Q. Li1, C. A. Banks1, T. Yamamoto1, D. Ayares2, D. C. Cleveland1, D. K. Cooper1

  • Absence of Non Alcoholic Fatty Liver Disease in Allografts from Morbidly Obese Donors: A Marker for Success?

    M. MacConmara, A. Mufti, S. Hanish, T. Kerr, P. Vagefi, C. Hwang

  • Absorbable Mesh Placement to Prevent Incisional Hernias after Donor Hepatectomy

    D. von Ahrens1, R. Hwang2, T. Kato2, J. Emond2, A. Griesemer2, B. Samstein1

  • Acceptability of Animated Video Medium to Educate Kidney Transplant Patients

    K. Bonner, M. Cobler- Lichter, N. Crenesse-Cozien, L. Lewis, T. Feeley, L. Kayler

  • Access to Deceased Donor Liver Transplant for Candidates in Hawaii and Puerto Rico

    A. M. Robinson1, I. K. Kim2, A. K. Mathur3, S. E. Rosas4

  • Acquired Resistance to Transplantation Tolerance as a Result of Prior Pregnancy Requires B Cells

    D. V. Tran, A. N. Suah, S. Khiew, J. S. Young, Q. Wang, D. Yin, M. Alegre, A. S. Chong

  • Activation of Oxidative Stress-Adoptive Responses during Extended Ex Situ Heart Perfusion

    S. Hatami, X. Qi, M. Buchko, C. W. White, S. Bozso, S. Himmat, J. Nagendran, D. H. Freed

  • Activation of Renal Fibroblasts by Anti- Major Histocompatibility Complex Antibody: A Missing Link in Allograft Fibrosis

    M. B. Oliver1, J. Chen2, A. Zmijewska1, R. B. Mannon1

  • Actual Outcomes and Technical Feasibility of Living Donor-Related Liver Re-Transplantation

    W. Kim1, G. Song2, S. Lee2

  • Adjunctive Therapy With Tocilizumab For Treatment Of Acute Antibody Mediated Rejection – 2 Year Experience

    K. Venkatachalam, R. Delos Santos, B. Heady, A. Malone, T. Alhamad

  • Adult-to-Adult Living-Donor Liver Transplantation: Towards a Prediction of Three-Month Survival Combining Graft-to-Recipient Weight and MELD in a Caucasian Population

    S. Iesari, R. Reding, J. Lerut, E. Bonaccorsi-Riani, L. Coubeau, O. Ciccarelli

  • Alemtuzumab Induction in Living Donor Renal Transplantation

    O. Witkowsky, H. Winters, K. Washburn, G. Bumgardner, A. Rajab, A. El-Hinnawi, T. Pesavento

  • Alemtuzumab versus Anti-Thymocyte Globulin Induction in the Setting of Immediate Post-Renal Transplant Acute Tubular Necrosis in an Urban, Minority Patient Population

    K. Tejani, E. Benedetti, A. Lichvar

  • Alemtuzumab versus Antithymocyte Globulin Induction Immunosuppression in Highly Sensitized Kidney Transplant Recipients

    A. Brueckner1, E. Yanqui1, C. Truong1, R. Baliga2, L. Bowman1

  • Allograft Quality Impacts Simultaneous Liver Kidney Transplant Survival Outcomes in Recipients That Undergo Liver Re-Transplantation

    J. Reyes, M. Eerhart, C. Blanton, P. Chlebeck, E. Polyak, Y. Yankol, L. Fernandez

  • Allograft Survival is Influenced by Gut Microbiota-Dependent Modulation of Innate Immunity

    V. Saxena1, Y. Xiong1, L. Hittle1, L. Li1, T. Simon2, W. Piao1, C. C. Brinkman1, E. M. Smyth1, T. Zhang1, C. Wagner1, C. M. Palusckievicz1, W. F. Fricke3, E. F. Mongodin1, J. S. Bromberg1

  • Alteration in Local Complement Activation in First 24h Post-Lung Transplantation (LTx) Helps Identify Recipients Developing Primary Graft Dysfunction

    H. Kulkarni1, M. Elvington2, L. Ma1, M. Cano1, K. Pugh3, R. Hachem1, J. Atkinson2, A. Gelman3

  • Alteration of Myocardial Velocities and T1 Times in Patients with Acute Cellular Rejection during First Year Post Heart Transplant

    R. Sarnari, A. Ruh, M. Abbasi, J. Blaisdell, R. Dolan, J. Wilcox, S. Khan, E. Vorovich, J. Rich, A. Anderson, C. Yancy, J. Carr, M. Markl, K. Ghafourian

  • Alterations in Brain Metabolites before and after Kidney Transplant

    A. Gupta1, P. Lee2, R. Lepping3, A. Jurgensen1, J. Klein1, P. Adany4, D. Cibrik1, J. Burns5, W. Brooks3, I. Choi6

  • Alterations in Cerebral Blood Flow before and after Kidney Transplantation

    A. Gupta1, I. Choi2, R. Lepping3, P. Adany4, A. Jurgensen1, J. Klein1, D. Cibrik1, J. Burns5, W. Brooks2, P. Lee2

  • Amiodarone And Primary Graft Dysfunction In Heart Transplantation: Reality Or Myth?

    M. Kittleson, J. Patel, D. H. Chang, E. Kransdorf, S. Dimbil, R. Levine, K. Yabuno, L. Czer, M. Hamilton, F. Esmailian, J. A. Kobashigawa

  • An Interesting Case of Proteinuria in Living Kidney Donor

    A. Yadav, W. Maley, P. Singh

  • Analgesia and Control of Pain Following Laparoscopic Donor Nephrectomy

    J. Hedvat1, N. W. Lange1, P. Sandoval2, L. E. Ratner2, D. S. Tsapepas2

  • Analysis Of Public Health Service Increased Risk Donors Shows No Viral Transmission In Liver Transplant Recipients And Similar Graft / Patient Survival When Compared To Non-increased Risk Donors

    A. Amin, T. Ito, D. Ng, R. McMillan, J. DiNorcia, V. Agopian, F. Kaldas, H. Yersiz, R. Busuttil, D. Farmer

  • Analysis and Regulation of Immune Reaction in the Transplantation from MHC Homozygous Donors to Heterozygous Recipients with Minor Antigen Mismatches

    T. Murata, H. Wada, R. Otsuka, H. Tsuji, A. Sasaki, M. Baghdadi, K. Seino

  • Analysis of Lactic Acid Response in Renal Transplant Patients

    A. A. Henderson1, H. Ahmed2, M. R. Wakefield1

  • Analyzing The Effect Of Liver Transplantation On Myocardial Strain Using Speckle Tracking Echocardiography In Nonalcoholic Steatohepatitis (NASH) Patients

    A. Chhatriwala, M. Lam, E. Kim, S. Raissi, N. Mazumder, J. Thomas, H. Maddur, M. Rinella

  • Anemia and Hemolysis on Dapsone Despite Normal Glucose-6-Phosphate Dehydrogenase Activity in Heart Transplant Recipients

    K. Lor, E. Kransdorf, J. Patel, M. Kittleson, D. Chang, J. A. Kobashigawa

  • Anti-CD272 Antibody (6B2) Induced Indefinite Survival of Fully MHC-Mismatched Murine Cardiac Allograft

    E. Yin, M. Uchiyama, Y. Yamamoto, M. Niimi

  • Anti-Complement Component 5 Antibody Based Immunosuppression Induced Accommodation in ABO Incompatible Heart Transplantation

    S. Park1, S. Lee1, J. Hwang1, J. Ryu2, T. Koo2, C. Ahn3, J. Yang4

  • Anti-Fungal Prophylaxis in Lung Transplant: A Systematic Review/Meta-Analysis

    K. Pennington, M. Baqir, P. Erwin, H. Murad, R. Razonable, C. C. Kennedy

  • Anti-HLA Antibodies Are Associated with Deterioration in Long-Term Renal Function Independently of Donor Specificity

    T. Mueller1, P. Cippa2, R. van Breemen1, S. von Moos1

  • Anti-Xa Level Monitoring for Treatment Dose Enoxaparin in Liver/Intestine Transplant Recipients

    J. Sullivan, J. Jebrock, J. Revollo, M. Perez, J. Garcia, T. Beduschi

  • Anti-cmv Antibody (cmv-ab) And Cmv-specific Cytotoxic T Cell (cmv-tc) Positivity Are Essential To Control Severe Viremia In Seronegative (sero[-]) Pediatric Kidney Transplant Recipients (ped Ktx Pts).

    B. Shin, H. Pizzo, D. Puliyanda, A. Petrosyan, D. Lovato, S. C. Jordan, M. Toyoda

  • Anti-ebv Antibody (ebv-ab) And Ebv-specific Cytotoxic T Cell (ebv-tc) Positivity Are Essential To Control Viremia In Seronegative (sero[-]) Pediatric Kidney Transplant Recipients (ped Ktx Pts).

    B. Shin, H. Pizzo, D. Puliyanda, A. Petrosyan, D. Lovato, S. C. Jordan, M. Toyoda

  • Anticoagulation in Post-Liver Transplant Recipients with Portal Vein Thrombosis

    L. Schumacher1, L. Lindberg1, D. Alonso2, R. Gilroy3, J. Krong4, L. Dong4, S. LeCorchick1

  • Antihypertensive Medication Requirements with Native Nephrectomy and Kidney Transplantation

    J. Buggs1, J. Sykes2, S. Lloyd2, E. Rogers1, L. Wang3, J. Wei3, J. Zhang3, A. Kumar3, R. Liu3, V. Bowers1

  • Apixaban Therapy Is Safe And Effective In Most Organ Transplant Populations

    A. Brown, S. Palkimas, W. Ally

  • Apparatus and Method to Facilitate In-Situ Cold Perfusion of Abdominal Organs in DCD Donors

    M. Jendrisak

  • Approach to Leukopenia in Older Kidney Transplant Recipients

    M. Shearer, M. Labonte, L. Erbe, R. Rodgriuez, A. Price, V. Rao, M. Casey, K. Soliman, D. Lazarus, D. Taber, M. Posadas Salas

  • Are Protocol Biopsies Necessary for Pediatric Renal Transplant Recipients?

    E. Allred, E. Ingulli

  • Are Ureteric Stents a Risk Factor for Bk Virus Activation in Kidney Transplantation?

    L. Tran, R. Akiki, A. Gautam

  • Arterial Blood Pressure Circadian Rhythm in Renal Transplant Recipients

    A. M. Arriaga, Y. J. Lopez, J. A. Cedillo, L. A. Marino, J. M. Mejia, I. Parra, A. Cohen, L. E. Morales

  • Arteriovenous Fistula Ligation In Stable Renal Transplant Patients Does Not Adversely Influence Graft Function

    A. Han, S. Ahn, S. Min, S. Min, S. Kim, J. Ha

  • Assessing Discarded Human Liver Quality with Normothermic Ex-Vivo Liver Perfusion

    F. Zhou, M. Xu, S. Garcia-Aroz, G. A. Upadhya, Y. Lin, W. C. Chapman

  • Assessing the Effectiveness of Early Maintenance Immunosuppression Practices in Liver Transplantation

    T. Bittermann, R. Hubbard, J. Lewis, D. Goldberg

  • Assessment Of Glomerular Filtration Rate Among Lung Transplant Candidates

    S. Akkina1, S. Hou2, D. Jain Arwindekar2, A. Desai2

  • Assessment of Health-Related Quality of Life and Graft Failure among Kidney Transplant Patients in the Benefit and Benefit-EXT Trials

    I. Purnajo1, J. L. Beaumont1, M. Polinsky2, E. Alemao2, M. J. Everly1

  • Association Between Cumulative Pre-transplant Amiodarone Dose And Post-transplant Outcomes After Heart Transplantation

    K. Lang1, M. Sullivan2, P. Simone1, S. Patel1, L. M. Lourenco1

  • Association Of Clinical Characteristics With Rate Of Kidney Transplant Function Decline In The 2 Years Prior To Allograft Loss

    L. A. Binari, P. E. Thorne, J. L. Morse, T. G. Stewart, R. C. Forbes, K. Rabb, L. Lipworth, K. Abdel-Kader, B. P. Concepcion

  • Association between CD19-Positive Rate and Antibody-Mediated Rejection Following Rituximab Administration in Kidney Transplant Recipients

    K. Nanmoku, T. Shinzato, T. Kubo, T. Shimizu, T. Yagisawa

  • Association between Recipient Sex and Risk of Heart Graft Failure

    A. Chackowicz1, X. Zhang2, M. Dahhou2, R. Sapir-Pichhadze3, H. Cardinal4, B. Foster5

  • Association of Histological Findings in Renal Graft Biopsy with Non-Adherence to Immunosuppressive Treatment

    B. D. Cardoso1, J. Montagner2, K. Pegas3, R. Kist4, J. Neumann5, H. S. Pinheiro6, V. D. Garcia4, E. Keitel1

  • Association of Induction Immunosuppression Agents with Incidence of Cytomegalovirus Infection Following Kidney Transplantation

    S. A. Medani, B. C. Astor, A. Djamali, M. A. Mohamed

  • Associations between State-Level Donor Designation Rate and Organ Procurement Organization Characteristics and Outcomes

    J. Bragg-Gresham1, P. Held2, J. P. Roberts3

  • Attitude towards Organ Donation among Medical Students: Relationship to Knowledge and Beliefs

    A. Cerrato, M. Salifu, M. Markell

  • Attitudes and Knowledge about Organ Donation in a Cohort of Medical Students: Association of Religion and Ethnicity

    M. Markell, A. Cerrato, M. Salifu

  • Atypical Hemolytic Uremic Syndrome Concomitant Complement Factor H Gene Variations Leading to Early Renal Allograft Loss: Multicenter Cases Report from China

    J. Wen1, Z. Jin2, N. Gong3, X. Xu4

  • Availability of Psychiatric and Chemical Dependency Treatment Services at US Hospitals Providing Transplantations

    S. K. Niazi1, A. Spaulding2, T. Schneekloth3, A. Keaveny4, A. Vasquez1, E. Vargas2, T. Rummans1, C. Taner5

  • Azole Use and Fungal Pathogens in Cystic Fibrosis versus Non-Cystic Fibrosis Lung Transplant Recipients

    F. J. Marco Canosa1, K. Brizendine2, H. Hassouna3

  • B7H1 Expression is Crucial for Tolerance Induction in Mouse Liver Transplantation

    M. Morita1, S. Datta1, C. Miller2, T. Hamilton1, K. Hashimoto3

  • BK Virus Infection Disparity between Black and Other Races; Do Not Blame the Mycophenolic Acid

    N. Raj1, R. Spong1, S. Jackson2, V. Vakil1, D. Keys1, E. Finger3, S. Riad1

  • BK Virus Infection among Kidney Transplant Recipients with High Immunological Risk and Strong Immunosupression

    G. Ledesma, M. O. Lopez, G. Carreño, M. J. Santana, M. A. Vaca, E. Gonzalez, C. Jimenez

  • BMI Changes and Its Impact on Long Term Follow-Up in Kidney Transplant Recipients

    P. A. Miarka, D. Cieniawski, E. Ignacak, A. Prokop, A. Hodun, K. Krzanowska, M. Kuzniewski

  • BMI Influence on the Outcomes of Renal Transplant

    V. Bianchi, I. D. Kostakis, T. Kasimatis, C. Flach, P. Paraskeva, C. Callaghan, B. Phillips, N. Karydis, N. Kessaris, F. Calder, I. Loukopoulos

  • Balance between Low DNA Concentration and Structural Damage of Extracellular Matrix during Recellularization Procedure as a Key to Successful Recellularization

    A. Berman, A. Adamiok, G. Tynicki, L. Kaczynski, M. Gomolka, M. Klak, M. Wszola

  • Barriers to Kidney Transplant Wait Listing among HIV Positive Patients with Advanced Kidney Disease

    S. M. Boyle1, K. Fehr1, C. Deering2, A. Raza1, M. Harhay1, G. Malat3, K. Ranganna1, D. Lee1

  • Barriers to Listing for Kidney Transplantation in LMICs: A Single Center Retrospective Cohort Study in Brazil

    Y. Yu1, G. Ferreira2, A. Saha1, M. Henderson1, D. Segev1, J. Bastos2, V. Colares2, A. Massie1

  • Barriers to Pre-Transplant Immunization: A Qualitative Study of Pediatric Liver-Transplant Stakeholders

    A. G. Feldman1, R. Marsh2, A. Kempe3, M. Morris2

  • Basiliximab vs. Low-Dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant Patients: Prospective Randomized Study in Southeastern Mexico

    G. Martinez-Mier, P. I. Moreno-Ley, L. F. Budar-Fernandez, M. T. Mendez-Lopez, D. A. Barrera-Amoros, M. De la Paz-Roman, L. A. Jimenez-López, E. G. Aguilar-Sandoval, C. A. Allende-Castellanos

  • Bcl-2/Bcl-xL Inhibition by Navitoclax vs. Bcl-2 Alone Inhibition by Venetoclax for Induction of Mixed Chimerism in Non-Human Primates

    H. Sasaki1, D. Ma1, T. Oura1, A. Dehnadi1, I. Rosales2, B. Cosimi1, P. Cippa3, T. Fehr3, T. Kawai1

  • Beneficial Association between Renin-Angiotensin-Aldosterone-System Blockade Usage and Graft Prognosis in Allograft Immunoglobulin A Nephropathy

    S. Park1, C. Baek2, M. Yu3, Y. Kim1, J. Moon1, H. Go2, Y. Kim2, J. Lee4, S. Min1, J. Ha1, K. Moon1, Y. Kim1, C. Ahn1, S. Park2, H. Lee1

  • Bespoke Immunosuppression: Prolonging Transplant Survival through Enhanced T-cell Activation Induced Cell Death

    R. Costello1, R. J. Ingram1, D. Longley2, J. McDaid3

  • Better Education of Kidney Recipients and Improved Access for Donor Referrals May Lead to Higher Living Donation Rates: An Early Single Center Analysis

    V. Humphreville, N. Sarabu, M. DebRoy, M. Schuster, E. Sanchez, A. Padiyar, A. Jittirat, K. Yadav, J. Rabets, A. Palanisamy, K. Chavin

  • Better Health-Related Quality of Life in Kidney Transplant Patients over Time Compared with Those in Chronic Kidney Disease Patients at Similar Renal Function

    J. Ryu1, T. Koo1, K. Oh2, C. Ahn3, J. Yang1

  • Beyond Medication Education: Opportunities for Improvement in Health Education of Solid Organ Transplant Recipients

    Y. J. Bababekov, Y. Hsu, C. G. Rickert, Y. Hung, J. A. Fishman, J. F. Markmann, L. Dageforde, D. C. Chang, H. Yeh

  • Bile Duct Anastomosis over Intraluminal Plastic Biliary Stent in Liver Transplant: Clinical Outcome

    H. Samant1, K. Patel1, W. Manatsathit2, N. Singh1, H. S. Amiri3, G. Zibari3

  • Biliary Atresia Patients Receiving Liver Transplantation Reflect Changing Birth Demographics in the United States between 1987-2018

    R. Sindhi, K. Soltys, G. Mazariegos, G. Bond, A. Khanna, P. McKiernan

  • Biomarkers in Multivisceral and Intestinal Transplantation

    D. A. Cheung1, J. Garcia1, T. Beduschi2, A. H. Langshaw1, K. L. Arheart3, I. A. Gonzalez4

  • Blockade of IL-1β and TNF-α Does Not Significantly Pose Risk or Affect Outcomes in Patients Infused with Microbial-Positive Autologous Islet Preparations

    K. Kumano1, C. Darden2, S. Vasu1, M. Lawrence1, B. Naziruddin3, A. Gupta3, E. Beecherl3, N. Onaca3

  • Blood Group Incompatible Living Donor Kidney Transplantation in Patients with End-Stage Kidney Disease Due to Diabetes Kidney Disease

    J. Uchida1, A. Kosoku1, K. Kabei1, S. Nishide1, H. Shimada1, K. Maeda2, Y. Yoshikawa3, T. Iwai1, N. Kuwabara1, T. Naganuma1, N. Kumada4, Y. Takemoto1, T. Nakatani1

  • Blood Profiling Reflects a Significant Down-Regulation in Oxidative Phosphorylation Following Renal Transplantation with DCD and AKI Allografts

    S. Walker1, L. Cox2, C. Langefeld2, B. Freedman2, A. Farney2, J. Rogers2, C. Jay2, R. Stratta2, G. Orlando2

  • Body Mass Index Alone Should Not Be Used to Exclude Potential Kidney Transplant Recipients

    D. Harriman, V. Gurram, A. Farney, G. Orlando, A. Reeves-Daniel, A. Mena-Gutierrez, C. Jay, R. Stratta, J. Rogers

  • Borderline Changes in Kidney Allografts Represents a Non-Homogenous Cohort with Different Outcome

    P. Hruba1, J. Maluskova1, Z. Krejcik2, M. Merkerova-Dostalova2, V. Stranecky3, J. Klema4, K. Osickova1, M. Wohlfahrtova1, E. Honsova1, O. Viklicky1

  • Borderline Lesions Following Lymphocyte Depletion: Effect of Treatment

    N. Wilson1, S. Tremblay1, P. Lee1, S. Bumb1, R. R. Alloway1, J. Kremer2, A. R. Shields2, E. S. Woodle1

  • Bortezomib Attenuates the Progression of Epithelial to Mesenchymal Transition through Smurf1 Akt mTOR P70S6K Pathway in Rat Allograft Renal Interstitial Fibrosis Model

    R. Tan, Z. Wang, S. Fei, Z. Han, J. Tao, X. Ju, M. Gu

  • Breaking Concepts: 10-year Follow-Up of the Everolimus versus Azathioprine Heart Transplant Multi-National Study

    J. A. Kobashigawa1, R. Starling2, E. Passano1, P. Bernhardt3, B. Azarbal1, R. Cheng1, F. Esmailian1, K. Khush4, D. Mancini5, J. Patel1, T. Sato1, S. Varnous6

  • Breakthrough Changes in the Access to Transplantation for the Patients with Atypical Hemolytic Uremic Syndrome in the Eculizumab Era

    J. Zuber, M. Frimat, P. Gatault, N. Kamar, L. Couzi, N. Jourde-Chiche, V. Chatelet, S. Caillard, R. Gaisne, D. Bertrand, J. Bamoulid, M. Louis, C. Pouteil-Noble, C. Legendre, M. Peraldi, E. Rondeau, M. Le Quintrec, V. Frémeaux-Bacchi

  • Broadly Profiling the Activation Status of Circulating Immune Cells in Chronic Active Antibody Mediated Rejetion Reveals Increased CD38 and CD16 Expression on Monocytes and NK Cells

    K. Sablik, N. Litjens, M. Klepper, M. Betjes

  • Build It, They Will Come: Surgical Renal Outpatient Infusion Room Decreases Readmission Rates

    J. Truckenbrod1, K. DeWall1, M. Jones1, E. VanLith1, M. Anderson1, L. Jaeger1, M. Phillips2, W. Kendall1, L. Burris1, T. Thambi1

  • C1 Esterase Inhibitor (C1INH) Treatment at Kidney Transplant Improves Long-Term Outcomes in Patients at Risk for Ischemia/Reperfusion Injury & Delayed Graft Function

    S. Jordan1, E. Huang2, N. Ammerman1, J. Choi1, O. Aubert3, S. Kumar1, A. Loupy4, A. Peng1, I. Kim1, R. Najjar1, D. Puliyanda1, T. Brennan1, S. Sethi1, A. Vo1

  • C1q Dominant Deposits in Renal Transplant Biopsies Are Not Associated with Allograft Dysfunction

    A. Babu1, S. Williamson2, N. Khoury1, M. Safwan1, A. Patel1

  • CD4 T Cell is Essential in an Innate-Immune Driven Ischemia-Reperfusion Injury in Mouse and Human

    S. Kageyama1, K. Kadono1, H. Hirao1, K. Nakamura1, T. Ito2, K. J. Dery1, D. Oncel1, R. A. Sosa3, E. F. Reed3, F. M. Kaldas2, R. W. Busuttil2, J. W. Kupiec-Weglinski1, Y. Zhai1

  • CD47 Blockade Promotes Hepatic Macrophage Polarization toward M1 during Normothermic Machine Perfusion of Discarded Human Livers

    M. Xu1, F. Zhou1, S. Garcia-Aroz1, B. Banan1, W. Yang2, G. Upadhya1, K. Byrnes3, B. Wong1, P. Manning4, Y. Lin1, W. Chapman1

  • CHOP Deficiency Attenuated Acute Liver Injury by Promoting Macrophage M2 Polarization via ATG5-Mediated Autophagy Activation

    H. Zhou, R. Liu, Q. Wang, C. Shi, F. Cheng, X. Wang, L. Lu

  • CMV-Specific Cell-Mediated Immunity Early after Transplantation Discriminates R+ Transplant Patients at Risk of CMV Infection among Different Solid Organ Transplants

    M. Jarque1, A. Cachero2, E. Garcia-Romero3, L. Lladó2, C. Baliellas2, C. Diez3, E. Melilli4, J. Fabregat2, J. Gonzalez-Costello3, O. Bestard4

  • CNV Screening For End-stage Renal Disease

    C. E. Fishman, B. Chang, A. Shaked, B. J. Keating

  • CURATE.AI: Personalized Liver Transplant Tacrolimus Dosing

    A. Zarrinpar1, T. Kee2, P. Wang3, J. Khong3, U. Kim1, J. Chong2, J. B. Jeong3, A. T. Truong2, S. Tan2, B. K. Betzler2, W. Ng2, C. Ho3, D. Ho2

  • CXCL12-CXCR4-Mediated Chemotaxis is a Potential Mechanism for Monocyte Recruitment in Ischemia-Reperfusion Injury in Orthotopic Liver Transplant Patients

    A. Q. Terry1, R. A. Sosa1, B. V. Naini1, V. Groysberg1, F. M. Kaldas2, R. W. Busuttil2, D. Gjertson1, J. Kupiec-Weglinski2, E. F. Reed1

  • Calcineurin Inhibitors and Long-Term Outcomes of Kidney Transplantation from Thai Transplant Registry

    S. Udomkarnjananun, N. Townamchai, Y. Avihingsanon, K. Praditpornsilpa

  • Can Cxcl8 Inhibitor (reparixin) Improve Islet Engraftment And Clinical Outcomes After Islet Allotransplantation? University Of Chicago Preliminary Results From A Phase 3 Multicenter Randomized, Double-blinded, Prospective Study.

    P. Bachul1, K. Golab1, L. Basto1, L. Wang1, M. Tibudan1, J. Golebiewska2, M. Para1, L. Perea1, F. Antic1, J. Fung1, P. Witkowski1

  • Can Financial Incentives Improve Patient Compliance with Optn Live Kidney Donor Follow-Up Policy? Results of a Randomized Controlled Trial

    M. Henderson, M. Waldram, S. DiBrito, A. Thomas, F. Al Ammary, S. Ottman, A. Massie, J. Garonzik Wang, D. Segev

  • Can National Data Predict Which Older Kidney Donors Are More Likely to Yield Higher eGFR 1-Year Post-Transplant?

    C. A. Custer1, R. J. Carrico1, T. L. Pruett2

  • Capturing Stories about Living Kidney Donation Using Storytelling Capture Technology: A Feasibility Assessment

    A. D. Waterman1, C. S. Anderson1, O. N. Ranasinghe1, Y. Cui2, S. Brecher1, W. Balliet3

  • Cardiac Risk Assessment in Kidney Transplant Candidates: Clinical Usefulness of Different Guidelines

    A. Velioglu1, S. Mehdiyev1, H. Arikan1, E. Asicioglu1, A. Cincin2, S. Tuglular1

  • Cardioprotective Effects of Pre-Operative Cyclosporine in Patients Undergoing Heart Transplantation

    Y. Hirase, M. Harris, M. Watson, H. Lee, C. Patel

  • Caregiving before Thoracic Transplantation–A Qualitative Inquiry

    C. C. Kennedy1, J. Ridgeway1, E. Stevens1, J. Kirsch2, K. Carroll1, J. Griffin1, R. Benzo1

  • Caregiving in Thoracic Transplantation–A SR/MA

    A. A. Rmilah, J. Lau, R. Mendpara, P. Erwin, C. C. Kennedy

  • Case Series Of Total Laparoscopic-hand Assisted Living Donor Right Hepatectomy: First 19 Cases At A Single Center In Usa

    P. N. Martins1, B. Movahedi2, D. Litwin2, A. Bozorgzadeh2

  • Case Series: Anti-Thymocyte Globulin as a Treatment for Steroid-Refractory Severe Acute Hepatitis in Children

    A. L. Peters, A. Miethke, K. Campbell

  • Causes of 30 Day Graft Loss among Shared Kidneys in the National Kidney Registry (NKR)

    J. Verbesey1, A. Thomas2, M. Ronin3, D. Segev4, A. Waterman5, S. Flechner6, M. Cooper1

  • Cd45rb Mediates Cd8+T Cell Persistence In An Allogeneic Heterologous Immune Response

    S. M. Krummey, A. B. Morris, M. L. Ford

  • Cellular And Molecular Characteristics Of Intra-graft Lymphoid Aggregates In Chronic Lung Allograft Dysfunction

    E. Miyamoto1, S. Juvet1, D. Hwang2, S. Keshavjee1, T. Martinu1

  • Cellular Sources of Cytokine Production during Cold Ischemia Induced AKI after Kidney Transplant

    S. Jain1, R. Plenter2, T. Nydam2, A. Jani1

  • Ceria-Zirconia Nanoparticles as an Enhanced Antioxidant Attenuates Apoptosis of Human Kidney Proximal Tubular Epithelial Cells in Hypoxia

    S. Yoon1, K. Yoon2, S. Hong3, S. Yun1, W. Hwang1, J. Moon4, J. Lee1, H. Jeon1

  • Challenges to Inpatient Management Post Abdominal Wall Transplant (AWT) – From App’s Perspective

    K. Hattori, D. Sudan, K. Ravindra

  • Changes in Body Mass Index and Outcomes after Kidney Transplantation: A Single Centre, Retrospective, Observational Study

    A. Arshad1, J. Hodson2, K. Khalil1, A. Sharif3

  • Changing Education Paradigms: Training Fellows for High Stake Procedures

    T. Rice1, H. Lewis1, M. Cuffy1, L. Ratner2, T. Diwan1

  • Characteristics And Outcomes Of Early Onset Cancers After Kidney Transplantation

    W. Lim1, E. Au2, A. Krishnan1, G. Wong2

  • Characteristics Associated with Immunosuppressant Adherence after Deceased Donor Kidney Transplant

    A. R. Wilk1, W. S. Cherikh1, J. Maghirang1, E. A. Witt2, H. Kirkham2, S. Boghani2, N. Hira3, G. Pietradoni2, D. K. Klassen1

  • Characteristics of Patients with Early vs Late BK Viremia after Kidney Transplantation

    S. Rehman1, J. Pryor2, A. Olyaei3, M. Stack1, D. Norman1, J. Lockridge1

  • Characterization Of Increased Risk Donor Post-transplant Viral Surveillance Protocol At A Comprehensive Transplant Center

    J. Dann, W. Ally, S. Pelletier, C. Sifri, A. Agarwal

  • Characterization Of Microscopic Hematuria Following Renal Transplant

    M. L. McDonald1, T. N. Duong2, N. Datta2, H. A. Gritsch1, S. Bunnapradist2

  • Characterization of Circulating T-cell Specific Exosomes during Acute Rejection in Murine Heart Transplantation Model

    R. Hu1, V. Korutla1, L. Korutla1, S. Rostami1, A. Habertheuer1, S. Addya2, J. Harmon1, P. Zielinski1, S. Reddy1, A. Freas1, C. Ram1, A. Naji1, P. Vallabhajosyula1

  • Chemokine Ligand 14 is a Novel Therapeutic Target in Kidney Fibrosis

    S. Lee1, Y. Kim1, J. Moon1, H. Lee1, S. Han1, J. Lee2, R. Cha3, D. Kim1, C. Lee4, K. Kim5, Y. Kim1, S. Yang6

  • Chimeric Allografts Induced by Stem Cell Mobilizing Agents in a Mouse Model of Kidney Transplantation: Role of CD133 Stem Cells

    J. Zhou, l. Qi, A. Ahmadi, R. Wesson, A. Cameron, J. Burdick, Z. Sun

  • Chylous Ascites Following Laparoscopic Live Donor Nephrectomy: A New Improved Treatment Paradigm

    L. Dale1, R. Sandoval2, L. E. Ratner2

  • Cidofovir for BK Nephropathy Rescue Treatment: A Single Center Experience

    J. Slatinska1, E. Honsova2, T. Rohal1, A. Slavcev3, P. Hruba4, O. Viklicky1

  • Circulating De Novo Donor Specific Antibodies and Carotid Intima-Media Thickness in Pediatric Kidney Transplant Recipients

    K. Sgambat1, S. Clauss2, A. Moudgil1

  • Circulating Exosomes with Cardiac Self-Antigens (Cardiac Myosin and Vimentin) and De Novo Development of Antibodies to Cardiac Self-Antigens Precedes Chronic Cardiac Allograft Rejection

    R. Ravichandran, Y. Itabashi, W. Liu, T. Mohanakumar

  • Clinical Features and Prognosis of Diffuse Intrahepatic Biliary Stricture in Adult ABO-Incompatible Living Donor Liver Transplantation

    J. Kwon, G. Song, S. Hwang, K. Kim, C. Ahn, D. Moon, T. Ha, D. Jung, G. Park, Y. Yoon, H. Cho, I. Jeong, J. Choi, S. Yoo, S. Lee

  • Clinical Features of IgA Nephropathy Recurrence after Kidney Transplantation

    H. HIGUCHI1, K. Hotta2, H. Harada1, Y. Wada1, A. Mitsuke1, D. Iwami2, N. Shinohara2

  • Clinical Impact of Spontaenous Portosystemic Shunts on the Short Term Outcome of Liver Transplantation

    E. A. Rodriguez1, R. M. Perez2, N. Zhang3, E. S. Lim3, C. R. Miller4, M. A. Schwartz2, A. J. McGirr4, A. Srinivasan5, W. R. Hewitt5, A. C. Silva4, J. Rakela1, H. E. Vargas1

  • Clinical Importance of the Updated Oxford Classification in Allograft IgA Nephropathy

    S. Park1, H. Go2, C. Baek2, J. Jeong1, Y. Kim1, Y. Kim1, Y. Kim2, J. Lee3, S. Min1, J. Ha1, E. Song1, Y. Kim1, S. Park2, K. Moon1, H. Lee1

  • Clinical Outcomes and Risk Factors for Delayed or Slow Graft Function in an Adult, Urban Renal Transplant Population

    K. Tejani, Z. Hajjiri, E. Benedetti, A. Lichvar

  • Clinical Outcomes of Living versus Deceased Donor Liver Transplantation for Primary Sclerosing Cholangitis: A Multicenter 15 Year Experience

    O. Y. Mousa1, K. D. Watt1, J. K. Heimbach2, A. P. Keaveny3, J. E. Eaton1, D. M. Harnois3, B. Taner3, E. J. Carey4, A. A. Moss4, C. B. Rosen5, T. Taner5

  • Clinical Outcomes of Patients with Portal Vein Tumor Thrombi after Living Donor Liver Transplantation

    D. Kim

  • Clinical Outcomes of Using mTOR Inhibitors with Reduced Dose of Calcineurin Inhibitors in Lung Transplant Recipients: A Single Center Experience

    M. Frawley1, J. Leedy1, A. James1, A. Salter1, V. Rusanov2

  • Clinical Presentation After Hepatitis B Recurrence In Liver Transplant Patients

    W. Lee, C. Cheng, T. Wu, Y. Wang, C. Lee, T. Wu, H. Chou, K. Chan

  • Clinical Trial of Allogeneic Islet Transplantation in the Treatment of Diabetes after Renal Transplantation

    W. liang, M. Hu, G. Peng, D. Zhou, C. Zeng, W. Zhou, q. Ye, Z. Wang

  • Clinical Utility of a Pharmacogenomic Testing Tool among Kidney Transplant Recipients

    S. LeCorchick, L. Lindberg, W. Stapley, S. Anand, D. Morris, T. Srinivas

  • Clinical Utility of the Edmonton Symptom Assessment System to Screen for Depression and Anxiety in Kidney Transplant Recipients

    E. Tang, S. Dano, A. Ayub, V. Li, I. Escudero, N. Ullah, N. Edwards, M. Novak, I. Mucsi

  • Clinical and Pathologic Differences between Young and Old Living Donors in Young Kidney Transplant Recipients

    C. Baek, H. Kim, H. Lee, Y. Kim, S. Park

  • Clinicopathologic Assessment of Monoclonal Immunoglobulin (Ig) Associated Renal Disease in the Kidney Allograft

    J. Kamal1, R. J. Crew1, X. Ye2, J. Swanson3, G. Appel1, G. Markowitz4, V. D'Agati4, I. Batal4

  • Clostridium difficile Infection Mimics Intestinal Acute Cellular Rejection in Pediatric Multivisceral Transplant – A Case Series

    D. A. Cheung1, T. Beduschi2, A. Tekin2, G. Selvaggi2, R. M. Vianna2, J. Garcia1

  • Cluster Analysis of Microvascular Inflammation in Indication Biopsies Unveils Distinct Pathological and Immunological Phenotypes with Prognostic Implications

    J. Malheiro1, A. Silva1, S. Santos1, S. Tafulo2, L. Martins1, L. Dias1, A. Castro-Henriques1

  • Combination of Ketoconazole and Tacrolimus Increases the Risk of Kidney Transplant Rejection in African Americans

    M. E. Sharshir, A. Zhang, E. Khan, B. Zhang, S. Giusti, R. Zhang

  • Combined Antithymocyte Globulin (ATG) and Rituximab (RTX) Induction in African American (AA) Kidney Transplant Recipients

    S. J. Patel, S. Kuten, C. Pham, R. Knight, M. Hobeika, D. Nguyen, E. Graviss, S. Yi, T. Eagar, A. Gaber

  • Combined Ischemic and Rapamycin Preconditioning Alleviated Liver Ischemia and Reperfusion Injury by Restoring Autophagy in Old Mice

    Z. Rao, X. Pan, W. Zhong, Z. Ding, H. Zhou, C. Liu

  • Combined Pre-Transplant Anti-Donor T-Cell Sensitization with Single Nucleotid Polimorphisms (SNPs) for CYP3A4 Tacrolimus Metabolism Identifies Kidney Transplant Patients at High Risk of Allograft Rejection

    E. Crespo1, A. Vidal1, A. Sefrin2, P. Fontova1, M. Stein2, H. Volk2, J. Grinyó3, P. Reinke2, N. Lloberas1, O. Bestard3

  • Comparative Use of Single mTOR vs Dual mTOR/PI3K Inhibition in Regulatory T Cell Expansion for Clinical Application in Transplantation

    R. Gedaly-Eidelman, F. Marti, L. Turcios, E. Chacon, D. Valvi

  • Comparing the Rate of Opportunistic Infection after Renal Transplant between Alemtuzumab and Basiliximab for Induction Immunosuppression

    J. A. Seaman1, S. G. Westphal2, F. Qiu3, D. Bremers4, D. Florescu5

  • Comparison Of Estimating Glomerular Filtration Equations In Living Kidney Donor Candidates Prior To Donation

    S. Hebert1, J. Xu2, H. Ibrahim1

  • Comparison between Urine and Blood NGAL for Early Prediction of Delayed Graft Function in Adult Kidney Transplant Recipients: A Systematic Review and Meta-Analysis

    Y. Li, Y. Li, L. Yan, H. Wang, X. Wu, J. Tang, L. Wang, Y. Shi

  • Comparison of Basiliximab and Alemtuzumab for Lung Transplant Induction

    S. Mietz1, D. Roe2, E. Lushin1, E. Anderson1, C. Hage2

  • Comparison of Functional β-cell Function and Insulin Sensitivity of Functioning Pancreas Transplant According to Pre-Transplant Matsuda’s Index

    S. Shin, Y. Ko, D. Kim, J. Kim, H. Kwon, J. Choi, J. Jung, Y. Kim, D. Han

  • Comparison of Long-Term Outcomes between Alemtuzumab and Rabbit Anti-Thymocyte Globulin for Acute Kidney Allograft Rejection

    M. van der Zwan, M. C. Clahsen-van Groningen, D. L. Roelen, M. W. van den Hoogen, M. Van Agteren, J. I. Roodnat, C. C. Baan, D. A. Hesselink

  • Comparison of Oral Microbiome in Stable vs Declining Kidney Function in Renal Transplant Recipients

    J. Wu1, A. Muthusamy2, G. Al-Ghalith3, B. Wu4, B. Guo4, W. Guan4, D. Knights3, W. Oetting5, D. Schladt2, R. Remmel5, P. Jacobson5, A. K. Sharma6, A. Matas7, A. Israni1, D. Skaar8

  • Comparison of Planned vs. Unplanned Pregnancies in Female Kidney Transplant Recipients

    S. Rao1, L. A. Coscia2, D. Kliniewski2, S. Constantinescu3, M. J. Moritz4

  • Comparison of Portal vs Systemic Venous Drained Pancreas Transplantation Alone Matched by Propensity Score Analysis

    F. Vistoli, N. Napoli, F. Palumbo, E. Kauffmann, V. Perrone, S. Iacopi, C. Lombardo, G. Amorese, P. Marchetti, U. Boggi

  • Comparison of Simultaneous Pancreas kidney Transplantation to Kidney Transplantation Alone for Type 2 Diabetes with End Stage Renal Disease

    Y. Fu, Z. Shen

  • Comparison of Tacrolimus or Cyclosporine Combined with Methotrexate for Graft versus Host Disease Prophylaxis after Allogeneic Hematopoietic Cell Transplantation: A Meta-Analysis

    M. Chen, B. Huang, Y. Zhang, W. Ju, X. He

  • Compatible Pairs And Non-directed Living Donors Enhance Paired Exchange Kidney Transplantation: Single-center Experience

    L. Jaber, C. Tiletile, J. Bellingham, N. Garg, A. Hassoun, H. Mahanty, N. Neidlinger, A. Sandhu, P. Patel, W. Bry, S. Katznelson, V. Peddi

  • Complete Robotic-Assisted Kidney Transplantation: Our Initial Experience

    A. Khan, C. Bhati, T. Reichman, A. Cotterell, D. Kumar, G. Gupta, L. Kamal, A. King, A. Sharma, M. Levy

  • Complex Live Donor Anatomy Does Not Preclude Kidney Transplantation

    P. Veitch, T. Brown, A. Courtney, J. McDaid

  • Complications of Interposition Grafts for Middle Hepatic Vein Reconstruction in Living Donor Liver Transplantation

    S. Kim, G. Chun, I. Song

  • Comprehensive and Combined Transcriptomic and Proteomic Analysis Reveals Key Factors Underlying Ischemia-Reperfusion Injury in Human Liver Transplantation

    S. Huang, X. He, C. Sun, Z. Guo, W. Ju, Z. Zhu, Q. Zhao, G. Chen

  • Consistent High Burden of Arteriosclerosis in Pediatric Kidney Transplant Recipients

    K. Ostendorf1, N. Memaran1, B. Borchert-Mörlins1, J. von der Born1, E. Bauer1, A. von Wick1, J. Oh2, M. J. Kemper3, R. Büscher4, B. M. Schmidt5, A. Melk1

  • Contemporary Predictors and Impact on Survival of Early Readmission after Kidney Transplant: Analysis of the Nationwide Readmission Database

    N. Elfadawy, N. Tashtish, S. Al-kindi, D. Hricik, E. Sanchez, N. Sarabu

  • Continuous 24-Hour vs. Daily Antithymocyte Globulin (ATG) Infusions for Treatment of Renal Allograft Rejection: Preliminary Results of a Prospective Trial

    S. J. Patel, S. Kuten, R. Knight, J. Nolte-Fong, D. Nguyen, E. Graviss, A. Gaber

  • Contrast-Enhanced Ultrasonography Predicts Insulin Secretion Ability at 1 Year after Pancreas Transplantation

    N. Aida1, T. Kenmochi1, T. Ito1, K. Kurihara1, A. Kawai1, T. Nishikawa2, I. Hiratsuka3, M. Shibata3, A. Suzuki3, M. Hasegawa4, M. Kusaka5, M. Hoshinaga5

  • Contribution of CD38 to Methionine Choline Deficient (MCD) Diet-Induced Liver Injury in Rats

    J. Kim, Y. Lee, B. F. Reader, C. Akateh, K. R. Maynard, K. W. Washburn, J. L. Zweier, B. A. Whitson, S. M. Black

  • Correlates of Significant Weight Changes Following Pancreas Alone Transplantation

    A. Arunachalam, F. Aziz, N. Garg, M. Mohamed, A. Djamali, J. Odorico, D. Mandelbrot, S. Parajuli

  • Correlates of Surgical Difficulty and Post-Operative Complications in Living Donor Kidney Procurement

    B. I. Shaw1, F. R. Schwartz2, F. Vernucci2, F. Rigiroli2, F. Gonzalez2, R. Lerebours3, A. S. Rege1, D. Vikraman1, D. Marin2, K. V. Ravindra1

  • Correlation between Gene Expression and Cardiac Function in Ex Vivo Perfused Porcine Hearts

    S. Rotich, N. Herbers, S. Hatami, J. Nagendran, M. Mengel, D. Freed, B. Adam

  • Correlation between Gene Expression and Histology in Transbronchial Lung Transplant Biopsies

    B. Adam, K. Du, S. Rotich, M. Mengel

  • Correlation between Self-Reported Medication Adherence and Side Effects in Cardiothoracic Transplant Recipients

    T. Harrison1, N. Patel1, H. Corbo1, K. Foster1, H. Meadows1, N. Pilch1, C. Perez1, J. Fleming1, D. Judge2, L. Paoletti3, D. Taber1

  • Correlation between Self-Reported Medication Adherence and Side Effects in Transplant Recipients

    T. Harrison1, K. Foster1, N. Patel1, H. Meadows1, C. Perez1, H. Corbo1, J. Fleming1, N. Pilch1, D. DuBay2, J. McGillicuddy2, S. Nadig2, V. Rohan2, D. Taber1

  • Correlation of Crossmatch Predictions with Actual Results and Clinical Outcomes

    R. Forbes1, B. Concepcion1, S. Fossey2

  • Correlations between Preoperative Hepatic Venous Pressure Gradient and Graft Hemodynamics after Reperfusion in Living Donor Liver Transplantation

    H. Matsushima, M. Fujiki, K. Sasaki, F. Aucejo, T. Diago Uso, C. Kwon, B. Eghtesad, C. Miller, C. Quintini, K. Hashimoto

  • Cost-Effectiveness Analysis of Renal Replacement Therapy Strategies in Haiti

    J. S. Pyda1, L. James2, J. J. Kim2, K. Khwaja1, M. Shrime3

  • Costimulatory Blockade and Allo-Specific Treg Therapy for Liver Transplant Recipients: Preclinical Data

    L. Contreras-Ruiz1, K. Shimozawa2, R. Zhang1, L. Turka3, J. F. Markmann3, E. C. Guinan2

  • Costs Associated with A2 to B Kidney Transplantation: A Barrier to Its Utilization?

    R. Forbes, B. Concepcion, D. Shaffer

  • Costs In Contemporary Transplant Practice

    M. Wyld, T. Ying, K. Wyburn, S. Chadban

  • Costs of Kidney Recoveries Varies Dramatically across Organ Procurement Organizations

    J. P. Roberts1, J. Bragg-Gresham2, P. J. Held3

  • Could Intravenous Iron Strengthen The Chances Of Heart Transplantation For Patients With Left Ventricular Assist Devices?

    A. Mardis1, C. Mardis2, J. Barham3, A. Poole3, S. Branham3, R. Napier4, J. Martin3, P. McCann4

  • Cryopreservation Allows for Extended Graft Survival in a Rat Orthotopic Hind Limb Model

    S. A. Fidder1, B. Oh1, F. Messner1, G. Furtmueller1, K. Helke2, E. Greene3, Z. Chen3, L. Campbell3, G. Brandacher1, K. Brockbank3

  • Cyclo (his-pro) Protects Against Gentamicin Induced Cell Apoptosis And Cisplatin Induced Acute Kidney Injury Through Inhibiting P53 Mediated Apoptotic Pathway.

    Y. Kim1, J. Moon1, J. Jeong1, J. Kim1, S. Lee1, M. Yu2, C. Lee3, Y. Kim1, S. Yang4

  • Cytokine Profiles in Children after Pediatric Kidney Transplantation with Acute Cellular Compared to Chronic Active Antibody-Mediated Rejection

    N. Borsum, T. Ahlenstiel-Grunow, L. Pape

  • Daily Use of a Muscle Pump Activator Device Reduces Hospitalization and Improves Graft Function Post Transplantation: A Randomized Controlled Trial

    W. Xie, S. Aquil, K. Pacoli, R. Al-Ogaili, P. Luke, A. Sener

  • Damage-Associated Molecular Pattern Release and Toll-Like Receptor Activation during Cold Storage and Ex Vivo Reperfusion of Old Rat Livers

    U. Scheuermann, E. R. Seyferth, M. Zhu, M. Song, J. Yerxa, R. P. Davis, W. Parker, M. Hartwig, J. Kwun, J. Lee, A. S. Barbas

  • Daratumumab for Treatment of Antibody-Mediated Rejection in a Kidney Transplant Recipient

    S. C. Jordan1, R. Vescio2, M. Toyoda3, N. Ammerman1, E. Huang1, A. Peng1, S. Sethi1, R. Najjar1, K. Lim1, A. Vo1

  • De Novo Hepatitis B Virus Infection after Pediatric Living Donor Liver Transplantation: Risk Factors, Recognition and Prevention Strategies

    G. Gu, Q. Xia

  • Deceased Donor Predictors for Pediatric Liver Allograft Utilization and Outcome of the Use of Paediatric Donor Livers in Adult Recipients

    S. Huang, C. Sun, X. He, Z. Guo, G. Chen

  • Decreased Rejection and Higher Graft Survival in Pediatric Deceased Donors

    P. Budhiraja1, D. Rotich2, J. Mahnken2, A. Ilahe1, A. Naik3, D. Cibrik1

  • Deficiency of IRE1a Ameliorates Renal Allograft Injury via Remodeling of Graft-Infiltrating Macrophages

    L. Qiu1, J. Wang1, X. Yeap1, S. Han1, F. Zheng1, D. Fang2, Z. J. Zhang1

  • Deficiency of the Transcription Factor Satb1 in T Cells Promotes Solid Organ Allograft Survival

    P. K. Gupta1, M. L. Miller2, L. Chen1, Y. Wang1, J. Conejo-Garcia3, A. Chong1, M. Alegre1

  • Delayed Graft Function as a Survival Prognostic Factor in Elderly Recipients of Kidney Transplantation

    G. J. Piñeiro, E. Guillen, P. Ventura, J. V. Torregrosa, R. Gelpi, I. Revuelta, F. Cofan, E. De Sousa, D. Cucchiari, J. Ugalde, F. Oppenheimer, F. Diekmann, N. Esforzado

  • Depleting Laminin α5 in Lymph Node Stromal Cells Promotes Transplant Tolerance

    L. Li, M. Shirkey, W. Piao, Y. Xiong, V. Saxena, T. Zhang, N. Toney, C. Paluskievicz, J. S. Bromberg

  • Desensitization Protocols vs Kidney Paired Donation to Overcome AB0 Incompatibility and/or Donor Specific Antibodies in Living Donor Kidney Transplantation

    F. Vistoli, V. Perrone, L. Gozzini, E. Kauffmann, N. Napoli, S. Iacopi, C. Lombardo, G. Amorese, U. Boggi

  • Desensitization Using Only IVIG: Is That an Option for Highly-Sensitized Patients Waiting for Kidneys from Cadaveric Donors?

    J. O. Paixão, L. R. Ulisses, P. S. Souza, G. Bezerra, F. Agena, H. P. Rodrgues, N. Panajotopoulos, F. J. Paula, E. David-Neto, M. R. Castro

  • Desensitization Using Only Polyvalent Immunoglobulins (IVIG) for Kidney Transplantation with Living Donors (LD)

    L. R. Ulisses, J. O. Paixão, P. S. Souza, G. Bezerra, H. Rodrigues, N. Panajatopoulos, F. J. De Paula, E. David-Neto, M. C. R Castro

  • Detection and Desensitization of Donor-Specific Antibody Reduces Risk of Early but Not Late Renal Transplant Failure in a Cohort of 1000 Cases

    M. Tsai, C. Lee, C. Yang, C. Chen

  • Determinants of Allograft Injury during Procurement in Deceased Donors

    E. Taber-Hight1, R. Cauwels2, E. Eidbo2, A. S. Paramesh3, R. Squires4, T. Taber1

  • Determining the Role of Insurance Coverage at the Time of Renal Transplantation as a Predictor of Medication Misadventure

    D. Wilkerson, P. Klem

  • Developing a Patient Reported Outcome Measure for Assessment of Calcineurin Inhibitor-Related Symptoms

    J. L. Beaumont1, I. Purnajo1, M. Polinsky2, E. Alemao2, M. J. Everly1

  • Developing a Patient Specific Search: Feedback from Kidney Transplant Candidates and Recipients

    W. T. McKinney1, M. J. Bruin2, C. R. Schaffhausen1, S. Chu2, J. Snyder3, A. Matas4, B. Kasiske5, A. K. Israni1

  • Development and Implementation of a Pediatric Transplant Consortium

    K. Soltys1, S. K. Rassmussen2, J. Squires3, R. Sindhi1, S. Pelletier2, K. Brayman2, M. Angelis4, T. Chin4, R. Teaster2, J. Oberholzer2, R. Gonzalez-Peralta5, B. Friedman4, D. Hupp6, M. Mendoza7, P. A. Eicker6, J. Middleton7, G. Mazariegos1

  • Development and Validation of a Capillary Blood Mitra-Based Assay for the Quantitative Determination of Advagraf® Concentrations in Transplant Patients

    N. Undre1, I. Dawson2, V. Aluvihare3, N. Kamar4, F. Saliba5, N. Torpey6, S. Anaokar7, G. Kazeem1

  • Development of De Novo Antibody in Renal Transplant Recipients with BK Viremia Managed with Immunosuppression Reduction

    M. Raijmakers1, A. Shetty2, R. Hod Dvorai2, A. Tambur2, M. G. Ison2

  • Development of De Novo DSA after Kidney Transplant Correlates with Low Quantity of Peripheral Blood “Antibody-Suppressor” CD8+ T Cells

    J. Zimmerer1, M. Basinger1, B. Ringwald1, R. Pelletier1, A. Rajab1, A. El-Hinnawi1, M. Abdel-Rousoul2, H. Parekh3, K. Washburn1, G. Bumgardner1

  • Development of a Novel Linear Model for Predicting Recipient’s Post-Transplant Serum Creatinine Level after Living Donor Kidney Transplantation: A Multicenter Cross-Validation Study

    S. Kim, S. Kim, J. Rhu, Y. Chung, S. Lee, K. Lee, J. Kim, G. Choi, J. Park, S. Lee, J. Joh

  • Development of a Recurrence Risk Score in IgA Nephropathy after Kidney Transplantation: Role of Recipient Age and HLA-B Mismatch

    L. M. Rodas Marin1, E. Ruiz2, A. García3, M. Blasco1, P. Ventura1, E. de Soussa1, O. Viñas4, F. Diekmann1, L. Quintana1

  • Development of an Aggressiveness Report Card

    L. Liyanage, M. Kosztowski, S. Bae, K. Jackson, C. Holscher, A. Massie, N. Desai, M. Henderson, D. Segev, J. Garonzik-Wang

  • Diagnostic Efficacy of Color Doppler Ultrasound on Recipients with Transplanted Renal Artery Stenosis: A Single Center Experience

    Y. Yang, Z. Wang, S. Fei, H. Chen, L. Sun, Z. Han, J. Tao, X. Ju, R. Tao, M. Gu

  • Dialysis Lowers Pulmonary Embolism Mortality Risk in Kidney Transplantation

    B. Javaid, A. Gilbert, G. Vranic, J. Moore, B. Thomas, P. Abrams, S. Ghasemian, J. Verbesey, S. Yi, M. Cooper

  • Diastolic Blood Pressure Derived from Twenty Four Hour Ambulatory Blood Pressure Monitoring Predicts Survival after Kidney Transplantation

    l. Basdeo, H. Wadei, M. Prendergast, M. Mai, C. Oshel, T. Jarmi

  • Dichotomous Role Of Donor T Cells In The Efficacy Of Tolerogenic Therapies For Transplant Rejection

    M. Iglesias Lozano, D. Bibicheff, M. Chicco, G. Brandacher, G. Raimondi

  • Differences in Graft Survival for Pediatric and Adult Kidney Recipients Followed and Lost to Follow-Up

    A. M. Robinson1, E. K. Hsu2, S. M. Bartosh3, D. E. Stewart1, G. V. Mazariegos4

  • Differences in the Cost of Kidney Organ Recovery by Organ Procurement Organization Size

    P. J. Held1, J. Bragg-Gresham2, J. P. Roberts3

  • Differences in the Cost of Recovering Organs over Time

    J. P. Roberts1, J. Bragg-Gresham2, P. Held3

  • Different Options Available For Patients Registered In A Kidney Paired Donation (KPD) Program

    S. Stepkowski, B. Mierzejewska, M. Rees

  • Differential Diagnosis of Membranous Nephropathy Occurs after Bone Marrow Transplantation and Renal Transplantation

    L. Guo1, H. Wang1, Y. Tan2, J. Shen1, R. Wang1, J. Wu1, J. Chen1

  • Differential Effects Of Prolonged Cold Ischemia On Outcomes In Donation After Cardio Circulatory Death Versus Acute Kidney Injury Donor Kidney Transplants

    D. Harriman, V. Gurram, J. Rogers, A. Farney, G. Orlando, C. Jay, A. Reeves-Daniel, A. Mena-Gutierrez, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta

  • Direct Oral Anticoagulants: An Evaluation of the Safety and Efficacy in Solid Organ Transplant Recipients

    T. Pasley, A. Logan, A. Brueckner, L. Bowman, A. Silverman, A. Rumore

  • Discovery and Validation of Blood Genomic Signatures of Acute Rejection in Liver Transplant Recipients

    J. Levitsky1, N. Bridges2, J. Odim2, M. Brown2, D. Ikle3, B. Armstrong3, A. Demetris4, S. Asrani5, G. Klintmalm5, T. Schiano6, A. Moss7, K. Chavin8, C. Miller9, M. Kandpal10, L. Zhao10, S. Kurian11, M. Abecassis10

  • Dissecting The Role Of Donor Acute Kidney Injury On Molecular Responses Post-transplantation

    S. Bontha1, D. Maluf1, E. Akalin2, L. Gallon3, J. Eason4, V. Mas5

  • Distribution And Outcomes Of Donor Right Kidneys In A National Paired Kidney Exchange Program

    G. Roll1, W. Irish2, M. Cooper3, M. Ronin4, G. Hil5, A. D. Waterman6, D. B. Leeser2

  • Do Heart Transplant Patients Have Support Personnel Ready to Help Them If Necessary?

    A. Velleca, K. Norland, M. Curry, N. Ransbottom, B. Kearney, R. Levine, S. Dimbil, R. Sharoff, E. Passano, J. A. Kobashigawa

  • Do Outcomes Differ in Glomerulitis Predominant Antibody Mediated Rejection and Peritubular capillaritis Predominant Antibody Mediated Rejection?

    S. Sethi1, J. Hou2, M. Lin2, Y. Ren2, A. Peng1, R. Najjar1, A. Vo1, S. Jordan1, M. Haas2, E. Huang1

  • Do Reimbursement Programs Increase The Number Of Living Organ Donations?

    A. Siddique1, J. Ortiz2, S. Fry-Revere2, V. Apte2, Y. Jin3, N. Koizumi1

  • Does Ethnicity Impact Elderly Kidney Transplant Recipient Outcomes?

    I. Bajjoka, A. Yaldo, S. Serra, S. Foley, C. Crombez, M. Abouljoud

  • Does Proton Pump Inhibitor Use Affect Renal Function in Kidney Transplant Recipients?

    K. Schütte-Nütgen1, D. J. Flothow1, B. Suwelack1, R. Schmidt2, H. Pavenstädt1, S. Reuter1

  • Don’t Believe the Hype: Machine Learning-Based Prediction of Kidney Transplant Outcomes

    S. Bae, D. Segev

  • Donor – Recipient Size Mismatch Has No Impact on Outcomes after Deceased Donor Whole Liver Transplantation: A Single Center Analysis

    A. Cabrales1, R. Mangus1, B. Ekser1, L. Timsina1, J. Fridell1, P. Mihaylov1, T. Nikumbh1, M. Ghabril2, M. Lacerda2, C. Kubal1

  • Donor Brain Death Affects Tolerance Induction in Non-Human Primates

    W. Sommer1, J. M. O2, K. B. Pruner3, J. T. Paster3, A. Bean3, A. Dehnadi3, I. M. Hanekamp3, I. Rosales4, R. N. Smith4, R. B. Colvin4, G. Benichou3, J. S. Allan3, T. Kawai3, J. C. Madsen5

  • Donor Derived Neoplasia: Will It Be a Risk after Clinical Pig Organ Xenotransplantation?

    A. Jagdale1, H. Iwase1, E. Klein2, D. Cooper1

  • Donor Exclusions and Shifting Trends in Living Liver Donor Evaluations: A Single Center Experience

    S. Ganesh, M. Molinari, A. Tevar, C. Hughes, A. Humar

  • Donor Hepatitis C Seropositivity Confers Poorer Post-transplant Outcomes In Recipients Of Marginal Livers In The Post-hepatitis C Treatment Era

    M. B. Shah, M. Gupta, X. Mei, R. Gedaly

  • Donor Lymphocyte Chimerism and Homozygosity Are Critical Indicators for Timely and Accurate Diagnosis of Acute Graft vs. Host Disease after Liver Transplantation

    A. Zhang, B. Eghtesad

  • Donor Management in Donation after Brain Death: A Window of Opportunity – Are Pro-Inflammatory Mediators the Target and What is the Effect of Duration of Brain Death?

    K. D. Bera1, J. Tabak2, M. L. Lo Faro1, R. J. Ploeg1

  • Donor Source of Kidney Transplantation in New Zealand by Ethnicity: A Longitudinal Cohort Study

    S. Donnellan1, N. Cross1, J. Williman2, S. C. Palmer3

  • Donor, Recipient Indices and Frailty Predict Outcomes after Heart-Kidney Transplantation

    C. Beifeld1, V. Dio Guardi1, K. Lau1, A. Di Carlo1, S. Karhadkar2

  • Donor-Derived Carbapenem-Resistant Klebsiella Pneumoniae Infection after Renal Transplantation

    B. Liu, M. Wang, F. Zeng, S. Chang, N. Gong, G. Chen, Z. Chen

  • Donor-Derived Cell-Free DNA (dd-cfDNA) Course after Rejection in Pediatric Kidney Transplant Recipients

    R. D. Swinford1, A. M. De Golovine1, C. Bell1, A. Pai1, A. R. Edwards1, S. Connor2, J. S. Bynon1

  • Donor-Derived Cell-Free DNA for Surveillance in Simultaneous Pancreas and Kidney Transplant Recipients, Can We Extrapolate from Kidney Transplant Alone?

    O. K. Olaitan1, S. Loeb1, E. Hetterman2, V. Peev1, S. Saltzberg1, M. Hertl1, S. Dholakia2

  • Donor-Recipient HLA Mismatched Peptides Calculated by PIRCHE Algorithm Associate with De Novo Donor-Specific Cellular and Humoral Alloreactivity and Predicts Inferior Graft Outcome

    M. Meneghini1, E. Crespo2, M. Niemann3, A. Torija2, E. Melilli4, M. Jarque2, N. Montero4, J. Cruzado1, J. Grinyo1, O. Bestard1

  • Donor-Specific Tregs Prolong Peripheral Chimerism in Baboons Receiving GalTKO hCD47-tg Porcine Peripheral Blood Stem Cells

    N. P. Llore1, J. Stern1, G. Pierre1, E. Lopes1, D. Ekanayake-Alper1, P. Alonso-Guallart1, K. Bruestle1, H. Sakai1, D. Ayares2, M. Lorber2, R. Hawley1, D. H. Sachs1, M. Sykes1, A. D. Griesemer1

  • Drug Metabolizing Capacity Of The Liver In Liver Donors Recovers Fully By One Month Post Donation

    M. Miah1, X. Wu1, I. H. Shaik1, H. J. Johnson1, S. Ganesh2, M. Molinari2, A. D. Tevar2, C. Hughes2, A. Humar2, R. Venkataramanan1

  • EBV Latent Proteins Encode for Peptides That Prevent Natural Killer Cell Inhibition

    B. Mbiribindi1, J. K. Pena1, O. Hatton2, C. Romero Moreno1, C. O. Esquivel1, O. M. Martinez1, S. M. Krams1

  • EBV Viremia and Development of EBV Specific Cytotoxic T-cells in Pediatric Renal Transplant Recipients

    H. Pizzo, D. Puliyanda, B. Shin, M. Toyoda, S. Jordan

  • EBV+ PTLD in the Modern Immunosuppression Era: Role of EBV Serology and DNAemia-Preliminary Data from CTOT-C06

    O. M. Martinez1, S. M. Krams1, M. A. Robien2, M. Lapasaran1, S. D. Boyd1, B. Armstrong3, C. Twist4, K. Weinberg1, D. Gratzinger1, B. Tan1, M. Sever3, D. Ikle3, M. Brown2, D. Bernstein1, C. O. Esquivel1

  • EBV+ PTLD Cell Lines Secrete Exosomes Containing microRNAs That Alter Immune Responses

    S. Syed, E. Maloney, A. Hui, O. Martinez, S. Krams

  • ECDI-Treated Donor Leukocytes in Primate Cardiac Allograft Recipients

    Z. Alikhassy Habibabady1, T. Zhang2, W. Sun2, X. Cheng2, L. Burdorf1, I. Tatarov2, S. Sendil2, I. Behroozfard2, B. Cerel1, D. Parsell2, R. N. Pierson III1, X. Luo3, A. M. Azimzadeh1

  • Early Allograft Dysfunction Does Not Predict Graft or Patient Survival in Recipients of Living Donor Liver Transplantation

    H. J. Braun, J. L. Dodge, J. D. Grab, N. L. Ascher, J. P. Roberts

  • Early Allograft Dysfunction in High Acuity Liver Transplant Recipients

    T. Ito, M. Lu, A. Murray, D. S. Graham, J. DiNorcia, V. G. Agopian, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas

  • Early Allograft Dysfunction in the Setting of Histologic Ischemia Reperfusion Injury Following Liver Transplantation: Analysis of Predictors and Outcomes

    T. Ito, J. Aziz, V. G. Agopian, S. Younan, J. DiNorcia, H. Yersiz, D. G. Farmer, R. W. Busuttil, F. M. Kaldas

  • Early And Late Borderline Lesions Exhibit Differential Outcomes In Renal Transplant Recipients

    N. K. Wilson1, S. Tremblay1, P. Lee1, S. Bumb1, R. R. Alloway1, A. R. Shields2, M. Cardi2, E. S. Woodle1

  • Early Cognitive Improvement One Month after Liver Transplant Measured by the NIH Toolbox

    M. Kim1, J. D. Peipert2, K. J. Reid1, E. M. Liotta1, M. B. Maas1, D. R. Ganger3, P. C. Zee1, D. P. Ladner4

  • Early Diagnosis of BK Virus Nephropathy Can Retrieve Kidney Allografts by Simple Reduction in Immunosuppressive Agents

    N. Iwahara, D. Iwami, K. Hotta, H. Okada, N. Shinohara

  • Early Pancreas Loss in Simultaneous Pancreas Kidney Transplants: Does It Matter for the Kidney?

    D. Das, J. Huskey, R. Heilman, K. S. Reddy, A. Moss, J. Harbell, C. Jadlowiec

  • Early Post-transplant Weight Gain In Inner-city Kidney Transplant Recipients (ktrs) Does Not Remit And Is Associated With Poor Food Quality, Stress And Anxiety.

    A. Myrie, J. Leong, J. Fazli, Y. Akivis, C. Wilson, M. Markell

  • Early Readmission After Renal Transplant As A Valuable Quality Measure

    S. Kim1, A. Osband1, B. Merhi2, G. Bayliss2, R. Gohh2, P. Morrissey1

  • Early T Cell Infiltration is Modulated by PD-1/PD-L1 Interactions in Kidney Graft

    Y. Shim, R. Fan, N. Dvorina, W. Baldwin

  • Early Everolimus Conversion For Renal Protection In Liver Transplantation: The Sooner The Better?

    M. Tomeczkowicz, N. Sulejmani, A. Jantz, B. Summers, T. Larson, R. Salgia

  • Economic Evaluation of Kidney Transplantation in the Elderly Stratified by Donor Quality

    M. Kadatz1, S. Klarenbach2, J. S. Gill1, J. Gill1

  • Effect of DSA-Free Heart Allocation on Children

    M. Skeans1, J. Pyke1, K. Audette1, R. White2, W. Mahle3, A. Savage4, J. Smith5

  • Effect of Enoxaparin Prophylaxis on Early VTE Post Lung Transplant

    S. Marshall1, K. Tsveybel1, S. Boukedes1, P. Burkett2, R. Chepuri2, A. Coppolino3, M. Divo2, S. El-Chemaly2, S. Keller2, J. Kennedy2, H. Mallidi3, G. Mody3, T. Thaniyavarn2, A. Trindade2, K. Townsend1, H. Goldberg2

  • Effect of HLA Mismatch on Recurrence and Graft Loss in Living versus Deceased Kidney Transplant Recipients with IgA Nephropathy

    T. Ishaque, F. A. Ammary, K. Jackson, D. L. Segev, A. B. Massie

  • Effect of Induction Therapy on Absolute CD4 Count and CD4 Percentage in HIV Positive Kidney Transplant Recipients

    S. A. Kuten1, I. E. Dunne1, A. E. Cantwell1, M. J. Hobeika2, S. G. Yi2, W. Musick1, R. J. Knight2, A. O. Gaber2

  • Effect of Influenza Vaccine in Patients with Kidney Transplant during 2017/2018

    K. Tsujimura1, M. Ota1, H. Ishida2, K. Tanabe2

  • Effect of Paricalcitol on Markers of Inflammation in De Novo Renal Transplant Recipients

    H. K. Pihlstrøm1, T. Ueland2, A. E. Michelsen2, G. Mjøen1, K. Midtvedt1, H. Holdaas1

  • Effect of Race and Antibody-Mediated Injury on Outcomes after Early Subclinical Inflammation

    E. P. Kasik, M. E. Seifert, M. Bernard, G. Agarwal, H. Fatima, R. Gaston, B. Julian, C. Kew, V. Kumar, S. Mehta, S. Ong, F. Rosenblum, G. Towns, R. B. Mannon

  • Effect of Renal Function on Asymmetric Dimethylarginine (ADMA) Homeostasis in Kidney Donors and Recipients

    M. Y. Said1, R. M. Douwes1, M. van Londen1, I. Minović1, A. Frenay2, M. H. de Borst1, E. van den Berg1, M. R. Heiner-Fokkema3, A. A. Kayacelebi4, A. Bollenbach4, H. van Goor5, G. J. Navis1, D. Tsikas4, S. J. Bakker1

  • Effect of Severe Diarrhea on Kidney Transplant Outcomes

    J. Kim, J. Ha, Y. Kim, S. Han

  • Effects of Co-Morbidities on Kidney Transplantation Outcome in South Korea: A Nationwide-Population Based Study

    M. Yu1, S. Park2, J. Moon2, J. Jeong2, J. Kim2, Y. Kim2, K. Han3, Y. Kim2, H. Lee2

  • Effects of IVIG Therapy and FcγR Polymorphisms on BK Virus Nephropathy in Kidney Transplant Recipients

    D. I. Min1, Y. Chang2, T. Shah3

  • Effects of Major Liver Allocation Policy Changes on Waitlist Outcomes in Multivisceral Transplantation

    S. Nagai1, M. Rizzari1, Y. Muszkat2, K. Collins1, A. Yoshida1, S. Jafri2, M. Abouljoud1

  • Effects of Omega-3 Fatty Acids on Outcome after Living Donor Right Hepatectomy

    S. Lee, J. Kim, G. Choi, J. Joh, S. Lee

  • Effects of Pretreated Bortezomib on Renal Function after Renal Ischemia – Reperfusion Injury in Mice

    X. Zheng

  • Effects of Proton Pump Inhibitors on Allograft Rejection and Adverse Effects in Kidney Transplant Recipients: A Systemic Review and Meta-Analysis

    B. Boonpheng1, C. Thongprayoon2, M. A. Mao3, W. Cheungpasitporn4

  • Effects of Statin Use on Cardiovascular Outcome in Patients with Renal Transplantation

    J. Kim1, K. Park1, S. Park1, M. Yu2, Y. Kim1, K. Kim1, M. Park3, H. Lee1

  • Effects of Thalidomide and Dexamethasone Co-Treatment on CD8+ T Cells

    J. Kim1, E. Kim2, Y. Cho1, H. Lee1, M. Kim3, Y. Kim3, K. Huh3, B. Kim4

  • Efficacious Home Processing of Urine for Messenger RNA Profiling: A Point-of-Care Approach for Molecular Monitoring of Kidney Transplant Recipients

    C. Snopkowski1, C. Li1, S. Albakry1, B. Botticelli1, M. Cassidy1, J. Lee1, M. Lubetzky1, D. Dadhania1, H. Yang1, R. Ding1, T. Muthukumar1, M. Suthanthiran2

  • Efficacy And Safety Of Febuxostat In Renal Transplant Recipients With Hyperuricemia

    L. Liu1, J. Jiang1, Q. Fu2, S. Long3, H. Zhang2, X. Su2, J. Li2, C. Wu2, R. Deng2, W. Zhang3, C. Wang2

  • Efficacy Of Rituximab Monotherapy On Anti-human Leukocyte Antigen Antibodies In Highly Sensitized Living Donor Kidney Transplant Patients.

    D. J. Sindi1, A. Al Jedai2, H. Aleid3, J. Brockmann4, M. Al-Awwami5, D. Alissa2, E. De Vol6, H. Al Khabbaz7, L. Fajji8

  • Efficacy and Safety of Alemtuzumab versus Basiliximab Induction in Lung Transplantation

    J. Choe, J. Au, A. Diamond, C. Ruggia-Check, S. Sehgal, F. Cordova, N. Shigemura, S. Keshavamurthy, Y. Toyoda

  • Efficacy and Safety of Everolimus in Pediatric Renal Transplantation

    T. Sandes-Freitas1, B. Pantoja2, M. Custódio2, A. Goersch Silva3, R. Costa2, M. Sales3, R. Esmeraldo3

  • Efficacy of Long-Acting Octreotide in Left Ventricular Assist Device Patients with Recurrent Gastrointestinal Bleeding

    T. Wilson1, D. Baran2, J. Herre2, C. Cameron1, W. Old3, G. Zeevi2, C. Barreiro4, C. Kemp4, J. Philpott4, A. Ingemi5

  • En Bloc Kidney Transplant from Infant Donors Less Than 5kg into Adult Recipients

    Z. Wang, Q. Xia, M. Wang, H. Li, J. Liu, J. Liu, J. Liu

  • Endogenous Erythropoietin is Required for Spontaneous Acceptance of Murine Renal Allografts

    J. Horwitz, P. Cravedi, P. Heeger

  • Endothelial Cells Do Not Regulate Expression of CD46, CD55 and CD59 in the Presence of Anti-HLA Class I and 11 Antibodies

    A. Babu1, T. Pham2, M. Hamdorf2, V. Jucaud2, M. Everly2, S. Daga3, D. Mitchell4

  • Endovascular Repair Of Abdominal Aortic Aneurysms In Kidney Transplant Recipients

    S. Kwon1, D. Jung1, Y. Kim1, S. Park2, S. Yoon2

  • Engaging Friends and Family in the Care of the Kidney Transplant Candidate: Identifying Needs and Barriers

    A. Hart1, M. Bruin2, M. Partin3, A. Matas4, A. Israni1

  • Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living Donor Kidney Transplantation

    R. D. Reed1, V. Kumar1, B. Berry1, D. Hendricks1, A. Carter1, B. A. Shelton1, M. N. Mustian1, P. A. MacLennan1, H. Qu1, L. Hannon2, C. Yates2, M. J. Hanaway1, J. E. Locke1

  • Epidemiology and Risk Factors of Early Post-Transplant Clostridium difficile Infection in Renal Transplant Recipients

    M. Jorgenson1, J. Descourouez1, D. Yang2, G. Leverson2, C. Saddler2, J. Smith2, R. Redfield2

  • Epidemiology of Parvovirus B19 and Anemia among Kidney Transplant Recipients

    N. Khoury1, C. Thongprayoon2, N. Leeaphorn3, J. Bruminhent4, W. Cheungpasitporn5

  • Epithelial to Mesenchymal Transition: A Cellular Mediator of Ischemic Cholangiopathy after Liver Transplant

    N. A. Wickramaratne1, R. Li2, R. C. Fyffe-Freil2, T. Tian2, M. J. Mangino2

  • Epitope-Based Matching in Pediatric Kidney Transplantation

    C. Boussard1, M. Ould Rabah2, O. Boyer2, M. Macher1, J. Taupin3, J. Hogan4

  • Epstein Barr Virus DNA Integration in B Cell Lymphomas of Post-Transplant Lymphoproliferative Disorder

    M. C. McPherson, O. M. Martinez

  • Erk-elk1-mir-711 Signalling In Cardiac Ischemia Reperfusion Injury In Heart Transplantation

    H. Zheng, Y. Su, C. Zhu, V. Veramkovich, X. Zheng

  • Estrogen Mediated Protection in Renal Ischemia Reperfusion Injury (IRI) is Extrinsic to the Kidney

    D. D. Aufhauser1, S. J. Concors1, P. T. Hernandez1, Z. Wang1, L. Krumeich1, D. R. Murken1, G. Ge1, W. W. Hancock2, M. H. Levine1

  • Etiology of Liver Disease Affects Weight Gain after Liver Transplant

    A. Chandrakumaran1, M. B. Siddiqui2, S. Patel2, F. Lin3, J. Laurenzano2, J. Clinton2, T. Reichman4, C. Bhati4, M. S. Siddiqui2

  • Eupatilin Ameliorates Tacrolimus Induced Nephrotoxicity via Inhibiting Apoptosis

    H. J. Jang, C. S. Park, M. Y. Oh

  • Evaluating Allo-Specific CD57+ T Cells during Memory and Proliferative Responses

    A. Lucander, H. Xu, A. Kirk

  • Evaluating Hepatitis C Treatment after Solid Organ Transplantation

    A. J. Burgos1, R. Yau1, C. Tunwar2, J. A. Goss3, S. Khaderi3, N. L. Sussman4

  • Evaluating Potentially Inappropriate Prescribing in Older Kidney Transplant Recipients

    L. DeVietro1, B. Richardson2, E. A. Cohen3, A. H. Toledo4, E. Marin5, K. R. Szempruch6

  • Evaluating the Predictive Utility of the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) for Post-Transplant Outcomes in Moderate to High-Risk Liver Transplant Candidates

    P. Sheiner, S. Spence, D. Gleason, J. Riley, M. Einstein, E. UrtasunSotil, C. Rochon, B. Maneckshana, O. Serrano

  • Evaluation Of BK Polyomavirus Monitoring And Management In Kidney Transplant Recipients

    M. Tomeczkowicz, S. Mondal, N. Sulejmani, B. Summers, T. Larson, A. Jantz

  • Evaluation Of Complement-related Factors In Tma Post-kidney Transplantation: A Retrospective Multicenter Study

    N. Fujiyama1, M. Tasaki2, H. Harada3, K. Tsutahara4, A. Matsumoto5, Y. Hara6, M. Okumi7, K. Saito2, Y. Watarai8, N. Inoue9, N. Wakamiya9, S. Satoh1

  • Evaluation Of Workplace Environment In Transplant Medicine: Harassment Should Not Be The “Reality Of Life”

    M. Reilly1, T. Branstool1, S. Gregory1, T. R. Pearson2, T. S. Purnell3, G. Gunasekaran4, B. Kelly5, P. N. Martins6, C. M. Mobley7, S. M. Black8, E. C. Maynard9, D. C. Simpson10, M. B. Shah11, O. Ekwenna1, J. Locke12, J. Ortiz1

  • Evaluation of Induction Immunosuppression in Elderly Kidney Transplant Recipients

    C. Pham, S. Kuten, A. Rogers, R. Knight, D. T. Nguyen, E. Graviss, A. Gaber

  • Evaluation of Infection and Renal Transplant Outcomes in the Hmong Population

    M. Jorgenson1, J. Descourouez1, D. Yang2, G. Leverson2, J. Smith2, R. Redfield2

  • Evaluation of Liver Function and Biomarkers Predicts Tumor Progression in Treatment-Naïve Hepatocellular Carinoma Patients

    K. Nunez, T. Sandow, S. Robertson, P. Thevenot, A. Cohen

  • Evaluation of Mycophenolate Mofetil Exposure in Renal Transplant Recipients

    M. C. Ott1, S. Mietz2, S. Chang3

  • Evaluation of Pretransplant Biopsy as a Influence Factor of Early Graft Function after Donated Kidney Transplantation

    X. Qiuxiang, W. Zhendi

  • Evolution Of Right Laparoscopic Nephrectomy, Report Of A Tertiary Care Center In Mexico

    L. Noriega- Salas, J. Cruz-Santiago, M. Quiñones-Gamero, J. Barcena, M. De Gante, G. Bernaldez-Gomez

  • Ex Vivo Assessment of Marginal Human Kidneys Using Computed Tomography

    M. K. Harris1, J. R. DiRito2, H. Liu3, N. Boutagy3, C. Liu4, S. Hosgood2, D. Mulligan1, M. L. Nicholson2, A. Sinusas3, D. Haakinson1, G. T. Tietjen1

  • Ex Vivo Resection And Autologous Liver Transplantation As Management Concept For Extensive Malignancy

    K. Bruestle1, A. Griesemer2, S. Lobritto2, M. Martinez2, J. Vittorio2, D. Yamashiro2, E. Bacha3, T. Kato2

  • Ex-vivo Xenoperfusion Of Wild Type And Galtko.hcd55 Pig Livers With Human Whole Blood

    D. Detelich, C. Rickert, C. Eymard, C. Carroll, S. Kimura, H. Yeh, J. Markmann

  • Examination of a Novel Immunoregulatory Marker in Kidney and Lung Transplant Recipients

    A. D. Desai1, G. J. Kavalam2, A. Chandraker2, S. Tripathi2

  • Excellent Outcome in African-American (AA), Type 1 and Type 2 Diabetic Recipients after Simultaneous Pancreas and Kidney Transplantation (SPK)

    A. Gruessner, S. Saggi, R. W. Gruessner

  • Excellent Outcomes in Liver Transplantation under Charity Care: An Opportunity to Mitigate Socio-Economic Disparities in Access to Transplantation

    F. Paterno1, J. Rosado1, R. Olivo2, S. Gavzy1, L. Brown1, D. Wilson1, B. Koneru1, N. Pyrsopoulos2, J. V. Guarrera1

  • Excellent Success with Safety and Efficacy of Direct-Acting Anti-Viral HCV Drugs in Kidney Transplant Recipients Using an Evolving Regimen. A Single Institution Experience

    A. Sharfuddin, S. A. Hussain, T. Taber, D. Mishler, O. Adebiyi, M. S. Yaqub

  • Exendin-4 for Donor Treatment in a Brain-Death Model of Kidney Transplantation

    H. Yang1, L. Luo1, X. Li1, C. Long1, Y. Shi2, Y. Xiong3, M. Chen4, J. Gao5, H. Li6, Z. Wang6

  • Exercise after Heart Transplantation: What is the Reality?

    A. Velleca, K. Norland, N. Musto, N. Mikhail, H. Barone, G. Jamero, R. J. Levine, S. Dimbil, R. Sharoff, E. Passano, J. A. Kobashigawa

  • Exercise for Solid Organ Transplant Candidates and Recipients: A Joint Position Statement of the Canadian Society of Transplantation (CST) and Canadian Network for Rehabilitation and Exercise for Solid Organ Transplant Optimal Recovery (CAN-RESTORE)

    T. Janaudis-Ferreira1, S. Mathur2, R. Deliva3, N. Howes4, C. Patterson5, A. Räkel6, S. So5, L. Wickerson7, M. White6, Y. Avitzur5, O. Johnston8, N. Heywood9, S. Singh7, S. Holdsworth10

  • Expansion Of The Use Of Left Lobe Grafts In Adult Liver Transplantation In The United States: Different Strategy Between Deceased And Living Donor Grafts

    M. Fujiki, H. Matsushima, K. Sasaki, C. Quintini, F. Aucejo, T. Diago, B. Eghtesad, C. Miller, K. Hashimoto

  • Expansion of Myeloid Derived Suppressor Cells Following Alum Administration

    A. G. Cuenca, N. J. Feeney, K. Deng, C. G. Rickert, J. F. Markmann

  • Exploration of the Stanford Integrated Psychosocial Assessment for Transplant with Psychosocial and Medical Outcomes in Kidney/Kidney-Pancreas Transplant Recipients

    G. Chen1, C. Bell2, P. Loughhead1, B. Ibeche2, J. S. Bynon2, D. R. Hall2, A. M. De Golovine2, A. Edwards2, W. A. Dar2

  • Exploring Perceptions of Organ Procurement: Need for a Formal Medical Student Curriculum

    L. Winer1, M. Vivero2, B. Scully3, A. Cortez1, A. Kassam1, J. Kuethe1, R. Nowygrod3, J. Emond3, R. C. Quillin III1

  • Extracorporeal Photopheresis for Specific Immune Tolerance Responses in Heart Transplant Recipients

    M. J. Barten1, K. Klaeske2, J. Wittke2, M. Borger2, J. Garbade2, S. Lehmann3, H. Reichenspurner1, M. Dieterlen2

  • Facilitators and Barriers to Implementing the Live Donor Champion Program

    A. D. Love1, D. R. Helfer1, S. Rasmussen1, M. Johnson1, J. M. Konel1, J. R. Wellen2, S. M. Nazarian3, E. King1, D. L. Segev1, T. Hwee1, A. M. Cameron1, M. L. Henderson1, E. J. Gordon4, J. M. Garonzik Wang1

  • Facilitators and Barriers to the Implementation of Culturally Competent Care to Increase Living Kidney Donation in Transplant Centers

    E. J. Gordon, E. Romo, D. Amortegui, A. Rodas, N. Anderson, J. Uriarte, J. Caicedo, M. Shumate

  • Factors Associated with the Acceptance of Livers for Liver Transplantation: Validation of the Discard Risk Index in the Eurotransplant Region

    J. D. Boer1, H. Putter2, J. J. Blok3, N. Cambridge1, S. Van den Berg1, U. Samuel1, G. Berlakovich4, M. Guba5, A. E. Braat3

  • Fasting Glood Glucose: A Simple and Reliable Marker to Predict Late Pancreas Graft Failure

    D. Cantarovich1, M. Ollivier2, L. Chaillous2, B. Cariou2, J. Branchereau1, G. Karam1

  • Fatal Graft versus Host Disease in Liver Transplantation. An Analysis of UNOS Registry

    S. Nagai1, A. Yoshida1, R. Salgia2, M. Abouljoud1, D. Moonka2

  • Favorable Outcome of Pathologic Downstaging by Locoregional Treatment for Hepatocellular Carcinoma in Liver Transplantation

    D. Kim, J. Lee, S. Kim, K. In, D. Joo, S. Kim, M. Kim

  • Fibrosis Scoring Correlates with Progression of Chronic Pancreatitis, Islet Isolation Yields and Transplant Outcomes in Patients Undergoing Islet Autotransplantation

    Y. Liu1, J. SoRelle2, K. Kumano3, S. Vasu3, M. Lawrence4, A. Gupta1, N. Onaca1, E. Beecherl1, B. Naziruddin4

  • Finding Opportunities for Increased Donation after Circulatory Death Liver Utilization: Results of an American Society of Transplant Surgeons/Association of Organ Procurement Organizations Survey

    M. Hobeika1, R. Glazner2, D. Foley1, S. Hanish1, C. Quintini1, E. Eidbo2, D. Axelrod1

  • First Experience For Cold Storage Of Donor Hearts With Paragonix SherpaPak

    L. Stastny1, M. Kofler1, D. Höfer1, G. Pölzl2, R. Breitkopf3, M. Grimm1, H. Antretter1, J. Dumfarth1

  • First Report and Mechanistic Analysis of Chronic GVHD after Solid Organ Transplantation

    J. Weiner, N. Svetlicky, J. Schmidt, J. Kang, M. Sadat, A. Karaballa, S. Moturi, O. Aguirre, J. Hawksworth, C. Matsumoto, T. Fishbein, A. Kroemer

  • First UK Experience of the Molecular Microscope (MMDX™) in the Kidney Transplant Clinic

    C. Lawrence1, S. Thiru2, A. Manoj1, S. Fluck1

  • Five Years after Right Hepatectomy for Living Liver Donation: Donor State of Health

    D. P. Hoyer, E. Malamutmann, G. Bagias, A. Oezcelik

  • Forensic Transplant Psychiatry: Ethical Issues and the Unique Assessment Needs of Candidates with Forensic Psychiatric Problems

    D. Banayan, S. Gershan

  • Fractalkine is Crucial in Ischemia Reperfusion Injury Related to Acute Rejection in an Allogeneic Heart Transplantation Model

    T. Kanzawa1, D. Tokita1, T. Yamakawa1, H. Ishigooka1, H. Fukuda1, H. Katsumata1, S. Miyairi1, R. Ishii1, T. Hirai1, K. Saiga1, M. Okumi1, T. Imai2, K. Tanabe1

  • Frailty and Causes of Morbidity and Mortality in Kidney Transplant Recipients

    L. Greco, S. Kaur, K. Lau, A. Fagenson, A. Di Carlo, S. Karhadkar

  • Frailty is Highly Prevalent in Lung Transplant Candidates and Varies by Frailty Tool

    A. O'Boye, K. Leitner, M. Kelly, J. Wright, J. Lee, M. Sala, R. Tomic, S. Bhorade

  • Full and Sustained Donor Hematopoietic Chimerism after an Isolated Kidney Transplantation

    J. Zuber1, O. Boyer1, B. Neven1, E. Six2, R. Berthaud1, M. Ould Rabah1, S. Sobrino2, C. Lagresle2, I. André-Schmutz2, M. Cavazzana1, S. Blanche1, R. Salomon1

  • Functional Dependence, Access to Kidney Transplantation and Waitlist Mortality

    A. Muzaale1, N. Chu1, H. Ying1, S. Norman2, S. Sison1, D. Segev1, M. McAdams-Demarco1

  • GFR Outcomes for Recipients and Donors with IgA, FSGS, Alports and Thin Basement Membrane Disease: A Comparison of Living Related to Unrelated Donors

    D. Keys, S. Jackson, S. Riad, R. Spong, V. Vakil, A. Matas, P. Nachman

  • Gait Speed Predicts Kidney Transplant Candidate Mortality

    M. N. Harhay1, K. Ranganna1, L. B. Levin Mizrahi1, G. Xiao2, G. Malat2, S. Guy2, D. Reich2, P. P. Reese3

  • Ganciclovir Based Prophylaxis against Cytomegalovirus Viremia in Pediatric Renal Transplant Patients: A Systematic Review and Meta-Analysis

    B. CHATANI1, W. Glaberson2, Z. Nemeth3, L. Tamariz4, I. A. Gonzalez1

  • Gender Disparities In Cirrhosis: New Findings In A Large Pretransplant Population

    N. Mazumder, K. Atiemo, A. Daud, L. Zhao, M. Abecassis, J. Levitsky, D. P. Ladner

  • Gender Disparity: Do Female Donors Suffer from Living Kidney Donation?

    N. Ebeling1, B. Suwelack1, M. Burgmer2, a. the SoLKiD Study Group1

  • Gene Expression Profiles in CD8+ T Cells in Chronic Antibody-Mediated Rejection (CAMR) of Kidney Transplantation

    P. Pontrelli1, F. Rascio2, M. Accetturo1, G. Castellano1, S. Simone1, G. Stallone2, L. Gesualdo1, G. Grandaliano2

  • Gene Expression Profiling for Cardiac Transplant Recipients: Results from the Outcomes AlloMap® Registry

    S. Hall1, G. Ewald2, P. Berman3, A. Kao4, T. Wolf-Doty5, J. Yee5, J. Kobashigawa6

  • Generation of Human/Pig Hybrid Thymus to Achieve Immune Tolerance to Pig Antigens with Optimal Immune Function

    M. Khosravi Maharlooei, H. Li, M. Holzl, A. Vecchione, A. Misra, A. Ruiz, R. Madley, G. Nauman, N. Danzl, G. Zhao, K. Yamada, M. Sykes

  • Generation of Thymic Epithelial Cells from Induced Pluripotent Stem Cells to Prolong Allograft Survival

    R. Otsuka, H. Wada, H. Tsuji, A. Sasaki, T. Murata, M. Baghdadi, K. Seino

  • Genome-Wide Profiling of BK Polyomavirus Integration in Urothelial Carcinoma of Kidney Transplant Recipients Reveals a Potential Microhomology or Nonhomologous End Joining Mediated Integration Mechanism

    Y. Jin1, Y. Zhou1, W. Deng1, R. Lee2, Y. Liu1, M. Blute3, R. Liu1, N. Elias4, F. Fu1, B. Guan1, J. Geng1, J. Ma5, J. Zhou5, N. Liu5, C. Wu6, Y. Miao1

  • Genomic Variations in Epstein Barr Virus are Associated with Post-Transplant Lymphoproliferative Disorder

    M. Arvedson, E. Maloney, C. Esquivel, O. Martinez, S. Krams

  • Geographic Disparities in Liver Supply/Demand Ratio within Fixed-Distance and Fixed-Person Circles

    C. Haugen1, T. Ishaque1, A. Sapirstein1, D. Segev1, S. Gentry2

  • Global Analysis of Fc-gamma Receptors Binding Capacity of Human Leukocyte Antigen Donor Specific Antibody

    E. S. Woodle, A. Girnita

  • Good Outcomes of Octagenerian Kidney-Transplant Recipients: A Single-Center Experience

    S. Sultan, M. Aull, M. Lubetzky, A. Watkins, S. Kapur

  • Graft-Infiltrating Regulatory T Cells Are Associated with Long Term Cardiac Xenograft Survival

    A. K. Singh1, G. Braileanu1, A. Hersfield1, L. DiChiacchio1, T. Zhang1, I. Tatarov1, D. Parsell1, B. Lewis1, F. Sentz1, D. Ayares2, M. Mohiuddin1

  • Growth and Function of En Bloc Kidney Transplantation: A Single-Center Experience

    H. Mo1, J. Ha1, A. Han1, S. Min1, S. Min1, S. Ahn1, I. Ha2, H. Kang2, S. Kim3

  • Guideline Adherence for Secondary Prevention of Stroke and Atherosclerotic Cardiovascular Disease among Liver Transplant Recipients

    P. T. Campbell1, M. Kosirog1, S. Montag2, S. Connolly1, A. Daud3, A. Das1, S. Pine1, D. Finn3, J. Levitsky1, J. L. Holl4, D. M. Lloyd-Jones5, L. B. VanWagner6

  • Gut Microbiota May Affect a Variability of Tacrolimus Trough Levels in Kidney Transplant Recipients

    J. Kim1, H. Cho2, J. Park3, M. Kwak4, B. Kim4, J. Lee5, D. Kim1, B. Kim6, Y. Kim1, H. Lee1

  • HLA-DR Upregulation in Pediatric Kidney Transplant Biopsies

    O. Moussa, S. Self, E. Bruner, K. Twombley

  • HOPE Act Deceased Donors Referrals: Barriers to Donation

    O. Kusemiju, C. Durand, B. Doby, M. Bowring, B. Barnaba, W. Werbel, D. Brown, A. Tobian, S. Seaman, D. Ostrander, D. Segev

  • HbA1c as a Noninvasive Predictor of Chronic Histopathologic Changes in Living Donors for Kidney Transplantation

    K. Tanaka1, S. Nishida1, K. Kinoshita1, Y. Hidaka1, M. Toyoda2, A. Inadome3, A. Takeda4, H. Yokomizo5, S. Uekihara6, J. Shoji7, S. Yamanaga1

  • Health Utility And Social Distress In Kidney Transplant (KT) Recipients

    S. Macanovic1, D. Li1, B. Liao1, I. Escudero1, V. Shah2, A. Nagee2, A. Che2, R. Khairalla2, M. Novak3, I. Mucsi1

  • Healthcare Resource Utilization and Associated Costs of Cytomegalovirus Management among Solid Organ Transplant Recipients

    W. Y. Cheng1, P. Thompson-Leduc1, H. Cheung1, R. Avery2, T. Bo3, S. Chavan3, M. Duh1, I. Hirji3

  • Heart En Bloc Thymus Cotransplantation in NHPs

    J. O1, W. Sommer2, K. Pruner3, J. T. Paster4, I. M. Hanekamp1, A. Dehnadi1, I. Rosales1, R. N. Smith1, R. B. Colvin1, G. Benichou1, J. S. Allan1, J. C. Madsen1

  • Hepatic Artery Anastomosis Post-Operative Anatomy Influences Doppler Ultrasound Systolic Acceleration Time after Liver Transplantation

    R. A. Choudhury, A. Yule, K. Conzen, E. A. Pomfret, T. L. Nydam

  • Hepatitis A Hospitalizations among Kidney Transplant Recipients in the United States: A Nationwide Study

    W. Cheungpasitporn1, C. Thongprayoon2, P. Ungprasert3, K. Wijarnpreecha4, P. T. Kroner4

  • Hepatitis C Antibody Positive (HCV Ab+)/Nucleic Acid Test Negative (NAT -) Deceased Donor Kidney Transplantation into Hepatitis C Negative (HCV -) Recipients: Is It Safe?

    Y. Taehwan, A. Rajab, G. Bumgardner, t. Pesavento, R. Daloul, A. Michaels, K. Washburn, A. El-Hinnawi

  • Hepatitis Flare in Hepatitis B Core Antibody Positive Kidney Recipients Treated with Rituximab

    M. Raja1, Y. Natori1, C. Donato1, D. De Lima1, J. Rivollo2, A. Centeno2, Y. Ebisu1, L. Abbo1, J. Simkins1, S. Anjan1, J. Camargo1, M. I. Morris1

  • Hepatocellular Carcinoma in Fontan Liver Disease

    V. Lamm1, J. Wedd2, C. Haydek2, C. Obineme2, A. Noll2, H. Veeramachaneni2, M. Muftah2, R. Ford2

  • Hepatopancreatobiliary Training In Transplant Fellowships: H And B, Maybe?

    R. Borscheid1, A. Saharia2, E. Cho1, F. Lewis1, H. Osman1, J. Kurtz1, D. Jeyarajah1, A. Gaber2

  • High HLA-DQ Epitope Mismatch Load and Low Tacrolimus Level Are Associated with Development of De Novo Donor Specific Antibody

    D. Lee1, B. Kim2, J. Kim3, I. Kim4, M. Jeon5, J. Ahn1, S. Choi6

  • High Health Care Utilizers in Kidney Transplantation: Do You Know Your Frequent Flyers?

    E. Weeda1, Z. Su2, D. Taber3, J. Bian2, T. A. Morinelli4, N. A. Pilch5, P. D. Mauldin2, D. A. DuBay4

  • High Prevalence of Allergic Disorders but No Specific Immune Phenotype Pattern in Children Awaiting Transplantation

    T. B. Kim1, Y. Avitzur2, L. Ionescu1, U. Allen2, S. Mital2, B. Foster3, T. Blydt-Hansen4, L. Hamiwka5, P. Birk6, V. Phan7, S. Urschel1

  • High Prevalence of De Novo Donor-Specific Antibodies during Rejection after Liver Transplantation

    J. Colmenero, N. Flores, A. Diaz, M. Vasquez, P. Ruiz, G. Crespo, J. Martorell, M. Navasa

  • High-Throughput Immune Synapse Detection as a Tool for the Measurement of T Cell Alloreactivity

    S. Moshkelgosha, S. C. Juvet

  • Higher Incidence of Coagulation Complications in Live Liver Donation

    B. Movahedi, p. Mahboub, N. Kim, P. Martins, A. Bozorgzadeh

  • Higher Post-Transplant CXCL13 Correlates with the Occurrence of Infection within 1 Year after Kidney Transplantation

    Y. Li1, Y. Li1, L. Yan1, L. Wang1, Y. Shi2, J. Tang1

  • Histone Deacetylase-8 (HDAC8) Inhibition is Protective in a Murine Model of Renal Ischemia Reperfusion Injury (IRI)

    P. T. Hernandez1, S. J. Concors1, D. D. Aufhauser1, L. Krumeich1, Z. Wang1, G. Ge1, A. Beeler2, M. Levine1, W. Hancock3

  • Hit Me with Your Best Shot! Multidisciplinary Team Approach to Live Vaccination Administration in Pediatric Transplant Candidates

    H. Corbo, K. Sprott, N. Pilch, K. Twombley, D. Taber

  • How Challenging Will Be My Living Donor? CT Scan and Clinical Evaluation Can Predict Technical Difficulty of Laparoscopic Donor Nephrectomy

    V. Bianchi1, G. Spagnoletti1, R. Iezzi2, F. E. Rossini1, A. Posa2, A. E. Rossini1, M. P. Salerno1, F. Citterio1, J. Romagnoli1

  • How Much Does Graft Function Cost Us? A Financial Analysis of Delayed Graft Function in Kidney Transplant Recipients

    A. Yaldo, I. Bajjoka, C. Crombez, M. Abouljoud

  • How Well Do Kidney Transplant Patients Understand Their Medications and Does Real-Time Assessment of Knowledge Improve Retention of Information?

    B. Clark1, B. Sirandas1, T. Larson2, A. Carlson1, C. Truax1, D. D. Ramirez1, L. Smith1, I. Hall1

  • HuR Dictates HO-1 Expression, Modulates Inflammation and Influences Recipient Outcomes in Liver Transplant Patients

    K. J. Dery, K. Nakamura, K. Kadono, H. Hirao, S. Kageyama, T. Ito, J. Aziz, B. Ke, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski

  • Human Adenovirus-Specific T Cell Response in Kidney Transplant Recipients Diagnosed with Adenovirus Infection

    J. Bruminhent1, N. Apiwattanakul2, S. Hongeng3, S. Kantachuvessiri4, S. P. Watcharananan1

  • Human Neutrophil Function against Pathogens in Solid Organ and Stem Cell Transplant Recipients

    N. Barros, N. Alexander, Z. Dagher, S. Knooihuizen, A. Viens, A. R. Hopke, D. Irimia, M. K. Mansour

  • Hyperglycemia Aggravates Acute Liver Injury by Promoting Macrophage NLRP3 Activation via AMPK/mTOR-Dependent Autophagy Inhibition

    H. ZHOU, Q. Wang, R. Liu, S. Zhou, F. Cheng, X. Wang, L. Lu

  • Hypertrophy Prediction Model for Contralateral Kidney after Living Donation

    K. Okumura1, K. Tanaka2, Y. Hidaka2, M. Toyoda3, S. Uekihara3, A. Inadome4, H. Yokomizo2, S. Yamanaga2

  • Hypoadiponectinemia is Associated with Low Handgrip Strength in Renal Transplant Recipients

    M. Lee1, B. Hsu2

  • Hypothermic Machine Perfusion Protects Donation After Cardiac Deathliver Graft Through Gstm1-mediated Cytochrome P450 Exogenous Substance Metabolism Pathway

    W. Liang, S. Ye, Z. Zhong, Q. Hu, Y. Wang, Q. Ye

  • ICOS+PD-1+ Circulating T Follicular Helper Cells Are a Biomarker of Humoral Alloreactivity and Predict Donor-Specific Antibody Generation Following Transplantation

    G. M. La Muraglia II, M. E. Wagener, M. L. Ford, I. R. Badell

  • IFNAR Signaling Augments Plasmacytoid Dendritic Cell Activation during Costimulation Independent Rejection

    J. Habib, D. Mathews, Y. Dong, A. Stephenson, A. Ghosh, C. Breeden, A. Adams

  • IL-10+ Plasma Cells Are Not Required for Breg Activity and Are Counterbalanced by Novel Pro-Inflammatory Plasma Cells

    Q. Ding, Y. Zhou, Z. Song, L. Zeng, D. Rothstein

  • IL-21 Induces the Transformation of Th Cell Subsets in Acute Rejection after Kidney Transplantation

    H. Deng, R. Wang, J. Shen, J. Chen

  • Idarucizumab For The Reversal Of Dabigatran In Patients Undergoing Heart Transplantation

    J. Van Keer1, T. Vanassche1, W. Droogne1, S. Rex2, F. Rega3, J. Van Cleemput1, P. Verhamme1, M. Naesens4

  • Identification of Adult Liver Transplant Recipients Eligible to Participate in an Immunosuppression Withdrawal Trial Employing Non-Invasive Assessments of Allograft Status

    J. Vionnet1, R. Miquel1, A. Douiri1, M. Elstad1, E. Kodela1, A. Quaglia2, J. Wall1, P. Ruiz Martin1, E. B. Riani3, J. Leithead4, A. Marshall2, M. Navasa5, P. Ruiz5, J. Ferguson6, K. Simpson7, A. Pascher8, E. Jaeckel9, R. Bishop10, F. Nevens11, S. Masson12, A. Sanchez-Fueyo1

  • Identification of Rare Genetic Disorders in Kidney Transplantation Recipients with Un-Diagnosed Nephropathy through NGS Approach

    G. Castellano, M. Giliberti, P. Pontrelli, M. Gigante, S. Diella, M. Accetturo, E. Stea, A. Mitrotti, L. Gesualdo

  • Identification of Relevant Renal Transplant Patient Reported Symptoms That Could Be Used for New Patient Reported Outcome Development

    I. Purnajo1, J. Beaumont1, M. Polinsky2, E. Alemao2, M. J. Everly1

  • Identifying Barriers to Organ Donation among Asians Americans

    M. T. Li, G. C. HIllyer, S. Mohan

  • Identifying a Clinically Relevant Cut-Off for Height That is Associated with a Higher Risk of Waitlist Mortality in Liver Transplant Candidates

    J. Ge, J. C. Lai

  • Identifying the Proverbial “Needle in the Arm” with Natural Language Processing

    G. R. Vece, J. Foutz, A. Placona

  • Ikaros/IRF4 Signaling Regulates SIRT1-Mediated Macrophage M2 Shift in Liver Ischemia-Reperfusion Injury: From Mouse-to-Human

    K. Kadono1, K. Nakamura1, H. Hirao1, S. Kageyama1, K. J. Dery1, T. Ito1, J. Aziz1, X. Li2, B. Ke1, R. W. Busuttil1, J. W. Kupiec‐Weglinski1

  • Immediate Post Reperfusion In Vivo Transcriptional Responses of Individual Human Renal Allograft Cell Populations to Circulating Anti-Angiotensin II Type I Receptor Antibody

    C. M. Castro -Rojas1, N. Salomonis2, K. Chetal2, R. R. Alloway3, E. Woodle3, D. A. Hildeman1

  • Immediate Post-Operative Extubation Decreases Pulmonary Complications in Liver Transplant Patients

    M. Safwan, C. Acho, Y. Morita, V. Fernandez, D. Galusca, M. Abouljoud, A. Yoshida, J. El-Bashir, S. Nagai

  • Immune Cells Composition of Humanized Mouse Kidney Compared to Normal Human Kidney

    S. Noel1, J. T. Kurzhagen1, S. Lee1, M. Sadasivam2, A. R. Hamad2, P. M. Pierorazio3, H. Rabb1

  • Immune Privilege May Predispose Patients after Orthotopic Heart Transplantation to Develop Recipient to Donor Atrial Connections Associated with Atrial Arrhythmias

    B. Herweg1, M. Nellaiyappan1, T. Tran1, G. Mabry1, K. Weston1, H. J. Eisen2, M. Weston3

  • Immunization Status at the Time of Pediatric Liver Transplant: A 1-year Study through The Society of Pediatric Liver Transplantation

    A. G. Feldman1, A. Kempe2, B. L. Beaty3, R. Torres1, D. Curtis4, S. S. Sundaram1

  • Immunobiogram, a New IVD Immunoassay to Test the Sensitivity Profile of Kidney Transplant Recipients to Immunosuppressive Drugs: Further Results from BH-Pilot Study

    C. Jimenez1, J. M. Portoles2, D. Blánquez3, L. Arribas3, A. Ortega4, T. Diez5, I. Portero6

  • Immunologic Impact Of Native Kidney Function On Liver Transplant Patients

    M. Mujtaba, S. Merwat, J. Fair, M. Bilal, A. Chatila, R. Kulkarni, J. Zou, S. Hussain, A. Gamilla-Crudo

  • Immunologic Outcomes In Recipients Of Orthotopic Liver Transplant Induced Only With Steroids

    S. N. Merwat, A. T. Chatila, M. Bilal, R. Kulkarni, H. L. Stevenson, J. H. Fair, S. K. Merwat, T. Kozlowski, M. A. Mujtaba

  • Immunologically Tolerant Liver Transplant Recipients Are Characterized by Donor-Specific Hypo Responsiveness of Circulating T-cells

    A. A. Duizendstra1, R. J. Knegt de1, M. G. Betjes2, M. P. Peppelenbosch1, N. H. Litjens2, J. Kwekkeboom1

  • Immunosuppressant Adherence in Adult Heart Transplant Recipients: An Analysis of Pharmacy Claims and Organ Procurement and Transplantation Network Data

    W. S. Cherikh1, A. R. Wilk1, J. Maghirang1, E. A. Witt2, H. Kirkham3, S. Boghani2, N. Hira4, G. Pietradoni2, D. K. Klassen1

  • Immunosuppressant Adherence in Adult Liver Transplant Recipients in the United States

    W. S. Cherikh1, A. R. Wilk1, J. Maghirang1, E. A. Witt2, H. Kirkham2, S. Boghani2, N. Hira3, G. Pietradoni2, D. K. Klassen1

  • Immunosuppression Reduction after Diagnosis of Sustained BK Viremia and the Risk of Allograft Rejection, Allograft Loss and Mortality

    F. A. Al Dhufairi1, M. Shokoohi2, A. M. Jevnikar1, A. A. House1, D. Kumar3, S. M. Hosseini-Moghaddam1

  • Impact Of Aggressive Utilization Of Liver Allografts On Outcomes

    A. Rana, M. Kueht, N. Galvan, R. Cotton, C. O'Mahony, J. Goss

  • Impact Of Donor And Recipient Race On Kidney Transplant Survivals Evaluated By The Physiochemically-calculated Hla Immunogenicity

    S. Stepkowski, B. Mierzejewska, M. Rees

  • Impact Of Inhaled Vasodilator Therapy On Early Morbidity And Mortality After Lung Transplant

    M. Tomeczkowicz1, A. Wexler1, M. Patel2, J. Fernandez-Castillo2, J. Rusniak1, E. Mancl3, S. Quddus2

  • Impact Of Rituximab And Maintenance Steroid In The Recurrence Of Focal Segmental Glomerulosclerosis

    L. A. Mendez Castaner

  • Impact Of Transplant Center And Regional Characteristics On Racial Disparities On Readmission After Kidney Transplantation

    J. Hogan1, K. Li1, R. Zhang1, J. Sun2, A. B. Adams1, R. E. Patzer1

  • Impact of Acute Kidney Injury in Elderly Deceased Donor on the Post-Transplant Clinical Outcomes

    J. Kim1, J. Lee2, Y. Kim3, K. Jin4, S. Han4, Y. Hong1, Y. Chang1, S. Kim1, H. Yoon5, C. Yang2, W. Park4, B. Chung2

  • Impact of Case Scheduling on Hospital Cost and Length of Stay in Living Donor Kidney Recipients

    J. Yu1, L. A. Dageforde2, M. B. Doyle1, A. S. Khan1, W. C. Chapman1, Y. Lin1, S. Shenoy1, T. Alhamad3, T. A. Horwedel4, J. R. Wellen1

  • Impact of Clinical Trial Enrollment on Renal Transplant Outcomes

    T. Shertel, A. Eisenhart

  • Impact of Cold Ischemia Time on DCD Kidney Transplant Outcomes

    J. Narvaez, L. Kayler

  • Impact of DAA Treatment on Graft Fibrosis in HCV Positive Liver Transplantation

    J. Wellington1, A. Ma2, S. Kottilil3, J. Husson3, E. Wilson3, D. Bruno4

  • Impact of Delayed Graft Function on Allograft Survival in DCD versus DBD Kidneys

    T. Ishaque, A. B. Massie, J. Ruck, C. Holscher, J. G. Wang, D. L. Segev

  • Impact of Discards for Living Donor Kidney Transplantation in Center Transplant Program

    H. Villafuerte1, E. De Sousa-Amorim2, L. Peri3, M. Musquera3, E. Palou4, M. Lozano5, J. Cid5, J. Martorell4, J. M. Campistol2, F. Oppenheimer2, F. Diekmann2, I. Revuelta2

  • Impact of Donor Abdominal Aortic Calcification on Bile Duct Complications of Recipients after Living Donor Liver Transplantation; a Retrospective Study

    Y. Imaoka, M. Ohira, K. Sato, H. Tahara, K. Ide, Y. Tanaka, H. Ohdan

  • Impact of Donor Acute Kidney Injury on GFR at 1 Year

    R. Heilman, A. Kumar, A. Srinivasan, M. Smith, J. Huskey, H. Khamash, A. Mathur, C. Jadlowiec, A. Moss, K. S. Reddy

  • Impact of Donor Acute Kidney Injury on the Outcome of Graft Delayed Graft Function

    C. Jadlowiec, A. Kumar, A. Srinivasan, A. Mathur, M. Smith, J. Huskey, A. Moss, H. Khamash, R. L. Heilman, K. S. Reddy

  • Impact of Enteric Vancomycin Resistant Enterococcus Colonization on Waitlist Outcomes among Liver Transplant Candidates

    E. Aldag, R. Pedersen, V. Gunabushanam, A. Sahajpal, T. J. Dilworth

  • Impact of Everolimus Therapy on HIV Persistence and Gene Expression in Transplant Patients

    A. Zarinsefat1, C. Schreiner1, C. Cameron2, S. Chu1, M. P. Busch1, T. Liegler1, S. G. Deeks1, T. J. Henrich1, P. G. Stock1

  • Impact of Everolimus on Secondary Nonmelanoma Skin Cancer Prevention in Solid Organ Transplant Recipients

    B. Clark1, D. D. Ramirez1, A. Carlson1, B. Sirandas1, C. Truax1, L. Smith1, I. Hall2

  • Impact of Glycemic Control on Long Term Graft and Patient Outcomes after Pancreas Transplantation

    V. S. Rohan1, K. Soliman1, V. Kalbhavi2, S. N. Nadig1, A. Lin1, V. Rao1, D. Taber1

  • Impact of Granulocyte Colony Stimulating Factor on Clinical Outcomes in Kidney Transplant Recipients with Neutropenia

    H. Yao1, A. Alam2, R. Sapir-Pichhadze2, D. D’Arienzo3, D. Baran2, S. Sandal2, M. Cantarovich2

  • Impact of HLA Mismatches and Cytomegalovirus Seropositivity on Outcomes Following Heart Transplantation

    A. Singhvi, R. Araujo-Gutierrez, M. H. Park, A. Bhimaraj, B. H. Trachtenberg, I. Hussain, A. Guha

  • Impact of Hepatitis C Viremia on Post-Transplant Diabetes Mellitus Development in Liver Transplant Recipients

    K. Klein1, J. Nelson2, B. Crowther1, C. Guerra3, E. Kincaide1, K. V. Speeg4, N. Alkhouri5, R. Hall1

  • Impact of MELD-Na Course (Delta MELD-Na) on Outcome after Liver Transplantation

    G. Silberhumer1, G. Gyoeri1, L. Unger2, G. Harpain1

  • Impact of Pre-Kidney Transplant Cinacalcet Use on Post-Transplant Outcomes

    L. Bowman1, S. Lloyd2, J. Buggs1, H. Pearson1, R. Baliga3, E. Rogers1, A. Kumar4

  • Impact of Previous Hepatic Resection on the Outcome of Liver Transplantation: A Case-Control Analysis

    M. Serenari, M. Paterno, A. D. Pinna, M. Ravaioli, E. Prosperi, M. Del Gaudio, C. Zanfi, V. Bertuzzo, G. Frascaroli, M. Cescon

  • Impact of Prolonged Venous Thromboembolism Prophylaxis on 30-Day Hemostatic Outcomes Following Kidney Transplantation in Patients with Hypercoagulable Risk Factors

    V. Behbahani, A. Santeusanio, S. Ames, R. Shapiro

  • Impact of Protease Inhibitor-Based Anti-Retroviral Therapy on Tacrolimus Intrapatient Variability in HIV+ Kidney Transplant Recipients

    M. H. Cooper, I. E. Dunne, S. A. Kuten, A. E. Cantwell, E. A. Graviss, D. T. Nguyen, M. J. Hobeika, A. O. Gaber

  • Impact of Revised Policy for Hepatocellular Carcinoma MELD Exception Points on Recurrence after Liver Transplantation

    P. Le1, L. McClelland1, K. Knapp1, T. Xu1, S. Pelletier2

  • Impact of Six-Month Surveillance Biopsies and Monitoring on 2-Year Outcomes in Pediatric Renal Transplant Recipients

    J. Lyons1, D. Ranch2, R. Hall1, P. Maxwell1, K. Hitchman2, B. Crowther1

  • Impact of Size Mismatch on Long-Term Graft Survival after Orthotopic Liver Transplantation

    K. Kamrani1, A. Okoh2, A. Mathur3, L. Brown4

  • Impact of T-cell Mediated Allograft Inflammation within First-Year after Kidney Transplantation: An Analysis of Paired Biopsies from a Single Center Study

    S. Tandukar, R. Mehta, I. Owoyemi, D. Jorgensen, P. Sood, S. Hariharan

  • Impact of T-cell Mediated Allograft Rejection and Antibody Mediated Rejection within the First Year after Kidney Transplantation

    I. Owoyemi, D. Jorgensen, S. Tandukar, R. Mehta, S. Hariharan

  • Impact of Transplant Surgery Advanced Practice Providers in the Management of Pancreas Transplant Recipients

    E. A. Herriman, J. M. Sharp, K. J. Brown, J. R. Montgomery, J. C. Magee, J. D. Punch, R. S. Sung, K. J. Woodside

  • Impact of Transplant Ureteral Stricture Location and Type of Ureteral Revision on Long-Term Graft Survival and Patient Outcomes in Kidney Transplantation

    C. Shepherd1, R. Cameron2, C. Holbrooks2, A. Lin3, S. Nadig3, J. McGillicuddy3, D. Dubay3, D. Taber3, P. Baliga3, V. Rohan3

  • Impact of Ureteral Stent on Urinary Tract Complications after Deceased Donor Renal Transplantation

    L. Zheng, H. Jia, H. Chen, J. Wu

  • Impact of a Liver Waitlist Candidate LDLT Educational Outreach Program on Referrals and Outcomes of Donor Evaluation

    C. Saroli Palumbo, J. Batisti, R. Batra, J. Dopico, D. Haakinson, L. Hughes, M. Joyce, S. Klein, S. Kulkarni, D. Mulligan, P. Narayanan, M. Schilsky, R. Tomlin, K. Ventura, S. Emre, A. Liapakis

  • Impact of a Novel Digital Medicine Program on Adherence and Utilization in Pediatric Transplant Patients

    S. Sullivan1, K. N. Triplett1, C. Sacks2, M. Tran2, D. M. Desai3

  • Impact of an Intra-Abdominal Cooling Device during Open Kidney Transplantation in Pigs

    A. Longchamp1, R. P. Meier2, N. Colucci3, A. Balaphas3, L. Orci3, A. Nastasi3, G. Longchamp1, S. Moll4, A. Klauser5, F. Lazeyras5, M. Pascual6, J. Corpataux7, L. Bühler8

  • Impact of an mHealth, Electronic Pillbox Intervention on Tacrolimus Variability in Kidney Transplantation: Results of a Prospective Randomized Clinical Trial

    J. W. McGillicuddy, L. Sox, J. Chandler, F. Treiber, D. Taber

  • Impact of the 2013 Change in Definition of Increased Risk Donors on Lung Transplant Outcomes

    C. J. Lehr1, R. Lopez2, S. Arrigain2, J. D. Schold2, M. Valapour1

  • Impact of the Organ Procurement Organization Surgeon on Utilization of High KDPI Kidneys

    C. S. Hwang1, J. Reese2, T. Anthony2, P. Vagefi1, B. Tanriover3, V. Ariyamuthu3, S. Levea3, M. MacConmara1

  • Impact of the Pediatric End-Stage Liver Disease Growth Failure Threshold on Waitlist Mortality in Children Awaiting Liver Transplant

    S. M. Swenson, J. P. Roberts, S. Rhee, E. R. Perito

  • Implementation of Novel Machine-Learning Techniques to Tailor Donornet® Organ Offers to Center and Surgeon Preference

    A. C. Perez-Ortiz, N. Elias

  • Implementation of a Longitudinal Comprehensive Multidisciplinary Transition Program and Seminar – Safely Making the Long Leap to the Adult World

    M. Moss, E. Steinberg, A. Sikora, K. McKinnon, J. Goebel, M. Bock

  • Improving Pre-Kidney Transplantion Laboratory Utilization in an Era of Increasing Waitlist Size

    G. K. Mahowald1, B. Kimball2, N. Elias2, E. Heher3, T. Girouard1, S. L. Saidman1, V. Pattanayak1

  • In Depth Look at Acute Rejections in LCP-Tacrolimus (LCPT; Envarsus XR) and Immediate-Release Tacrolimus (IR-Tac)-Treated De Novo Kidney Transplant Recipients

    A. Condon1, M. Mujtaba2, S. J. Patel3, D. R. Stevens3, U. Meier-Kriesche3

  • In Vivo Treg Expansion under Costimulation Blockade Targets Early Rejection and Improves Long-Term Outcome

    C. Schwarz1, B. Mahr2, L. Unger1, N. Pilat2, H. Regele3, T. Wekerle2

  • In Vivo/In Situ Behaviour of Allogeneic Spleen versus Bone Marrow Cells in Wild-Type Neonatal Mice: Insights into Robust Transplant Tolerance Induction

    R. A. Bascom, K. Tao, L. J. West

  • Inadequate (ax) Transbronchial Biopsies Are Not Associated With Clad Or Death After Lung Transplantation

    L. Levy1, E. Huszti2, J. Tikkanen3, R. Ghany3, S. Keshavjee3, T. Martinu3

  • Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis

    A. Chewcharat1, C. Thongprayoon2, B. Boonpheng3, A. Torres-Ortiz4, M. A Mao2, N. J Khoury5, W. Cheungpasitporn4

  • Incidence and Risks for Non-alcoholic Fatty Liver Disease and Steatohepatitis Post Liver Transplant: Systematic Reveiw and Meta-Analysis

    N. Saeed1, P. Sharma2, L. Glass2, C. Shannon2, C. Sonnenday2, M. Konerman2

  • Incidence of De Novo Donor Specific Antibodies and Treatment Response for AMR in Pediatric Kidney Transplant Recipients

    S. Gattis1, R. Liverman1, A. Serluco1, J. Yin1, H. C. Sullivan2, R. A. Bray3, H. M. Gebel3, S. Jernigan4, R. George4, P. D. Winterberg4, R. Garro4

  • Incidence of Viral Infections in Kidney Transplant Recipients with Alemtuzumab or Rabbit Antithymocyte Globulin Induction

    A. Brueckner1, C. Truong1, E. Yanqui1, R. Baliga2, L. Bowman1

  • Incidence, Risk Factors, Outcomes and Clinical Management of BK Viremia in the Modern Era of Kidney Transplantation

    J. Kim

  • Incisional Hernia Repair Post Liver and or Kidney Transplantation

    J. Buggs1, A. Brando2, J. Sokolich1, E. Rogers1, A. Kumar3, V. Bowers1

  • Incisional Ventral Hernia Repair (IVHR) in Post Liver Transplant Recipients (OLT) through a Robotic-Assisted Intervention (RAI): Initial Single-Center Experience

    A. Mejia, C. G. Fasola, A. Stegall

  • Inclusion of Compatible Pairs in the Australian Paired Kidney Exchange Program

    E. van Hardeveld1, S. McGinn2, L. Cantwell3, M. Kummrow3, P. Hughes1

  • Increased Frequency of Myeloid-Derived Suppressor Cells Contributing to Prolong Skin Allograft Survival in Aged Mice

    W. Lee, Y. Wang, T. Wu, C. Cheng, C. Lee, T. Wu, H. Chou, K. Chan

  • Increased Ratio of Circulating Tfh for Tfr Cells in Chronic Renal Allograft Dysfunction: A Pilot Study

    L. Yan, Y. Li, Y. Li, X. Wu, X. Wang, L. Wang, Y. Shi, J. Tang

  • Increasing Doses of Pain Medications Pre-Heart Transplant as a Risk Factor for Outcomes after Transplant

    K. Shah, D. H. Chang, J. Patel, R. J. Levine, S. Dimbil, E. Passano, J. A. Kobashigawa

  • Increasing Incidence and Transplantation of Individuals Listed with Alcoholic Liver Disease

    E. L. Godfrey1, A. Rana2, J. A. Goss2

  • Increasing the Number of Liver Transplants through Active Review of Offers Turned Down

    M. L. Melcher, C. A. Bonham, A. Gallo, W. Concepcion, I. Jacobson, C. O. Esquivel

  • Independent Risk Factors for Discard of Pediatric Liver Allografts

    T. H. Malik1, J. Goss2, N. T. Galvan2, M. L. Kueht II2, A. Rana3

  • Indicators of Impending Pig Organ Xenograft Failure: Relevance to Clinical Xenotransplantation

    H. Iwase1, A. Jagdale1, T. Yamamoto1, G. Zhang1, Q. Li1, J. Foote1, D. Ayares2, H. Hara1, D. K. Cooper1

  • Individualized Preconditioning for ABO-Incompatible Living Donor Kidney Transplantation: An Initial Report of 48 Cases from China

    X. -. Wang

  • Induction Immunosuppression Practices in Liver Transplantation are Variable and Predict Post-Transplant Survival

    T. Bittermann1, R. Hubbard2, J. Lewis1, D. Goldberg1

  • Induction Therapy Modulated by the Absence of Preformed Donor-Specific Antibodies (DSAS) Regardless of the Level of Sensitization

    M. Cristelli, K. Linhares, R. de Marco, L. Viana, C. Felipe, M. Gaspar, C. Peixoto, G. Marcelo Gomes, J. Toniato Rezende, K. Nunes Ficher, L. Alfaro Villanueva, V. Lima, M. Gerbase de Lima, J. Medina Pestana, H. Tedesco Silva Junior

  • Induction Therapy in Elderly Kidney Transplant Recipients with Low Immunological Risk

    C. Masset1, J. Boucquemont2, V. Garrigue3, M. Ladrière4, F. Buron5, E. Cassuto6, Y. Foucher2, J. Dantal1

  • Induction Type Does Not Influence Kidney Graft or Patient Survival in Recipients with a Previous Heart Transplant in the United States

    S. M. Riad1, A. Tamas1, S. Jackson2, C. Martin1

  • Induction Type Does Not Influence Kidney Graft or Patient Survival in Recipients with a Previous Lung Transplant in the United States

    S. Riad1, U. Goswami2, S. Jackson3, M. Hertz2

  • Induction with Thymoglobulin in DCD Kidneys. Dose Effect and Predictors of Outcome

    A. Asderakis, T. Sabah, A. Jones, E. Ablorsu, L. Szabó, R. Chavez

  • Infectious Complications after Treatment of Antibody-Mediated Kidney Allograft Rejection: A National Cohort Study

    N. Perrottet1, D. Golshayan2, O. Manuel2, V. Aubert2, M. Koller3, K. Hadaya4, L. Bühler4, T. Mueller5, U. Huynh-Do6, S. Dahdal6, I. Binet7, M. Dickenmann3, S. Schaub3, J. Steiger3, M. Pascual2, M. Fernández-Ruiz2

  • Infectious Risk of Rejection Therapy Following Heart Transplantation; Can It Be Avoided?

    M. Kittleson, J. Patel, S. Dimbil, R. J. Levine, G. Esmailian, A. Shen, T. Hage, J. A. Kobashigawa

  • Inferior Graft and Patient Survival Following Offspring to Parent Living Donor Liver Transplantation

    R. A. Choudhury, A. Dagan, H. Yaffe, D. Yoeli, E. A. Pomfret, T. L. Nydam

  • Inflammation and Fibrosis Are Observed in 34% of Clinically Stable Adult Liver Transplant Recipients

    L. Sun1, J. Levitsky2, S. Feng3, A. Humar4, A. J. Demetris4, J. Emond5, A. Shaked6, G. Klintmalm7, K. Mason8, M. DesMarais1, A. Priore9, N. Bridges9, B. E. Burrell10, S. Chandran3, J. Markmann11

  • Influence Of HLA-DR Mismatches On Long Term Outcomes Following Heart Transplantation

    A. Singhvi, R. Araujo-Gutierrez, M. H. Park, A. Bhimaraj, B. H. Trachtenberg, I. Hussain, A. Guha

  • Inhibition of CXCR3 Expression through Blockade of STAT3 Alpha Signaling Down-Regulate Inflammation of Renal Ischemia-Reperfusion Injury

    J. Kim1, J. Park2, K. Yoo2, J. Moon1, J. Jeong1, C. Lee3, Y. Kim1, S. Yang4

  • Inhibition of Sialidase Activity and Galectin Binding Reduces Xenogeneic Neutrophil-Endothelial Adhesion

    B. M. Cerel1, B. M. French2, D. G. Harris2, C. Laird2, L. Burdorf1, X. Cheng2, C. Feng3, A. S. Cross4, S. E. Goldblum4, G. R. Vasta3, R. N. Pierson III1, A. M. Azimzadeh1

  • Inhibition of TLR4 Mediated Programmed Necrosis Does Not Improve Graft Function and Histology in a Murine Kidney Transplant Model

    S. Jain1, R. Plenter2, T. Nydam2, A. Jani1

  • Inhibition of Th1 and Th17 Cell Differentiation and Prolonged Graft Survival through NFAT Pathway Downregulation

    C. Dai1, R. Tan1, B. Yang1, J. Markmann2, D. Chen1, L. Wei1, Z. Chen1

  • Initial Peritoneal sST2 Levels Are Associated with Peritoneal Failure and ST2 Blockade Mitigates TGF-β and High Glucose-Induced Peritoneal Fibrosis

    Y. Kim1, S. Lee1, M. Yu1, H. Lee1, Y. Kim1, C. Lee2, R. Cha3, S. Yang4

  • Initial Single-Center Results from the Pilot Transplant Quality Improvement Project in Liver Transplant

    A. Zarinsefat, S. M. Syed, R. Hirose

  • Innate Immunity in Brain Dead Donors: Implications of Necroptosis in Kidney Allograft Outcomes

    A. Ang1, A. Zmijewska2, T. M. Stevens3, J. Murphy1, R. B. Mannon2

  • Innovations in Transplant Education: 360⁰ Virtual Reality Videos of a Live Kidney Donation and Transplantation

    V. A. Huurman1, A. D. Pieterse2, F. Luk2, M. E. Reinders2

  • Inpatient versus Outpatient Management of Hyperglycemia in Post-Transplant Patients Following High Dose Steroid Pulses for Acute Rejection

    J. L. Wisniewski1, W. Bruneau2, E. A. Cohen2

  • Insertion of Internal Stent in Duct-to-Duct Biliary Reconstruction to Reduce Bile Duct Complication in Living Donor Liver Transplantation

    H. Choi1, G. Na2

  • Insulin Resistance as a Surrogate Marker for Post-Transplantation Diabetes Mellitus

    D. D. de Lucena, É. B. Rangel, J. R. de Sá, J. O. Medina-Pestana

  • Insurance Status Impacts Treatment for Hepatocellular Carcinoma

    L. Sobotka1, A. Hinton2, L. Conteh1

  • Integration Of Business Intelligence (BI) Solution In Tertiary Renal Transplant Centre To Drive Clinical Decisions.

    M. Heer, S. Yausis, P. R. Trevillian

  • Interferon Sensitivity Promotes Recovery from Acetaminophen Induced Liver Injury

    S. Datta, T. Hamilton, G. C. Sen

  • International Multicenter Study Evaluating Clinical Outcomes Associated with Acute Antibody-Mediated Rejection

    S. Corman1, I. Hirji2, E. Brouwer2, S. H. Park1, C. Macahilig3, A. Vergani2, T. Bo2, P. Wolthoff3, P. Keown4

  • Interpretable Post-Transplant Graft Failure Prediction Using Decision Tree Neural Networks

    J. N. Valdez1, T. Fu1, J. Hogan2, S. Adhikary1, M. Arenson2, R. Zhang2, X. Zhang3, K. Li2, A. B. Adams2, R. E. Patzer2, J. Sun1

  • Interstitial CD68+ Cells Infiltration and Kidney Graft Outcome

    E. Paoletti1, E. Bussalino2, L. Marsano1, D. Bellino1, R. Russo1, A. Parodi1, G. Garibotto2, J. L. Ravetti3

  • Intra-Abdominal Hypertension in Simultaneous Pancreas-Kidney Transplantation

    T. Ameen, G. Papadakis, R. Punjala, N. Karydis

  • Intra-Operative Kinetics of Anti-HLA Antibodies in Simultaneous Liver-Kidney Transplantation

    M. Kueht, P. Jindra, M. Cusick, N. Galvan, A. Rana, J. Goss

  • Intracerebral Hemorrhage in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease: A Nationwide Analysis

    W. Cheungpasitporn1, C. Thongprayoon2, P. Ungprasert3, K. Wijarnpreecha4, F. T. Chebib2, P. T. Kroner4

  • Intraoperative Blood Loss and Transfusion during Pediatric Liver Transplantation: A Single Center Experience

    J. A. Villarreal1, D. Yoeli2, J. Yoeli3, R. Ackah4, R. Sigireddi1, M. Kueht1, N. Galvan1, R. Cotton1, A. Rana1, C. O’Mahony1, J. Goss1

  • Intravenous Methamphetamine Does Not Appear To Be A Contraindication For Heart Donation In Heart Transplantation

    A. Velleca, J. Patel, M. Kittleson, R. Levine, S. Dimbil, S. Mersola, M. Hamilton, F. Esmailian, J. A. Kobashigawa

  • Intrinsic Organ Quality Assessment Using Integrative Short Outcome Prediction Composite Scores

    K. Archer1, V. Bontha2, Y. Zhang1, J. Eason3, A. Bajwa2, L. Gallon4, E. Akalin5, D. Maluf2, V. Mas6

  • Introduction of Universal Hepatitis E RNA Screening in Deceased Organ Donors – The UK Experience

    I. Ushiro-Lumb1, K. Tettmar1, I. Johannessen2, K. Simpson2, I. Hart3, J. Timms4, A. Hale5, S. Ijaz6, R. Tedder6, J. Forsythe1

  • Investigation and Regulation of Induced Anti-Pig Antibody Production in GTKO Pig-to-Cynomolgus Monkey Artery Retransplantation

    S. Hurh1, E. Lee1, J. Jeong2, G. Lee1, S. Park1, S. Ahn3, S. Min3, C. Ahn4

  • Is HLA Donor-Specific Antibody (DSA)-C3d+ Assay a Potential Predictor of Subclinical Antibody Mediated Damage in the Renal Graft?

    A. G. Contreras1, M. I. Solis-G1, C. Ramirez-Espinoza1, J. Hernandez-Rosales2, M. Vilatoba-Chapa1, R. Cruz-Martínez1, J. Granados1, L. E. Morales-Buenrostro3, J. Alberú1, J. M. Arreola-Guerra4

  • Is Living Donor Kidney Donor Profile Index Useful for Japanese?

    K. Okumura1, K. Tanaka2, Y. Hidaka2, M. Toyoda3, S. Uekihara3, A. Inadome4, H. Yokomizo2, S. Yamanaga2

  • Is Muscular Dystrophy A Contraindication To Heart Transplantation?

    M. Kittleson, J. Patel, D. H. Chang, S. Dimbil, R. Levine, L. Czer, J. A. Kobashigawa

  • Is Narrative Storytelling Ethical to Use to Educate the Public about Living Donation? Transplant Professionals Weigh In

    W. Balliet1, L. Holland-Carter1, S. N. Maurer1, M. P. Salas1, C. S. Anderson2, O. N. Ranasinghe2, A. D. Waterman2

  • Is Pre-transplant Plasmapheresis For Patients With Insignificant Abo Blood Type Antibody In Abo Blood Type Incompatible Kidney Transplant Necessary? – A Japanese Single Center Study.

    M. Miyazaki, A. Mitsuke, H. Higuchi, N. Fukuzawa, H. Tanaka, T. Hirano, T. Seki, H. Harada

  • Ischemia-Free Liver Transplantation Protects Bile Duct from Ischemia/Reperfusion Injury

    J. Yang, S. Huang, Z. Zhang, Q. Zhao, W. Ju, Z. Zhu, Y. Tang, L. Wang, Y. Zhang, C. Sun, L. Wu, Z. Guo, X. He

  • Karnofsky Performance Score as a Predictor of Acute Cellular Rejection Post Liver Transplantation

    N. Kapila1, K. Al Khalloufi2, F. Salomon3, K. Kapila4, A. Gupta3, X. B. Zervos2

  • Kidney & Pancreas Transplant Waitlist Management – A Tiered System Approach

    H. L. Busch

  • Kidney Allograft Survival Among Kidney-pancreas Recipients Compared To Solitary Kidney Recipients: A Mate Analysis Of The Unos/optn Database

    O. K. Serrano1, R. Kandaswamy2, E. B. Finger2

  • Kidney Allografts Induce Systemic Tolerance of Heart Allografts and is Dependent on Foxp3+ Cells

    C. Yang1, J. Ge1, P. S. Russell1, J. C. Madsen1, A. Alessandrini1, R. B. Colvin2

  • Kidney Biopsies In Hiv-negative To Hiv-positive Kidney Transplants – An Institutional Experience

    V. Walavalkar1, A. Zarinsefat2, A. Urisman1, D. Dobi1, J. Vasquez3, P. Stock2, Z. Laszik1

  • Kidney Donor 70 Years Of Age Or Older – How Far Can We Go? A Registry Analysis

    R. W. Gruessner, J. F. Renz, F. Tedla, A. Brar, S. Saggi, M. Salifu, A. C. Gruessner

  • Kidney Donor Profile Index Significantly Correlates With Reperfusion Biopsy Findings

    A. Perez-Gutierrez1, P. Witkowski1, J. Fung1, D. N. Danz2, R. Cummings1, A. Chang3

  • Kidney Function Evaluation Among Living Donors In A Multiracial Population. The Results From A Brazilian Single-center Cohort Study.

    L. R. Requião-Moura, P. R. Bicalho, A. Pacheco-Silva

  • Kidney Grafts Ultrasound Guided Biopsy Performed By Nephrologist. Regaining Technique And Improving Results

    J. Juega, M. Perez, L. Cañas, J. Soler, M. Troya, I. Bancu, R. Lauzurica

  • Kidney Transplant Education outside the Transplant Center – Initial Experience with an On-Line Transplant Education Hub

    D. Belenko1, C. Richardson1, A. Li1, N. Edwards1, J. Lam1, A. D. Waterman2, A. Garg3, M. Novak4, I. Mucsi1

  • Kidney Transplant Outcome between Identical Twins in USA from 2001-2017

    D. R. Jorgensen, S. Hariharan

  • Kidney Transplant Outcomes among Patients with Obstructive Sleep Apnea

    R. Tiwari, B. Lyu, S. Alagusundaramoorthy, B. C. Astor, D. Mandelbrot, S. Parajuli

  • Kidney Transplant Outcomes in Patients with ESRD Due to Myeloma

    A. Riaz, A. Khalil, M. S. Yaqub, T. Taber, O. Adebiyi, A. Sharfuddin

  • Kidney Transplant Outcomes in Recipients with Physical Impairments

    A. G. Thomas1, J. Ruck2, N. Chu2, D. Agoons2, A. Shaffer2, C. Haugen2, H. Ying2, B. Swenor2, S. Norman3, J. Garonzik-Wang2, D. Segev2, M. McAdams-DeMarco2

  • Kidney Transplant Recipient Outcomes from Living Donors with Stones

    S. Doshi, T. Taber, M. S. Yaqub, O. Adebiyi, D. MIshler, C. Sundaram, J. Powelson, W. Goggins, A. Sharfuddin

  • Kidney Transplantation after Sleeve Gastrectomy in the Morbidly Obese Candidate: Results of a Five-Year Experience

    Y. Kim, A. J. Bailey, M. C. Morris, J. Hlavaty, M. C. Cuffy, E. S. Woodle, S. A. Shah, T. S. Diwan

  • Kidney Transplantation in Older Recipients with HLA-DR Mismatch: Impact of Induction Type on Outcomes

    K. K. Sureshkumar1, N. L. Thai2, B. Chopra1

  • Kidney Transplantation in Patients with Neurogenic Bladder

    Z. Jurekovic, M. Knotek

  • Kidney Transplants Following Donation after Circulatory Death and Donation after Brain Death Have Similar Early Outcomes

    M. Hobeika1, D. Nguyen2, E. Graviss2, A. Gaber1, H. Podder1, S. Yi1, S. Kuten3, S. Patel3, R. Knight1

  • Kidney Volumes in Healthy Donors – Does Size Really Matter?

    F. R. Schwartz1, B. I. Shaw2, F. Vernuccio1, F. Rigiroli1, F. Gonzalez1, R. Lerebours3, K. Ravindra2, D. Marin1

  • Lack of Linguistically and Culturally Tailored Initiatives in Kidney Transplant Programs in the United States

    S. Carbunaru1, A. Ortiz2, C. Ortiz3, J. Ortiz3, J. Locke4, J. Caicedo1

  • Laminin Dependent T Cell Migration Determines Allograft Survival

    L. Li, M. Shirkey, W. Piao, Y. Xiong, V. Saxena, T. Zhang, B. M. Cerel, C. Paluskievicz, J. S. Bromberg

  • Large Series Of Liver Transplantation In Patients With Portal Vein Thrombosis

    Y. Cheah, C. J. Simon, R. L. Jenkins, M. E. Akoad

  • Late Onset J C Virus Allograft Nephropathy

    M. Samra, I. Tang, S. Setty

  • Learning Curve for Living Donor Laparoscopic Left Lateral Sectionectomy

    R. Hwang1, D. von Ahrens2, A. Griesemer1, T. Kato1, J. Emond1, D. Cherqui3, B. Samstein2

  • Leukopenia at the Time of Liver Transplantation: Medication Tolerance and Clinical Outcomes

    E. Tiao1, J. Casale1, J. LaMattina2, S. Hammad1

  • Leukopenia in Older Kidney Transplant Recipients is Associated with Decreased Allograft Survival and Increased Patient Survival

    R. Rodriguez, A. Price, K. Soliman, R. Vinaya, D. Lazarus, M. Casey, M. Labonte, L. Erbe, M. Shearer, D. Taber, M. Posadas Salas

  • Lifelong Immunosuppression, I Am Sure We Told Them That?: Long Term Medication Adherence in Liver Transplant Patients

    K. Foster1, C. Perez1, T. Harrison1, H. Corbo1, N. Patel1, J. Fleming1, H. Meadows1, D. Taber1, D. DuBay2, J. McGillicuddy2, N. Pilch1

  • Ligation of the Proximal Splenic Vein to Keep Adequate Portal Flow in Patients with Large Splenorenal Shunts during Living Donor Liver Transplantation

    C. Cheng

  • Limited Accessibility of Kidney Transplantation in Rural Residents: A Nationwide Data of South Korea

    J. Kim1, K. Park1, S. Park1, M. Yu2, Y. Kim1, J. Jeong1, K. Kim1, M. Park3, H. Lee1

  • Listening to the Patients Voice for Developing Transplant Education

    S. Brown, H. Li, D. Tsapepas

  • Listing Practices and Graft Utilization Lag behind Supply of Hepatitis C Positive Deceased Donors for Liver and Kidney Transplant

    C. E. Kling1, J. D. Perkins2, S. W. Biggins3, C. Johnson4, A. P. Limaye5, L. Sibulesky1

  • Liver Allograft Provides Protection Against Cardiac Allograft Rejection In Combined Heart And Liver Transplantation

    K. Zhao1, R. Wang2, M. Kamoun3, K. Olthoff1, M. Hoteit4, E. Rame5, M. Levine1, R. Mclean5, P. Abt1

  • Liver Circle-Based Allocation: LSAM Modeling Results

    D. Schladt1, T. Weaver1, J. Pyke1, A. Herreid1, B. Thompson1, B. Kasiske1, J. Snyder1, W. Kim2, J. Lake3, A. Israni1, J. Heimbach4

  • Liver Transplant Candidates Derive a Survival Benefit from Accepting a Macrosteatotic Liver

    K. Jackson, M. Bowring, C. Haugen, C. Holscher, L. Liyanage, S. Ottmann, B. Philosophe, A. Massie, D. Segev, A. Cameron, J. Garonzik-Wang

  • Liver Transplantation in Acute Hepatic Insufficiency Induced by Imatinib

    A. I. David1, D. N. Alvarenga de Rezende2, M. C. Fantauzzi3, T. Di Santi3, N. C. Confuorto3, G. T. Martinho3, P. S. Antunes3

  • Liver Transplantation in Children with Type 1 and Type 2 Autoimmune Hepatitis

    I. G. Roepe, J. A. Goss, T. Miloh

  • Liver Waitlist Dropout and Transplant Rates for Metropolitan vs. Non-Metropolitan Candidates

    D. Schladt1, T. Weaver1, J. Pyke1, A. Herreid1, B. Thompson1, B. Kasiske1, J. Snyder1, W. Kim2, J. Lake3, A. Israni1

  • Living Donor Kidney Transplantation. Overcoming Sex Disparity In Japan

    M. Yoshikawa

  • Living Donor Renal Transplantation without Any Induction Immunosuppression in Spousal Donors – Single Center Experience

    R. Bhat, F. Aziz, I. N. Abubecker, S. Narayanan, B. Hafeeque

  • Living Donor vs. Deceased Donor Liver Transplantation for Pediatric Patients with Metabolic Liver Disease

    G. Gu, Q. Xia

  • Living Kidney Donor Time Zero Biopsy Findings Predict Graft Loss in the Recipient

    N. Issa1, C. Lopez1, A. Denic1, J. J. Larson1, R. Narasimhan1, L. Archila1, S. S. Taler1, H. Chakkera2, J. Augustine3, M. Stegall4, A. Rule1

  • Long Term Cold Ischemia Time in Kidney Transplantation. The Role of Hypothermic Machine Perfusion

    G. ADANI1, U. Baccarani1, P. Tulissi2, C. Vallone2, A. Risaliti1

  • Long Term Follow-Up of the Use of Checkpoint Inhibitors in Kidney Transplant Recipients

    K. Venkatachalam, R. Delos Santos, T. Alhamad

  • Long Term Impact of Intraoperative Autologous Blood Transfusion on HCC Recurrence in Liver Transplantation

    G. Kelly1, J. L. Pasko1, E. Dewey2, E. Maynard1, S. L. Orloff1, C. Enestvedt1

  • Long Term Outcomes of Patients Transplanted for Hepatocellular Carcinoma with Human Immunodeficiency Virus Infection

    R. Gedaly-Eidelman, E. Chacon, P. Eman, M. Gupta, J. Berger, A. El-Husseini, X. Mei, F. Marti, L. Turcios, M. Shah

  • Long-Term Efficacy of Direct-Acting Antiviral Agents

    J. Zhang, W. Sun, J. Lin, Y. Tian, L. Ma, L. Zhang, Y. Zhu

  • Long-Term Exposure to Particulate Matter Air Pollution and the Risk of Graft Failure and Mortality in Kidney Transplant Recipients

    Y. Kim1, S. Kwon1, J. Park2, J. Lee3

  • Long-Term Influence of Arteriosclerosis in Kidney Grafts Proven by a Zero-Hour Biopsy

    Y. Kakuta1, M. Okumi1, T. Kanzawa1, K. Unagami2, H. Ishida1, K. Tanabe1

  • Long-Term Outcome and Surgical Complications Following Live-Donor Kidney Transplantation in Children Weighting Less Than 15 Kg: A Single Center Experience in Japan

    Y. Aoki1, H. Satoh2, Z. Matsui2, R. Hamada3, R. Harada3, M. Muramatsu4, Y. Hamasaki4, S. Shishido4

  • Long-Term Outcomes and Safety of Living Kidney Transplantation from Older Donors

    Y. Kakuta1, M. Okumi1, T. Kanzawa1, K. Unagami2, H. Ishida2, K. Tanabe1

  • Long-Term Outcomes of Elderly Living Donors: A Nationwide Population-Based Study

    H. Yoon1, Y. Kim2, S. Shin1, J. Ahn3, C. Yang1, B. Chung1

  • Long-Term Outcomes of Older Kidney-Transplant Recipients: A Single-Center Experience

    S. Sultan, M. Aull, M. Lubetzky, A. Watkins, S. Kapur

  • Long-term Impact of Antihypertensive Treatment and Tacrolimus Dose in Renal Allograft Recipients 5 Years Post-Transplantation

    D. Rush1, S. Cockfield2, S. Wilson3, J. Schwartz4

  • Long-term Outcomes And The Feasibility Of Kidney Retransplantation In Pediatric Survivors Of Post-transplant Lymphoproliferative Disease

    S. Kizilbash, P. Verghese, B. Chavers

  • Low Dose Anti-Thymocyte Globulin is Enough to Prevent Acute Cellular Rejection in Kidney Transplant

    P. W. Baron1, J. Weissman2, F. Fazeli3, C. Zuppan4, R. Villicana3, P. Wai1, L. Beeson5, M. De Vera1

  • Low Dose Thymoglobulin Has No Disadvantages to Standard Higher Dose: A Report of the Midwest Pediatric Nephrology Consortium

    I. Ashoor1, R. Beyl2, C. Gupta3, A. Jain4, S. Kiessling5, H. Patel6, J. Sherbotie7, D. J. Weaver Jr8, R. Zahr9, V. Dharnidharka10

  • Low Incidence of Acute Renal Failure with Minimal Prophylaxis after Iodinated-Contrast TC in Ambulatory Renal Transplant Patients

    C. Jimenez1, S. Afonso1, M. O. Lopez1, M. E. Gonzalez1, M. J. Santana1, A. Santiago2, M. A. Vaca1, M. Ferreira1, R. Selgas1

  • Low Specific Gravity Of First Morning Urine Predicts Bkvn in Kidney Transplant Recipients With Bk Viruria

    G. Huang1, X. Chen1, Z. Wang2, Y. Nuertai2, W. Chen3, S. Yang3, P. Chen4, C. Wang1

  • Low-Dose Valacyclovir Prophylaxis for Cytomegalovirus Infection in Renal Transplant Recipients with Intermediate Risk

    A. Velioglu1, H. Arikan1, E. Asicioglu1, S. Alagoz2, N. Seyahi2, S. Tuglular1, C. Ozener1

  • Lower Alcohol Taxes Are Associated with Increased Liver Transplant Listing

    N. T. Shen1, M. Raver1, N. Hutchison1, A. Jesudian1, J. Bray2, B. Schackman3, R. S. Brown1

  • Lower Stanford Integrated Psychosocial Assessment (SIPAT) for Transplantation Score is Predictive of Successful Listing for Kidney Transplant Candidates

    A. Kumar1, J. Salaway2, M. Dorris2, J. Newman3, A. Doyle1, S. Rao1

  • Lung Allocation Score Should Be Implemented in China

    C. Ju, Q. Lian, B. Wei, X. Xu, R. Chen, J. He

  • Lung Transplantation in the Elderly Patients with Multi-Comorbidities

    N. Shigemura, Y. Toyoda

  • Lymphotoxin Beta Receptor Determines Lymph Node Structure for Treg Migration and Suppression of Graft Rejection

    V. Saxena, W. Piao, L. Li, C. M. Paluskievicz, Y. Xiong, T. Simon, J. S. Bromberg

  • MELD-Na Alterations on the Liver Transplant Waiting List and Its Impact on Listing Outcome

    G. Silberhumer1, G. Gyoeri1, L. Baumann1, S. Zehetmayer2, T. Soliman1, G. Berlakovich1

  • MHC Cross-Dressing in Mixed Hematopoietic Chimerism

    B. Gonzalez Nolasco1, M. Wang1, W. Orent1, A. Prunevieille1, K. Pruner1, J. O1, J. Paster1, J. C. Madsen2, G. Benichou1

  • Management and Outcome of Hepatic Artery Thrombosis in Pediatric Liver Transplantation

    A. Channaoui, R. Tambucci, A. Pire, C. de Magnée, R. Reding

  • Management of Dyslipidemia after Liver Transplantation

    S. S. Patel1, V. A. Rodriguez2, M. B. Siddiqui1, M. Faridnia3, F. Lin4, J. Laurenzano4, J. Clinton4, A. Chandrakumaran3, T. Reichman5, C. Bhati5, M. S. Siddiqui1

  • Management of Orphan Ducts After Pediatric Living Donor Liver Transplantation

    N. Celik1, A. Ganoza2, A. Khanna2, G. Bond2, K. Soltys2, R. Sindhi2, J. Crowley3, A. Humar1, G. Mazariegos2

  • Management of Post Operative Pain after Pancreas Transplant – Liposomal Bupivicaine Injection or Continuous Catheter Infiltration Reduces Daily Opioid Usage

    S. Nagaraju, Y. Yeap, R. Mangus, J. Fridell, J. Wolfe, J. Powelson

  • Mathematical Model of Post-Transplant Serum Creatinine

    B. Jun Bae, O. Chang-Kwon

  • Measuring of Outcomes in Liver Transplant Patients with or without Splenectomy: A Meta Analysis

    M. Chen, B. Huang, Y. Zhang, W. Ju, X. He

  • Meet Your Mate: Lessons Gleaned from Analysis of 154 Paired Kidneys Transplanted at a Single Center

    M. Lubetzky1, M. Aull2, K. Rhee1, S. Sultan2, S. Kapur2

  • Meld Score / Grwr Ratio (meldgr) Can Predict Surgical Outcomes And Prognosis Of The Recipients In Adult-to-adult Living Donor Liver Transplantation

    A. Tanemura, A. Hayasaki, T. Fujii, Y. Iizawa, H. Kato, Y. Murata, N. Kuriyama, Y. Azumi, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji

  • Mesangiopathic Glomerulonephritis in Kidney Transplants

    G. Towns, G. Agarwal, S. Ong, R. Mundra, C. Kew

  • Metabolic Liver Transplant: A Single Cooperative 2002-2017

    N. Yazigi1, K. Chapman2

  • Metabolic Liver Transplantation – Can We Afford It?

    N. Yazigi1, W. Fujiwara2

  • Metabolic Profiling of Steatotic Human Livers during Ex-Vivo Normothermic Machine Perfusion

    S. Raigani1, N. Karimian2, V. Huang2, S. Geerts2, S. Nagpal2, K. Uygun1, M. Yarmush1, H. Yeh1

  • Metabolomic Study Of Sarcopenia In Patients Prior To Liver Transplantation

    S. Ries,1, N. J. Skill1, E. Campbell1, R. Daniel2, C. A. Kubal1, M. S. Richard1, M. A. Maluccio1

  • Microcirculation Inflammation with TCMR is Associated with Poor Graft Outcomes in Kidney Transplant Recipients (KTRs) without ABMR

    A. Cherukuri, S. Tandukar, S. Hariharan, R. Mehta

  • Microsteatosis in Livers from Donation after Circulatory Death (DCD) Donors is Associated with Inferior Graft and Patient Survival Following Liver Transplantation (LTX)

    N. Bath, G. Leverson, D. Foley

  • Microvascular Rarefaction and Long-Term Graft Dysfunction in Kidney Transplant Recipients with Delayed Graft Function

    A. Doreille, S. Larivière-Beaudoin, A. Karakeussian-Rimbaud, M. Hébert, M. Dieudé, N. Patey, H. Cardinal

  • Minimally Invasive Kidney Transplantation Using a Novel Intraoperative Cryogenic Circulatory Cooling Device

    H. Dai, L. Peng, L. Song, Z. Tang, N. Wu, C. Fang, M. Nie, T. Li, Y. Zheng, X. Xie, S. Yu

  • Mismatched Antibody Epitopes and the Development of HLA-DQ De Novo DSA during Immunosuppression Withdrawal in Liver Transplant Recipients

    V. Jucaud1, A. Shaked2, M. DesMarais3, P. Sayre4, S. Feng4, J. Levitsky5, M. Everly1

  • Mitigating Racial and Gender Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation’s Longest Single-Center Kidney Chain

    M. N. Mustian, V. Kumar, K. Stegner, D. Mompoint-Williams, M. Hanaway, M. H. Deierhoi, C. Young, B. Orandi, D. Anderson, P. A. MacLennan, R. D. Reed, B. A. Shelton, D. Eckhoff, J. E. Locke

  • Modeling Multiple Registrations and the Impact at the National and Regional Scale

    C. Harvey, R. Weigel

  • Modeling Patients as Dynamical Systems: Evaluating the Efficiency of Kidney Transplantation through Multi-Stage Data Envelopment Analysis

    F. J. Santos Arteaga1, D. Di Caprio2, D. Cucchiari3, J. M. Campistol3, F. Oppenheimer3, F. Diekmann3, I. Revuelta3

  • Modeling the Effect of Presumed Consent on Waitlist Candidate Quantities

    L. DeRoos1, W. Marrero1, M. Lavieri1, D. Hutton2, N. Parikh3

  • Molecular Features of Rejection in Endobronchial Mucosa Biopsies

    M. D. Parkes, K. M. Halloran, J. Chang, P. F. Halloran and The INTERLUNG Study Group

  • Mortality around the One-Year Survival Metric after Liver Transplantation in the United States

    C. Blebea1, P. Chatterjee2, A. Nathan1, J. Diamond1, H. J. Goldberg2, A. Courtwright1

  • Moving from Local Allocation to National Allocation Using Gravity Model

    F. Bayer1, B. Audry2, C. Antoine2, C. Jasseron2, C. Legeais2, O. Bastien2, C. Jacquelinet1

  • Multi-Center Validation of TruGraf V2 – A Peripheral Blood Diagnostic for Subclincal Kidney Rejection

    C. Marsh1, S. Kurian1, C. Schieve2, R. Heilman3, M. Stegall4, S. Rose2, J. Case1, J. Friedewald5, M. Abecassis5, R. First2

  • Multi-Disciplinary Considerations Concerning the Impacts of Kidney Transplantation on Cervical and Lumbar Spinal Fusion Operations

    L. Mugge, C. Gallagher, W. Qu, A. Caras, N. Henkel, O. Ekwenna, J. Ortiz

  • Multicenter Experience Evaluating Outcomes of HCV-Seropositive Donors to HCV-Seronegative Recipients Liver Transplantation

    K. Wijarnpreecha1, B. Aqel2, S. Pungpapong1, C. Taner3, K. Reddy4, M. Leise5, R. Dickson2

  • Multidisciplinary Practitioner Perspectives on Cardiovascular Disease Guideline Interventions in Liver Transplant Recipients

    M. Kosirog1, L. Adamski1, A. Daud2, D. Finn2, D. Gregory1, D. M. Lloyd-Jones3, J. L. Holl4, L. B. VanWagner5

  • Multidisciplinary Transplant UTI Service; Challenging the Stalemate

    J. J. Chong, A. Adiki, D. Ness, J. Olsburgh, R. H. Zakri

  • Multilevel Correlates of Immunosuppressive Nonadherence in Kidney Transplant Patients – The Multicenter ADHERE BRAZIL Study

    H. Sanders-Pinheiro1, F. A. Colugnati1, K. Denhaerynck2, E. O. Marsicano1, J. O. Medina3, S. De Geest2, A. ADHERE BRAZIL Study team1

  • Multimodal Analgesia Reduces Opioid Use after Liver Transplantation

    K. Tong, W. Nolan, D. O'Sullivan, H. Kutzler

  • Murine Cytomegalovirus Infection Down-Regulates Receptor Tyrosine Kinase MerTK on Macrophages to Abrogate Allograft Tolerance

    S. Yu, A. Dangi, M. Burnette, X. Luo

  • Mycophenolate Mofetil versus Azathioprine in Kidney Transplant Recipients on Steroid-Free Low-Dose Cyclosporine Immunosuppression: The ATHENA Trial

    P. Cravedi1, P. Ruggenenti2, E. Gotti2, A. Plati2, S. Sandrini3, N. Bossini3, F. Citterio4, E. Minetti5, D. Montanaro6, R. Tardanico3, E. Sabadini2, F. Gaspari7, A. Villa7, F. Peraro7, G. Remuzzi7

  • Mycophenolic Acid Area under the Curve Monitoring via Limited Sampling Strategy in Pediatric Heart Transplant Recipients

    S. Crow, S. H. Dahl, J. N. Johnson

  • Myeloid Derived Suppressor Cells (MDSC) Home to the Allograft and Can Control T Cell Responses

    Y. S. Lee, T. Zhang, J. S. Bromberg, J. R. Scalea

  • National Landscape of Donors Allocated through the Hope Act in the United States

    A. R. Wilk1, R. Hunter2, M. A. McBride2, D. K. Klassen2

  • Natural Course Of Tacrolimus Intra-patient Variability In Liver Transplant Recipients

    N. Wilson, S. Tremblay, N. S. Ejaz, K. Zheng, J. Garrett, S. A. Shah, R. R. Alloway, T. E. Kaiser

  • Natural Evolution Of Tacrolimus Intra-patient Variability Among Renal Transplant Recipients

    K. Zheng, S. Tremblay, N. S. Ejaz, N. K. Wilson, K. Hoffman, T. Kaur, M. Anand, E. S. Woodle, R. R. Alloway, T. E. Kaiser

  • Near-Infrared Fluorescence Imaging with ZW800-1 Dye to Assess Donor Kidneys While on Ex-Vivo Normothermic Machine Perfusion

    A. S. Arykbaeva1, K. M. Rozenberg2, M. L. Lo Faro2, J. Hunter2, J. B. Doppenberg1, A. R. Valentijn3, A. G. Terwisscha van Scheltinga3, H. Putter4, I. P. Alwayn1, J. V. Frangioni5, J. Burggraaf6, A. L. Vahrmeijer1, R. J. Ploeg2, V. A. Huurman1

  • Near-Miss Events during Donor Left Liver Lobe Hepatectomy: A Potential Quality-Control to Assess Donor Safety in Living Donor Liver Transplantation Programs

    E. BONACCORSI-RIANI, V. Daudré-Vignier, O. Ciccarelli, L. Coubeau, S. Iesari, R. Tambucci, C. De Magnee, A. Pire, R. Reding

  • Need of a New Formula to Estimate Creatinine Clearance in Immediate Post Kidney Transplant Period with Functioning Allograft

    A. B. Jain1, U. Farooq2, A. Brooks1, T. Dohi1, F. Butt1, Z. Kadry1

  • Neighborhood Deprivation is Associated with Decreased Rates of Organ Donor Designation

    S. I. Wadhwani1, J. Bucuvalas2, C. Brokamp1, M. A. Bhuiyan1, J. C. Lai3, A. Beck1

  • Nephrotoxicity Caused by Calcineurin Inhibitors is Meditated by BAX, NOL3 and XIAP Apoptotic Genes Dysregulation

    G. Queipo1, M. Fonsecha-Sanchez1, J. Sanchez1, L. Garcia1, M. Carmona2, E. Villanueva1, G. Melendez1, L. Morales-Buenrostro3, M. Alamilla1

  • Neutralization of Interlukin-6 by ALD518-P18 (Murine Clazakizumab) Attenuates Donor Specific Antibody Responses in a Mouse Model of Allogeneic Sensitization: A Report of Dosage Finding Study

    I. Kim, G. Wu, N. Chai, T. Brennan, A. Klein, S. Jordan

  • New Reactive Oxygen Species Scavenger Prevents Injury in Ischemia-Reperfusion Injury Model

    N. Bath, W. Fahl, R. Redfield III

  • New-Onset Diabetes after Kidney Transplantation: Risk Factors and Early Graft Function Outcome

    Z. Li, W. Peng, J. Chen

  • Ninety-Day Complications in 214 Intestinal Transplant Patients: A Calvien-Dindo Analysis and Assessment of Long Term Outcomes

    A. Zimmerman, J. Hawksworth, A. Kroemer, P. Radkani, K. Khan, S. Kaufman, N. Yazigi, S. Subramanian, T. Fishbein, C. Matsumoto

  • Nivolumab-Induced Rejection of a Liver Allograft: PD-1 Inhibition Thwarts Liver Allograft Resistance to Humoral Rejection

    B. T. Lee, H. Han, S. Chopra, A. J. Ahearn

  • No Indication of Increased CMV Infection in Kidney Transplant Recipients without Pharmacological Prophylaxis Receiving a Single 3mg/kg Dose of Rabbit Anti-Thymocyte Globulin (ATG) Instead of No-Induction

    M. Ivani de Paula, M. Grace Bowring, A. A. Shaffer, J. Garonzik-Wang, A. Barros Bessa, C. Rosso Felipe, M. Pontello Cristelli, A. B. Massie, J. Medina Pestana, H. Silva Junior, D. L. Segev

  • No Plan is a Bad Plan! Results of the American Society of Transplantation (AST) Living Donor Community of Practice Mortality Workgroup Survey on Disaster Planning Following a Living Donor Death

    M. L. Henderson1, S. E. Van Pilsum Rasmussen1, M. M. Waldram1, K. L. Lentine2, D. A. Mandelbrot3, R. L. Hays3, D. G. Maluf4, M. Cooper5

  • Nodular Regenerative Hyperplasia after Liver Transplant – It is All in the Presentation

    A. K. Chen1, S. Yamaguchi2, C. Praglin2, E. Agudelo2, F. K. Yao2, S. M. Syed2, G. R. Roll2

  • Normal Coronary Angiogram Pre-Transplant Does Not Predict Cardiac Events in Diabetic Kidney Transplant Recipients

    F. Aziz, A. Mulay, M. Anders, S. Parajuli, D. Mandelbrot, A. Djamali

  • Normothermic Ex-Situ Liver Perfusion Parameters of Liver Viability in a Porcine Model of Liver Transplantation with Marginal Grafts

    I. Linares-Cervantes1, J. Echeverri1, S. Cleland1, M. Kaths1, R. Rosales1, T. Goto1, D. Kollmann1, M. Hamar1, P. Urbanellis1, L. Mazilescu1, S. Ganesh1, O. Adeyi1, P. Yip1, B. Bojko2, P. Gorynzka2, K. Gorynski2, D. Grant1, N. Selzner1, M. Wasowicz1, M. Selzner1

  • Normothermic Machine Perfusion of Human Kidneys without an Oxygen Carrier

    D. Detelich, C. Eymard, M. Aburawi, C. Carroll, K. Uygun, H. Yeh, J. F. Markmann

  • Notch1 Signaling Protects Liver Grafts from Ischemia Reperfusion Injury: From Mouse to Human

    K. Kadono, S. Kageyama, H. Hirao, K. Nakamura, T. Ito, K. J. Dery, D. Oncel, B. Ke, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski

  • Novel Cell-Free and Concentrated Ascites Reinfusion Therapy for Management of Refractory Ascites in Liver Transplant Candidates

    K. Sato, M. Ohira, Y. Imaoka, S. Hashinoto, H. Tahara, K. Ide, T. Kobayashi, Y. Tanaka, H. Ohdan

  • Novel Cooling Device for Kidney Transplant Surgery

    A. Dergham1, L. Witherspoon2, T. A. Skinner2

  • Novel In Vitro Germinal Center Culture System Demonstrates More Aggressive B Cell to Plasma Blast Differentiation in Allosensitized Nonhuman Primates

    P. Schroder, J. Yoon, R. Schmitz, Z. Fitch, J. Kwun, S. J. Knechtle

  • Novel Insights into Blocking the IL-6 / IL-6 Receptor Pathway after Pig Kidney Xenotransplantation in Baboons

    H. Hara1, G. Zhang1, H. Iwase1, T. Yamamoto1, D. Ayares2, D. E. Eckhoff1, D. K. Cooper1

  • Novel Oral Anticoagulants in Kidney Transplantation: Results from a Pilote Study

    J. Leon, J. Zuber, L. Amrouche, D. Anglicheau, G. Divard, C. Legendre, R. Sberro-Soussan

  • Novel Role of Qa-1-Restricted Immunoregulation in Murine Cardiac Transplantation

    J. Y. Choi1, S. K. Eskandari1, J. Assaker1, I. Sulkaj1, S. Cai1, H. Allos1, M. Uehara1, M. Mohammad1, B. S. Al Dulaijan1, A. Bano1, E. Al Huassain1, H. I. Cantor2, J. R. Azzi1

  • Nutritional Literacy and Diet Quality in a Cohort of Inner-City Kidney Transplant Recipients (KTRs)

    S. Leventer, G. Yang, J. Leong, K. Lembrikova, C. Wilson, M. Markell

  • Obese Simultaneous Pancreas And Kidney Transplant Recipients In Type 2 Diabetes Have Similar Risks Of Pancreas Failure As Non-obese

    T. Alhamad1, K. Espinoza1, J. R. Wellen1, S. Chang1, D. C. Brennan2, K. L. Lentine3

  • Obesity Induced IL-18 Production Impairs FOXP3+ Treg Function and Increases Risk of Primary Graft Dysfunction in Lung Transplant Recipients

    W. W. Hancock1, T. Zhang1, U. H. Beier1, A. Samanta1, R. Han1, L. Wang1, J. Jiao1, J. M. Diamond2, D. S. Wilkes3, D. J. Lederer4, R. A. Simmons2, J. D. Christie2, T. Akimova2

  • One Organ Procurement Organization’s Uncontrolled Donation After Cardiocirculatory Death Program Increases The Donor Pool And Results In The Transplantation Of 254 Organs

    R. D. Hasz, S. M. West, H. M. Nathan

  • Opioid Use Policies and Practices in Liver Transplant and Lung Transplant Candidates: A Comparison of National Surveys

    H. Bruschwein1, V. Andersen1, H. Patel2, S. S. Rogal3, J. N. Fleming4

  • Optimizing Patient Blood Management in Simultaneous Kidney and Pancreas Transplantation

    D. P. Al-Adra, J. Odorico, D. Kaufman, R. Redfield, J. P. Connor

  • Oral Ribavirin Therapy for Respiratory Syncytial Virus (RSV) in Lung Transplant Recipients: The Impact of Policy Implementation on Cost and Appropriate Use

    B. Berak, N. Sulejmani, A. Jantz, T. Larson, S. Davis, B. Summers

  • Organ Donation Rates And Transplantation Activity Comparing Opt-out Versus Opt-in Systems: A Cross-sectional Study Of Oecd Countries

    A. Arshad1, M. Babiker2, B. Anderson2, A. Sharif2

  • Organ Procurement Organization Performance is Not Related to Educational Spending

    J. P. Roberts1, J. Bragg-Gresham2, P. Held3

  • Organ Procurement Organization Surgeon Improves Utilization of Livers from Pediatric Donors

    M. MacConmara1, J. Reese2, T. Anthony2, A. Aqul3, S. Hanish1, P. Vagefi1, D. Desai1, C. Hwang1

  • Organ Transportation by Drone: Surgeon Perspectives

    T. Talaie1, R. Barth2, J. R. Scalea1

  • Organ Vigilance in Germany: Malignancy Transmission from Organ Donor to Recipient

    K. Moench, A. Rahmel, A. P. Barreiros

  • Organ-Procurement Organization and Donor Factor-Related Variation in Deceased Donor Kidney Biopsies and Discards: A National Practice Patterns Analysis

    K. Lentine1, A. Naik2, M. Schnitzler1, H. Randall1, J. Wellen3, B. Kasiske4, G. Marklin5, D. Brockmeier5, M. Cooper6, H. Xiao1, Z. Zhang1, R. Gaston6, R. Rothweiler5, D. Axelrod7

  • Organ-Specific Injury and Recovery Mechanisms in Post-Transplant Ischemia Reperfusion Injury

    S. Bontha1, A. Bajwa1, L. Gallon2, J. Eason3, D. Maluf1, V. Mas4

  • Osmotic Demyelination Syndrome after Liver Transplantation- Etiology and Treatment Options

    P. Mihaylov1, D. Soma2, D. Kuruppu2, B. Ekser2, R. Mangus2, J. Fridell2, R. Snook2, C. Kubal2

  • Outcome Differences in Urine Leak Repair Modality Post Kidney Transplantation

    J. Buggs1, V. Gamarra2, E. Rogers1, R. Watson1, J. Sokolich1, H. Pearson1, J. Huang1, A. Kumar2, V. Bowers1

  • Outcome Of Late Biopsy-negative Rejection After Heart Transplantation

    M. Kittleson, J. Patel, E. Kransdorf, S. Dimbil, R. Levine, J. A. Kobashigawa

  • Outcome Of Left Main Stenting After Heart Transplantation

    S. Dimbil, J. Patel, B. Azarbal, M. Kittleson, R. Levine, D. H. Chang, J. A. Kobashigawa

  • Outcome Of Living Donor Liver Transplantation In Elderly Patients >65 Years With And Without Hepatocellular Carcinomas: A Retroepsective Analysis

    A. Thorat, L. Jeng, S. Hsu, H. Yang, C. Yeh, T. Chen, K. Poon, P. Li

  • Outcome of Renal Transplantation in Systemic Amyloidosis

    S. Law1, L. Helen2, T. Resk2, A. Wechalekar2, J. Gillmore2, R. Motallebzadeh1

  • Outcome of Treated Cellular Rejection (CMR) in Renal Transplant Patients

    N. Raj, S. Jackson, S. Riad, R. Spong, V. Vakil, A. Matas, D. Keys

  • Outcomes Analysis of U.S. Transplant Centers Performing High Volumes of Hard to Place Kidneys

    Y. Qazi1, D. Bahl2, N. Mehta3, Z. Haddad4, M. Smogorzewski4

  • Outcomes Following Open Inguinal Hernia Repair in Liver Transplant versus Cirrhotic Patients

    N. Siegel, A. Kernodle, S. DiBrito, T. Ishaque, D. Segev, J. Garonzik-Wang

  • Outcomes From Very Old Deceased Kidney Donors For Transplantation

    E. Guillen1, P. Ventura-Aguiar1, A. Ruiz2, G. Piñeiro1, D. Cucchiari1, I. Revuelta1, V. Torregrosa1, F. Cofan1, E. De Sousa1, N. Esforzado1, M. Musquera3, L. Peri3, F. Oppenheimer1, F. Diekmann1

  • Outcomes Of Dosing Weight Selection On Rabbit Anti-thymocyte Globulin Induction Immunosuppression In High-risk, Obese Renal Transplant Recipients

    A. C. Cordry1, K. Trobaugh1, L. Ramsey2, A. L. Castellanos3, H. Fattah3, T. Rendulic1

  • Outcomes Of Simultaneous Pancreas/kidney Transplantation In Bmi Extremes

    A. Al-Kurd, M. Safwan, D. Kim, M. Abouljoud, S. Nagai

  • Outcomes Of Treatment Of Late Vs Early Acute Antibody-mediated Rejection In Renal Transplant Recipients – A Single Center Experience

    R. Prashar, N. Sulejmani, A. Patel

  • Outcomes after Declining Increased Infectious Risk Kidney Offers for Pediatric Candidates in the United States

    M. Bowring, K. Jackson, H. Wasik, A. Neu, J. Garonzik-Wang, C. Durand, N. Desai, A. Massie, D. Segev

  • Outcomes after Incompatible Living Donor Kidney Transplantation in Older Recipients

    J. Long1, K. Jackson1, J. Motter1, S. Bae1, A. Massie1, M. Waldram1, K. Covarrubias1, J. Chen1, B. Orandi2, N. Desai1, D. Segev1, J. Garonzik-Wang1

  • Outcomes after Prolonged Therapeutic Plasma Exchange in Pediatric Kidney Transplant Patients with Early Recurrence of Focal Segmental Glomerular Sclerosis

    D. K. O'Conor1, P. R. Srivaths2, K. Hosek3, E. Gerzina1, A. Huynh1, A. Thorsen1, E. Brewer2, T. Galvan1

  • Outcomes for Lung Transplantation Recipients with Non-Alcoholic Fatty Liver Disease

    A. J. Trindade1, P. Burkett1, S. El-Chemaly1, N. Hashemi2, T. Thaniyavarn1, H. R. Mallidi3, H. J. Goldberg1

  • Outcomes in Preformed Donor-Specific Human Leukocyte Antibody Positive Living Kidney Transplant Recipients Desensitized with Intravenous Immunoglobulin and Rituximab

    Y. kakuta1, M. Okumi1, T. Kanzawa1, K. Unagami2, H. Ishida2, K. Tanabe1

  • Outcomes of Induction Therapy with Bortezomib and High-Dose Intravenous Immunoglobulin for Kidney Transplantation with Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibodies

    Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika

  • Outcomes of Liver Transplantation for Hepatocellular Carcinoma in Septuagenarians

    M. Najjar1, K. Bruestle1, P. Jiang1, E. Lieberman1, R. Hwang1, A. Mathur1, E. C. Verna1, A. Griesemer1, B. Samstein2, T. Kato1, Y. M. Saenger1, K. J. Halazun2, J. C. Emond1

  • Outcomes of Phenotypes in Early Subclinical Inflammation (SCI) Determined by Presence of Interstitial Inflammation with or without Concomitant Tubulitis

    R. Mehta, S. Tandukar, D. Jorgensen, I. Owoyemi, P. Sood, A. Tevar, S. Hariharan

  • Outcomes of Portal Vein Extension Grafts in Pancreas Transplantation: A Single-Centre Analysis

    S. R. Punjala, B. L. Phillips, N. Karydis, F. Calder, C. J. Callaghan

  • Outcomes of Reduced Thymoglobulin Induction Dosing in Elderly Kidney Transplant Recipients at a Steroid Sparing Center

    E. C. Liu, J. H. Lee, R. Abramova

  • Outcomes of Renal Transplantation in Elderly Patients Older Than 60 Years of Age

    R. Yemini1, E. Nesher2, R. Rahamimov3, S. Eizner2, V. Mazhybovsky2, V. Tennak2, M. Gurevich2, R. Ghinea2, E. Mor2

  • Outcomes of Total Pancreatectomyand Islet Autotransplantation, a Single Center Experience

    A. Rajab1, J. Buss1, L. F. Lara2, S. Meng3, K. Kuntz4, D. Conwell2, P. A. Hart2, K. Washburn1

  • Overcoming Anti-HLA Sensitization in Kidney Transplantation

    R. C. Siqueira1, P. Malafronte2, J. C. Baptista-Silva2, E. F. Silva2, M. C. Camargo2, M. C. Ribeiro Castro2

  • Page Kidney Phenomenon in a Trauma Patient: A Case Report and Recommendations for Management

    M. M. Estrada, D. R. Hall, W. Dar, J. S. Bynon

  • Pancreas Allograft Importation Should Be Fostered by Any Transplant Center Challenged by Excessively Long Waitlist Times

    J. Torabi, J. P. Rocca, L. Lirano, Y. Azzizi, M. Ajaimy, C. Pynadath, E. Akalin, M. Kinkhabwala, J. A. Graham

  • Pancreas Transplantation Outcomes – A Single Center Experience 400 Cases

    J. CHOI, J. Kim, H. Kwon, S. Shin, Y. Kim, D. Han

  • Panel Reactive Antibody Stratification as a Guide to Induction Selection in Deceased-Donor Kidney Transplantation: Impact of Clinical Practice on Outcomes

    H. Ibrahim1, J. Gregg1, K. Alquadan1, U. Akanit2, K. L. Womer1, A. H. Santos1

  • Panniculectomy at the Time of Living Donor Renal Transplantation: An Eight Year Experience

    L. M. Ngaage1, A. Elegbede2, K. K. Tasidina1, S. Gebran3, E. Rada1, A. J. Nam3, J. R. Scalea4, S. Niederhaus4, D. Singh1, J. S. Bromberg4, S. T. Bartlett4, Y. M. Rasko1

  • Paradoxical Differential Post-transplant Rates Of Change Of Serum Proteins In Pediatric Liver Patients With Evidence For A Novel Sarcopenic-dependent Serum Protein Stimulating Factor

    C. M. Schmidt1, J. Molleston2, G. S. Rao2, C. A. Kubal1, S. Atoa1, R. S. Mangus1

  • Paradoxical Liver Simulated Allocation Model (LSAM) Projections for Changes to Waitlist Mortality under Acuity Circle Distribution Model

    R. Lynch1, K. Ross1, S. Karp2

  • Parental Anxiety and Depression Rates across Pediatric Solid Organ Transplant Populations

    A. M. Lofton1, A. Wille1, E. A. Steinberg2, C. Buchanan2

  • Partial Freezing: Subzero Whole Liver Preservation In The Presence Of Ice

    S. E. Cronin1, C. A. Pendexter1, R. J. deVries1, S. Kimura2, S. Ozer1, P. D. Banik1, S. Nagpal1, H. Yeh2, S. N. Tessier1, K. Uygun1, M. Toner1

  • Partial Parathyroidectomy And Allograft Function In Renal Transplant Patients

    M. Gao1, E. Vilayur1, D. Ferreira2, C. Bendinelli1, C. Sankoorikal1

  • Passive Veno-venous Bypass Instead Of Centrifugal Pump Is Feasible And Low Cost For Experimental Pig Liver Transplant

    J. A. Kalil, M. Sanchez-Galvez, M. Hertl, E. Schadde

  • Pathologic Vascular Invasion Correlates with Worse Outcome in Hepatoblastoma Patients Treated with Liver Transplantation – A Hepatoblastoma Transplant Consortium Study

    T. H. Malik1, H. Zhu2, T. Ha3, S. Commander4, C. Trautz5, R. Sindhi5, S. Kim6, K. Vakili6, N. Vachharajani7, W. Chapman7, A. Griesemer8, M. Martinez8, J. A. Goss9, S. Vasudevan10

  • Patient Reported Side Effects Associated with Reduced Quality of Life after Living Donor Kidney Transplant

    J. Peipert, J. C. Caicedo-Ramirez, K. Ensor, J. Friedewald, M. Abecassis, D. Cella, D. Ladner, Z. Butt

  • Patient Response to a Formal Living Donor Liver Transplant Educational Program

    P. Narayanan, C. Palumbo, K. Ventura, R. Tomlin, L. Hammers, M. Joyce, D. Wuerth, D. Haakinson, S. Kulkarni, D. Mulligan, S. Emre, A. Liapakis

  • Patient-Reported Self-Management in Lung Transplant Candidates

    C. C. Kennedy1, M. Budev2, S. Chandrashekaran3, D. Erasmus4, E. D. Lease5, D. Levine6, K. Thompson1, E. Stevens1, R. Benzo1

  • Patients With Biliary Complications Following Orthotopic Liver Transplantation Can Be Successfully Managed By Serial Endoscopic Retrograde Cholangio-pancreatography

    R. Kaur, I. C. Morales, D. Dhillon, M. S. Ilias, S. Nagai, D. Venkat, A. Yoshida, S. Jafri

  • Patients With Persistently Low MELD-Na Scores Continue To Be At Risk Of Liver Related Death

    N. Mazumder, K. Atiemo, S. Montag, A. Daud, A. Kho, M. Abecassis, J. Levitsky, D. Ladner

  • Patients with Immunological Diseases or on Peritoneal Dialysis Are Prone to False Positive Flow Cytometry Cross Match

    Q. Xu1, A. House2, S. Leckie1, L. Gunaratnam2, P. Luke3, A. Jevnikar2

  • Patterns of Emergency Department (ED) Utilization between Transplant and Non-Transplant Centers and Impact on Clinical Outcomes in Kidney Recipients

    H. Perkins, N. Patel, V. Rohan, Z. Su, D. DuBay, J. McGillicuddy, D. Taber

  • Pediatric Kidneys: One for Two or Two for One?

    D. Das, J. Harbell, A. Mathur, A. Singer, W. Hewitt, K. S. Reddy, A. Moss, R. Heilman, C. Jadlowiec

  • Pediatric Liver Transplantation during the Opioid Epidemic: UNOS Analysis of Organ Availability and Outcomes

    J. Chu1, J. Franke2, C. Almy1, R. Annunziato2, R. Arnon1

  • Pediatric Liver Transplantation for Metabolic Disorders without Intrinsic Liver Disease: A 25 Year Experience

    P. Vuong, L. Lee, N. Mineyev, S. Conlon, R. Shetty, W. Concepcion, C. A. Bonham, A. Gallo, T. Pham, S. Busque, M. L. Melcher, G. M. Enns, C. O. Esquivel

  • Perception Of Hospital Staff On Transplant: Pre And Post-intervention

    J. Wise1, A. Sarvestani1, K. Briggs2, J. Malik2, M. Ott3, L. Markham3, H. Wilkins3, D. Neel2, C. Richart4, J. Foxworth1, M. Moncure2

  • Performance Improvement Initiative: Ambulatory Tool to Improve Tacrolimus Intrapatient Variability (IPV) Monitoring in Kidney & Liver Transplant Recipients

    T. E. Kaiser1, N. S. Ejaz1, S. Tremblay1, N. J. Parrish2, S. Schinasi2, J. Harris2, A. Govil1, N. Anwar1, R. R. Alloway1

  • Peri-Operative Basiliximab is Not Associated with Post-Transplant Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients

    D. Salerno1, N. Lange1, E. Simoneau2, C. Sammons3, D. Bley1, R. S. Brown Jr4, J. Emond2, K. Halazun5

  • Perioperative Blood Transfusion Significantly Increases Inpatient Morbidity and Mortality in Renal Transplant Recipients: 15-year Experience

    K. Mahendraraj1, G. Medrano del Rosal1, M. Kruse1, R. Shah1, T. Katsichtis1, T. Brennan2, N. Nissen2, T. Todo2, K. Kosari2, A. Klein2, I. Kim2

  • Perioperative Blood Transfusion and Risk for Post-Transplant Sensitization and Rejection

    A. Chung1, M. Kleman1, T. Pesavento1, M. Abdel-Rasoul2, R. Daloul1

  • Perioperative Cardiac Xenograft Dysfunction after Orthotopic Transplantation is for Real

    M. Mohiuddin1, A. Singh1, L. DiChiacchio1, D. Kaczorowski1, B. Lewis1, T. Zhang1, F. Sentz1, I. Tatarov1, D. Parsell1, P. Odonkor1, E. Strauss1, B. Williams1, K. Deatrick1, D. Ayares2, B. Griffith1, S. Bartlett1

  • Perioperative Lactate Levels Are Sensitive Marker to Predict Early Allograft Dysfunction and Short-Term Graft Failure after Liver Transplant

    K. Takahashi1, S. Nagai2, K. Collins2, M. Rizzari2, M. Safwan2, S. Jafri3, T. Oda1, A. Yoshida2, M. Abouljoud2

  • Peripheral Blood Chemokine Levels in Kidney Allograft Rejection

    E. Van Loon, D. Schols, S. Claes, M. Naesens

  • Peripheral Blood Regulatory T Cells In The Folow In The Kidney-transplant Patients

    M. A. Carmona-Escamilla1, G. Queipo2, L. A. Garcia-Mosqueda3, R. Lascurain4

  • Periphery Blood ddcfDNA Can Significantly Differentiate Acute Humoral Rejection from Banff’s Type I Acute Rejection in Kidney Transplantation

    R. Wang1, T. Jiang2, J. Shen1, J. Ge3, W. Lei1, X. Yang3, H. Deng1, W. Kong1, J. Zhou1

  • Peritubular Capillary C4d Positivity in Renal Allograft Biopsies: Implications for Allograft Survival

    A. Bailey, S. Tremblay, A. R. Shields, J. Wang, R. Alloway, E. S. Woodle

  • Personality Traits of Liver Transplant Candidates – Unappreciated Challenges

    D. Ladner1, J. Lai2, A. N. Hall1, E. D. Bastarache1, A. Daud1, T. Bogg3, A. Lebsack1, T. Kalume1, D. Mroczek1

  • Pgc1α Protects against Graft Ischemic Injury and Reduces Alloimmunity

    T. J. Borges1, M. T. Tran2, S. Cai1, N. Murakami1, A. Uffing1, M. Uehara1, E. P. Rhee3, S. M. Parikh4, L. V. Riella1

  • Pharmacist Impact on Vaccinations Rates in Cardiothoracic Transplant Recipients

    K. Zaborowski, J. Dedering, R. Felkner

  • Pharmacist-Led Management of Post-Transplant Hyperglycemia Reduces Hospitalizations

    V. H. Do1, I. Figueroa2, A. Elshafie3, R. Belfort De Aguiar3, D. Haakinson3, E. Cohen1

  • Pharmacokinetics of Innovative versus Generic Valganciclovir in Kidney Transplant Recipients

    I. Parra-Avila1, A. Cohen-Bucay1, J. Alberu2, G. Castañeda-Hernandez3, L. E. Morales-Buenrostro1

  • Pharmacological Enhancement of Bile Duct Preservation and Function during Ex-Situ Normothermic Machine Perfusion

    Y. L. Boteon, J. Attard, A. P. Boteon, L. Wallace, G. Reynolds, D. Mirza, H. Mergental, R. Bhogal, S. Afford

  • Phenotype and Course of Renal Tubular Cell Death during Cold Ischemia versus Cold Ischemia Followed by Transplant

    S. Jain1, R. Plenter2, T. Nydam2, A. Jani1

  • Phenotypic and Functional Analysis of Non-Activated and Allo-Activated Eomesodermin+ CD8+ T Cells in Humans and Nonhuman Primates

    A. Perez Gutierrez1, A. W. Thomson2, D. M. Metes2, M. B. Ezzelarab2

  • Pictogram Tool to Improve Medication Adherence in Heart Transplant Families with Limited English Proficiency and Low Health Literacy

    A. C. Rothkopf1, J. Chen2, N. Jasiak-Panek3, K. Le3, A. Joong4, L. J. Addonizio1

  • Pilot Testing Of A Novel Transition Program

    J. Uze, N. Yazigi

  • Platelets Stimulate Liver Regeneration in a 30% Partial Liver Transplantation Model in Rat

    C. Liang, K. Takahashi, T. Oda, N. Ohkohchi

  • Pleural Effusion In Liver Transplantation Associated With Worse Hospital Outcomes And Lower Patient Survival

    C. Vega1, J. Clouse2, A. Cabrales1, W. Bush1, C. Kubal1, R. S. Mangus2

  • Pluripotent Stem Cell Differentiation: Delaying Forward Differentiation Signals Maintains Definitive Endoderm Phenotype for Cellular Transplantation

    J. Fair1, M. M. Shoja1, N. Liu1, I. Patrikeev2, M. Motamedi2, W. S. Fagg1

  • Pneumocystis jirovecii Pneumonia among Kidney Transplant Recipients: The Forgotten Infection

    L. Bowman1, R. Baliga2, K. Zeitler1

  • Policy Changes in Liver Graft Allocation for Hepatocellular Carcinoma in the USA: Improved Survival for African American Recipients

    M. Molinari1, D. Jorgensen1, A. Tevar1, C. Hughes1, A. Humar1, N. Jonassaint2

  • Polyomavirus Genotypes In Renal Transplant Recipients In The United States

    N. Khoury1, C. Thongprayoon2, N. Leeaphorn3, J. Bruminhent4, W. Cheungpasitporn5

  • Poor Nutritional And Bone-mineral Density Parameters Pretransplant Predict Complications Posttransplant

    A. Padiyar1, A. Agrawal1, D. Hricik1, J. Kerner2, J. Benavides2, N. Sarabu1, A. Jittirat1, K. Yadav2, E. Sanchez2, M. DeBroy2, V. Humphreville2, J. Rabets2, A. Palanisamy2, K. Chavin2

  • Poor Outcomes in Kidney Transplant Candidates & Recipients with History of Falls

    N. Chu1, H. Ying1, Z. Shi1, C. Haugen1, S. Norman2, D. Segev1, M. McAdams-DeMarco1

  • Poor Practitioner Adherence to Clinical Tobacco Use Guidelines in Liver Transplant Recipients

    M. Kosirog1, P. T. Campbell1, S. Montag2, S. Connolly1, A. Daud3, A. Das1, S. Pine1, D. Finn3, J. Levitsky1, J. L. Holl4, D. Lloyd-Jones5, L. B. VanWagner6

  • Post-Donation Hypertension is Highly Associated with Estimated Nephron Number, Post-Donation Weight Gain, and Family History: A Prospective 5-Year Follow-Up after Living Kidney Donation

    T. Schachtner1, N. M. Otto2, P. Reinke2

  • Post-Transplant Anti- A Titer >1:128 in A2-Incompatible Kidney Recipients is Associated with Subclinical Antibody Mediated Rejection

    V. Kumar, D. Williams, P. MacLennan, M. Mustian, B. Orandi, L. Williams, J. Locke

  • Post-Transplant Cancer Following Living Donor HLA-Incompatible Kidney Transplantation

    J. D. Motter1, K. Jackson1, S. Bae1, X. Luo1, J. Long1, L. Kucirka1, B. Orandi2, A. Muzaale1, J. Coresh1, J. Garonzik-Wang1, D. Segev1, A. Massie1

  • Post-Transplant Cancer and Graft Failure in Kidney Transplant Recipients

    J. Kim, J. Ha, S. Min, H. Lee, Y. Kim, S. Han

  • Post-Transplant Functional Status Trajectory among Adult Kidney Transplant Recipients

    N. Chu, Z. Shi, H. Ying, C. Haugen, D. Segev, M. McAdams-DeMarco

  • Post-Transplant Lymphopenia is Associated with Higher Risk of Graft Failure, Death and Viral Infections

    A. Dujardin1, M. Lorent2, C. Kerleau1, S. Brouard3, M. Giral1

  • Post-Transplant Lymphoproliferative Disorders after Living-Donor Liver Transplantation: A Retrospective Cohort Study in 1,900 Cases of Single Center Experience

    T. Tajima1, K. Hata1, H. Haga2, M. Nishikori3, J. Kusakabe1, I. Tamaki1, T. Ito1, T. Kaido1, A. Takaori-Kondo3, S. Uemoto1

  • Post-Transplant Lymphoproliferative Disorders in Pediatric Renal Transplant Recipients: Case Series of 5 Patients

    M. E. Araujo1, C. Metran1, R. Cardoso1, G. Araujo1, T. De Paula1, L. Cristofani2, M. F. Pereira3, D. David4, A. Watanabe1

  • Post-transplant Lymphoproliferative Disorder Following Intestine Transplantation: Contemporary Single Center Experience

    A. Zimmerman, J. Hawksworth, A. Kroemer, P. Radkani, K. Khan, S. Kaufman, N. Yazigi, S. Subramanian, T. Fishbein, C. Matsumoto

  • Postoperative Atrial Fibrillation in Kidney Transplant Recipients: A Retrospective Study Evaluating Risk of Anticoagulation

    P. Serrano Rodriguez1, A. Vijayakumar2, P. D. Strassle3, K. Szempruch1, C. S. Desai1, A. Vijay1, A. H. Toledo1, D. A. Gerber1

  • Postoperative Telemonitoring Following Kidney Transplantation: Effects on Early Hospital Readmissions and Graft Outcomes

    N. Elfadawy, V. Humphreville, A. Padiyar, E. Sanchez, N. Sarabu

  • Pre Transplant Intact FGF 23 Modifies Post-Transplant Improvement in Cognition

    J. A. Klein1, A. Jurgensen1, J. Stubbs1, P. Rowe1, D. Cibrik1, W. Brooks2, J. Burns3, Z. Lauer4, A. Gupta1

  • Pre-Kidney Transplant Patient Education: Information Retention is Associated with Improved Waitlist Outcomes

    S. Patel, J. Ptasinski-Anderson, G. Dela Torre, S. Akkina

  • Pre-Operative C-Peptide Predicts Weight Gain after Pancreas Transplantation

    J. Torabi, J. P. Rocca, E. Kestenbaum, M. Ajaimy, M. Kinkhabwala, J. A. Graham

  • Pre-Transplant Multidimensional Flow Cytometric Analysis of Kidney Transplant Recipients Reveals Novel Immune Signature of Allograft Rejection

    P. Schroder1, J. S. Yi1, K. J. Weinhold1, C. Chan2, M. Joshi3, C. Walters3, J. Kwun1, S. J. Knechtle1

  • Pre-Transplant Patient and Caregiver Assessments: A Systematic Review and Meta-Analysis

    J. Lau, A. A. Rmilah, R. Mendpara, P. J. Erwin, C. C. Kennedy

  • Pre-Transplant Ventricular Assist Device (VAD) Impacts Heart Transplant (HT) Survival

    M. S. Gharibdousti1, M. T. Khasawneh2, A. L Friedman3

  • Pre-Treatment Lymphocyte Status in HCC Patients Associates with DEB-TACE Response and Correlates with Increased Regulatory Immune Cells

    K. Nunez1, T. Sandow2, S. Robertson1, P. Thevenot1, A. Cohen1

  • Pre-emptive Ivig For Dsa Positive Living Donor Kidney Transplant Recipients

    B. Abdalla1, D. Kellner2, A. Diaz2, Y. Zheng3, E. Reed4, Q. J. Zhang4

  • Predicting Deceased Donor Kidney Transplant Outcomes: Comparing KDRI/KDPI with Machine Learning

    E. Pahl

  • Predicting Graft Function And Long-term Outcomes Following Kidney Transplantation Using An Intraoperative Tissue Oximetry Sensor

    H. Lau, A. Shimomura, E. Tantisattamo, U. G. Reddy, D. Dafoe, H. Ichii

  • Predicting Metabolic Outcomes in Islet Autotransplantation before Transplantation

    M. A. Kanak, P. Saravanan, J. Kalivarathan, Y. Shindo, M. F. Levy

  • Predicting Post Liver Transplant 30-Day Readmission Using Deep Neural Network Model

    S. K. Niazi1, H. O. Park2, R. E. Carter3, A. Keaveny4, T. Schneekloth5, A. Spaulding6, D. Harnois4, P. F. Moreno-Franco7, E. Vargas6, T. Rummans1, C. Taner7

  • Predicting Risk of Cytomegalovirus with Viral-Antigen-Specific CD154+ T-cells after Liver or Intestine Transplantation

    C. Ashokkumar, K. Soltys, M. Green, G. Mazariegos, G. Bond, K. Jones, A. Rzempoluch, M. Zaccagnini, P. Sethi, B. W. Higgs, R. Sindhi

  • Prediction of Renal Allograft Chronic Rejection Using a Model Based on Contrast Enhanced Ultrasonography

    C. Yang1, T. Zhu1, W. He2

  • Predictive Factors for BKV Nephropathy in Renal Transplant Recipients with BK Viruria

    I. Alshaer, M. Bottomley, S. Mehta, J. Galante, I. Roberts, E. Sharples

  • Predictors Of Persistent Hyperparathyroidism After Successful Kidney Transplant: A Single Center Pilot Study

    S. Ong, K. Wille, F. Saad, C. Kew

  • Predictors of Glomerular Filtration Rate after Renal Transplantation

    O. Andacoglu, Y. Dong, J. Liu, M. Parides, J. Rocca, J. Graham, M. Ajaimy, Y. Azzi, C. Pynadath, L. Liriano-Ward, M. Kinkhabwala, E. Akalin, S. Greenstein

  • Pregnancy Outcomes by Conception Age in Female Liver Transplant Recipients

    M. Sarkar1, L. A. Coscia2, D. Kliniewski2, S. Rao3, S. Constantinescu4, M. J. Moritz5

  • Pregnancy Outcomes in Kidney Transplant Recipients

    H. SHIRAKAWA1, S. WAKAI2, K. UNAGAMI3, K. OMOTO4, T. SHIMIZU4, Y. KAKUTA5, M. OKUMI5, H. ISHIDA5, M. OGAWA6, K. TANABE5

  • Pregnancy after Renal Transplantation

    A. Schwarz1, F. Keller2, H. Haller1

  • Pregnancy in Renal Transplant Recipients A Single Center Retrospective Study

    O. PISCORAN1, K. Bhatia1, T. Augustine1, S. Kopargaonkar2, J. Gillham2

  • Preoperative Marginal Factors Do Not Affect the Medically Complex Living Donors for Kidney Transplantation

    T. Hiramitsu, T. Tomosugi, K. Futamura, M. Okada, M. Tsujita, T. Ichimori, N. Goto, S. Narumi, Y. Watarai

  • Preoperative Simulation and Rehearsal of Robotic Living Donor Transplant Nephrectomy Using Patient Specific 3D Printed Hydrogel Models

    R. Kashyap1, G. Wu2, R. Melnyk2, E. Coppola2, S. Farooq2, T. Holler2, M. Thompson3, M. Dokus1, J. Taylor4, R. Hernandez1, J. Joseph2, A. Ghazi2

  • Prevalence of Diabetes after Transplant in a Single Center

    L. J. Koh1, W. P. Yau2, M. Than1, K. H. Ng1, A. Vathsala3, H. K. Yap1

  • Prevalence of Donor Specific Antibody in Heart Transplant Recipients with Antibody-Mediated Rejection as Compared to Abnormal Intragraft mRNA Transcripts by Molecular Microscope System

    K. Shah, R. J. Levine, S. Dimbil, S. Sana, P. F. Halloran, J. Patel, D. H. Chang, E. Kransdorf, M. Kittleson, J. A. Kobashigawa

  • Prevalence of Non-Adherence to Immunosuppressive Medications in Kidney Transplant Recipients, Barriers and Predictors

    S. Taj1, H. Baghaffar2, D. Alnajjar2, N. Almashabi3, S. Ismail4

  • Prevalence of Overweight and Obesity in Children after Kidney Transplantation. Risk Factors and Outcomes

    M. L. Monteverde1, J. M. Velasco1, M. E. Izzo2, M. Mannarino2, J. P. Ibanez1, A. B. Chaparro1, C. E. Vezzani1

  • Prevalence of Recurrent and De Novo Glomerular Diseases after Renal Transplantation: A Single Center Experience

    M. Ajaimy, O. Mohammed, E. Akalin

  • Prevalence of Varicella Zoster Infection in Renal Transplant Recipients

    P. T. Gaynor, D. Nanayakkara, O. E. Beaird, J. Schaenman, S. Bunnapradist

  • Prevention of Diabetes in the NOD Mice Reconstituted with Bone Marrow Cells from Allogeneic CD4 Knockout, CD8 Knockout or B-Cell Knockout B6 Mice

    Y. Huang, H. Xu, Y. Wen, S. Ildstad

  • Prevention of Diabetic Nephropathy after Kidney Transplantation Requires More Than Pursuing Low Levels of Glycated Hemoglobin

    M. Coemans, E. Van Loon, E. Lerut, D. Kuypers, B. Sprangers, P. Gillard, C. Mathieu, G. Verbeke, M. Naesens

  • Prevention of Islet Allo- and Xenograft Rejection with Immunoglobulin M Immunotherapy

    M. Ma, P. Chhabra, K. Brayman

  • Primary Nonfunction after Kidney Transplantation is Associated with Elevated Donor Urinary Biomarkers

    S. Mohan, P. Reese, I. Hall, M. Doshi, Y. Jia, H. T. Philbrook, E. Akalin, J. Bromberg, M. Harhay, S. Mansour, T. Muthukumar, B. Schröppel, P. Singh, F. Weng, C. Parikh

  • Primary Uretero-Ureterostomy In Organ Transplants

    H. Shokouh-Amiri, B. Samant, N. Singh, R. McMillan, D. Aultman, T. Siskron, H. Samant, G. Zibari

  • Prognostic Value Of Dobutamine Stress Echocardiography In Heart Transplantation Recipients

    A. Singhvi, R. Araujo-Gutierrez, M. H. Park, A. Bhimaraj, B. H. Trachtenberg, I. Hussain, A. Guha

  • Prolonged Cold Ischemic Storage Induces Allograft Necro-Inflammation That Increases Graft Susceptibility to T Cell Mediated Rejection

    N. Chun1, R. Ang1, J. Horwitz1, R. Fairchild2, W. Baldwin III2, A. Ting1, P. S. Heeger1

  • Prolonged Fluoroquinolone Prophylaxis to Prevent BK Viremia in Kidney Transplant Recipients

    S. A. Muhsin1, S. J. Ripley2, M. L. Jacobs3, K. Safa1, D. M. Wojciechowski1

  • Prolonged Heterotopic Cardiac Xenograft Survival from Thrombomudulin Expressing Multigene Donor Pig

    A. K. Singh1, L. DiChiacchio1, T. Zhang1, A. Hersfield1, I. Tatarov1, D. Parsell1, B. Lewis1, F. Sentz1, D. Ayares2, M. Mohiuddin1

  • Prospective BK Virus Screening in the Early Post-Kidney Transplant Period: A Single Center Experience

    N. Parrish1, S. Stander2, M. Anand2, B. G. Abu Jawdeh2, A. Govil2

  • Prospective Evaluation of Living Kidney Donor Anxiety: Concerns, Anxiety Mitigation, and Realized Negative Experiences

    A. A. Krause, R. S. Mangus, M. French, V. Martine, J. Powelson, W. C. Goggins

  • Protective Effect of Ischemic-Free Liver Transplantation Technique on Distant Multiple Organ Function

    L. Wang1, Z. Guo1, L. Yang2, W. Xiong2, S. Huang1, T. Zhang2, Y. Tang1, Z. Zhang1, Z. Zhu1, C. Zhu1, X. He1

  • Protocol Cidofovir for Refractory Polyomavirus Associated Nephropathy in Kidney Transplant Recipients

    J. Clark, A. Haririan

  • Proximal Splenic Artery Embolization Is A Safe And Effective Tool To Treat Two Sides Of The Same Coin After Liver Transplant: Persistent High Hepatic Artery Resistive Index And Refractory Ascites And Hydrothorax Due To Portal Hyperperfusion

    L. Lomaglio, H. Matsushima, A. Simioni, G. D'Amico, T. Diago Uso, K. Hashimoto, B. Eghtesad, M. Fujiki, F. Aucejo, K. Sasaki, C. Kwon, C. Coppa, M. Bayona Molano, C. Miller, C. Quintini

  • Pulmonary Complications in Living Liver Donors

    D. Esendagli1, E. Ayvazoglu Soy2, E. Kupeli1, A. Akdur2, S. Yildirim2, A. Torgay3, S. Boyacioglu4, M. Haberal2

  • Pushing the Limits: A Large Multicentric Case-Control Study Evaluating the Impact of Kidney Transplants from Expanded Criteria Donors after Controlled Circulatory Death the Limits: A Large Multicentric Case-Control Study Evaluating the Impact of Kidney Transplants from Expanded Criteria Donors after Controlled Circulatory Death

    N. Toapanta1, R. Alvarez2, G. Lluís3, C. Facundo3, F. Diekmann4, I. Revuelta4, M. Meneghini2, F. Moreso1, O. Bestard2

  • QA of MMR/VZV Protocol-Driven Serologic Screening and Infectious Disease Consultation (IDC) Are Strongly Recommended in Heart, Lung, Liver (HLL) SOTs

    Z. Seckin, L. Brumble, C. Libertin

  • Qualitative Recovery Outcomes of Living Kidney Donors

    J. Huang1, M. Mahoney2, J. Buggs1, E. Rogers1, A. Kumar3

  • Quality of Life After Islet/Pancreas Transplantation in Insulin Dependent Diabetic Patients: A Systematic Review of the Literature.

    I. Mosca1, S. Knight2, S. Mittal3, P. J. Friend1

  • Quality of Life in Tolerant Living Donor Kidney Transplants vs. Standard of Care

    D. Tollerud1, J. Leventhal2, J. Galvin2, J. Mathew2, L. Gallon2, D. Stare2, J. Miller2, M. Abecassis2, S. Ildstad3

  • Quantifying Opioid Use after Renal Transplantation

    B. C. Noell, J. R. Brown, K. T. Cooper, A. M. Wagner, A. Kupsco, V. Casingal

  • Quantifying Patient Perspectives On Paired Kidney Exchange

    M. Duda1, M. Houston1, D. Collins1, P. Porrett2

  • Quantitative Epstein-Barr Virus Viral Load Monitoring in Pediatric Kidney Transplantation

    C. Metran1, M. E. Araujo1, R. Cardoso1, G. Araujo1, T. De Paula1, L. Cristofani2, F. Penteado3, M. F. Pereira3, A. Watanabe1

  • Quantitative Measuring of Iliac Artery Calcification in Renal Transplantation

    C. Choi1, A. Han2, S. Ahn2, M. Ahn1, S. Min2, J. Ha2

  • Quantitative Proteomics Analysis of Ischemia Reperfusion Injured Liver Tissue Provides Insight into Liver Allograft Quality Evaluation

    M. Chen, M. Han, W. Ju, Q. Zhao, D. Wang, Z. Guo, X. He

  • REHANNA: Renal Transplants in Hepatitis C Negative Recipients with Nucleic Acid Positive Donors with Short Course Direct Acting Antiviral Prophylaxis

    C. Durand, B. Barnaba, D. Brown, N. Bair, F. Naqvi, M. Bowring, D. Segev, M. Sulkowski, N. Desai

  • RNA Splicing and Lineage Progression: Identification of an Integrated Splicing Pattern in Endodermal Lineage Progression

    J. Fair1, N. Liu1, S. G. Widen2, W. S. Fagg1

  • Rabbit Anti-Thymocyte Globulin (rATG) Induction in Heart Transplant Recipients at High Risk for Rejection

    B. Kitto1, B. Baetz1, S. Krim2, H. Patel2, S. Mandras2, S. Desai2, C. Eiswirth2, H. Ventura2, S. Thai1

  • Racial Differences in Acute Kidney Injury Occurrence among Deceased Kidney Donors

    M. Doshi1, I. Hall2, S. Mohan3, C. Liu4, H. Philbrook4, P. Reese5, S. Mansour6, F. Weng7, E. Akalin8, J. Bromberg9, M. Harhay10, T. Muthukumar11, B. Schroeppel12, P. Singh13, C. Parikh4

  • Racial Differences in Cancer Mortality for Kidney Transplant Recipients

    K. Cordrey, J. Motter, A. Kernodle, K. Jackson, M. Camp, T. Purnell, D. Segev, J. Garonzik Wang

  • Racial Disparities in Documentation of Non-Adherence and Its Relation to Rejection in Pediatric Kidney Transplant Recipients

    T. Melanson, J. Hogan, K. Maroney, R. Patzer, R. George

  • Racial and Ethnic Differences in Physician Trust and Hypertension Treatment Adherence among Living Kidney Donors in the United States

    J. S. Wilson Jr1, L. Cooper2, M. Johnson2, M. Waldram2, Y. Yu2, J. Perkins2, D. Crews2, N. Lacy3, M. Henderson2, A. Massie2, K. Lentine4, D. Segev2, T. Purnell2

  • Rcor1 and Regulation of Foxp3+ T-Regulatory Cells In Vitro and In Vivo

    Y. Xiong, L. Wang, R. Han, W. W. Hancock

  • Real World Data Support International Consenus Guidelines on Management of CMV after Kidney Transplantation

    A. Asberg, G. B. Kro, A. V. Reisæter, A. Hartmann, K. Midtvedt

  • Real World Impact of HCV Viremic Solid Organs on Waitlist Times

    N. Kapila1, A. Ur Rahman1, K. Gupta2, K. Al Khalloufi3, E. Navas3, D. Reino3, S. Ebaid3, N. Agarwal3, J. Shaw3, C. Murgas3, S. Rhazouani3, A. Zeeshan3, A. Tzakis3, C. Sheffield3, J. Vanatta3, X. Zervos3

  • Recipient Predictors of Post-Donation End Stage Renal Disease in Living Kidney Donors

    J. Wainright1, A. Robinson1, A. Wilk1, D. Klassen2, W. Cherikh1, L. Cartwright1, D. Stewart1

  • Recipient TIM4 Expression is Essential for Hepatocellular Function in Liver Transplantation

    K. Kadono, S. Kageyama, H. Hirao, K. Nakamura, K. J. Dery, D. Oncel, T. Ito, B. Ke, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski

  • Recipient and Donor Factors at the Time of Transplant as Predictors of Graft Outcomes

    K. Soliman1, V. Rohan2, S. Zemin1, A. Price1, A. P. Salas1, D. Lazarus1, M. Casey3, D. J. Taber2, V. Rao3

  • Redefining Cirrhotic Cardiomyopathy; A Shifting Paradigm

    M. J. Izzy1, M. Angirekula2, M. Leise2, A. Allen2, K. Watt2

  • Redox State of HMGB1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation

    R. A. Sosa1, A. Q. Terry1, J. Nevarez-Mejia1, M. Rossetti1, B. V. Naini1, V. M. Groysberg1, F. M. Kaldas2, R. W. Busuttil2, D. W. Gjertson1, J. W. Kupiec-Weglinski2, E. F. Reed1

  • Reduced Intensity Induction Therapy in Patients Undergoing Repeat Kidney Transplants

    K. Linhares, M. Cristelli, C. Felipe, L. Viana, H. Proença, R. E. de Marco, J. Pestana, H. Tedesco

  • Reduction of Circulating DSA: Does It Affect Histology?

    M. Gupta1, E. Edusei1, S. Tsai2, M. Magruder2, J. Lee1, J. Lee1, C. Hartono1, T. Muthukumar1, M. Everly3, D. Dadhania1

  • Reduction of Pre-Existing Alloantibodies in Highly Sensitized Belatacept-Treated Kidney Recipients

    R. F. Parsons1, S. Bumb2, H. Decker1, A. Zahid1, C. Sullivan1, T. Pearson1, C. Larsen1, M. Levine3, M. Kamoun3, R. A. Bray1, H. M. Gebel1

  • Reference Ranges Donor-Derived Cell-Free DNA in a Heart Transplant Population

    A. Kao1, S. Dholakia2, M. Deng3

  • Regeneration of Kidney with a Novel Biomimetic Vascular Scaffold

    S. Min1, H. Mo1, A. Han1, J. Ha1, J. Yoo2

  • Rejection, Infectious, and Renal Outcomes with Perioperative Desensitization in Orthotopic Heart Transplant Recipients

    M. Plazak, B. Reed, S. Hammad, S. Gale, V. Ton, D. Kaczorowski, T. Trobiano, B. Ravichandran

  • Relationship between HLA-DPB1 Gene Expression in Pre-Implantation Kidney Biopsies, Rs9277534 Polymorphism, and Late Graft Function

    K. L. Mine1, T. B. Mourão1, C. Felipe2, G. F. Rampim1, J. O. Medina-Pestana2, H. Tedesco-Silva2, M. Gerbase-DeLima1

  • Renal Allograft Survival after Dual Kidney Transplantation is at Least as Favorable as Outcome after Expanded Criteria Donor Kidney Transplantation

    A. Brar1, M. Sattar1, A. Gruessner1, R. M. Jindal2, R. Nee3, R. Gruessner1, M. Salifu1

  • Renal Cell Carcinoma in Dialysis Patients: Criteria for Transplant Wait List Inclusion

    D. B. Laskar1, J. Zeng1, S. Sharma2, M. T. Smith Jr3, A. D. Nicastri1, D. Levitan4, R. Maglantay1, D. John3, S. R. Gottesman1

  • Renal Function between Tenofovir and Entecavir in Post-Liver Transplanted Hepatitis B Patients

    S. Kim, J. Kim, S. Lee, J. Rhu, Y. Chung, S. Kim, J. Joh, S. Lee, G. Choi, J. Park, S. Lee, K. Lee

  • Renal Function, Albuminuria, and the Risk of Hemorrhage and Thrombosis after Kidney Transplantation

    N. N. Lam1, P. Ravani2, R. R. Quinn2, M. Tonelli2, F. Ye1, B. R. Hemmelgarn2, M. M. Sood3

  • Renal Pathological Findings in Living Kidney Donor Candidates with Minimal Urinary Abnormalities

    H. Ahmed1, C. Drachenberg2, R. Ugarte1, N. Costa1, C. Cangro1, R. N. Barth3, M. Weir1, A. Harirain1

  • Renal Transplantation and Sleep: What do Patients Distress for?

    L. Long, J. Liu, J. Xie, J. Yan

  • Renal Transplantation from a Living Donor with a Horseshoe Kidney

    J. CHOI, J. Jung, J. Kim, H. Kwon, S. Shin, Y. Kim, D. Han

  • Repeat Liver Transplantation after Failed First Transplant in Childhood: Development of a Retransplant Risk Index

    M. Gupta1, M. Barry2, M. Levine3, K. Olthoff3, A. Shaked3, P. Abt3

  • Report of 20 HLAMatchmaker Eplets Present on Denatured Class I HLA Molecules

    R. de Marco1, A. C. Lima2, N. F. Pereira2, M. Gerbase-DeLima1

  • Requirements Of A Successful Pediatric To Adult Transition Program For Kidney Transplant Recipients. A Single Center Experience.

    H. Youness, D. Zepeda-Orozco, L. Harshman, S. Kuppachi

  • Resistance of T Follicular Helper Cells to Depletion by Anti-Thymocyte Globulin

    M. Pérez-Sáez1, N. Murakami2, T. J. Borges2, P. T. Sage2, J. Pascual1, L. V. Riella2

  • Resource Utilization in Hepatocellular Carcinoma Liver Transplantation before and after the Six Month Wait Time

    J. Sokolich1, W. McClellan2, J. Buggs1, E. Rogers1, K. Barber1, K. Cocuy1, A. Kumar2

  • Responder B Cell Depletion Increased Allo-Reactive Regulatory T Cells Generated in Allo-Anergization

    N. Tanimine1, L. Contreras-Ruiz2, K. Deng1, N. Feeney1, C. Rickert1, K. Lee1, E. Guinan3, J. Markmann1

  • Restrictive Medicaid Policies Reduce Access to Liver Transplant for Alcohol-Associated Liver Disease

    B. P. Lee, V. Eric, P. Mark, J. Dodge, N. Terrault

  • Retroperitoneoscopic Native Nephrectomy in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease

    K. Hotta1, D. Iwami2, J. Furumido2, K. Morita3, T. Tanabe4, T. Mochizuki4, H. Higuchi2, N. Iwahara2, T. Abe2, K. Kanagawa4, N. Shinohara2

  • Retrospective Evaluation of Dapsone Prophylaxis Complications in Kidney Transplant Recipients

    S. Hamel1, V. Johnson2, D. Johnson2, E. Blumberg3, R. Bloom4, J. Trofe-Clark2

  • Retrospective Evaluation of Optimal Cmv Prophylaxis Regimens in Lung Transplant Patients: Analysis of Patient Outcomes Pre and Post Protocol Dosing Alterations

    J. Hunt, A. Nasar, R. Walia, L. Cherrier

  • Retrospective Nested Case Control Study of the Impact of Immunosuppression on Post Transplant Malignancy among Adult Heart Transplant Patients

    S. Crow, R. J. Bubik, S. S. Kushwaha, K. C. Mara, R. A. Dierkhising, N. L. Pereira

  • Return to Work after Sick Leave in Kidney Transplant Recipients: A 365-Day Cohort of the Japan Academic Consortium of Kidney Transplantation (JACK) Study

    K. Miyake1, M. Okumi1, K. Unagami2, Y. Kakuta1, M. Furusawa1, K. Omoto3, T. Shimizu3, M. Endo4, H. Ishida2, K. Tanabe1

  • Risk Factors for Graft Loss Vary with Recipient MELD Score in Liver Transplantation

    J. A. Steggerda1, M. B. Bloom1, T. Todo2, T. V. Brennan2, N. N. Nissen2, A. S. Klein2, I. K. Kim2

  • Risk Factors for Post-Transplant Outcomes in Living and Deceased Donor Liver Transplantation. An Analysis of UNOS Registry

    T. Kitajima, S. Nagai, K. Collins, M. Rizzari, A. Yoshida, M. Abouljoud

  • Risk Factors for Recurrent Urinary Tract Infections and Antimicrobial Resistant Organisms in Kidney Transplant Recipients

    S. Greissman1, A. Mattiazzi2, J. Quinonez1, M. Grady1, R. Zukerman1, A. Wawrzyniak3, M. Morris4, S. Anjan4, J. Simkins4, J. Camargo4, L. Abbo5

  • Risk Factors for Sensitization in the Failing Allograft: A Multi-Center Experience

    M. Lubetzky1, O. Mohammed2, N. Hauser1, R. Friedlander1, V. Sharma1, A. Colovai2, T. Muthukumar1, J. Lee1, E. Akalin2, D. Dadhania1

  • Risk Predictive Strategy to Expand Pancreas Donor Selection

    J. W. Mensink1, K. M. Ooms - de Vries2, V. A. Huurman1, R. A. Pol3, I. P. Alwayn1, A. E. Braat1

  • Risk of Opportunistic Infection in Kidney Transplant Recipients with Cytomegalovirus Infection and Associated Outcomes

    M. Jorgenson1, J. Descourouez1, B. Cardinale2, B. Lyu3, B. Astor3, N. Garg3, C. Saddler3, J. Smith3, D. Mandelbrot3

  • Rituximab Desensitization to Liver Transplantaiton Recipients with Preformed Donor Specific Antibodies to Prevent Antibody Mediated Rejecton

    Y. Ogura, M. Shizuku, N. Kurata, K. Jobara, H. Kamei

  • Rituximab Protects against Development of Atherosclerotic Cardiovascular Disease after Kidney Transplantation, a Propensity Matched Analysis

    D. Kim, J. Lee, J. Lee, B. Kim, M. Kim, S. Soon Il, Y. Kim, K. Huh, S. Kim, D. Joo, K. In, E. Kim

  • Robotic Donor Nephrectomy: Is It Safe Alternative?

    D. Friedman, R. Shahbazov, I. Bandler, T. Malik, Z. Acun, K. Olivera-Wright, B. Gallay, O. Pankewycz, M. Laftavi

  • Robotic Kidney Transplantation For Obese Patients: First Year Experience In Single Institute

    S. Lee1, L. A. Cantrell2, A. Agarwal1, S. K. Rasmussen1, S. Pelletier1, K. Brayman1, J. Oberholzer1

  • Robotic Pancreas Kidney Transplantation For Type 1 Diabetic Patient With End stage Renal Disease: First Year Experience In Single Institute

    S. Lee1, L. A. Cantrell2, A. Agarwal1, S. K. Rasmussen1, S. Pelletier1, K. Brayman1, J. Oberholzer1

  • Role of Kidney Biopsy in Simultaneous Heart-Kidney Transplantation

    P. B. Shah1, M. A. Josephson1, K. Henriksen2, A. Chang2

  • Role of Mitochondria, Metabolism and Inflammation: Pathways Influencing Short Term Outcomes Post-Renal Transplantation

    S. Bontha1, A. Bajwa1, G. Lorenzo2, J. Eason3, D. Maluf4, V. Mas5

  • Role of Molecular Microscope in the Interpretation of Endarteritis and Acute Thrombotic Microangiopathy

    M. Ciszek1, A. Perkowska-Ptasińska1, D. Deborska-Materkowska1, A. Debska-Slizien2, P. F. Halloran3, M. Myslak4

  • Role of RIPK3 in Chronic Rejection Following Human Lung Transplantation

    S. Angara, R. Ravichandran, H. Sodawalla, M. Smith, R. Bremner, T. Mohanakumar

  • Room for Improvement: Adherence to Vaccination Recommendations in a Heart Transplant Cohort

    D. Jandhyala, J. D. Lewis

  • S1PR1 and S1PR4 Regulate T Cell Migration into Afferent Lymphatics

    Y. Xiong1, W. Piao1, C. Brinkman1, L. Li1, J. Kulinski2, A. Olivera2, A. Cartier3, T. Hla4, K. Hippen5, B. Blazar6, S. Schwab7, J. Bromberg1

  • Safety Outcomes in Elderly Patients Who Receive Alemtuzumab Induction for Kidney Transplant

    S. Anders, A. Freeman, A. Mohammed, L. Hutchinson, U. Kaszubski, M. Janusek, J. Garces, H. Bohorquez

  • Safety and Efficacy of Alemtuzumab Compared to Rabbit Anti-Thymocyte Globulin as Induction for Secondary Transplant after a Primary Transplant with Alemtuzumab Induction

    J. L. Fose1, M. R. Jorgenson1, G. E. Leverson2, R. R. Redfield2

  • Safety and Efficacy of Anti Xa Inhibitors Post-Transplant with Concomitant Calcineurin Inhibitors

    K. A. McMurry1, J. Shuster2, K. Bain2, T. Horwedel3, J. Hartupee2

  • Safety and Efficacy of Peri-Operative Sublingual Tacrolimus in Pancreas Transplant as Compared to Oral Tacrolimus

    N. Patel, C. Perez, D. Taber, V. Kalbavi, V. Rohan

  • Scaffold-Free 3D-Bioprinting of Human Extrahepatic Bile Duct

    K. Saglam1, W. Zhang1, L. J. Smith2, A. Isidan1, A. M. Chen1, R. A. Naqvi1, E. Gramelspacher1, P. Li1, B. Ekser1

  • Screening for Renal Cell Masses in Kidney Transplant

    H. E. Fernandez, D. Tsapepas, D. J. Cohen, M. Sumit, L. E. Ratner

  • Self-reported Marijuana Use In Kidney Transplant Candidates And Its Association With Access To Transplantation

    S. Rodriguez Ramirez, E. Tang, O. Famure, A. Bansal, J. Kim, I. Mucsi

  • Sensitivity of 5-Tier System to Unadjusted Confounding

    N. Salkowski, A. Wey, J. Snyder

  • Sequential Dosing of Rituximab and IVIg for Desensitization of Highly-HLA Sensitized (HS) Patients Awaiting HLAi Kidney Transplantation

    A. A. Vo, E. Huang, S. Williamsons, C. Myers, A. Peng, R. Najjar, S. Sethi, K. Lim, N. Ammerman, S. C. Jordan

  • Sequestration of PLIN2 Regulates High-Fat Diet Induced Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in a Mouse Model of Ischemia Reperfusion Injury

    K. Loh1, X. Liu1, L. Belyayev1, C. Albanese2, W. Cui1, T. M. Fishbein1, K. M. Khan1, A. Kroemer1

  • Serum Adipocyte Fatty Acid Binding Protein Level is Negatively Associated with Vascular Reactivity Index Measured by Digital Thermal Monitoring in Kidney Transplant Patients

    M. Lee1, B. Hsu2

  • Serum Apolipoproteins B and A1 Predict the Development of Late Post-Transplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients

    R. Malyala, L. Rapi, M. Nash, G. Prasad

  • Severe Acute Rejection In Human Leukocyte Antigen Identical Renal Transplants: Reviving Mixed Lymphocyte Culture

    P. Rajendran1, M. Cusick2, S. Dhingra3, B. Murthy1

  • Severe Hyponatremia with Intraoperative Desmopressin Use in (Deceased and Living Donor) Renal Transplant Recipients

    M. Gill, S. Kuppachi, C. Thomas

  • Sex Specific Regulation of Podocyte-Specific Genes and Proteins Determines Glomerular Response to mTOR Inhibition

    A. Kusch1, O. AlDiab2, D. Gürgen2, C. Sünkel3, F. Grahammer4, M. Rinschen5, T. Huber4, N. Rajewsky3, D. Dragun2

  • Sex, Race, Social Networks, and Requests for Living Donation

    A. Gillespie1, H. Gardiner2, E. L. Fink3, P. P. Reese4, C. Gadegbeku1, Z. Obradovic5

  • Share 21 Rather Than Share 15: Balancing Transplant Opportunity without Compromising Waitlist Outcomes

    S. Nagai1, L. C. Chau1, M. Abouljoud1, K. Collins1, S. Jafri2, M. Safwan1, D. Moonka2

  • Short and Long Term Outcomes of Retrograde vs Antegrade Reperfusion of Liver Transplants. A Propensity Matched Pair Analysis

    H. Sharma, B. Shrum, D. Quan, A. Skaro, W. Wall, V. McAlister.

  • Should Preceding Solo-Kidney Transplantation for Patients with Type 1 Diabetes with End Stage Renal Failure Be Carried Out?

    T. Ito, T. Kenmochi, K. Kurihara, A. Kawai, N. Aida

  • Significant Implications of Prior Transplantation on Treatment and Outcomes of Patients Suffering from Traumatic Brain Injury

    L. Mugge, W. Qu, C. Gallagher, A. Caras, N. Henkel, O. Ekwenna, J. Ortiz

  • Silent Allograft Fibrosis in 10-Year Post-Transplantation Histology of Pediatric Liver Transplantation: Is It Really Silent?

    S. Lee, S. Lee, J. Rhu, Y. Chung, S. Kim, K. Lee, S. Lee, J. Kim, G. Choi , J. Park, S. Kim, J. Joh

  • Similar Quality in Chronic Kidney Disease Multidisciplinary Follow-Up between Kidney Transplant and Pre-Dialysis Patients

    M. Carminatti, N. M. Fernandes, F. A. Colugnati, H. Sanders-Pinheiro

  • Simulation of DSA-Free Lung Allocation

    M. Skeans1, J. Pyke1, K. Audette1, R. Lehman2, K. Uccellini2, K. M. Chan3, E. D. Lease4, R. Daly5, M. Valapour6

  • Simulation vs. Reality: 250NM as First Unit of Lung Allocation

    M. Skeans1, J. Pyke1, C. Lehr2, R. Lehman3, K. Uccellini3, K. M. Chan4, E. D. Lease5, R. Daly6, M. Valapour2

  • Simultaneous Recipient Iliac Endarterectomy and Renal Transplantation: A Propensity Score Matched Study

    O. Okoye, M. Spaggiari, J. Almario, V. Qiao, K. Tulla, P. Di Cocco, E. Benedetti, I. Tzvetanov

  • Single-Port Robotic Kidney Transplantation: Initial Pre-Clinical Experience Using the SP Surgical System

    M. Eltemamy, J. Garisto, R. Bertolo, E. Miller, A. Wee, J. Kaouk

  • Single-center Retrospective Analysis of Prophylaxis and Treatment of Pneumocystis Carinii Pneumonia in Patients with Poor Renal Function

    Y. Fu, J. Pan, Z. Shen

  • Sirolimus in Geriatric Kidney Transplantation: Modification of Outcomes by Pre-Transplant History of Malignancy or Cardiovascular Disease

    H. Ibrahim1, C. Chen2, K. Alquadan3, X. Wen4, K. L. Womer3, A. H. Santos Jr1

  • Slowed Progression of Maximal Intimal Thickening by Intravascular Ultrasound after Initiation of Sirolimus

    A. Putschoegl1, K. Campbell1, M. Everitt1, S. Miyamoto1, B. Pietra2, S. Auerbach1

  • Social Determinants of Quality of Life in Patients Evaluated for Kidney Transplant

    H. Wesselman1, S. Wang2, C. J. Chang2, J. R. Pleis3, K. Kendall2, E. Croswell2, M. Dew2, M. L. Unruh4, R. Shapiro5, L. Myaskovsky4

  • Soluble Fibrinogen-Like Protein 2 Regulates MDSCs Differentiation and Function in Allograft Immunity

    C. Yang

  • Specific Donor/Recipient HLA Disparities are Associated with Better Long-Term Kidney Allograft Survival among 4-, 5-, and 6-HLA (A/B/DR)-Mismatched Pairs

    D. Bekbolsynov, H. Zhang, B. Mierzejewska, M. Rees, K. Xu, S. Stepkowski

  • Specific Reasons for Public Health Service (PHS) Increased Risk (IR) Designation Had Little Influence on Doctors’ Kidney Offer Acceptance Decisions in Controlled “Lab” Experiment

    D. Stewart1, J. Rosendale1, H. McGehee1, J. Schold2, J. Lindemans3, J. Kessler4, C. Sullivan4, K. Mekeel5, R. Stratta6, R. Formica7, D. Klassen1

  • Speckle Echo Pre and Post Kidney Transplant: A Pilot Study

    M. Olivares-Perez1, Y. Gao1, A. Webber1, F. Ghahghaie1, M. Lassen2, A. Qasim1, M. Park1

  • Sphingosine 1-Phosphate Receptors and CCR7 Sequentially Coordinate T Cell Migration

    Y. Xiong1, W. Piao1, C. Brinkman1, J. Kulinski2, A. Olivera2, A. Cartier3, T. Hla4, K. Hippen5, B. Blazar5, S. Schwab6, J. Bromberg1

  • Stabilization of Cell Junctions Ameliorates the Effects of Brain Death Induced Acute Lung Injury Post-Transplantation

    D. P. Allen1, Z. Tu1, C. Wallace1, C. Li1, J. Kilkenny1, K. J. Patel1, D. Nord2, S. N. Nadig1, C. Atkinson2

  • Stakeholder Perspectives in Peer Mentoring Program for Pediatric Solid Organ Transplant Recipients

    C. Strachan, M. Paton, J. Reason, S. Amaral

  • Standardized Pain Management Post Donor Nephrectomy Results in Decreased Length of Stay

    N. Alvey1, B. Hohoff2, M. Brokhof1, N. Kenyon1, E. Hollinger3

  • Steadily Dropping Malignancy Rates after Pediatric Kidney Transplantation Have Now Reversed in the Most Recent Era: A Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)

    V. Dharnidharka1, C. Cramer2, A. Chua3, A. Moudgil4, K. Martz5, T. Blydt-Hansen6, J. Smith7, A. Neu, on behalf of the NAPRTCS Investigators8

  • Store-Operated/Calcium Release Activated Calcium Channel Orai3 is a Novel Target for Immunoregulation

    D. Shankaranarayanan1, M. Lagman1, V. Sharma1, C. Li1, M. Cassidy1, C. Snopkowski1, H. Yang1, T. Muthukumar1, K. Machaca2, M. Suthanthiran1

  • Studying the Association of Melanocortin Receptor-4 Gene Polymorphism and Renal Transplant Rejection

    F. Yilmaz1, R. Abdi1, B. J. Keating2, V. R. Mas3

  • Subclinical Antibody Mediation Rejection in Stable Kidney Recipients with De Novo Donor Specific Antibodies and Correlation with Donor Derived Cell Free DNA Testing

    A. P. Bregman, E. J. Stites, J. Gralla, A. Wiseman, J. E. Cooper

  • Subclinical Rejection is Common on Surveillance Biopsies in Children with Kidney Transplant

    S. Gattis1, R. Liverman1, A. Serluco1, J. Yin1, J. Hogan2, S. Jernigan2, R. George2, P. D. Winterberg2, R. Garro2

  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.

    J. Arreola Guerra1, R. Reyes Acevedo2, A. Chew Wong1, F. Haro Alcalde1, L. Zuñiga Macias1, R. Delgadillo Castañeda2, R. Villafan3

  • Successful Kidney Transplant Improves Glucose Tolerance – A Paradoxical Report From A Single Center

    A. Mitsuke, H. Harada, H. Higuchi, N. Fukuzawa, H. Tanaka, T. Hirano, T. Sekii

  • Successful Kidney Transplantation in a Small Child with an Atretic Inferior Vena Cava

    J. A. Geha1, J. D. Geha1, M. Goss1, M. L. Kueht1, R. T. Cotton1, J. A. Goss1, A. Rana1, C. A. O'Mahony1, P. Srivaths2, E. Brewer2, N. N. Galvan1

  • Successful Repair of Kidney Graft Artery Rupture Secondary to Infection Using a Preprocessed Homologous ‘Y’-Shaped Iliac Artery

    G. Liu, X. Wang, J. Wu, W. Peng, R. Wang, H. Huang, J. Chen

  • Successful Use of Nonantigen Specific Immunoadsorption In ABO-Incompatible Desensitization and Humoral Rejection Treatment in Kidney Transplantation

    E. Montagud-Marrahi

  • Supercooling Preservation Prolonged Mouse Cardiac Graft Cold Ischemia Time

    W. Que1, X. Hu1, M. Fujino1, Y. Yamada2, L. Zhong3, X. Li1

  • Superiority of Donor-Specifically vs. Polyclonally Expanded Regulatory T Cells in Controlling Graft Rejection in the NSG Mouse Human Skin Graft Model

    J. H. Voss1, F. Zheng1, M. D. Jendrisak2, J. R. Leventhal1, Z. J. Zhang1, J. M. Mathew1

  • Surgical Outcome and Analysis of Risk of Complications in Kidney Donors Receiving Laparoscopic Live Donor Nephrectomy

    C. Yang, C. Yeh, C. Lee, C. Chen, I. Lai, P. Lee, M. Tsai

  • Surgical Site Complications in Kidney Transplant Recipients: Incidence and Outcomes in the Modern Era

    J. S. Kim

  • Synergistic Effect of HLA Eplet Mismatch Load and CMV Viremia on Clinical Antibody-Mediated Rejection in Lung Transplantation

    Y. Im1, S. Yeramaneni2, Y. Yim3, J. Dodderer4, M. Askar1, H. J. Huang5

  • Systematic Testing and Specificity Mapping of Alloantigen-Specific Chimeric Antigen Receptors in T Regulatory Cells

    C. Lamarche, N. Dawson, P. Bergqvist, R. Hoeppli, M. Mojibian, V. Feung, Q. Huang, J. Gillies, P. Orban, M. Levings

  • T Cell-Intrinsic Dysfunction in Donor-Specific Transplantation Tolerance

    C. M. McIntosh1, M. L. Miller2, Y. Wang1, A. Chong3, M. Alegre1

  • TCR Transgenes to Understand Human Xenotolerance Induction

    G. Nauman, C. Borsotti, N. Danzl, M. Khosravi-Maharlooei, H. Li, E. Chavez, Y. Yang, M. Sykes

  • TMA Development in Kidney and Heart Xenografts Treated with Anti-CD40 or Anti-CD154 Antibodies

    D. H. Ma1, H. Sasaki1, J. M. O1, K. Ahrens1, D. Becerra1, C. G. Rickert1, D. M. Detelich1, T. Oura1, W. Somer1, I. Rosales2, R. N. Pierson1, J. Markmann1, J. C. Madsen1, T. Kawai1

  • Tacrolimus Activated BMP Signaling Acts in Synergy with Stress-Activated FOXO1 to Induce Loss of Beta-Cell Function and Identity

    J. Trinañes1, P. ten Dijke2, T. J. Rabelink3, E. J. de Koning4, F. Carlotti1, A. P. de Vries1

  • Taking a Step toward Standardization: Results of an American Society of Transplant Surgeons/Association of Organ Procurement Organizations Survey of Donation after Circulatory Death Liver Recovery Practices

    M. Hobeika1, R. Glazner2, D. Foley1, S. Hanish1, C. Quintini1, E. Eidbo2, D. Axelrod1

  • Tandem Mass Tags Based Liquid Chromatography/ Mass Spectrometry Analysis of Quantitative Proteomic Changes in Renal Allograft Biopsies with Polyomavirus BK Nephropathy

    F. Fang, P. Liu, L. Song, Y. Zhao, G. Zeng, G. Tseng, K. Xiao, P. Randhawa

  • Targeted Epitope Mutagenesis as a Strategy to Decrease Xenoantibody Binding

    J. Ladowski, G. Martens, Z. Wang, L. Reyes, M. Tector, J. Tector

  • Targeting Pyroptosis in Brain-Dead Donors Improves Renal Function after Transplantation in Rat

    H. Yang1, Y. Shi2, X. Li1, L. Luo1, C. Long1, Y. Xiong3, M. Chen4, J. Gao4, H. Li5, Z. Wang5

  • Targeting Syk Signaling in Myeloid Cells Protects against Liver Fibrosis and Hepatocarcinogenesis

    A. Torres-Hernandez, W. Wang, G. Miller

  • Temporal Trends Following Uncontrolled Donation after Cardiac Death Kidney Transplantation: Implications for Normothermic Regional Perfusion?

    R. A. Choudhury, K. Prins, D. Yoeli, H. B. Moore, T. L. Nydam

  • The Adapter Protein TSAd Regulates Mitochondrial Lck Activity and is Potent to Enhance Immunoregulation Following Transplantation

    J. Wedel1, M. P. Stack1, T. Seto1, K. Liu1, I. E. Stillman2, D. M. Briscoe1

  • The Association Of Frailty With Risk Of Cytomegalovirus And BK Infection

    J. Norman1, A. Gupta2, A. Naik3, D. Cibrik2, S. Norman3

  • The Association of BK Virus Infection and Risk of Subsequent Cytomegalovirus Infection after Renal Transplant

    M. R. Jorgenson, J. L. Descourouez, B. Lyu, B. C. Astor, C. M. Saddler, S. Parajuli

  • The Association of Estimated Glomerular Filtration Rate at One Year Post-Kidney Transplant with Graft Loss is Not Modified by Delayed Graft Function

    J. Gill, M. Kadatz, J. Gill

  • The Association of Health Literacy with Physical and Mental Health-Related Quality of Life in Organ Transplant Candidates

    K. Chapin1, S. Rega1, L. Dageforde2, D. Moore1, M. Via1, I. D. Feurer1

  • The Association of Kidney Transplant Center Volume with 3-Year Outcomes

    E. M. Sonnenberg1, J. B. Cohen2, J. Y. Hsu3, V. S. Potluri2, M. H. Levine1, P. L. Abt1, P. P. Reese2

  • The C-Statistic Provides No Information on the Accuracy of Program Evaluations or the Presence of Unmeasured Confounders

    A. Wey, N. Salkowski, B. Kasiske, M. Skeans, S. Gustafson, A. Israni, J. Snyder

  • The Centennial Allograft? Observation Of Greater Than 100-year Allograft Survival Is More Common Among Liver Allograft Recipients Than Renal Allograft Recipients.

    J. F. Renz, A. C. Gruessner, R. C. Misawa, A. Masi, R. W. Gruessner

  • The Changing Paradigm of Ethics in Uterus Transplantation: A Systematic Review

    L. M. Ngaage1, S. Ike2, A. Elegbede3, S. Gebran4, C. J. Vercler5, F. Liang4, E. M. Rada1, C. Cooney3, R. J. Redett3, Y. M. Rasko1

  • The Clinical Outcomes of Kidney Transplant Recipients with Early Graft Failure: A Nationwide Study in South Korea

    Y. Kim1, S. Kwon1, S. Park1, J. Moon1, J. Seon1, J. Kim1, M. Yu2, K. Han3, D. Kim1, Y. Kim1, H. Lee1

  • The Comparison of Glycemic Profiles during Post-Operative Early Period between Liver and Kidney Transplantation Assessed by Continuous Glucose Monitoring System

    H. Yu1, H. Jin2, S. Lee2, J. Yang1, S. Park2, S. Ahn1, H. Hwang1

  • The Crucial Role of Molecular Microscope in the Interpretation of Ambiguous Lesions Such as Banff Borderline Changes and Tubulo-Interstitial Inflammation Accompanying PVAN

    D. Deborska-Materkowska1, A. Perkowska-Ptasinska1, M. Ciszek1, P. F. Halloran2, M. Myslak3

  • The Dry Weight Revealed!, What Transplanted Kidneys Teach Us about the (Dry Weight).

    M. Hamid1, S. Oyewolle-Eletu2, G. Gudleski2, K. Speta3, J. Kumar1, S. Chang1

  • The Effect Of Missed Hemodialysis Treatment Prior To Transplant

    A. Padiyar1, A. Agrawal1, D. Hricik1, N. Sarabu1, A. Jittirat1, K. Yadav2, E. Sanchez2, M. Debroy2, V. Humphreville2, J. Rabets2, A. Palanisamy2, K. Chavin2

  • The Effect of Intravenous Immunoglobulin on Human Complement-Dependent Cytotoxicity of Pig Cells: Benefit? Or Harm?

    T. Yamamoto1, Q. Li1, A. Banks1, H. Iwase1, D. Ayares2, D. K. Cooper1, H. Hara1

  • The Effect of the Beneficial Activity of α-Lipoic Acid Treatment Depend on the Quality of the Graft Kidneys

    F. Osella1, N. Ambrosi2, G. Werber1, F. Caro2, S. Beltramino1, I. Cabrera1, G. Hilchenbach1, L. Diaz Alvarez1, C. Incardona3, E. Chuluyan2, D. Casadei1

  • The Effects Of Simultaneously Training Additional Surgeons In The Living Donor Robotic Assisted Kidney Transplant

    J. D. Stracke, M. Safwan, L. Malinzak, A. Yoshida

  • The Effects of Chronic Kidney Disease on Antiviral T Cell Response

    R. L. Crepeau1, H. Li2, L. P. Daley-Bauer3, M. L. Ford1, P. D. Winterberg2

  • The Experience of Somatostatin to Prevent Small-for-Size Syndrome in Patients with Small Graft in Living Donor Liver Transplantation

    D. Kim, K. Yoon, H. Jo, W. Kang

  • The Feasibility Of Donation After Cardiac Death In Liver Transplantation: A Registry Analysis

    A. C. Gruessner, R. Misawa, A. Masi, Z. Moghadamyeghaneh, J. F. Renz, R. W. Gruessner

  • The First Human Organ Transported by Drone and Steps Forward to Large Scale Organ Drone Use in the USA

    J. R. Scalea1, M. Scassero2, N. Wereley3

  • The High Burden of Vaccine Preventable Infections Following Pediatric Solid Organ Transplant

    A. G. Feldman1, B. L. Beaty2, D. Curtis3, E. Juarez-Colunga2, A. Kempe4

  • The Immunomodulatory Role of Type I Interferons in Alloimmunity

    I. Sulkaj, H. Allos, S. K. Eskandari, J. M. Safadi, J. Y. Choi, B. S. Al Dulaijan, E. Al-Hussain, S. Cai, J. R. Azzi

  • The Impact Of Early Statin Use Following Lung Transplantation On The Development Of Bronchiolitis Obliterans Syndrome

    B. Lindner1, S. Strout1, P. Shah2

  • The Impact of Acute Rejection in Heart Transplantation on Post-Transplant Malignancy

    K. Kamrani1, A. Okoh2, D. Hanos1, M. Camacho1, M. Zucker2, K. Clarke1

  • The Impact of Changes in OPTN Oversight of Kidney Programs on Organ Yield and Offer Acceptance Practices

    A. Wey1, N. Salkowski1, B. Carrico2, S. Sheppard2, B. Kasiske1, B. Thompson1, A. Israni1, J. Snyder1

  • The Impact of Early Subtherapeutic Tacrolimus Troughs with Alemtuzumab Induction

    L. Bowman1, E. Yanqui1, C. Truong1, R. Baliga2, A. Brueckner1

  • The Impact of Race on Metabolic, Graft and Patient Outcomes after Pancreatic Transplantation

    V. S. Rohan, S. N. Nadig, J. Mcgillicuddy, V. Rao, D. Dubay, K. Soliman, P. Baliga, D. Taber

  • The Impact of Reduction of Warm Ischemia on DCD Kidney Transplantation Outcomes

    S. Aquil, D. Wonjoon, M. Levine, R. Al Ogaili, A. Sener, P. Luke

  • The Impact of Share 35 on Living Donor Liver Transplant Utilization in the United States: Analysis of UNOS Data

    H. J. Braun, J. L. Dodge, J. D. Grab, R. Hirose, P. G. Stock, N. L. Ascher

  • The Impact of Thrombin / Protease-Activated Receptor-1 Pathway in Hepatic Ischemia-Reperfusion Injury in Mice

    D. Noguchi, N. Kuriyama, T. Fujii, H. Kato, M. Kishiwada, S. Mizuno, M. Usui, H. Sakurai, S. Isaji

  • The Implications of Donor Proteinuria in Deceased Donor Kidney Transplantation

    A. Vinson, T. Keough-Ryan, K. West, K. Tennankore

  • The Importance of BMP4 Gene Defects in Renal Transplant Patients with CAKUT

    E. Baskin1, V. Sahin1, Y. Terzi2, K. Gulleroglu1, N. Uslu3, A. Akdur4, G. Moray4, F. Sahin2, M. Haberal4

  • The Important Roles of Dendritic Cells in Transplantation

    T. Ueno1, M. M. McGrath1, M. Y. Yeung1, S. Cai1, Y. Ueno1, T. Yokoyama2, Y. Kihara2, O. Konno2, Y. Nakamura2, H. Iwamoto2, A. K. Chandraker1

  • The Incidence of Fungal Infections in Pancreas Transplant Recipients in the Absence of Systemic Antifungal Prophylaxis

    S. Shaikh1, M. Cooper1, A. Nolan1, P. Abrams2

  • The Influential Yet Highly Variable Role of Biopsy Findings on Kidney Offer Acceptance Decisions: An Organ Offer Simulation Study

    D. Stewart1, J. Rosendale1, H. McGehee1, I. Hall2, G. Gupta3, K. Reddy4, B. Kasiske5, K. Andreoni6, D. Klassen1

  • The Interaction between Post-Transplant Anemia and Allograft Function in Kidney Transplantation

    Y. Kakuta1, M. Okumi1, T. Kanzawa1, K. Unagami2, H. Ishida2, K. Tanabe1

  • The Inverted Renal CD4/CD8 Ratio Associated with the Development of Transplant Glomerulopathy and Arteriosclerosis

    B. H. Ozdemir1, F. N. Ozdemir2, A. Ok Atılgan1, E. Akcay1, M. Haberal3

  • The Kidney Donor Profile Index (KDPI) Predicts the Risk of Graft Loss in Patients with a Kidney Transplant from Maastricht Type III Asystolic Donors

    V. Lopez Jimenez, C. Casas, P. Ruiz-Esteban, M. Cabello, E. Sola, P. Hidalgo, J. Alonso, M. González-Molina, D. Hernandez

  • The Medical Intensive Liver Unit: A Novel Multi-disciplinary Program For The Intensive Care Of Patients With Advanced Liver Disease

    C. C. Lindenmeyer1, G. Flocco1, A. Sobotka1, L. Kokoczka2, B. Dolan2, C. Strauser2, C. Romero-Marrero1, E. Mireles-Cabodevila2, H. Khouli2, C. Quintini3, A. Kapoor2

  • The Molecular Features of Chronic Lung Allograft Dysfunction (CLAD) in Transbronchial and Endobronchial Mucosa Biopsies

    M. D. Parkes1, K. M. Halloran1, J. Chang2, P. F. Halloran and the INTERLUNG study group1

  • The Molecular Pathology of Immune Checkpoint Inhibitor-Associated Renal Allograft Rejection: Overlap with Acute Interstitial Nephritis

    B. Adam1, C. Boils2, L. Bu3, K. Renaudin4, K. Wen1, M. Mengel1

  • The Molecular Profile of Kidney Allografts Unveil Specific Biomarkers for Subclinical Acute Rejection (SAR). Towards an Early Detection and a Targeted Treatment

    S. N. Cox, S. Chiurlia, F. P. Schena

  • The Natural History and Time to Seroconversion of CMV in the Era of Post-Transplantation Chemoprophylaxis: A Single Center Study

    S. Farran, T. Zangeneh, M. Al-Obaidi

  • The Need for Diabetic Medications after Pancreas Transplantation

    A. Bhansali, O. El Shamy, M. Menon, R. Shapiro, V. Delaney, G. De Boccardo

  • The Negative Costimulatory Pd-1/pd-l1 Pathway Is Upregulated In Early Cell-mediated Rejection

    T. Kurashige, R. Khedraki, K. Keslar, N. Dvorina, W. Baldwin

  • The Number of Donor-Specific IL-21 Producing Cells before and after Transplantation Predicts Kidney Graft Rejection

    N. M. van Besouw1, L. Yan1, R. de Kuiper1, M. Klepper1, D. Reijerkerk1, M. Dieterich1, D. L. Roelen2, F. H. Claas2, M. C. Clahsen-van Groningen3, D. A. Hesselink1, C. C. Baan1

  • The Outcomes of Living Donor Kidney Transplantation in Donors or Recipients with Donors’ Renal Arteriosclerotic Lesions on Preoperative Computed Tomography

    Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika

  • The Potential Role of IL-33/ST2 Pathway in Renal Allograft Rejection

    M. Yu1, Y. Kim2, J. Moon2, S. Lee2, H. Lee2, D. Kim2, C. Lee3, Y. Kim2, S. Yang2

  • The Power of Young Donor Liver; Elixir of Life for Sick Liver Transplant Recipient

    J. Kusakabe1, J. McVey2, D. J. Firl2, M. Fujiki2, F. N. Aucejo2, C. Quintini2, K. Hashimoto2, K. Sasaki2

  • The Predictive Value Of Pre-transplant Biopsies For Short-term And Long-term Graft Function In Kidney Transplantation

    H. Zhang1, L. Liu1, S. Yang2, W. Chen2, X. Chen1, Y. Li2, C. Wang1

  • The Pregnancy Experiences of Uterus Transplant Recipients

    A. E. Wall, L. Johannesson, G. Testa, A. Warren

  • The Rapidly Aging Population of Liver Transplant Patients with Hepatocellular Carcinoma

    J. B. Rubin, G. Cullaro, N. Mehta, J. C. Lai

  • The Reduced Tacrolimus Metabolism Rate and Its Association with Estimated Glomerular Filtration Rate and Interstitial Fibrosis: A Study Using Korean Organ Transplantation Registry (KOTRY) Dataset

    J. Jeong1, H. Ro2, T. Koo3, J. Yang3, M. Kim4, S. Shin5, J. Park6, T. Ban7, S. Han8, T. Kim9, C. Ahn10

  • The Response to Human Papillomavirus Vaccination in Pediatric Patients before and after Kidney Transplantation

    C. Nailescu1, R. D. Nelson2, K. Twombley3, P. S. Verghese4, A. S. Chishti5, M. Mills6, J. E. Slaven7, J. D. Mahan8, M. L. Shew1

  • The Role of Non-Traditional Environmental Factors in Long-Term Outcomes of Liver Transplantation

    J. Buggs1, D. Patino2, B. Evans1, C. Anderson1, C. Delfavero1, E. Rogers1, A. Alsina1, A. Kumar3

  • The Role of Recipient Weight in Renal Transplantation Revisited; Not Quite the Obesity Paradox

    A. Asderakis, R. Tahawar, T. Sabah, U. Khalid, M. Stephens

  • The Safety Of Adjuvant Chemotherapy In Kidney Transplant Patients With Urothelial Carcinoma

    Z. Wang, J. Xiao, Y. Zhu, J. Lin, Y. Guo, Y. Tian

  • The Significance and Impact of Screening Preservation Fluid Cultures in Renal Transplant Recipients

    A. Reticker, A. Lichvar, A. Gross, E. Benedetti, S. Patel

  • The Study on the DNA Methylation Dynamic Changes after Renal Transplantation

    C. Zhu, H. Jiang, J. Chen

  • The Therapeutic Potential of Ex Vivo Induced Monocytic Myeloid-Derived Suppressor Cells from Bone Marrow in a Mouse Cardiac Allotransplantation Model

    K. Uchida, K. Fujimoto, E. Yin, H. Bashuda, K. Okumura, K. Takeda

  • The Treatment of Hepatitis C Virus (HCV) with Direct Acting Antiviral (DAA) Treatment in the Post Orthotopic Liver Transplant (OLT) Patient is Safe and Efficacious

    P. Brown1, Z. Demertzis1, S. Jafri2

  • The Use Of First-year Intravascular Ultrasound In The Tacrolimus Era In Heart Transplantation

    S. Dimbil1, M. Kittleson1, J. Patel1, D. Geft1, R. Cheng1, R. Levine1, T. Sato1, L. Czer1, R. Zabner2, P. Zakowski2, J. A. Kobashigawa1, B. Azarbal1

  • The Use of Focus Groups to Explore the Public Attitudes on the Use of Imminent Death Donation

    P. Moolchandani1, R. Ackah2, L. Washburn1, D. O'Connor1, E. L. Godfrey1, T. Galván1, A. Rana1, J. A. Goss1

  • The Use of High Volume Perioperative Normal Saline Increases the Risk of Delayed Graft Function after Kidney Transplantation

    K. Kolodzie1, O. S. Cakmakkaya2, E. S. Boparai3, M. Tavakol4, J. Feiner1, C. U. Niemann5

  • The Use of Mobile Software for Real-Time, Secure, Team-Based Procurement and Transplantation Team Communication to Improve the Deceased Donor Organ Transplantation Process

    E. Pahl

  • The Utility Of Intraoperative Vascular Anastomotic Inflow Measurements In Donation After Circulatory Death (DCD) Liver Transplantation

    A. Nair, L. Coromina Hernandez, K. Sasaki, C. Kwon, T. Diago Uso, M. Fujiki, F. Aucejo, K. Hashimoto, B. Eghtesad, C. Miller, C. Quintini

  • The Utility of Donor and Recipient BK Virus Antibody Testing Prior to Renal Transplantation in Risk Assessment for Developing BK Viremia

    N. Donmez, S. I. Al-Akash

  • The Value of SCS Perfusate Biomarkers for Predicting DGF of DCD Donor Kidneys

    X. Li, W. Wang, X. Zhang

  • The lncRNA-mRNA Co-Expression Analysis in Acetaminophen-Induced Liver Injury

    J. Zheng, F. Xue

  • Thymoglobulin Efficacy: The Role of Dosing on Viral Infection and Rejection in Pancreas Transplantation

    H. Sarumi, B. Johnson, S. Jackson, S. Hogan, J. Fisher, S. Riad, R. Kandaswamy, T. Pruett

  • Thymoglobulin Induction with Tacrolimus and Everolimus Maintenance Therapy in Elderly Kidney Transplantation Results in Prolonged Lymphocyte Depletion and Do Not Favor Regulatory Profile

    E. David-Neto1, G. Ramos de Freitas1, M. Fernandes1, F. Agena1, F. Brambate Carvalhinho Lemos1, F. Jota de Paula1, V. Coelho2, N. Zocoler Galante1

  • Thymoglobulin Versus Alemtuzumab Induction in High Immunologic Risk Kidney Transplants

    J. Lockridge1, J. Pryor1, D. Norman1, A. Olyaei2

  • Tibetans and Hans Have Comparable Transplant Outcomes- A Propensity Score Matched Cohort Analysis

    T. Lin, Y. Jiang, T. Song, Y. Fan

  • Time to First Therapeutic Tacrolimus Trough in Kidney Transplant Recipients: A Comparison of a Weight Based versus a Non-Weight Based Dosing Strategy

    M. Chunduru, K. Schnelle, S. Zhao, L. Wei, R. Daloul

  • Timeline for Resuming Physical Activities after Renal Transplantation: A Mid West Pediatric Nephrology Consortium Study

    P. Baddi1, H. Patel2, H. Janjua3, D. Y. Kim4, A. Jain5

  • Timing Matters: Improving Prediction of Hospital Readmission Post Kidney Transplantation

    J. Hogan1, M. Arenson1, S. Adhikary2, K. Li1, X. Zhang1, R. Zhang1, J. Valdez3, J. Sun3, A. B. Adams1, R. E. Patzer1

  • Timing, Duration, and Source of Hepatitis C Virus (HCV) Antibodies (Ab) among HCV-Negative Recipients of an Organ from an HCV-Infected Donor

    P. Porrett1, P. Reese1, E. Blumberg1, P. Abt1, R. Bloom1, K. Reddy1, V. Holzmayer2, K. Coller2, M. Kuhns2, G. Cloherty2, D. Goldberg1

  • Tolerance to ABO A-Antigen Following Treatment of Infant Mice with A-Expressing MHC-Identical Erythrocytes

    B. Motyka1, J. Fersovich1, M. Sulzer1, I. Adam1, J. Pearcey1, K. Tao1, C. W. Cairo2, P. J. Cowan3, L. J. West1

  • Torque Teno Virus is a Prognostic Biomarker for Acute Biopsy-Proven Alloreactivity in Kidney Transplants

    K. Doberer

  • Totally Robotic Donor Hepatectomy: Feasibility And Early Outcomes

    Y. Cheah, C. J. Simon, W. D. Lewis, R. L. Jenkins, M. E. Akoad

  • Towards 3D-Bioprinting of Bionic Pancreas: Effect of Pressure on the Viability of Pancreatic Islets

    M. Klak, K. Kosowska, E. Majdanska, T. Dobrzanski, A. Berman, L. Kaczynski, P. Kowalska, M. Gomolka, M. Wszola

  • Towards Human Leukocyte Antigen Immunogenicity Assessment at the Individual Patient Level

    H. Copley1, H. McDowell2, D. Pinelli2, A. R. Tambur2, V. Kosmoliaptsis1

  • Tracheostomy Following Liver Transplantation

    J. Almario, O. Okoye, M. Spaggiari, K. Jacob, P. Di Cocco, E. Benedetti, I. Tzvetanov

  • Transfer of Healthy Mitochondria in Established Ischemic Injury Reduces Progression to Interstitial Fibrosis and Tubular Atrophy

    A. Bajwa1, V. Bontha1, D. Maluf1, J. Eason2, V. Mas3

  • Transition from Pediatric to Adult Care of Kidney Transplant Recipients: A Retrospective Analysis of a French Monocentric Cohort

    M. Mazloum1, M. Charbit2, O. Aubert1, D. Anglicheau1, A. Scemla1, R. Salomon2, P. Krug2, C. Legendre1, R. Sberro-Soussan1

  • Transplant Outcomes of DCD Kidneys Recovered with vs. without Pre-Recovery Heparin Administration

    J. Narvaez, L. Kayler

  • Transplant Provider Adherence to Cardiovascular Disease Primary Prevention Guidelines in Liver Transplant Recipients

    M. Kosirog1, P. T. Campbell1, S. Montag2, S. Connolly1, A. Daud3, A. Das1, S. Pine1, D. Finn3, J. Levitsky1, J. L. Holl4, D. M. Lloyd-Jones5, L. B. VanWagner6

  • Transplant Regimen Adherence For Kidney Recipients By Engaging Information Technologies: The Take It Trial

    D. P. Ladner1, M. S. Wolf2

  • Transplantation Alone Induces Myeloid-Derived Suppressor Cells Which Can Suppress T Cell Responses

    Y. Lee, T. Zhang, J. S. Bromberg, J. R. Scalea

  • Transplantation of Hepatitis C Virus Positive Donor Kidneys into Hepatitis C Negative Older Recipients

    J. A. Graham1, M. Ajaimy2, J. Torabi1, T. Powell3, J. Weiss4, T. Weinstein5, S. Greenstein1, O. Andacoglu1, A. Campbell6, J. Carrero1, J. Lapponese1, M. Kinkhabwala1, E. Akalin2, J. P. Rocca1

  • Transport Medium Fluid Cultures in Paediatric Renal Transplantation: Are We Ready to Make a Consensus on Prophylaxis?

    D. Furnell1, S. Boyle1, N. Kessaris2, S. D. Marks1, J. Stojanovic1

  • Treatment of Cardiovascular Risk Factors Improves Long Term Outcome Post Liver Transplantation

    S. Alghamdi, O. Altayar, T. Zhu, A. Bayudan, J. Fleckenstein, M. Lisker-Melman, J. Crippin, A. Flores

  • Treatment of Latent Tuberculosis Infection with Short-Course Regimens in Potential Living Kidney Donors

    J. Simkins, C. Donato-Santana, M. I. Morris, L. M. Abbo, J. F. Camargo, S. Anjan, Y. Natori, G. Guerra

  • Treg Lymphotoxin and Lymphatic Endothelial Cell Lymphotoxin Receptor Interactions Are Required for Treg Stability and Allograft Protection

    V. Saxena, W. Piao, L. Li, C. M. Palusckievicz, Y. Xiong, T. Simon, J. S. Bromberg

  • Trends in Utilization of Deceased Donor Kidneys Based on Donor Hep C Antibody and Nucleic Acid Status

    V. Ariyamuthu1, R. M. LaHoz1, N. AbdulRahim1, S. Levea1, M. MacConmara2, C. Hwang2, B. Sandikci3, B. Tanriover1

  • Treprostinil Attenuates Renal Ischemia-Reperfusion Injury in Rat

    M. Ding1, E. Tolbert2, M. Birkenbach3, C. Chung4, R. Gohh5, F. Akhlaghi1, N. Ghonem1

  • Treprostinil as a Bridge Therapy to Heart-Lung Transplants with Severe Pulmonary Arterial Hypertension

    C. Ju, Q. Lian, B. Wei, X. Xu, J. He, R. Chen

  • Tumor Necrosis as a Result to Pre-Transplant Bridging Treatment for Hepatocellular Carcinoma and Its Effect on Post-Transplant Outcome

    S. Radunz1, A. Kirschner1, J. M. Theysohn2, C. Schotten3, T. Benkö1

  • Twin Epidemics: Drug Overdoses And Suicides Are Increasingly Fueling The United States Donor Liver Supply

    M. Goss1, M. Kueht1, N. Galvan1, J. Reece2, A. Rana1

  • Two-Year, Single Center, Retrospective Review of Herbal Supplement Use in Living Kidney Donors

    N. Persun1, D. Johnson1, A. Leonberg-Yoo2, J. Bahrainwala2, P. P. Reese2, D. M. Collins3, M. Houston3, A. Naji4, J. Trofe-Clark1

  • Type of Induction Does Not Impact Patient or Kidney Allograft Survival in Simultaneous Liver and Kidney Transplant Recipients in the United States

    S. Riad1, N. Lim2, S. Jackson3, J. Lake2

  • Unfair Waiting Time Calculation? Impact of Accumulated Wait Time Restart with a Decrease in Status from 1A to 1B or 2 on Mortality of Heart Transplant Candidates

    S. Yu, M. Kosztowski, M. Waldram, D. L. Segev, A. B. Massie

  • Unfavorable Donor after Cardiac Death Characteristics in Lung Transplantation: An Analysis of the UNOS Registry

    A. Y. Choi1, O. K. Jawitz2, V. Raman2, Y. Barac2, M. S. Mulvihill2, C. Moore2, M. G. Hartwig2

  • Unhinged or Unselfish: A Deep Dive into Non-Directed Donors

    J. Verbesey1, M. Williams2, S. Ghasemian1, A. Bacigalupo1, A. Gilbert1, G. Vranic1, B. Javaid1, M. Cooper1, A. Marsh2

  • Unplanned Pregnancies after Liver Transplant Are Associated with Adverse Pregnancy Outcomes

    M. Sarkar1, L. A. Coscia2, D. Kliniewski2, S. Rao3, S. Constantinescu4, M. J. Moritz5

  • Unsuccessful Resuscitative Thoracotomy Patients Are Potential Kidney Donors

    K. Prins1, H. B. Moore1, A. Sauaia1, R. Choudhury1, R. C. McIntyre1, A. Cralley2, S. Urban1, E. E. Moore2, E. A. Pomfret1, T. L. Nydam1

  • Unusual Suspects: Real Time Physiological Evaluation of Stressors during Laparoscopic Donor Nephrectomy

    C. A. Wilson1, S. Chahine1, S. Cristancho1, S. Aquil2, M. Mandurah2, M. A. Levine2, A. Sener2

  • Urinary Extracellular Vesicles-Related Protein Biomarkers for the Non-Invasive Monitoring of Rejection in Kidney Transplanted Patients

    L. Carreras-Planella1, I. Bancu2, D. Cucchiari3, L. Cañas2, J. Juega2, M. Franquesa1, M. Perez-Mir2, I. Revuelta3, F. Diekman4, R. Lauzurica2, F. Borràs1

  • Urinary Microtubule-Associated Protein Light Chain3 and Neutrophil Gelatinase-Associated Lipocalin, as Potential Noninvasive Biomarkers for Subclinical Rejection at 3 Months after Kidney Transplantation

    S. Tajima1, R. Fu2, M. Fukuda2, K. Suetsugu2, Y. Okabe3, S. Masuda1

  • Urinary Podocin mRNA as Predictor of Renal Allograft Function Decline

    A. Naik1, J. Aqeel1, D. Cibrik2, M. Samaniego3, L. Wickman1, S. Wang1, M. Chowdhury1, R. Wiggins1

  • Urine Recirculation Maintains Hemodynamics and Enhances Function in Normothermic Kidney Perfusion

    A. Weissenbacher1, C. D. Ceresa2, D. Voyce3, J. Hunter2, R. Ploeg2, C. C. Coussios4, P. Friend2

  • Use of Anti-Vimentin Antibodies as a Possible Marker for Graft Dysfunction Following Renal Transplant, a Prospective Study

    E. Acosta1, T. Divanyan1, D. Patel1, F. Jourd'heuil2, D. Jourd'heuil2, R. Lopez-Soler3

  • Use of Belatacept in Pancreas Transplantation

    P. D. Uva, A. Quevedo, J. Roses, R. Pilotti, E. Chuluyan, D. Casadei

  • Use of Eculizumab for Active Antibody-Mediated Rejection That Occurs Early Post-Kidney Transplantation: A Consecutive Series of 15 Cases

    E. Tan1, B. J. Andrew2, P. G. Dean2, M. F. Shaheen1, M. D. Stegall2, C. A. Schinstock2

  • Use of GLP-1 Receptor Agonists in Kidney Transplant Recipients with Type 2 Diabetes

    A. Kukla, J. Hill, M. Merzkani, A. Bentall, E. Lorenz, W. Park, P. Shah, N. Issa, M. Stegall

  • Use of Opioids and NSAIDs in Living Kidney Donors: Clinical Correlates and Early Outcomes

    K. Lentine1, L. Vest1, Z. Zhang1, F. Koraishy1, M. Schnitzler1, A. Garg2, D. Axelrod3, B. Kasiske4, G. Hess5, A. Naik6, D. Segev7, M. Henderson7, A. Massie7, N. Lamm8

  • Use of TruGraf Serial Testing for Confirming Stability in Kidney Transplant Patients with Stable Renal Function

    V. Peddi1, C. Schieve2, S. Rose2, M. First2

  • Use of an Ideal Body Weight-Based Rabbit Anti-Thymocyte Globulin Dosing Protocol in Kidney Transplant Recipients to Decrease Cost and Maintain Outcomes at a Large Academic Medical Center

    L. J. Myhre1, R. J. Bubik1, K. T. Peterson1, H. A. Personett1, S. A. Crow1, P. G. Dean2

  • Use, Safety and Effectiveness of Hepatitis B Virus NAT-Positive Donor Livers in the Current Era

    T. C. Lee, K. Safdar, L. K. Winer, M. C. Morris, A. Kassam, K. Luckett, R. Quillin III, K. Bari, N. Anwar, S. A. Shah

  • Usefulness of the Assessment of CT-Based Donor Kidney Function Compared with Radionuclide Scintigraphy

    K. Park, J. Yoon, H. Kim, C. Baek, S. Park, H. Kim

  • Using a Massive Open Online Course on Clinical Kidney, Prancreas and Islet Transplantion in Different Settings of Transplant Education

    P. G. De Jong1, R. A. Hendriks1, F. Luk2, M. E. Reinders2

  • Utility of Gallium-67 Single Photon Emission Computed Tomography in the Evaluation of Left Ventricular Assist Device Infections

    F. Parkar1, A. Tlamsa2, J. Nistico2, V. A. Muggia2, G. Y. Minamoto2, U. Jorde3, D. J. Goldstein3, R. Moadel1, Y. A. Puius2

  • Utility of Protocol Ultrasound Surveillance in Liver Transplantation

    N. Kemmer1, W. McClellan2, D. Patino3, E. Rogers1, A. Kumar2, J. Buggs1

  • Utility of a Novel dd-cfDNA Test to Detect Injury in Renal Post-Transplant Patients

    J. Peabody1, P. Billings2, Z. Demko2, D. Paculdo1, M. Tran1, S. Moshkevich2, C. Valdenor1

  • Utilization of Hepatitis C Donors is Safe and Cost Effective

    J. Shaw, D. Reino, N. Kapila, K. Al Khalloufi, S. Ebaid, S. Rhazouani, X. Zervos, J. Vanatta, N. Agrawal

  • Utilization of LCP-Tacrolimus (ENVARSUS XR) in Simultaneous Pancreas and Kidney (SPK) Transplant Recipients

    J. Torabi, A. Campbell, E. Akalin, M. Ajaimy, Y. Azzi, C. Pynadath, L. Liriano-Ward, J. P. Rocca, J. A. Graham

  • Utilization of Small Pediatric Donor Kidneys to Improve Access to Kidney Transplantation for Underappreciated Uremic Children in China

    X. Su1, W. Shang2, L. Liu1, Y. Feng2, H. Zhang1, J. Li1, Q. Fu1, X. Pang2, G. Feng2, C. Wang1

  • Variable Glycosylations of Anti-HLA Antibodies Detected with Single Antigen Beads in Kidney Transplant Recipients

    Y. Chang1, N. Lemp2, J. Cicciarelli1, T. Shah3, D. Min4

  • Variable Outcomes of Recurrent Autoimmune Diabetes Post Pancreas Transplant Treated with Rituximab

    K. Venkatachalam, A. Markwardt, B. Heady, T. Alhamad, A. Malone

  • Variables Associated with Intracardiac Thrombus during Orthotopic Liver Transplant: A Retrospective Single-Center Study

    M. Groose1, J. Mezrich2, L. Hammel1

  • Variation in Living Donor Kidney Transplantation and the Impact of Medicaid Expansion

    T. A. Melanson1, S. Pastan2, R. Patzer1

  • Variations in Recipient and Donor Clinical Characteristics between Kidney Transplant Centers

    W. T. McKinney1, M. Bruin2, S. Chu2, D. Schladt3, J. Snyder3, A. Matas4, B. Kasiske5, A. K. Israni3

  • Viability Testing and Transplantation of Marginal Donor Livers (VITTAL) Trial Outcomes: Proteomic Analysis of Perfusates from Livers Undergoing Normothermic Machine Liver Perfusion Reveals Biomarkers Predictive of Graft Viability and Post-Transplant Complications

    S. Afford1, L. Wallace1, J. Attard1, Y. Boteon1, R. Laing1, J. Yu2, T. Perera3, D. Mirza4, H. Mergental5

  • Vimentin Inhibition Improves Post-Transplant Survival in a Mouse Renal Transplant Model

    R. Lopez-Soler1, Z. Zhang2, H. Chin3, J. Wang4, K. Ridge5

  • Viral Enteritis in Intestinal Transplant Recipients

    A. Servais, M. Vacha, D. F. Florescu, M. Keck

  • Waitlisted for Lung Transplant and the Role of Patient Travel Distance: A National Cohort Study

    W. Tsuang, S. Arrigain, R. Lopez, M. Snair, K. McCurry, M. Budev, J. Schold

  • What Are Factors That Can Influence The High Immunological Graft Loss Rate In Young Pancreas Transplant Recipients

    A. C. Gruessner, J. Renz, S. Saggi, R. W. Gruessner

  • What Do We Not Know about Long Term Liver Transplant Patients? A Look at Side Effect Burden and Medication Adherence

    K. Foster1, C. Perez1, T. Harrison1, H. Corbo1, N. Patel1, D. Taber1, H. Meadows1, J. Fleming1, D. DuBay2, J. McGillicuddy2, N. Pilch1

  • What is the Post-Heart Transplant Risk of Infectious Complications from Pre-Transplant Desensitization Therapy?

    E. Kransdorf, J. Patel, S. Dimbil, R. Levine, D. H. Chang, J. A. Kobashigawa

  • When to Hold: Apixaban in Renal Transplant Recipients

    V. H. Do1, D. Haakinson2, K. D. Belfield1

  • When to Transplant for Wilson’s Disease: A Review

    M. Flanagan, S. Koohmaraie, M. Kueht, R. Cotton, C. O'Mahony, A. Rana, J. Goss, N. Galvan

  • Whole Body CT Imaging in Deceased Donor Screening

    J. W. Mensink1, R. A. Pol.2, W. N. Nijboer1, J. de Jonge3, K. M. Ooms - de Vries4, M. F. van der Jagt5, M. C. van de Poll6, I. P. Alwayn1, A. E. Braat1

  • Willingness to Acquire Donor-Derived Hepatitis C Infection May Reduce Waitlist Mortality for Heart Transplant Candidates

    B. E. Lonze, A. Reyentovich, N. Moazami, D. E. Smith, C. Gidea, R. A. Montgomery

  • Xenorejection of Porcine Islets in Humanized Mice is Dominated by a Human Th17 Cytokine Immune Response

    F. T. Lee1, A. Dangi2, M. Burnette2, B. Hering3, X. Luo2

  • Yellow Fever and Renal Transplantation: Influence of Vaccination and Infection on the Emergence of Antibody-Mediated Rejection

    M. V. Sousa1, R. L. Zollner2, R. S. Stucchi3, I. F. Boin4, E. C. Ataide4, M. Mazzali1

  • mTOR Inhibitors Associated with Higher Cardiovascular Adverse Events – A Large Population Database Analysis

    V. N. Nguyen1, R. Abagyan2, S. Tsunoda2

  • mTOR Inhibitors Enhance Antitumor Activity of Liver Resident NK Cells

    J. Saparbay, Y. Tanaka, A. Seidakhmetov, H. Ohdan

  • miRNA Signatures as Prediction Tool for DSA Development and Rejection

    M. Hamdorf1, L. M. Rebellato2, K. P. Briley2, M. J. Everly1

  • simplifyKDPI: An Animated Video to Educate Kidney Transplant Candidates about the Kidney Donor Profile Index

    K. Bonner, R. Seibert, L. Kayler

  • ­Pediatric Heart and Lung Graft Loss during the “High-Risk Age Window”

    J. Long1, J. Motter1, K. R. Jackson1, M. Kosztowski1, B. Orandi2, X. Luo1, K. Van Arendonk3, A. Massie1, E. Bush1, R. S. Higgins1, D. L. Segev1, J. M. Garonzik-Wang1

  • α -1,3-galactosyltransferase Knockout Porcine Tissue And Organ May Reduce The Risks Of Antibody Mediated Rejection Via Less Rhesus Igm Cross-reactivity.

    J. Yoon, B. Ezekian, M. Manook, J. Kwun, S. Knechtle

  • “Desens Light”: Single Center Experience Using Rituximab for High Immunologic Risk Kidney Transplant Recipients with Historic DSA

    A. Casillas-Abundis, A. Tambur, A. Shetty, C. D'Agostino, J. R. Leventhal

  • “What I Wish I Would Have Known….” Patient Impressions of Transplant Education

    K. Collins1, A. Yaldo1, E. Rubinstein1, K. Kippen2, H. Olden2, S. Nagai1, M. Abouljoud1

  • Exogenous Erythropoietin Administration Promotes Murine Cardiac Allograft Survival via a Myeloid Cell-Dependent Mechanism

    J. Horwitz, P. Cravedi, P. Heeger

  • Pediatric Liver Retransplantation: Prognostic Scoring Tool

    A. Kuhne, D. Vock, J. Back, K. Ramanathan, A. Matas, S. Chinnakotla

  • Role of Innate Allorecognition Pathways in Mouse Renal Allograft Rejection

    D. Zhao1, H. Dai1, K. Abou-Daya1, A. Williams1, M. Oberbarnscheidt1, X. Li2, F. Lakkis1

  • Three-Year Outcomes of Highly-Sensitized Kidney Transplant Recipients Desensitized with Imlifidase (IdeS)

    E. Huang1, J. Choi1, A. Vo1, A. Peng1, R. Najjar1, S. Sethi1, C. Kjellman2, L. Winstedt2, N. Ammerman1, S. C. Jordan1

  • Central Role of Graft Resident Memory T Cells in Pathogenesis of GVHD after Bowel Transplantation

    J. Weiner, N. Svetlicky, J. Schmidt, S. Moturi, O. Aguirre, J. Kang, M. Sadat, K. Khan, J. Hawksworth, C. Matsumoto, T. Fishbein, A. Kroemer

  • Fifteen Year Outcomes in the Astellas Double Blind Randomized Controlled Trial (RCT) Comparing Early Corticosteroid Withdrawal (CSWD) and Long-Term Corticosteroid Therapy Continuation (CCS) in Kidney Transplantation

    E. Woodle1, S. Clark2, D. Stewart3, M. First4, R. Alloway5, J. Gill6, .. Split Rock Group7

  • Lymphotoxin Beta Receptor in Lymphatic Endothelial Cells Regulates Treg Migration and Allograft Protection

    V. Saxena, W. Piao, L. Li, C. M. Paluskievicz, Y. Xiong, T. Simon, J. S. Bromberg

  • Oxygenated Hypothermic Machine Perfusion of Kidneys Donated after Circulatory Death: An International Randomised Controlled Trial

    I. Jochmans1, H. S. Hofker2, L. Davies3, S. Knight3, J. Pirenne1, R. J. Ploeg3, -. on behalf of COPE and participating centres4

  • ABO Incompatibility in Kidney Transplantation Can Increase a Safety Margin of Epitope Mismatch Levels against De Novo DSA Production

    T. Kobayashi1, K. Iwasaki1, M. Okada2, K. Horimi1, Y. Matsuoka1, A. Takeda2, N. Goto2, S. Narumi2, Y. Watarai2

  • Actions Speak Louder Than Labs – The Impact of Dialysis Compliance on Posttransplant Outcomes

    D. Sawinski1, H. Lindner2, J. Schults3, J. Locke4, P. Reese1

  • Butyrate-Producing Gut Bacteria and Future Development of Viral Infections in Kidney Transplant Recipients

    J. Lee1, J. Huang1, M. Magruder1, L. Zhang1, M. Lubetzky1, D. Dadhania1, E. Edusei1, E. Pamer2, M. Suthanthiran1

  • Discovery and Validation of an Early Post-Transplant Biomarker Model Predictive of Chronic Kidney Disease in Liver Transplant Recipients

    J. Levitsky1, S. Asrani2, G. Klintmalm2, T. Schiano2, A. Moss3, K. Chavin4, C. Miller5, L. Zhao6, K. Guo6, N. Bridges7, J. Odim7, M. Brown7, D. Ikle8, B. Armstrong8, M. Abecassis9

  • Alloreactive B Cells in Transplant Tolerant Recipients Cannot Differentiate into Antibody-Secreting Cells but Can Suppress Donor-Specific IgG Production By Naïve B Cells

    S. H. Khiew1, J. Chen1, D. Jain1, Q. Wang1, D. Yin1, M. Alegre2, A. S. Chong1

  • Bcl-2 Inhibition with Venetoclax Promotes Induction of Mixed Chimerism and Renal Allograft Tolerance without Severe Myelosuppression in Non-Human Primate

    H. Sasaki1, D. Ma1, T. Oura1, A. Dehnadi1, I. Rosales2, B. Cosimi1, P. Cippa3, T. Fehr3, T. Kawai1

  • Long Term Renal Function Following Islet Transplantation in the Clinical Islet Transplantation Consortium

    L. G. Hunsicker1, T. L. Eggerman2, M. R. Rickels3, t. Clinical Islet Transplantation (CIT) Consortium4

  • Intact Lymphatics Are Essential for Costimulation Blockade-Induced Lung Allograft Survival

    L. Wang1, H. Reed2, R. Han1, M. Kahn2, W. W. Hancock1

« View all sessions from the 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences